kwr-20211231
false --12-31 1 30000000 P7Y P1Y P2Y P3Y P5Y P3Y FY 0000081362 3 2024-08-01 5 2028 0000081362 2021-01-01 2021-12-31 0000081362 2021-06-30 0000081362 2020-12-31 0000081362 2019-12-31 0000081362 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0000081362 srt:MinimumMember us-gaap:RestrictedStockMember 2020-01-01 2020-12-31 0000081362 srt:MinimumMember us-gaap:StockCompensationPlanMember 2020-01-01 2020-12-31 0000081362 srt:MaximumMember us-gaap:StockCompensationPlanMember 2020-01-01 2020-12-31 0000081362 srt:MaximumMember us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-12-31 0000081362 2020-01-01 2020-12-31 0000081362 us-gaap:RestrictedStockMember 2020-12-31 0000081362 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0000081362 2019-01-01 2019-12-31 0000081362 2018-12-31 0000081362 kwr:InsuranceContractMember us-gaap:FairValueInputsLevel3Member 2020-01-01 2020-12-31 0000081362 us-gaap:FairValueInputsLevel3Member kwr:RealEstateFundMember 2020-01-01 2020-12-31 0000081362 us-gaap:FairValueInputsLevel3Member 2020-01-01 2020-12-31 0000081362 us-gaap:FairValueInputsLevel2Member 2020-12-31 0000081362 us-gaap:FairValueInputsLevel3Member 2020-12-31 0000081362 us-gaap:FairValueInputsLevel1Member 2020-12-31 0000081362 kwr:StockOptionsCompensationExpenseMember 2020-01-01 2020-12-31 0000081362 kwr:StockOptionsCompensationExpenseMember 2019-01-01 2019-12-31 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2020-01-01 2020-12-31 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2019-01-01 2019-12-31 0000081362 kwr:EmployeeStockPurchasePlanCompensationExpenseMember 2020-01-01 2020-12-31 0000081362 kwr:EmployeeStockPurchasePlanCompensationExpenseMember 2019-01-01 2019-12-31 0000081362 kwr:MatchingStockContribution401KPlanCompensationExpenseMember 2020-01-01 2020-12-31 0000081362 kwr:MatchingStockContribution401KPlanCompensationExpenseMember 2019-01-01 2019-12-31 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2020-01-01 2020-12-31 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2019-01-01 2019-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-01-01 2020-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-12-31 0000081362 us-gaap:CustomerListsMember 2020-12-31 0000081362 us-gaap:OtherIntangibleAssetsMember 2020-12-31 0000081362 2021-12-31 0000081362 kwr:StockOptionsCompensationExpenseCYMember 2020-01-01 2020-12-31 0000081362 kwr:StockOptionsCompensationExpensePY1Member 2020-01-01 2020-12-31 0000081362 kwr:StockOptionsCompensationExpensePY2Member 2020-01-01 2020-12-31 0000081362 kwr:StockOptionsCompensationExpensePY3Member 2020-01-01 2020-12-31 0000081362 kwr:StockOptionsCompensationExpenseCYMember 2019-01-01 2019-12-31 0000081362 kwr:StockOptionsCompensationExpensePY1Member 2019-01-01 2019-12-31 0000081362 kwr:StockOptionsCompensationExpensePY2Member 2019-01-01 2019-12-31 0000081362 kwr:StockOptionsCompensationExpensePY3Member 2019-01-01 2019-12-31 0000081362 us-gaap:RestrictedStockMember 2021-12-31 0000081362 us-gaap:RestrictedStockMember 2021-01-01 2021-12-31 0000081362 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0000081362 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0000081362 kwr:TrademarksFormulationsandproducttechnologymemberMember 2020-12-31 0000081362 us-gaap:CustomerListsMember 2021-12-31 0000081362 kwr:TrademarksFormulationsandproducttechnologymemberMember 2021-12-31 0000081362 us-gaap:OtherIntangibleAssetsMember 2021-12-31 0000081362 us-gaap:FairValueInputsLevel1Member 2021-12-31 0000081362 us-gaap:FairValueInputsLevel2Member 2021-12-31 0000081362 us-gaap:FairValueInputsLevel3Member 2021-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-12-31 0000081362 kwr:ShareRepurchaseProgramMember 2015-12-31 0000081362 srt:AsiaPacificMember kwr:EquityMethodInvesteeNameNipponQuakerJapanMember 2021-12-31 0000081362 kwr:ExercisePriceRange3Member 2021-12-31 0000081362 kwr:ExercisePriceRange4Member 2021-12-31 0000081362 kwr:ExercisePriceRange6Member 2021-12-31 0000081362 kwr:ExercisePriceRange7Member 2021-12-31 0000081362 kwr:ExercisePriceRange3Member 2021-01-01 2021-12-31 0000081362 kwr:ExercisePriceRange4Member 2021-01-01 2021-12-31 0000081362 kwr:ExercisePriceRange6Member 2021-01-01 2021-12-31 0000081362 kwr:ExercisePriceRange7Member 2021-01-01 2021-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-12-31 0000081362 kwr:RealEstateFundMember us-gaap:FairValueInputsLevel3Member 2020-12-31 0000081362 kwr:InsuranceContractMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0000081362 kwr:RealEstateFundMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0000081362 kwr:InsuranceContractMember us-gaap:FairValueInputsLevel3Member 2019-12-31 0000081362 kwr:InsuranceContractMember us-gaap:FairValueInputsLevel3Member 2020-12-31 0000081362 2022-01-31 0000081362 us-gaap:InterestRateSwapMember 2020-01-01 2020-12-31 0000081362 us-gaap:InterestExpenseMember 2020-01-01 2020-12-31 0000081362 us-gaap:InterestExpenseMember 2019-01-01 2019-12-31 0000081362 srt:MaximumMember us-gaap:LandMember 2021-12-31 0000081362 us-gaap:EMEAMember us-gaap:ProductMember 2020-01-01 2020-12-31 0000081362 us-gaap:ProductMember srt:AsiaPacificMember 2020-01-01 2020-12-31 0000081362 us-gaap:EMEAMember us-gaap:ProductMember 2019-01-01 2019-12-31 0000081362 us-gaap:ProductMember srt:AsiaPacificMember 2019-01-01 2019-12-31 0000081362 kwr:CombinationAndOtherAcquisitionRelatedMember 2020-01-01 2020-12-31 0000081362 srt:AsiaPacificMember kwr:EquityMethodInvesteeNameHoughtonKoreaMember 2021-12-31 0000081362 us-gaap:ForeignCountryMember 2021-12-31 0000081362 kwr:CombinationAndNormanHayMember 2021-12-31 0000081362 kwr:KoreaHoughtonCoporationMember 2020-12-31 0000081362 kwr:KoreaHoughtonCoporationMember 2021-12-31 0000081362 kwr:ExpirationInYearFiveMember 2021-01-01 2021-12-31 0000081362 kwr:ExpirationintwentyyearsmemberMember 2021-01-01 2021-12-31 0000081362 us-gaap:LineOfCreditMember 2021-12-31 0000081362 us-gaap:DomesticLineOfCreditMember 2021-12-31 0000081362 us-gaap:ForeignLineOfCreditMember 2021-12-31 0000081362 kwr:IndustrialDevelopmentBondsMember 2021-12-31 0000081362 kwr:IndustrialDevelopmentBondsMember 2020-12-31 0000081362 us-gaap:LineOfCreditMember 2020-12-31 0000081362 us-gaap:RevolvingCreditFacilityMember 2019-08-01 0000081362 us-gaap:DomesticLineOfCreditMember 2019-08-01 0000081362 us-gaap:ForeignLineOfCreditMember 2019-08-01 0000081362 kwr:HoughtonMember 2019-01-01 2019-12-31 0000081362 kwr:QhProgramMember 2020-01-01 2020-12-31 0000081362 kwr:QhProgramMember 2021-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember us-gaap:EquitySecuritiesMember 2021-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember us-gaap:DebtSecuritiesMember 2021-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember us-gaap:EquitySecuritiesMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember us-gaap:DebtSecuritiesMember 2020-12-31 0000081362 kwr:RealEstateFundMember us-gaap:FairValueInputsLevel3Member 2019-12-31 0000081362 us-gaap:FairValueInputsLevel3Member 2019-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember us-gaap:OtherLiabilitiesMember kwr:ClevelandBakersAndTeamstersPensionFundMember 2020-01-01 2020-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember kwr:ClevelandBakersAndTeamstersPensionFundMember 2020-01-01 0000081362 us-gaap:PensionPlansDefinedBenefitMember kwr:ClevelandBakersAndTeamstersPensionFundMember 2020-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember kwr:ClevelandBakersAndTeamstersPensionFundMember 2021-01-01 2021-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember kwr:ClevelandBakersAndTeamstersPensionFundMember 2021-12-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-12-31 0000081362 us-gaap:InterestRateSwapMember kwr:OtherLiabilitiesCurrentMember 2019-11-30 0000081362 us-gaap:PensionPlansDefinedBenefitMember country:US 2020-01-01 2020-12-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember country:US 2020-01-01 2020-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember country:US 2021-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember country:US 2020-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember us-gaap:EquitySecuritiesMember country:US 2021-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember us-gaap:DebtSecuritiesMember country:US 2021-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember us-gaap:EquitySecuritiesMember country:US 2020-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember us-gaap:DebtSecuritiesMember country:US 2020-12-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember country:US 2021-12-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember country:US 2020-12-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember country:US 2019-01-01 2019-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember country:US 2019-01-01 2019-12-31 0000081362 country:US us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2020-01-01 2020-12-31 0000081362 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0000081362 country:US us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2019-01-01 2019-12-31 0000081362 srt:AmericasMember 2020-01-01 2020-12-31 0000081362 us-gaap:EMEAMember 2020-01-01 2020-12-31 0000081362 srt:AsiaPacificMember 2020-01-01 2020-12-31 0000081362 srt:AmericasMember 2019-01-01 2019-12-31 0000081362 us-gaap:EMEAMember 2019-01-01 2019-12-31 0000081362 srt:AsiaPacificMember 2019-01-01 2019-12-31 0000081362 srt:AmericasMember 2021-12-31 0000081362 us-gaap:EMEAMember 2021-12-31 0000081362 srt:AsiaPacificMember 2021-12-31 0000081362 srt:AmericasMember 2020-12-31 0000081362 us-gaap:EMEAMember 2020-12-31 0000081362 srt:AsiaPacificMember 2020-12-31 0000081362 srt:AmericasMember 2019-12-31 0000081362 us-gaap:EMEAMember 2019-12-31 0000081362 srt:AsiaPacificMember 2019-12-31 0000081362 us-gaap:NonUsMember 2021-12-31 0000081362 us-gaap:NonUsMember 2020-12-31 0000081362 srt:MaximumMember 2021-12-31 0000081362 srt:AmericasMember kwr:EquityMethodInvesteeNameKelkoPanamaMember 2021-12-31 0000081362 srt:AmericasMember kwr:EquityMethodInvesteeNamePrimexMember 2021-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember country:US kwr:OtherMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember kwr:OtherMember 2020-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember country:US kwr:OtherMember 2021-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember kwr:OtherMember 2021-12-31 0000081362 us-gaap:FairValueInputsLevel3Member kwr:OtherAlternativeInvestmentsMember 2019-12-31 0000081362 us-gaap:FairValueInputsLevel3Member kwr:OtherAlternativeInvestmentsMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel3Member kwr:OtherAlternativeInvestmentsMember 2021-12-31 0000081362 us-gaap:FairValueInputsLevel3Member kwr:OtherAlternativeInvestmentsMember 2020-01-01 2020-12-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-12-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-12-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-12-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-12-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-01-01 2020-12-31 0000081362 kwr:KoreaHoughtonCoporationMember 2020-01-01 2020-12-31 0000081362 kwr:EquityMethodInvesteeNameNipponQuakerJapanMember 2020-01-01 2020-12-31 0000081362 kwr:EquityMethodInvesteeNameKelkoPanamaMember 2020-01-01 2020-12-31 0000081362 kwr:EquityMethodInvesteeNameGrindaixMember 2020-01-01 2020-12-31 0000081362 kwr:EquityMethodInvesteeNamePrimexMember 2020-01-01 2020-12-31 0000081362 kwr:KoreaHoughtonCoporationMember 2019-01-01 2019-12-31 0000081362 kwr:EquityMethodInvesteeNameNipponQuakerJapanMember 2019-01-01 2019-12-31 0000081362 kwr:EquityMethodInvesteeNameKelkoPanamaMember 2019-01-01 2019-12-31 0000081362 kwr:EquityMethodInvesteeNameGrindaixMember 2019-01-01 2019-12-31 0000081362 kwr:EquityMethodInvesteeNamePrimexMember 2019-01-01 2019-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-12-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-01-01 2021-12-31 0000081362 srt:AmericasMember kwr:MetalsMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000081362 kwr:MetalsMember us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2020-01-01 2020-12-31 0000081362 kwr:MetalsMember us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2020-01-01 2020-12-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2020-01-01 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember kwr:MetalworkingMember 2020-01-01 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember kwr:MetalworkingMember 2020-01-01 2020-12-31 0000081362 us-gaap:ProductMember srt:AmericasMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000081362 us-gaap:ProductMember us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2020-01-01 2020-12-31 0000081362 us-gaap:ProductMember us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2020-01-01 2020-12-31 0000081362 us-gaap:ProductMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000081362 kwr:MetalsMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2020-01-01 2020-12-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-12-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2020-01-01 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2020-01-01 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-12-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember us-gaap:TransferredOverTimeMember 2020-01-01 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember us-gaap:TransferredOverTimeMember 2020-01-01 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember us-gaap:TransferredOverTimeMember 2020-01-01 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:TransferredOverTimeMember 2020-01-01 2020-12-31 0000081362 srt:AmericasMember kwr:MetalsMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0000081362 kwr:MetalsMember us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2019-01-01 2019-12-31 0000081362 kwr:MetalsMember us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2019-01-01 2019-12-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2019-01-01 2019-12-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember kwr:MetalworkingMember 2019-01-01 2019-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember kwr:MetalworkingMember 2019-01-01 2019-12-31 0000081362 kwr:MetalsMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2019-01-01 2019-12-31 0000081362 us-gaap:ProductMember srt:AmericasMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0000081362 us-gaap:ProductMember us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2019-01-01 2019-12-31 0000081362 us-gaap:ProductMember us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2019-01-01 2019-12-31 0000081362 us-gaap:ProductMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2019-01-01 2019-12-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember kwr:GlobalSpecialtyBusinessesMember 2019-01-01 2019-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember kwr:GlobalSpecialtyBusinessesMember 2019-01-01 2019-12-31 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2019-01-01 2019-12-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2019-01-01 2019-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2019-01-01 2019-12-31 0000081362 us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember us-gaap:TransferredAtPointInTimeMember 2019-01-01 2019-12-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember 2019-01-01 2019-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember 2019-01-01 2019-12-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember us-gaap:TransferredOverTimeMember 2019-01-01 2019-12-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember us-gaap:TransferredOverTimeMember 2019-01-01 2019-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember us-gaap:TransferredOverTimeMember 2019-01-01 2019-12-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:TransferredAtPointInTimeMember 2019-01-01 2019-12-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:TransferredOverTimeMember 2019-01-01 2019-12-31 0000081362 kwr:QhProgramMember 2019-12-31 0000081362 kwr:QhProgramMember 2020-12-31 0000081362 2018-01-01 2018-12-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember 2019-12-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2019-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2019-12-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2020-12-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember 2021-12-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2021-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2021-12-31 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2019-12-31 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2021-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-12-31 0000081362 kwr:RealEstateFundMember country:US us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2021-12-31 0000081362 kwr:RealEstateFundMember country:US us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0000081362 kwr:RealEstateFundMember country:US us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0000081362 kwr:RealEstateFundMember country:US us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0000081362 country:US us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2021-12-31 0000081362 country:US us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0000081362 country:US us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0000081362 country:US us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0000081362 kwr:RealEstateFundMember country:US us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2020-12-31 0000081362 kwr:RealEstateFundMember country:US us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2020-12-31 0000081362 kwr:RealEstateFundMember country:US us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2020-12-31 0000081362 kwr:RealEstateFundMember country:US us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2020-12-31 0000081362 country:US us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2020-12-31 0000081362 country:US us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2020-12-31 0000081362 country:US us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2020-12-31 0000081362 country:US us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2021-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0000081362 kwr:InsuranceContractMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2021-12-31 0000081362 kwr:InsuranceContractMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0000081362 kwr:InsuranceContractMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0000081362 kwr:InsuranceContractMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member kwr:EquityFundsDiversifiedMember 2021-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member kwr:EquityFundsDiversifiedMember 2021-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member kwr:EquityFundsDiversifiedMember 2021-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member kwr:EquityFundsDiversifiedMember 2021-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member us-gaap:FixedIncomeFundsMember 2021-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:FixedIncomeFundsMember 2021-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:FixedIncomeFundsMember 2021-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:FixedIncomeFundsMember 2021-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member kwr:DomesticAndForeignGovernmentDebtSecuritiesMember 2021-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member kwr:DomesticAndForeignGovernmentDebtSecuritiesMember 2021-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member kwr:DomesticAndForeignGovernmentDebtSecuritiesMember 2021-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member kwr:DomesticAndForeignGovernmentDebtSecuritiesMember 2021-12-31 0000081362 kwr:RealEstateFundMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2021-12-31 0000081362 kwr:RealEstateFundMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0000081362 kwr:RealEstateFundMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0000081362 kwr:RealEstateFundMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0000081362 us-gaap:ForeignPlanMember kwr:OtherAlternativeInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2021-12-31 0000081362 us-gaap:ForeignPlanMember kwr:OtherAlternativeInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0000081362 us-gaap:ForeignPlanMember kwr:OtherAlternativeInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0000081362 us-gaap:ForeignPlanMember kwr:OtherAlternativeInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2021-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2020-12-31 0000081362 kwr:InsuranceContractMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2020-12-31 0000081362 kwr:InsuranceContractMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2020-12-31 0000081362 kwr:InsuranceContractMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2020-12-31 0000081362 kwr:InsuranceContractMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member kwr:EquityFundsDiversifiedMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member kwr:EquityFundsDiversifiedMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member kwr:EquityFundsDiversifiedMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member kwr:EquityFundsDiversifiedMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member us-gaap:FixedIncomeFundsMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:FixedIncomeFundsMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:FixedIncomeFundsMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:FixedIncomeFundsMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member kwr:DomesticAndForeignGovernmentDebtSecuritiesMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member kwr:DomesticAndForeignGovernmentDebtSecuritiesMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member kwr:DomesticAndForeignGovernmentDebtSecuritiesMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member kwr:DomesticAndForeignGovernmentDebtSecuritiesMember 2020-12-31 0000081362 kwr:RealEstateFundMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2020-12-31 0000081362 kwr:RealEstateFundMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2020-12-31 0000081362 kwr:RealEstateFundMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2020-12-31 0000081362 kwr:RealEstateFundMember us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2020-12-31 0000081362 us-gaap:ForeignPlanMember kwr:OtherAlternativeInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2020-12-31 0000081362 us-gaap:ForeignPlanMember kwr:OtherAlternativeInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2020-12-31 0000081362 us-gaap:ForeignPlanMember kwr:OtherAlternativeInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2020-12-31 0000081362 us-gaap:ForeignPlanMember kwr:OtherAlternativeInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2020-12-31 0000081362 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2021-12-31 0000081362 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0000081362 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0000081362 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0000081362 us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0000081362 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member 2020-12-31 0000081362 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2020-12-31 0000081362 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2020-12-31 0000081362 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2020-12-31 0000081362 us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 kwr:CoralChemicalCompanyMember 2020-12-22 2020-12-22 0000081362 kwr:GlobalSpecialtyBusinessesMember 2019-01-01 2019-12-31 0000081362 kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-12-31 0000081362 kwr:GlobalSpecialtyBusinessesMember 2019-12-31 0000081362 kwr:GlobalSpecialtyBusinessesMember 2020-12-31 0000081362 kwr:GlobalSpecialtyBusinessesMember 2021-12-31 0000081362 kwr:DefinedContributionPlanMember 2021-01-01 2021-12-31 0000081362 kwr:PerformanceIncentiveStockUnitsMember 2020-01-01 2020-12-31 0000081362 kwr:PerformanceIncentiveStockUnitsMember 2019-01-01 2019-12-31 0000081362 kwr:CombinationAndOtherAcquisitionRelatedMember 2019-01-01 2019-12-31 0000081362 us-gaap:ForeignPlanMember 2020-01-01 2020-12-31 0000081362 us-gaap:ForeignPlanMember 2021-01-01 2021-12-31 0000081362 country:US 2020-01-01 2020-12-31 0000081362 us-gaap:ForeignPlanMember 2021-12-31 0000081362 country:US 2021-12-31 0000081362 country:US 2020-12-31 0000081362 us-gaap:ForeignPlanMember 2020-12-31 0000081362 country:US 2019-12-31 0000081362 us-gaap:ForeignPlanMember 2019-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-01-01 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-12-31 0000081362 kwr:HoughtonMember 2021-01-01 2021-12-31 0000081362 us-gaap:CorporateBondSecuritiesMember 2021-12-31 0000081362 us-gaap:CorporateBondSecuritiesMember 2021-01-01 2021-12-31 0000081362 us-gaap:ForeignCountryMember country:BR 2021-01-01 2021-12-31 0000081362 us-gaap:ForeignCountryMember country:MX 2021-01-01 2021-12-31 0000081362 us-gaap:ForeignCountryMember country:NL 2021-01-01 2021-12-31 0000081362 us-gaap:ForeignCountryMember country:CN 2021-01-01 2021-12-31 0000081362 us-gaap:ForeignCountryMember country:GB 2021-01-01 2021-12-31 0000081362 us-gaap:ForeignCountryMember country:IN 2021-01-01 2021-12-31 0000081362 us-gaap:StateAndLocalJurisdictionMember 2021-01-01 2021-12-31 0000081362 us-gaap:LineOfCreditMember 2021-01-01 2021-12-31 0000081362 us-gaap:RevolvingCreditFacilityMember 2021-12-31 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2021-12-31 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2020-12-31 0000081362 kwr:ShareRepurchaseProgramMember 2021-12-31 0000081362 us-gaap:RevolvingCreditFacilityMember us-gaap:LetterOfCreditMember 2021-12-31 0000081362 us-gaap:LineOfCreditMember us-gaap:LetterOfCreditMember 2021-12-31 0000081362 kwr:CombinationMember 2019-01-01 2019-12-31 0000081362 srt:MaximumMember kwr:AcpMember 2021-12-31 0000081362 srt:MinimumMember kwr:AcpMember 2021-12-31 0000081362 srt:MaximumMember kwr:AsbestosClaimsMember 2021-12-31 0000081362 2007-01-01 2007-12-31 0000081362 srt:MaximumMember kwr:HoughtonEnvironmentalMattersMember 2021-12-31 0000081362 srt:MinimumMember kwr:HoughtonEnvironmentalMattersMember 2021-12-31 0000081362 kwr:HoughtonEnvironmentalMattersMember 2021-12-31 0000081362 kwr:HoughtonEnvironmentalMattersMember 2020-12-31 0000081362 srt:MinimumMember 2021-01-01 2021-12-31 0000081362 srt:MaximumMember 2021-01-01 2021-12-31 0000081362 country:US us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000081362 country:US us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0000081362 us-gaap:DomesticLineOfCreditMember 2020-12-31 0000081362 us-gaap:ForeignLineOfCreditMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-01-01 2021-12-31 0000081362 us-gaap:DefinedBenefitPlanEquitySecuritiesMember kwr:CommingledFundsMember 2021-12-31 0000081362 kwr:CommingledFundsMember us-gaap:FixedIncomeSecuritiesMember 2021-12-31 0000081362 kwr:CommingledFundsMember us-gaap:OtherDebtSecuritiesMember 2021-12-31 0000081362 us-gaap:OtherDebtSecuritiesMember kwr:DiversifiedInvestmentFundRegisteredInvestmentCompaniesMember 2021-12-31 0000081362 us-gaap:FixedIncomeSecuritiesMember kwr:DiversifiedInvestmentFundRegisteredInvestmentCompaniesMember 2021-12-31 0000081362 us-gaap:DefinedBenefitPlanEquitySecuritiesMember kwr:DiversifiedInvestmentFundRegisteredInvestmentCompaniesMember 2021-12-31 0000081362 srt:MinimumMember us-gaap:BuildingAndBuildingImprovementsMember 2021-01-01 2021-12-31 0000081362 srt:MaximumMember us-gaap:BuildingAndBuildingImprovementsMember 2021-01-01 2021-12-31 0000081362 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2021-01-01 2021-12-31 0000081362 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2021-01-01 2021-12-31 0000081362 srt:MinimumMember us-gaap:SoftwareDevelopmentMember 2021-01-01 2021-12-31 0000081362 srt:MaximumMember us-gaap:SoftwareDevelopmentMember 2021-01-01 2021-12-31 0000081362 us-gaap:SoftwareDevelopmentMember 2021-12-31 0000081362 us-gaap:SoftwareDevelopmentMember 2020-12-31 0000081362 kwr:BaronIndustriesMember 2021-11-01 2021-11-30 0000081362 kwr:GrindaixMember 2021-09-01 2021-09-30 0000081362 kwr:GrindaixMember 2021-02-28 0000081362 kwr:GrindaixMember 2021-02-01 2021-02-28 0000081362 kwr:AssetsForChemicalMaskantsMember 2021-06-01 2021-06-30 0000081362 kwr:TinPlatingSolutionsBusinessMember 2021-02-01 2021-02-28 0000081362 kwr:TinPlatingSolutionsBusinessMember 2021-02-28 0000081362 us-gaap:CustomerRelationshipsMember kwr:TinPlatingSolutionsBusinessMember 2021-02-28 0000081362 us-gaap:CustomerRelationshipsMember kwr:TinPlatingSolutionsBusinessMember 2021-02-01 2021-02-28 0000081362 kwr:ProductTechnologyMember kwr:TinPlatingSolutionsBusinessMember 2021-02-28 0000081362 kwr:ProductTechnologyMember kwr:TinPlatingSolutionsBusinessMember 2021-02-01 2021-02-28 0000081362 us-gaap:TrademarksMember kwr:TinPlatingSolutionsBusinessMember 2021-02-28 0000081362 us-gaap:TrademarksMember kwr:TinPlatingSolutionsBusinessMember 2021-02-01 2021-02-28 0000081362 kwr:AssetsFrom3SMhendislikAsMember 2021-11-01 2021-11-30 0000081362 kwr:CoralChemicalCompanyMember 2020-01-01 2020-12-31 0000081362 srt:ScenarioPreviouslyReportedMember kwr:CoralChemicalCompanyMember 2020-12-22 0000081362 srt:RestatementAdjustmentMember kwr:CoralChemicalCompanyMember 2020-12-22 0000081362 kwr:CoralChemicalCompanyMember 2020-12-22 0000081362 srt:ScenarioPreviouslyReportedMember kwr:CoralChemicalCompanyMember 2020-12-22 2020-12-22 0000081362 srt:RestatementAdjustmentMember kwr:CoralChemicalCompanyMember 2020-12-22 2020-12-22 0000081362 kwr:CoralChemicalCompanyMember 2021-01-01 2021-12-31 0000081362 kwr:TelnordicMember 2020-05-01 2020-05-31 0000081362 kwr:TelnordicMember 2020-04-01 2020-06-30 0000081362 kwr:TelnordicMember 2020-05-31 0000081362 kwr:SouthAfricaEquityAffiliateMember 2020-12-31 0000081362 kwr:SouthAfricaEquityAffiliateMember 2020-03-01 2020-03-31 0000081362 kwr:NormanHayMember 2019-10-01 2019-10-31 0000081362 kwr:NormanHayMember 2020-01-01 2020-03-31 0000081362 us-gaap:EMEAMember us-gaap:ProductMember 2021-01-01 2021-12-31 0000081362 us-gaap:ProductMember srt:AsiaPacificMember 2021-01-01 2021-12-31 0000081362 srt:AmericasMember 2021-01-01 2021-12-31 0000081362 us-gaap:EMEAMember 2021-01-01 2021-12-31 0000081362 srt:AsiaPacificMember 2021-01-01 2021-12-31 0000081362 kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-12-31 0000081362 us-gaap:NonUsMember 2021-01-01 2021-12-31 0000081362 us-gaap:NonUsMember 2020-01-01 2020-12-31 0000081362 us-gaap:NonUsMember 2019-01-01 2019-12-31 0000081362 srt:AmericasMember us-gaap:IntersegmentEliminationMember 2021-01-01 2021-12-31 0000081362 srt:AmericasMember us-gaap:IntersegmentEliminationMember 2020-01-01 2020-12-31 0000081362 srt:AmericasMember us-gaap:IntersegmentEliminationMember 2019-01-01 2019-12-31 0000081362 us-gaap:EMEAMember us-gaap:IntersegmentEliminationMember 2021-01-01 2021-12-31 0000081362 us-gaap:EMEAMember us-gaap:IntersegmentEliminationMember 2020-01-01 2020-12-31 0000081362 us-gaap:EMEAMember us-gaap:IntersegmentEliminationMember 2019-01-01 2019-12-31 0000081362 srt:AsiaPacificMember us-gaap:IntersegmentEliminationMember 2021-01-01 2021-12-31 0000081362 srt:AsiaPacificMember us-gaap:IntersegmentEliminationMember 2020-01-01 2020-12-31 0000081362 srt:AsiaPacificMember us-gaap:IntersegmentEliminationMember 2019-01-01 2019-12-31 0000081362 us-gaap:IntersegmentEliminationMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-12-31 0000081362 us-gaap:IntersegmentEliminationMember kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-12-31 0000081362 us-gaap:IntersegmentEliminationMember kwr:GlobalSpecialtyBusinessesMember 2019-01-01 2019-12-31 0000081362 us-gaap:NonUsMember 2019-12-31 0000081362 srt:AmericasMember kwr:MetalsMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-12-31 0000081362 kwr:MetalsMember us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2021-01-01 2021-12-31 0000081362 kwr:MetalsMember us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2021-01-01 2021-12-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2021-01-01 2021-12-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember kwr:MetalworkingMember 2021-01-01 2021-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember kwr:MetalworkingMember 2021-01-01 2021-12-31 0000081362 us-gaap:ProductMember srt:AmericasMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-12-31 0000081362 us-gaap:ProductMember us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2021-01-01 2021-12-31 0000081362 us-gaap:ProductMember us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2021-01-01 2021-12-31 0000081362 us-gaap:ProductMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-12-31 0000081362 kwr:MetalsMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-12-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2021-01-01 2021-12-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-12-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-12-31 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-12-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-12-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2021-01-01 2021-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2021-01-01 2021-12-31 0000081362 us-gaap:OperatingSegmentsMember 2021-01-01 2021-12-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-12-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-12-31 0000081362 srt:AmericasMember us-gaap:OperatingSegmentsMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-12-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-12-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-12-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-12-31 0000081362 kwr:QhProgramMember 2021-01-01 2021-12-31 0000081362 kwr:StockOptionsCompensationExpenseMember 2021-01-01 2021-12-31 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2021-01-01 2021-12-31 0000081362 kwr:EmployeeStockPurchasePlanCompensationExpenseMember 2021-01-01 2021-12-31 0000081362 kwr:MatchingStockContribution401KPlanCompensationExpenseMember 2021-01-01 2021-12-31 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2021-01-01 2021-12-31 0000081362 kwr:PerformanceIncentiveStockUnitsMember 2021-01-01 2021-12-31 0000081362 kwr:CombinationAndOtherAcquisitionRelatedMember 2021-01-01 2021-12-31 0000081362 kwr:StockOptionsCompensationExpenseCYMember 2021-01-01 2021-12-31 0000081362 kwr:StockOptionsCompensationExpensePY1Member 2021-01-01 2021-12-31 0000081362 kwr:StockOptionsCompensationExpensePY2Member 2021-01-01 2021-12-31 0000081362 kwr:StockOptionsCompensationExpensePY3Member 2021-01-01 2021-12-31 0000081362 kwr:KoreaHoughtonCoporationMember 2021-01-01 2021-12-31 0000081362 kwr:EquityMethodInvesteeNameNipponQuakerJapanMember 2021-01-01 2021-12-31 0000081362 kwr:EquityMethodInvesteeNameKelkoPanamaMember 2021-01-01 2021-12-31 0000081362 kwr:EquityMethodInvesteeNameGrindaixMember 2021-01-01 2021-12-31 0000081362 kwr:EquityMethodInvesteeNamePrimexMember 2021-01-01 2021-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-01-01 2021-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-01-01 2021-12-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-01-01 2021-12-31 0000081362 us-gaap:InterestRateSwapMember 2021-01-01 2021-12-31 0000081362 us-gaap:InterestExpenseMember 2021-01-01 2021-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-12-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember country:US 2021-01-01 2021-12-31 0000081362 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember kwr:MetalremovalfluidsLineMember 2021-01-01 2021-12-31 0000081362 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember kwr:MetalremovalfluidsLineMember 2020-01-01 2020-12-31 0000081362 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember kwr:MetalremovalfluidsLineMember 2019-01-01 2019-12-31 0000081362 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember kwr:RollingLubricantsProductLineMember 2021-01-01 2021-12-31 0000081362 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember kwr:RollingLubricantsProductLineMember 2020-01-01 2020-12-31 0000081362 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember kwr:RollingLubricantsProductLineMember 2019-01-01 2019-12-31 0000081362 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember kwr:HydraulicFluidsProductLineMember 2021-01-01 2021-12-31 0000081362 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember kwr:HydraulicFluidsProductLineMember 2020-01-01 2020-12-31 0000081362 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember kwr:HydraulicFluidsProductLineMember 2019-01-01 2019-12-31 0000081362 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember kwr:CustomerConcentrationRiskTopFiveMember 2021-01-01 2021-12-31 0000081362 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember kwr:LargestCustomerMember 2021-01-01 2021-12-31 0000081362 kwr:ExercisePriceRange8Member 2021-12-31 0000081362 kwr:ExercisePriceRange8Member 2021-01-01 2021-12-31 0000081362 us-gaap:EmployeeStockOptionMember 2021-12-31 0000081362 us-gaap:EmployeeStockOptionMember 2020-12-31 0000081362 us-gaap:EmployeeStockOptionMember 2019-12-31 0000081362 kwr:StockOptionsCompensationExpensePYMember 2021-01-01 2021-12-31 0000081362 kwr:StockOptionsCompensationExpensePYMember 2020-01-01 2020-12-31 0000081362 kwr:StockOptionsCompensationExpensePYMember 2019-01-01 2019-12-31 0000081362 kwr:PerformanceIncentiveStockUnitsMember 2021-12-31 0000081362 kwr:PerformanceIncentiveStockUnitsMember 2020-12-31 0000081362 kwr:PerformanceIncentiveStockUnitsMember 2019-12-31 0000081362 kwr:DefinedContributionPlanMember 2020-01-01 2020-12-31 0000081362 us-gaap:ForeignCountryMember kwr:NetherlandsAndSpainMember 2021-01-01 2021-12-31 0000081362 us-gaap:ForeignCountryMember kwr:HoughtonMember country:IT 2021-12-31 0000081362 us-gaap:ForeignCountryMember kwr:HoughtonMember country:DE 2021-12-31 0000081362 kwr:EquityMethodInvesteeNameGrindaixMember 2021-02-28 0000081362 srt:AmericasMember kwr:EquityMethodInvesteeNameKelkoVenezuelaMember 2021-12-31 0000081362 country:US 2021-01-01 2021-12-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember country:US 2021-01-01 2021-12-31 0000081362 kwr:ForeignTaxAuthorityNonIncomeIndirectTaxMember 2021-07-01 2021-09-30 0000081362 us-gaap:InsuranceClaimsMember 2021-09-30 0000081362 us-gaap:InsuranceClaimsMember 2021-01-01 2021-12-31 0000081362 kwr:BrazilianIndirectTaxesMember 2021-04-01 2021-06-30 0000081362 us-gaap:InterestRateSwapMember kwr:OtherAccruedLiaiblitiesMember 2021-01-01 2021-12-31 0000081362 us-gaap:InterestRateSwapMember kwr:OtherAccruedLiaiblitiesMember 2020-01-01 2020-12-31 0000081362 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember 2021-01-01 2021-12-31 0000081362 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember 2020-01-01 2020-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-12-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-12-31 0000081362 country:US us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000081362 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember kwr:CommingledFundsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember 2020-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember kwr:DiversifiedInvestmentFundRegisteredInvestmentCompaniesMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember 2020-12-31 0000081362 country:US us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member kwr:PooledSeparateAccountsMember 2021-12-31 0000081362 us-gaap:FairValueInputsLevel1Member country:US us-gaap:FairValueMeasurementsRecurringMember kwr:PooledSeparateAccountsMember 2021-12-31 0000081362 us-gaap:FairValueInputsLevel2Member country:US us-gaap:FairValueMeasurementsRecurringMember kwr:PooledSeparateAccountsMember 2021-12-31 0000081362 us-gaap:FairValueInputsLevel3Member country:US us-gaap:FairValueMeasurementsRecurringMember kwr:PooledSeparateAccountsMember 2021-12-31 0000081362 country:US us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember kwr:CommingledFundsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember 2021-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember kwr:DiversifiedInvestmentFundRegisteredInvestmentCompaniesMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember 2021-12-31 0000081362 us-gaap:ForeignPlanMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0000081362 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember 2021-12-31 0000081362 srt:MaximumMember us-gaap:LineOfCreditMember 2021-12-31 0000081362 srt:MinimumMember us-gaap:LineOfCreditMember 2021-12-31 0000081362 srt:MinimumMember kwr:TermLoanMember 2021-12-31 0000081362 us-gaap:DefinedBenefitPlanEquitySecuritiesMember kwr:PooledSeparateAccountsMember 2021-12-31 0000081362 us-gaap:FixedIncomeSecuritiesMember kwr:PooledSeparateAccountsMember 2021-12-31 0000081362 kwr:InsuranceContractMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-12-31 0000081362 us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-12-31 0000081362 us-gaap:FairValueInputsLevel3Member kwr:RealEstateFundMember 2021-01-01 2021-12-31 0000081362 us-gaap:FairValueInputsLevel3Member kwr:OtherAlternativeInvestmentsMember 2021-01-01 2021-12-31 0000081362 country:US us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2021-01-01 2021-12-31 0000081362 srt:SubsidiariesMember 2021-12-31 0000081362 srt:SubsidiariesMember 2021-01-01 2021-12-31 0000081362 srt:SubsidiariesMember 2020-01-01 2020-12-31 0000081362 srt:SubsidiariesMember 2019-01-01 2019-12-31 0000081362 srt:MaximumMember kwr:BaronIndustriesMember 2021-11-30 0000081362 kwr:BaronIndustriesMember 2021-11-30 0000081362 us-gaap:CustomerRelationshipsMember kwr:BaronIndustriesMember 2021-11-30 0000081362 kwr:ProductTechnologyMember kwr:BaronIndustriesMember 2021-11-30 0000081362 us-gaap:CustomerRelationshipsMember kwr:BaronIndustriesMember 2021-11-01 2021-11-30 0000081362 kwr:ProductTechnologyMember kwr:BaronIndustriesMember 2021-11-01 2021-11-30 0000081362 kwr:GrindaixMember 2021-09-30 0000081362 us-gaap:SubsequentEventMember kwr:AssetsRelatedToSealingAndImpregnationOfMetalCastingsMember 2022-01-01 2022-01-31 0000081362 us-gaap:SubsequentEventMember kwr:AssetsRelatedToPicklingInhibitorTechnologiesMember 2022-01-01 2022-01-31 0000081362 us-gaap:RestrictedStockMember 2020-01-01 2020-12-31 0000081362 us-gaap:RestrictedStockMember 2019-01-01 2019-12-31 0000081362 us-gaap:RestrictedStockMember 2018-01-01 2018-12-31 0000081362 kwr:TermLoanMember 2021-01-01 2021-12-31 0000081362 kwr:ShareRepurchaseProgramMember 2021-01-01 2021-12-31 0000081362 kwr:ShareRepurchaseProgramMember 2020-01-01 2020-12-31 0000081362 kwr:ShareRepurchaseProgramMember 2019-01-01 2019-12-31 0000081362 kwr:AsbestosClaimsMember 2005-01-01 2005-12-31 0000081362 kwr:AsbestosClaimsMember 2007-01-01 2007-12-31 0000081362 kwr:AsbestosClaimsMember 2021-12-31 0000081362 kwr:AsbestosClaimsMember 2020-12-31 0000081362 srt:SubsidiariesMember us-gaap:AssetsTotalMember us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-12-31 0000081362 srt:SubsidiariesMember us-gaap:GeographicConcentrationRiskMember us-gaap:SalesRevenueNetMember 2021-01-01 2021-12-31 0000081362 country:US us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel12And3Member kwr:PooledSeparateAccountsMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel1Member country:US us-gaap:FairValueMeasurementsRecurringMember kwr:PooledSeparateAccountsMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel2Member country:US us-gaap:FairValueMeasurementsRecurringMember kwr:PooledSeparateAccountsMember 2020-12-31 0000081362 us-gaap:FairValueInputsLevel3Member country:US us-gaap:FairValueMeasurementsRecurringMember kwr:PooledSeparateAccountsMember 2020-12-31 0000081362 us-gaap:CommonStockMember 2019-01-01 2019-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-12-31 0000081362 us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-12-31 0000081362 us-gaap:CommonStockMember 2018-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000081362 us-gaap:RetainedEarningsMember 2018-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2018-12-31 0000081362 us-gaap:CommonStockMember 2019-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000081362 us-gaap:RetainedEarningsMember 2019-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2019-12-31 0000081362 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0000081362 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-12-31 0000081362 us-gaap:CommonStockMember 2020-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000081362 us-gaap:RetainedEarningsMember 2020-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2020-12-31 0000081362 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0000081362 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-12-31 0000081362 us-gaap:CommonStockMember 2021-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000081362 us-gaap:RetainedEarningsMember 2021-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2021-12-31 0000081362 us-gaap:CommonStockMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2018-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2018-12-31 0000081362 us-gaap:RetainedEarningsMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2018-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2018-12-31 0000081362 us-gaap:NoncontrollingInterestMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2018-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2018-12-31 0000081362 us-gaap:CommonStockMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2018-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2018-12-31 0000081362 us-gaap:RetainedEarningsMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2018-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2018-12-31 0000081362 us-gaap:NoncontrollingInterestMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2018-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2018-12-31 0000081362 us-gaap:CommonStockMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0000081362 us-gaap:RetainedEarningsMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0000081362 us-gaap:NoncontrollingInterestMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0000081362 us-gaap:CommonStockMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000081362 us-gaap:RetainedEarningsMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000081362 us-gaap:NoncontrollingInterestMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000081362 kwr:HoughtonMember 2021-12-31 0000081362 kwr:HoughtonMember 2020-12-31 0000081362 us-gaap:ForeignCountryMember country:IT 2021-12-31 0000081362 us-gaap:ForeignCountryMember us-gaap:SubsequentEventMember country:IT 2022-02-28 0000081362 us-gaap:ForeignCountryMember us-gaap:SubsequentEventMember country:IT 2022-02-01 2022-02-28 0000081362 kwr:EquityMethodInvesteeNameKelkoVenezuelaMember 2021-12-31 0000081362 kwr:EquityMethodInvesteeNameKelkoVenezuelaMember 2020-12-31 iso4217:BRL iso4217:DKK iso4217:EUR iso4217:GBP iso4217:USD iso4217:ZAR xbrli:pure xbrli:shares iso4217:USD xbrli:shares dummy:People dummy:Item
 
 
 
 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM
10-K
 
ANNUAL REPORT PURSUANT TO SECTION
 
13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended
December 31, 2021
or
 
TRANSITION REPORT PURSUANT TO
 
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
 
OF 1934
For the transition period from
 
to
 
Commission file number
001-12019
 
QUAKER CHEMICAL CORPORATION
(Exact name of registrant as specified in its charter)
 
 
 
 
A
Pennsylvania
 
Corporation
 
No.
23-0993790
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)
 
 
 
 
901 E. Hector Street
,
Conshohocken
,
Pennsylvania
 
19428-2380
(Address of principal executive offices)
 
(Zip Code)
Registrant’s telephone number, including area code: (
610
)
832-4000
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $1 par value
KWR
New York Stock Exchange
 
Securities registered pursuant to Section 12(g) of the Act:
None
Indicate by check mark if the registrant is a well-known seasoned
 
issuer, as defined in Rule 405 of the Securities Act.
 
Yes
 
 
No
 
Indicate by check mark if the registrant is not required to file
 
reports pursuant to Section 13 or Section 15(d) of the Act.
 
Yes
 
 
No
 
Indicate by check mark whether the registrant (1) has filed all reports
 
required to be filed by Section 13 or 15(d) of the Securities
 
Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant
 
was required to file such reports), and (2) has been subject
 
to such filing requirements for the past 90
days.
 
Yes
 
 
No
 
Indicate by check mark whether the registrant has submitted electronically
 
every Interactive Data File required to be submitted pursuant
 
to Rule 405 of Regulation S-
T (
§
 
232.405 of this chapter) during the preceding 12 months (or
 
for such shorter period that the Registrant was required
 
to submit such files).
 
Yes
 
 
No
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated
 
filer, a non-accelerated filer, a smaller reporting company, or an emerging
growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2
 
of the
Exchange Act.
 
 
 
Large accelerated filer
 
 
Accelerated filer
 
 
 
Non-accelerated filer
 
Smaller reporting company
 
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use
 
the extended transition period for complying with any new
 
or revised
financial accounting standards provided pursuant to Section 13(a)
 
of the Exchange Act.
 
Indicate by check mark whether the registrant has filed a
 
report on and attestation to its management’s assessment of the effectiveness of its internal control
 
over
financial reporting under Section 404(b) of the Sarbanes-Oxley
 
Act (15 U.S.C. 7262(b)) by the registered public accounting
 
firm that prepared or issued its audit
report.
 
Yes
 
 
No
 
Indicate by check mark whether the registrant is a shell company (as
 
defined in Rule 12b-2 of the Act).
 
Yes
 
 
No
 
State the aggregate market value of the voting and non-voting
 
common equity held by non-affiliates computed by reference to the
 
price at which the common equity
was last sold, or the average bid and asked price of such
 
common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter. (The
aggregate market value is computed by reference to the last
 
reported sale on the New York Stock Exchange on June 30, 2021): $
4,210,881,271
Indicate the number of shares outstanding of each of the registrant’s classes of
 
common stock, as of the latest practicable date:
17,899,345
 
shares of Common Stock,
$1.00 Par Value, as of January 31, 2022.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the Registrant’s definitive Proxy Statement relating to the 2022 Annual
 
Meeting of Shareholders are incorporated by reference into Part
 
III.
 
 
 
1
QUAKER CHEMICAL CORPORATION
 
Table of
 
Contents
Page
 
Part I
Item 1.
Business.
2
Item 1A.
Risk Factors.
7
Item 1B.
Unresolved Staff Comments.
18
Item 2.
Properties.
18
Item 3.
Legal Proceedings.
18
Item 4.
Mine Safety Disclosures.
18
Item 4(a).
Information about our Executive Officers.
19
Part II
Item 5.
Market for Registrant's Common Equity,
 
Related Stockholder Matters and Issuer Purchases of Equity Securities.
21
Item 6.
Selected Financial Data.
22
Item 7.
Management’s Discussion and Analysis
 
of Financial Condition and Results of Operations.
23
Item 7A.
Quantitative and Qualitative Disclosures About Market Risk.
40
Item 8.
Financial Statements and Supplementary Data.
42
Item 9.
Changes in and Disagreements With Accountants on
 
Accounting and Financial Disclosure.
93
Item 9A.
Controls and Procedures.
93
Item 9B.
Other Information.
94
Item 9C.
Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.
94
Part III
Item 10.
Directors, Executive Officers and Corporate Governance.
95
Item 11.
Executive Compensation.
95
Item 12.
Security Ownership of Certain Beneficial Owners and Management
 
and Related Stockholder Matters.
95
Item 13.
Certain Relationships and Related Transactions,
 
and Director Independence.
95
Item 14.
Principal Accountant Fees and Services.
95
Part IV
Item 15.
Exhibits and Financial Statement Schedules.
96
Item 16.
Form 10-K Summary.
99
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2
PART
 
I
As used in this Annual Report on Form 10-K (the “Report”), the terms “Quaker
 
Houghton,” the “Company,”
 
“we,” and “our”
refer to Quaker Chemical Corporation (doing business as Quaker
 
Houghton), its subsidiaries, and associated companies, unless the
context otherwise requires.
 
The term Legacy Quaker refers to the Company prior to the closing of its combination
 
with Houghton
International, Inc. (“Houghton”) (herein referred to as the “Combination”)
 
on August 1, 2019.
 
Throughout the Report, all figures
presented, unless otherwise stated, reflect the results of operations
 
of the combined company for the years ended December 31, 2020
and 2021; and for the year ended December 31, 2019, the results of Legacy
 
Quaker plus five months of Houghton’s operations
 
post-
closing of the Combination on August 1, 2019.
Item 1.
 
Business.
General Description
The Company was organized in 1918, incorporated as a Pennsylvania
 
business corporation in 1930, and in August 2019
completed the Combination with Houghton to form Quaker Houghton.
 
Quaker Houghton is the global leader in industrial process
fluids.
 
With a presence around the world, includi
 
ng operations in over 25 countries, the Company’s
 
customers include thousands of
the world’s most advanced and specialized
 
steel, aluminum, automotive, aerospace, offshore, can,
 
mining, and metalworking
companies.
 
Quaker Houghton develops, produces, and markets a broad range of formulated
 
chemical specialty products and offers
chemical management services (which we refer to as “Fluidcare
TM
”) for various heavy industrial and manufacturing applications
throughout its four segments: Americas; Europe, Middle East and Africa
 
(“EMEA”); Asia/Pacific; and Global Specialty Businesses.
The major product lines of Quaker Houghton include metal removal fluids,
 
cleaning fluids, corrosion inhibitors, metal drawing
and forming fluids, die cast mold releases, heat treatment and quenchants,
 
metal forging fluids, hydraulic fluids, specialty greases,
offshore sub-sea energy control fluids, rolling
 
lubricants, rod and wire drawing fluids and surface treatment chemicals.
 
The following
are the respective contributions to consolidated net sales of each of our principal
 
product lines representing more than 10% of
consolidated net sales for any of the past three years based on the Company’s
 
current product line segmentation:
2021
2020
2019
Metal removal fluids
23.4
%
23.9
%
19.9
%
Rolling lubricants
22.2
%
21.8
%
21.9
%
Hydraulic fluids
13.6
%
13.3
%
13.0
%
Sales Revenue
A substantial portion of the Company’s
 
sales worldwide are made directly through its own employees and its Fluidcare
TM
programs, with the balance sold through distributors and agents.
 
The Company’s employees typically
 
visit the plants of customers
regularly, work on
 
site, and through training and experience, identify production needs which can be resolved
 
or otherwise addressed
either by utilizing the Company’s existing
 
products or by applying new formulations developed in its laboratories.
As part of the Company’s Fluidcare
TM
 
business, certain third-party product sales to customers are managed by the
 
Company.
 
Where the Company acts as principal, revenues are recognized on
 
a gross reporting basis at the selling price negotiated with its
customers.
 
Where the Company acts as an agent for its customers, revenue is recognized on
 
a net reporting basis at the amount of the
administrative fee earned by the Company for ordering the goods.
 
See Note 5 of Notes to Consolidated Financial Statements in Item 8
of this Report.
Competition
The specialty chemical industry comprises a number of companies similar in
 
size to the Company, as well
 
as companies larger
and smaller than Quaker Houghton.
 
The Company cannot readily determine its precise competitive position
 
in every industry it
serves.
 
However, the Company estimates it holds a leading
 
global position in the market for industrial process fluids including
significant global positions in the markets for process fluids in portions of
 
the automotive and industrial markets, and a leading
position in the market for process fluids to produce sheet steel and aluminum.
 
The offerings of many of the Company’s
 
competitors
differ from those of Quaker Houghton; some offer
 
a broad portfolio of fluids, including general lubricants, while others have more
specialized product ranges.
 
All competitors provide different levels of technical
 
services to individual customers.
 
Competition in the
industry is based primarily on the ability to supply products that meet the needs of
 
the customer and provide technical services and
laboratory assistance to the customer, and
 
to a lesser extent, on price.
Major Customers and Markets
In 2021, Quaker Houghton’s
 
five largest customers (each composed of multiple subsidiaries or divisions
 
with semi-autonomous
purchasing authority) accounted for approximately 10% of
 
consolidated net sales, with its largest customer accounting for
approximately 3% of consolidated net sales.
 
A significant portion of the Company’s
 
revenues are realized from the sale of process
fluids and services to manufacturers of steel, aluminum, automobiles,
 
aircraft, industrial equipment, and durable goods and, therefore,
Quaker Houghton is subject to the same business cycles as those experienced
 
by these manufacturers and their customers.
 
 
3
The Company’s financial
 
performance is generally correlated to the volume of global production within
 
the industries it serves, rather
than directly related to the financial performance of its customers.
 
Furthermore, steel and aluminum customers typically have limited
manufacturing locations compared to metalworking customers and
 
generally use higher volumes of products at a single location.
Raw Materials
Quaker Houghton uses approximately 3,000
 
raw materials, including animal fats, vegetable oils, mineral oils, oleochemicals,
ethylene, solvents, surfactant agents, various chemical compounds
 
that act as additives to our base formulations, and a wide variety of
other organic and inorganic compounds and
 
various derivatives of the foregoing.
 
The price of mineral oil and its derivatives can be
affected by the price of crude oil and industry refining
 
capacity.
 
Animal fat and vegetable oil prices, as well as the prices of other raw
materials, are impacted by their own unique supply and demand factors,
 
and by biodiesel consumption which is affected by the price
of crude oil.
 
Accordingly, significant fluctuations
 
in the price of crude oil can have a material impact on the cost of these raw
materials.
 
In addition, many of the raw materials used by Quaker Houghton are
 
commodity chemicals which can experience
significant price volatility.
 
As experienced during 2021, the Company’s
 
earnings have been and could continue to be affected by
market changes in raw material prices.
 
Reference is made to the disclosure contained in Item 7A of this Report.
Patents and Trademarks
Quaker Houghton has a limited number of patents and patent applications including
 
patents issued, applied for, or acquired in the
U.S. and in various foreign countries, some of which may prove to be material
 
to its business, with the earliest patent expiry in 2024.
 
The Company principally relies on its proprietary formulae and its applications
 
know-how and experience to meet customer needs.
 
Quaker Houghton products are identified by numerous trademarks that
 
are registered throughout its marketing area.
Research and Development—Laboratories
The Company maintains approximately thirty separate laboratory
 
facilities worldwide that are primarily devoted to applied
research and development.
 
In addition, the Company maintains quality control labs at each of its manufacturing
 
facilities.
 
Quaker
Houghton research and development is directed primarily
 
toward applied technology since the nature of the Company’s
 
business
requires continual modification and improvement of formulations to provide
 
specialty chemicals to satisfy customer requirements.
 
If
problems are encountered which cannot be resolved by local laboratories,
 
the problem is referred to one of our ten principal
laboratories, located in Conshohocken, Pennsylvania; Valley
 
Forge, Pennsylvania; Aurora, Illinois; Santa Fe Springs, California;
Uithoorn, the Netherlands; Coventry,
 
United Kingdom; Dortmund, Germany; Barcelona, Spain; Turin,
 
Italy or Qingpu, China.
Research and development costs are expensed as incurred.
 
Research and development expenses during the years ended
December 31, 2021, 2020 and 2019 were $44.9 million, $40.0 million and
 
$32.1 million, respectively.
Recent Acquisition Activity
The Company has completed several recent acquisitions that expand its strategic product
 
offerings and increase the Company's
presence in its core industries.
 
The Company's 2021 and 2022 acquisitions consist of:
 
In January 2022, the Company acquired a business related to the sealing
 
and impregnation of metal castings for the
automotive sector, as well as impregnation resin
 
and impregnation systems for metal parts for approximately $1.4 million.
 
This business expands the Company's geographic presence in Germany
 
as well as broadens its product offerings and service
capabilities within its existing impregnation business that was initially entered into
 
as part of its past acquisition of Norman
Hay.
In January 2022, the Company acquired a business that provides pickling
 
inhibitor technologies for the steel industry,
drawing lubricants and stamping oil for metalworking, and various other
 
lubrication, rust preventative, and cleaner
applications, for approximately $8.0 million.
 
This business broadens the Company’s
 
product offerings within its existing
metals and metalworking business in the Americas
 
region.
In November 2021, the Company acquired a business that provides hydraulic
 
fluids, coolants, cleaners, and rust preventative
oils for approximately $3.7 million.
 
This business expands the Company’s
 
geographic presence in Turkey as well as
broadens its product offerings within its existing metalworking
 
business.
In November 2021, the Company acquired Baron Industries ("Baron"),
 
a U.S. based privately held company that provides
vacuum impregnation services of castings, powder metal and electrical components
 
for an initial payment of approximately
$7.1 million.
 
Baron expands the Company's geographic presence as well as broadens its product
 
offerings and service
capabilities within its existing impregnation business.
In September 2021, the Company acquired the remaining interest in Grindaix-GmbH
 
(“Grindaix”), a Germany-based, high-
tech provider of coolant control and delivery systems for approximately $2.9
 
million.
 
Previously, in February 2021,
 
the
Company acquired a 38% ownership interest in Grindaix for approximately $1.7
 
million.
 
Grindaix expands the Company's
geographic presence in Germany and broadens its product offerings
 
and service capabilities within its equipment solutions
and fluid intelligence business.
4
In June 2021, the Company acquired certain assets for the Company’s
 
chemical milling maskants product line for
approximately $2.8 million.
In February 2021, the Company acquired a tin-plating solutions business for
 
the steel end market for approximately $25.0
million.
 
This business broadens the Company’s product
 
offerings within its existing metals business globally.
Impact of COVID-19
The global outbreak of COVID-19, and its variants, has negatively impacted
 
all locations where the Company does business.
 
Although the Company has now operated in this COVID-19 environment
 
for almost two years, the full extent of the outbreak and
related business impacts continue to remain uncertain and volatile.
 
This outbreak has significantly disrupted the operations of the
Company and those of its suppliers and customers.
 
Management continues to monitor the impact that the COVID-19 pandemic
 
is
having on the Company,
 
the overall specialty chemical industry,
 
and the economies and markets in which the Company operates.
Regulatory Matters
In order to facilitate compliance
 
with applicable federal, state, and local statutes and regulations relating
 
to occupational health
and safety and protection of the environment, the Company has an ongoing
 
program of site assessment for the purpose of identifying
capital expenditures or other actions that may be necessary to comply with
 
such requirements.
 
The program includes periodic
inspections of each facility by the Company and/or independent
 
experts, as well as ongoing inspections and training by on-site
personnel.
 
Such inspections address operational matters, record keeping, reporting requirements
 
and capital improvements.
 
Capital
expenditures directed solely or primarily to regulatory compliance amounted
 
to approximately $4.2
million, $3.7 million and $4.4
million during the years ended December 31, 2021, 2020 and 2019,
 
respectively.
Company Segmentation
The Company’s operating
 
segments, which are consistent with its reportable segments, reflect the structure of the
 
Company’s
internal organization, the method by which the Company’s
 
resources are allocated and the manner by which the chief operating
decision maker assesses the Company’s
 
performance.
 
The Company has four reportable segments: (i) Americas; (ii) EMEA; (iii)
Asia/Pacific; and (iv) Global Specialty Businesses.
 
See Note 4 of Notes to Consolidated Financial Statements in Item 8 of this Report.
Non-U.S. Activities
Since significant revenues and earnings are generated by non-U.S. operations,
 
the Company’s financial results are
 
affected by
currency fluctuations, particularly between the U.S. dollar and the
 
euro, the British pound sterling, the Brazilian real, the Mexican
peso, the Chinese renminbi and the Indian rupee, and the impact of those currency
 
fluctuations on the underlying economies.
 
Reference is made to (i) the foreign exchange risk information
 
contained in Item 7A of this Report, (ii) the geographic information in
Note 4 of Notes to Consolidated Financial Statements included
 
in Item 8 of this Report, and (iii) information regarding risks attendant
to foreign operations included in Item 1A of this Report.
Number of Employees
On December 31, 2021, Quaker Houghton had approximately 4,700
 
full-time employees globally of whom approximately 1,200
were employed by the parent company and its U.S. subsidiaries, and approximately
 
3,500 were employed by its non-U.S. subsidiaries.
 
Associated companies of Quaker Houghton (in which it owns 50% or less and has
 
significant influence) employed approximately 600
people on December 31, 2021.
Core Values
Quaker Houghton considers its employees as its greatest strength in differentiating
 
our business and strengthening our market
positions.
 
We have established
 
core values that are inclusive of embracing diversity and creating a culture
 
where we learn from and
are inspired by the many cultures, backgrounds and knowledge of our
 
team members.
 
The Company’s goal is to have
 
an organization
that is inclusive of all its people and is representative of the communities
 
in which we operate.
The Company’s core values
 
are (i) live safe; (ii) act with integrity; (iii) drive results; (iv) exceed customer
 
expectations; (v)
embrace diversity; and (vi) do great things together.
 
Our core values embody who we are as a company,
 
guide our decisions and
inspire us.
 
Our commitment to these values, in words and actions, builds a safer,
 
stronger Quaker Houghton, and these values guide
the Company’s internal conduct
 
and its relationship with the outside world.
 
By fostering a culture and environment that exemplifies
our core values, we gain, as a company,
 
unique perspectives, backgrounds and varying experiences to ensure
 
continued long-term
success.
 
The Company respects and values all of its employees and believes inclusion,
 
diversity and equality are essential pillars to
drive the Company’s success.
 
Sustainability Report
We report our
 
progress on Environmental, Social, and Governance (“ESG”) milestones in our
 
sustainability report, which is
published annually and is available free of charge on our corporate
 
website at home.quakerhoughton.com/sustainability.
 
The
Company’s 2020 Sustainability
 
Report reflects the most recent available data on a variety of topics, including
 
specific information
5
relating to the Company’s:
 
(i) environmental footprint and climate change commitments;
 
(ii) diversity initiatives; (iii) safety initiatives
and performance;
 
and (iv) training courses our employees have completed.
 
Information in these sustainability reports and on our
website are not incorporated by reference in this Report and, accordingly,
 
should not be considered part of this Report.
Environmental Strategy
 
In 2020, we established the Board Sustainability Committee, which has specific
 
responsibility to assist the Board of Directors (the
“Board”) in its assessment, evaluation, and oversight of the Company’s
 
sustainability programs and initiatives pertaining to the
Company’s business, operations,
 
and employees.
 
In formulating our environmental strategy,
 
our Executive Leadership Team
 
(“ELT”)
and Board consider certain risks and uncertainties that may materially impact
 
our financial condition and results of operations.
 
These
risks and uncertainties are further described in Item 1A of this Report.
In 2021, we set a target to achieve carbon neutrality in our global
 
operations by 2030 and net zero emissions across our entire
value chain by 2050.
 
The Company established 15 long-term goals,
 
based on the results of the Company's 2020 materiality
assessment, which was completed with input from customers, investors, suppliers,
 
and internal stakeholders.
 
Our 15 long-term goals
are closely aligned with the United Nations Sustainable Development Goals.
 
We also identified short
 
-
 
and medium-term milestones
that may help support the achievement of our 2030 targets.
 
Talent
 
Management and Retention
Maintaining a robust pipeline of talent is crucial to our continued
 
success and is a key aspect of succession planning efforts across
the organization.
 
Our ELT
 
and human resources teams are responsible for attracting and retaining top talent by facilitating
 
an
environment where employees want to show up to work and do great
 
things together.
 
To achieve sustained high performance,
management invests in the development, safety,
 
and wellbeing of our employees.
 
Among other metrics, we measure training hours,
turnover, time to hire, and diversity hiring
 
to assess our progress in these areas.
 
Additionally, we
 
regularly evaluate our compensation and benefits packages
 
for our employees, including health and wellness
benefits, paid-time off policies, monetary compensation,
 
and educational reimbursements, to ensure that our total compensation and
benefits packages are aligned with our business strategy,
 
organizational culture, and diversity and inclusion philosophy
 
while ensuring
that we remain competitive in the markets we serve while following
 
local and statutory wage and benefits laws and guidelines.
 
Diversity, Equity,
 
and Inclusion
As a global company,
 
we want to build an organization that is inclusive of all people and representative of
 
the communities in
which we operate.
 
Quaker Houghton provides equal employment opportunities and does not discriminate
 
based on age, ethnicity,
gender identity,
 
disability / medical, race, religion, or sexual orientation.
 
We believe that diversity and
 
inclusion are embodied by
having working norms and cultural familiarities whereby employees
 
feel included, engaged, and rewarded, regardless of their
background or where they sit in the organization.
Inclusion and diversity begin with the Board and ELT.
 
The Board is comprised of twelve individuals with diverse experience and
credentials, selected for their business acumen and ability to challenge and add
 
value to management.
 
Our current Board composition
includes two female and four racially diverse directors out of a total of
 
twelve directors.
 
For additional information on the Company’s
leadership, refer to Item 4(a) Information about our Executive Officers
 
and Item 10.
 
Directors, Executive Officers and Corporate
Governance.
We published
 
our workforce demographics in our Sustainability Report.
 
By publicly disclosing our workforce demographics, we
increase transparency in the composition of our workforce as well as facilitate accountability
 
in achieving progress in our diversity
goals, including ensuring that diverse candidates are actively considered
 
for roles throughout the organization.
 
Workplac
 
e
 
Safety
We are committed
 
to maintaining a strong safety culture and to emphasizing the importance of
 
our employees’ role in identifying,
mitigating and communicating safety risks.
 
We maintain policies and
 
operational practices that communicate a culture where all
levels of employees are responsible for safety.
 
We believe that
 
the achievement of superior safety performance is both an important
short-term and long-term strategic goal in managing our operations.
 
We emphasize ten
 
“lifesaving” rules which make a significant
difference in preventing serious injuries and fatalities.
 
We also require
 
all employees to regularly complete safety training.
 
Additionally, our
 
ELT is closely involved
 
in our safety programs and conducts regular reviews of safety performance
 
metrics and
reviews the Company’s safety
 
performance during Company-wide meetings.
Quaker Houghton on the Internet
Financial results, news and other information about Quaker Houghton
 
can be accessed from the Company’s
 
website at
https://www.quakerhoughton.com
 
.
 
This site includes important information on the Company’s
 
locations, products and services,
financial reports, news releases and career opportunities.
 
The Company’s periodic and current reports
 
on Forms 10-K, 10-Q, 8-K, and
other filings, including exhibits and supplemental schedules filed therewith,
 
and amendments to those reports, filed with the Securities
and Exchange Commission (“SEC”) are available on the Company’s
 
website, free of charge, as soon as reasonably practicable after
they are electronically filed with or furnished to the SEC.
 
Information contained on, or that may be accessed through, the Company’s
website is not incorporated by reference in this Report and, accordingly,
 
you should not consider that information part of this Report.
6
Factors that May Affect Our Future Results
(Cautionary Statements under the Private Securities Litigation Reform
 
Act of 1995)
Certain information included in this Report and other materials filed or
 
to be filed by Quaker Chemical Corporation with the SEC,
as well as information included in oral statements or other written statements made
 
or to be made by us, contain or may contain
forward-looking statements within the meaning of Section 27A of the
 
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended.
 
These statements can be identified by the fact that they do not relate strictly to
historical or current facts.
 
We have based
 
these forward-looking statements, including statements regarding the potential
 
effects of the
COVID-19 pandemic and global supply chain constraints on the Company’s
 
business, results of operations, and financial condition,
our expectation that we will maintain sufficient liquidity and
 
remediate any of our material weaknesses in internal control over
financial reporting, and statements regarding the impact of increased
 
raw material costs and pricing initiatives on our current
expectations about future events.
 
These forward-looking statements include statements with respect to
 
our beliefs, plans, objectives, goals, expectations,
anticipations, intentions, financial condition, results of operations, future
 
performance, and business, including:
 
 
the potential benefits of the Combination and other acquisitions;
 
 
the impacts on our business as a result of the COVID-19 pandemic and
 
any projected global economic rebound or
anticipated positive results due to Company actions taken in response;
cost increases in prices of raw materials and the impacts of constraints and
 
disruptions in the global supply chain;
 
 
 
our current and future results and plans including our sustainability goals
 
;
 
and
 
 
statements that include the words “may,”
 
“could,” “should,” “would,” “believe,” “expect,” “anticipate,” “estimate,”
“intend,” “plan” or similar expressions.
Such statements include information relating to current and future business activities,
 
operational matters, capital spending, and
financing sources.
 
From time to time, forward-looking statements are also included in the Company’s
 
other periodic reports on Forms
10-K, 10-Q and 8-K, press releases, and other materials released to,
 
or statements made to, the public.
Any or all of the forward-looking statements in this Report, in the Company’s
 
Annual Report to Shareholders for 2021 and in any
other public statements we make may turn out to be wrong.
 
This can occur as a result of inaccurate assumptions or as a consequence
of known or unknown risks and uncertainties.
 
Many factors discussed in this Report will be important in determining our future
performance.
 
Consequently, actual results may
 
differ materially from those that might be anticipated from our forward-looking
statements.
We undertake
 
no obligation to publicly update any forward-looking statements, whether
 
as a result of new information, future
events or otherwise.
 
However, any further disclosures made on
 
related subjects in the Company’s subsequent
 
reports on Forms 10-K,
10-Q, 8-K and other related filings should be consulted.
 
A major risk is that demand for the Company’s
 
products and services is
largely derived from the demand for our customers’ products, which
 
subjects the Company to uncertainties related to downturns in a
customer’s business and unanticipated customer production
 
slowdowns and shutdowns, including as is currently being experienced by
many automotive industry companies as a result of supply chain disruption.
 
Other major risks and uncertainties include, but are not
limited to, the primary and secondary impacts of the COVID-19 pandemic,
 
including actions taken in response to the pandemic by
various governments, which could exacerbate
 
some or all of the other risks and uncertainties faced by the Company,
 
as well as the
potential for significant increases in raw material costs, supply chain
 
disruptions, customer financial instability,
 
worldwide economic
and political disruptions such as the current conflict between Russia and Ukraine
 
,
 
foreign currency fluctuations, significant changes in
applicable tax rates and regulations, future terrorist attacks and other acts of violence.
 
Furthermore, the Company is subject to the
same business cycles as those experienced by our customers in the steel, automobile,
 
aircraft, industrial equipment, and durable goods
industries.
 
The ultimate impact of COVID-19 on our business will depend on,
 
among other things, the extent and duration of the
pandemic, the severity of the disease and the number of people infected
 
with the virus including new variants, the continued
uncertainty regarding global availability,
 
administration, acceptance and long-term efficacy
 
of vaccines, or other treatments for
COVID-19 or its variants, the longer-term effects on the
 
economy of the pandemic, including the resulting market volatility,
 
and by
the measures taken by governmental authorities and other third parties restricting
 
day-to-day life and business operations and the
length of time that such measures remain in place, as well as laws and other
 
governmental programs implemented to address the
pandemic or assist impacted businesses, such as fiscal stimulus and other legislation
 
designed to deliver monetary aid and other relief.
 
Other factors could also adversely affect us, including those related
 
to the Combination and other acquisitions and the integration of
acquired businesses.
 
Our forward-looking statements are subject to risks, uncertainties and
 
assumptions about the Company and its
operations that are subject to change based on various important factors,
 
some of which are beyond our control.
 
These risks,
uncertainties, and possible inaccurate assumptions relevant to our business
 
could cause our actual results to differ materially from
expected and historical results.
 
Therefore, we caution you not to place undue reliance on our forward-looking
 
statements.
 
For more information regarding these
risks and uncertainties as well as certain additional risks that we face,
 
refer to the Risk Factors section, which appears in Item 1A of
this Report and in our quarterly and other reports filed from time to time
 
with the SEC.
 
This discussion is provided as permitted by
the Private Securities Litigation Reform Act of 1995.
 
7
Item 1A.
 
Risk Factors.
There are many factors that may affect our business and
 
results of operations, including the following risks relating to: (1) the
demand for our products and services and our ability to grow our
 
customer base; (2) our business operations, including internal and
external factors that may impact our operational continuity; (3) our international
 
operations; (4) our supply chain; (5) domestic and
foreign taxation and government regulation and oversight; and (6)
 
more general risk factors that may impact our business.
Risks Related to the Demand for our Products and Services and our
 
Customer Base
Changes to the industries and markets that we serve could have a material
 
adverse effect on our liquidity, financial position
 
and
results of operations.
As the leader in industrial process fluids, the Company is subject to the same business
 
cycles as those experienced by our
customers that participate in the steel, automobile, aircraft, industrial
 
equipment, aerospace, aluminum and durable goods industries.
 
Because demand for our products and services is largely
 
derived from the global demand for their products, we are subject to
uncertainties related to downturns in our customers’ businesses and unanticipated
 
shutdowns or curtailments of our customers’
production, including as a result of adverse changes affecting
 
national, regional and global economies or increased competitive
pressure within our customers’ industries.
 
Our customers may experience deterioration of their businesses, cash flow shortages
 
and
difficulty obtaining financing, leading them
 
to delay or cancel plans to purchase products, and they may not be able to fulfill their
obligations in a timely fashion.
 
We have limited
 
ability to adjust our costs contemporaneously with changes in sales; thus, a
significant sudden downturn in sales due to reductions in global production
 
within the industries we serve and/or weak end-user
markets could have a material adverse effect on our
 
liquidity, financial position and results
 
of operations.
 
Further, our suppliers and
other business partners may experience similar conditions, which
 
could impact their ability to fulfill their obligations to us and also
result in material adverse effects on our liquidity,
 
financial position and results of operations.
Changes in competition in the industries and markets we serve could have
 
a material adverse effect on our liquidity, financial
position and results of operations.
The specialty chemical industry is highly competitive and there are
 
many companies with significant financial resources and/or
customer relationships that compete with us to provide similar products
 
and services.
 
Some competitors may be able to offer more
favorable or flexible pricing and service terms or,
 
due to their larger size or greater access to resources, may be better able to adapt
 
to
changes in conditions in our industries, fluctuations in the costs of raw materials
 
or changes in global economic conditions, potentially
resulting in reduced profitability and/or a loss of market share for us.
 
The pricing decisions of our competitors could lead us to
decrease our prices which could negatively affect our margins
 
and profitability.
 
In addition, our competitors could potentially
consolidate their businesses and gain scale or better position their
 
product offerings, which could have a negative impact on our
profitability and market share.
 
Competition in our industry historically has also been based on the ability
 
to provide products that
meet the needs of the customer and render technical services and laboratory
 
assistance, which our competitors may be able to
accomplish more effectively than we are able to do.
 
Further, in connection with obtaining regulatory approval
 
of the Combination, we
divested certain of Houghton’s products
 
and related assets to a competitor which they may use to compete with us in certain areas
where we continue to sell those products.
 
If we are unsuccessful with differentiating ourselves, it could
 
have a material adverse effect
on our liquidity, financial
 
position and results of operations and we could lose market share to our compe
 
titors.
Loss of a significant customer, bankruptcy
 
of a major customer, or the closure of or significant
 
reduction in production at a
customer site could have a material adverse effect on our liquidity,
 
financial position and results of operations.
During 2021, the Company’s
 
top five largest customers (each composed of multiple subsidiaries or divisions
 
with semi-
autonomous purchasing authority) together accounted for approximately
 
10% of our consolidated net sales, with the largest customer
accounting for approximately 3% of our consolidated
 
net sales.
 
The loss of a significant customer could have a material adverse effect
on our liquidity, financial
 
position and results of operations.
 
Also, a significant portion of our revenues is derived from sales to
customers in the cyclical steel, aerospace, aluminum and automotive
 
industries, where bankruptcies have occurred in the past and
where companies have periodically experienced financial difficulties.
 
If a significant customer experiences financial difficulties or
files for bankruptcy protection, we may be unable to collect on our receivables,
 
and customer manufacturing sites may be closed, or
contracts voided.
 
The bankruptcy of a major customer could therefore have a material adverse effect
 
on our liquidity, financial
position and results of operations.
 
Also, some of our customers, primarily in the steel, aluminum and aerospace industries, often
 
have
fewer manufacturing locations compared to other metalworking customers
 
and generally use higher volumes of products at a single
location.
 
The loss, closure,
 
or significant reduction in production at one or more of these locations or other major sites of
 
a significant
customer could have a material adverse effect on our
 
business.
We may not be able
 
to timely develop, manufacture and gain market acceptance of new and enhanced
 
products required to
maintain or expand our business, which could adversely affect
 
our competitive position and our liquidity, financial
 
position and
results of operations.
We believe that
 
our continued success depends on our ability to continuously develop and manufacture
 
new products and product
enhancements on a timely and cost-effective basis in response
 
to customer demands for higher performance process chemicals and
other product offerings.
 
Our competitors may develop new products or enhancements to their products
 
that offer performance,
features and lower prices that may render our products less competitive
 
or obsolete, and we may lose business and/or significant
 
8
market share.
 
The development and commercialization of new products requires
 
significant expenditures over an extended period of
time, and some products that we seek to develop may fail to gain traction or never
 
become profitable.
 
In any event, ongoing
investments in research and development for the future do not yield an
 
immediate beneficial impact on our operating results and
therefore could result in higher costs without a proportional increase in revenues.
 
In addition, our customers use our specialty chemicals for a broad range
 
of applications.
 
Changes in our customers’ products or
processes or changes in regulatory,
 
legislative or industry requirements may lead our customers to reduce consumption
 
of the specialty
chemicals that we produce or make them unnecessary or less attractive.
 
Customers may also adopt alternative materials or processes
that do not require our products.
 
An example of such evolving customer demands and industry trends is the
 
movement towards light
weighting of materials and electric vehicles.
 
Should a customer decide to use a different material due to price,
 
performance or other
considerations, we may not be able to supply a product that meets the customer’s
 
new requirements.
 
Consequently, it is important
 
that
we develop new products to replace the products that mature and decline
 
in use.
 
Despite our efforts, we may not be able to develop
and introduce products incorporating new technologies in a timely manner
 
that will satisfy our customers’ future needs or achieve
market acceptance.
 
Moreover, new products may have lower margins
 
than the products they replace.
 
Our business, results of
operations, cash flows and margins could be materially
 
adversely affected if we are unable to manage successfully the maturation
 
or
obsolescence of our existing products and the introduction of new products.
Risks Related to Business Operations, Including Internal and External Factors
 
that May Impact Our Operational Continuity
Our ability to profitably operate our consolidated company as anticipated
 
requires us to effectively identify and consummate the
strategic acquisitions we identify and to successfully integrate
 
these acquisitions into our consolidated operations.
 
An inability to
appropriately capitalize on growth, including organic growth and future acquisitions,
 
could adversely affect our liquidity,
 
financial
position and results of operations.
We have completed
 
several acquisitions over the past several years as discussed in Note 2 of the Notes to the Consolidated
Financial Statements included in Item 8 of this Report.
 
Acquired companies may have significant latent liabilities that may not be
discovered before they are acquired and may not be reflected in the price
 
we pay.
 
Acquisitions also could have a dilutive effect on our
financial results and while they generally result in goodwill, goodwill
 
could be impaired in the future resulting in a charge to earnings.
Our ability to implement our growth strategy may be limited by our
 
ability to identify appropriate acquisition or joint venture
candidates, our financial resources, including available cash and
 
borrowing capacity, and our ability
 
to negotiate and complete suitable
arrangements.
 
Further, the success of our growth depends on our ability
 
to navigate risks such as those listed above and successfully
integrate acquisitions, including, but not limited to, our ability to:
successfully execute the integration or consolidation of the
 
acquired or additional business into our existing processes and
operations;
develop or modify financial reporting, information systems and other
 
related financial tools to ensure
 
overall financial
integrity and adequacy of internal control procedures;
identify and take advantage of potential synergies, including
 
cost reduction opportunities, while retaining legacy business and
other related attributes;
 
adequately address challenges arising from the increased scope, geographic
 
diversity and complexity of our operations; and
further penetrate existing, and expand into new,
 
markets with the product capabilities acquired in acquisitions.
If we fail to successfully integrate acquisitions into our existing business,
 
our financial condition and results of operations could
be adversely affected.
 
We may fail to
 
obtain the benefits we anticipate from our recently completed or future
 
acquisitions or joint
ventures and we may not create the appropriate infrastructure to support
 
such additional growth from organic or acquired businesses,
which could also have a material adverse effect on our liquidity,
 
financial position and results of operations.
Gulf and its wholly-owned subsidiary, QH Hungary
 
Holdings Limited, have a significant minority stake in the Company and the
contractual ability to nominate certain directors of the Company,
 
which may enable them to influence the direction of our business
and significant corporate decisions.
As a result of the Combination, Gulf and its wholly-owned subsidiary,
 
QH Hungary Holdings Limited (together,
 
the “Gulf
Affiliates”), have become our largest shareholders.
 
If they were to make available for sale a portion of their shares, that portion could
represent a significant amount of common stock of the Company being sold
 
which could have an adverse impact on the Company’s
stock price.
In addition, the Gulf Affiliates currently have the right
 
to designate three individuals for election to the Board and this right,
together with their share ownership, gives them substantial influence over
 
our business, including over matters submitted to a vote of
our shareholders, including the election of directors, amendment of our organizational
 
documents, acquisitions or other business
combinations involving the Company,
 
and potentially the ability to prevent extraordinary transactions such as a takeover
 
attempt or
business combination.
 
The concentration of ownership of our shares held by the Gulf Affiliates may
 
make some future actions more
difficult without their support.
 
The Gulf Affiliates, however, among
 
other provisions in the shareholders agreement, have agreed that
 
9
for so long as any of their designees are on the Board, and for six months thereafter,
 
they will vote all Quaker Houghton shares
consistent with the recommendations of the Board for each director nominee
 
as reflected in each proxy statement of the Company,
including in support of any Quaker Houghton directors nominated for election
 
or re-election to the Board (except as would conflict
with their rights to designees on the Board).
 
Nevertheless, the interests of Gulf may conflict with our interests or the interests of our
other shareholders, though we are not aware of any such existing conflicts of interest at
 
this time.
Failure to comply with any material provision of our principal credit facility
 
or other debt agreements could have a material
adverse effect on our liquidity, financial
 
position and results of operations.
We significantly
 
increased our level of indebtedness in connection with the closing of
 
the Combination.
 
Our principal credit
facility requires the Company to comply with certain provisions
 
and covenants, and, while we do not currently consider these
provisions and covenants to be overly restrictive, they could become
 
more difficult to comply with as business or financial conditions
change.
 
We are also subject to
 
interest rate risk due to the variable interest rates within the credit facility and if interest rates rise
significantly, these
 
interest costs would increase as well.
Our principal credit facility contains provisions that are customary
 
for facilities of its type, including affirmative and negative
covenants, financial covenants and events of default, including
 
restrictions on (a) the incurrence of additional indebtedness, (b)
investments in and acquisitions of other businesses, lines of business and
 
divisions, (c) the making of dividends or capital stock
purchases and (d) dispositions of assets.
 
We may declare
 
dividends and make share repurchases in annual amounts not exceeding
 
the
greater of $50 million annually and 20% of consolidated EBITDA (earnings
 
before interest, taxes, depreciation and amortization) if
we are otherwise in compliance with the credit facility and we may also distribute
 
certain other amounts to our shareholders if we
satisfy a consolidated net leverage ratio.
 
Other financial covenants contained in our principal credit facility
 
include a consolidated
interest coverage test and a consolidated net leverage test.
 
Customary events of default in the credit facility include, among others,
defaults for non-payment, breach of representations and warranties, non
 
-performance of covenants, cross-defaults, insolvency,
 
and a
change of control of the Company in certain circumstances.
 
If we are unable to comply with the financial and other provisions of
 
our
principal facility,
 
we could become in default.
 
The occurrence of an event of default under the credit facility could result in all loans
and other obligations becoming immediately due and payable and the facility
 
being terminated.
 
In addition, deterioration in the
Company’s results of operations
 
or financial position could significantly increase borrowing costs.
Changes to the LIBOR calculation method or the replacement of LIBOR may have adverse
 
consequences for the Company that
cannot yet reasonably be predicted.
The Company’s principal
 
credit facility permits interest on certain borrowings to be calculated based on the
 
London Interbank
Offered Rate (“LIBOR”).
 
The LIBOR benchmark has been subject of national, international, and other regulatory
 
guidance and
proposals for reform and will cease to be provided with certain rates as of December
 
31, 2021 through June 30, 2023.
 
In December
2021, the Company entered into the Second Amendment to Credit Agreement
 
(“Second Amendment”) with Bank of America N.A., to
provide an update for the use of a non-U.S. dollar (“non-USD”) currency LIBOR successor
 
rate.
 
The transition away from LIBOR
presents various risks and challenges, including with respect to our borrowings
 
and hedging arrangements that rely on the LIBOR
benchmark.
 
Further, the overall financial market may be disrupted as a result
 
of the phase-out or replacement of LIBOR.
 
Various
parties are working on industry wide and company specific transition plans
 
related to derivatives and cash markets exposed to LIBOR.
 
The U.S. Federal Reserve, in conjunction with the Alternative Reference
 
Rates Committee, a steering committee comprised of large
U.S. financial institutions, is considering replacing LIBOR with the Secured
 
Overnight Financing Rate (“SOFR”), a new index
calculated using short-term repurchase agreements,
 
backed by Treasury securities.
 
At this time, it remains uncertain what rate will
succeed LIBOR.
 
It is not possible to predict whether SOFR will attain market traction as a LIBOR replacement
 
or to predict any other
reforms to LIBOR that may be enacted.
 
The potential effect of the phase-out or replacement of LIBOR on the Company’s
 
financial
position or results of operations cannot yet be predicted but may affect
 
the level of interest payments on our portion of indebtedness
that bear interest at variable rates.
Risks Related to our International Operations
 
Our global presence subjects us to political and economic risks that could adversely affect
 
our business, liquidity, financial
position and results of operations.
A significant portion of our revenues and earnings are generated by our non
 
-U.S. operations.
 
Our success as a global business
depends, in part, upon our ability to succeed across different legal,
 
regulatory, economic,
 
social and political conditions by developing,
implementing and maintaining policies and strategies that are effective
 
in all of the locations where we do business.
 
Risks inherent in
our global operations include:
increased transportation and logistics costs, or restrictions on transportation
 
of materials;
increased cost or decreased availability of raw materials;
trade protection measures including import and export controls, trade embargoes,
 
and trade sanctions between countries or
regions we serve that could result in our losing access to customers and suppliers
 
in those countries or regions;
unexpected adverse changes in export duties, quotas and tariffs and
 
difficulties in obtaining export licenses;
 
10
termination or substantial modification of international trade agreements
 
that may adversely affect our access to raw
materials and to markets for our products;
our agreements with counterparties in countries outside the U.S. may
 
be difficult for us to enforce and related receivables
may take longer or be difficult for us to collect;
 
difficulties of staffing and managing dispersed
 
international operations;
 
less protective foreign intellectual property laws, and more generally,
 
legal systems that may be less developed and
predictable than those in the U.S.;
limitations on ownership or participation in local enterprises as well as the potential
 
for expropriation or nationalization of
enterprises;
the impact of widespread public health crises, such as the COVID-19 pandemic;
 
instability in or adverse changes to the economic, political, social, legal or regulatory
 
conditions in a country or region where
we do business, including hyperinflationary conditions or as a result of
 
terrorist activities, or as a result of political and/or
military conflict; and
complex and dynamic local tax regulations, including changes in foreign
 
laws and tax rates or U.S. laws and tax rates with
respect to foreign income that may unexpectedly increase the rate at which
 
our income is taxed, impose new and additional
taxes on remittances, repatriation or other payments by subsidiaries, or
 
cause the loss of previously recorded tax benefits.
The current global geopolitical and trade environment creates the potential
 
for increased escalation of domestic and international
tariffs and retaliatory trade policies.
 
Further changes in U.S. trade policy and additional retaliatory
 
actions by U.S. trade partners
could result in a worsening of economic conditions.
 
If we are unable to successfully manage these and other risks associated with
 
our
international businesses, the risks could have a material adverse effect
 
on our business, results of operations and financial condition.
Additionally, on January
 
31, 2020, the United Kingdom’s
 
(“U.K.”) ended its membership in the European Union (“EU”)
(commonly referred to as “Brexit”).
 
The U.K. and the EU entered into a trade and cooperation agreement effective
 
January 1, 2021,
but uncertainty remains regarding its implications and implementation
 
,
 
and whether any new trade agreements with other countries or
territories will be agreed upon and implemented and how any such agreements
 
may impact our business.
 
The long-term economic,
legal, political and social implications of Brexit, including regarding
 
data protection in the U.K. and the free movement of goods,
services, and people between the U.K., the EU, and elsewhere, also remains
 
unclear,
 
and the precise impact of the Brexit decision will
only become clearer as Brexit progresses.
 
Brexit has caused and could cause further disruptions to, and create unce
 
rtainty
surrounding, our business in the U.K. and EU, including affecting our
 
relationships with our existing and future customers, suppliers
and employees.
 
Brexit could lead to legal uncertainty and potentially divergent national laws and
 
regulations as the U.K. determines
which EU laws to replace or replicate.
 
Brexit could also lead to calls for similar referendums in other European jurisdictions
 
which
could cause increased economic volatility in the European and global markets.
 
Uncertainty around these and related issues could lead
to adverse effects on the economy of the U.K. or in the other economies
 
in which we operate.
 
There can be no assurance that any or
all of these events will not have a material adverse effect on our business operations,
 
results of operations and financial condition.
 
The scope of our international operations subjects us to risks from currency fluctuations
 
that could adversely affect our liquidity,
financial position and results of operations.
Our non-U.S. operations generate significant revenues and
 
earnings.
 
Fluctuations in foreign currency exchange rates may affect
product demand and may adversely affect the profitability
 
in U.S. dollars of the products and services we provide in international
markets where payment for our products and services is made in the local
 
currency.
 
Our financial results are affected by currency
fluctuations, particularly between the U.S. dollar and the euro, the Brazilian
 
real, the Mexican peso, the Chinese renminbi, and the
Indian rupee, and the impact of those currency fluctuations on the
 
underlying economies.
 
During the past three years, sales by our
non-U.S. subsidiaries, which use their local currencies as their functional currency,
 
accounted for approximately 60% to 70% of our
consolidated net sales.
 
We generally do not use
 
financial instruments that expose us to significant risk involving foreign curren
 
cy
transactions; however, the relative size of our non-U.S.
 
activities has a significant impact on reported operating results and our net
assets.
 
Therefore, as exchange rates change, our results can be materially
 
affected.
 
Incorporated by reference is the foreign exchange
risk information contained in Item 7A of this Report and the geographic information
 
in Note 4 of Notes to Consolidated Financial
Statements included in Item 8 of this Report.
 
Also, we occasionally source inventory in a different country
 
than that of the intended sale.
 
This practice can give rise to foreign
exchange risk.
 
We seek to mitigate this risk through
 
local sourcing of raw materials in the majority of our locations.
 
11
Risks Relating to Our Supply Chain
 
If we are unable to obtain price increases or contract concessions sufficient to
 
offset increases in the costs of raw materials, this
can continue to result in a loss of sales, gross profit, and/or market share and can
 
have a material adverse effect on our liquidity,
financial position and results of operations.
 
Conversely, if we fail to adjust prices in a declining raw material cost environment,
 
we
could lose sales, gross profit, and/or market share which could have a material
 
adverse effect on our liquidity, financial position
and results of operations.
Quaker Houghton uses approximately 3,000 different
 
raw materials, including animal fats, vegetable oils, mineral oils,
oleochemicals, ethylene, solvents, surfactant agents, various chemical
 
compounds that act as additives to our base formulations, and a
wide variety of other organic and inorganic
 
compounds, and various derivatives of the foregoing.
 
The price of mineral oils and their
derivatives can be affected by the price of crude oil
 
and industry refining capacity.
 
Animal fat and vegetable oil prices, as well as the
prices of other
 
raw materials, are impacted by their own specific supply and demand factors, as well as by
 
biodiesel consumption
which is also affected by the price of crude oil.
 
Accordingly, significant
 
fluctuations in the price of crude oil in the past have had and
are expected to continue to have a material impact on the cost of our raw materials.
 
In addition, many of the raw materials we use are
commodity chemicals, which can experience significant price volatility.
We generally
 
attempt to pass through changes in the prices of raw materials to our customers, but we
 
may be unable to do so (or
may be delayed in doing so).
 
In addition, raising prices we charge to our customers
 
in order to offset increases in the prices we pay
for raw materials could cause us to suffer a loss of sales volumes.
 
Although we have been successful in recovering a substantial
amount of raw material cost increases while retaining our customers as experienced
 
in 2021, there can be no assurance that we will be
able to continue to offset higher raw material costs or
 
retain customers in the future.
 
A significant change in margin or the loss of
customers due to pricing actions could result in a material adverse effect
 
on our liquidity, financial position
 
and results of operations
as described within Item 7 of this Report.
Lack of availability of raw materials and issues associated with sourcing from single suppliers
 
and suppliers in volatile economic
environments could have a material adverse effect on our liquidity,
 
financial position and results of operations.
The specialty chemical industry periodically experiences supply shortages
 
for certain raw materials.
 
In addition, we source some
materials from a single supplier or from suppliers in jurisdictions that have
 
experienced political or economic instability.
 
Even if we
have multiple suppliers of a particular raw material, there are occasionally
 
shortages.
 
Any significant disruption in supply could affect
our ability to obtain raw materials or satisfactory substitutes or could
 
increase the cost of such raw materials or substitutes, which
could have a material adverse effect on our liquidity,
 
financial position and results of operations.
 
In addition, certain raw materials
that we use are subject to various regulatory laws, and a change in our ability to legally
 
use such raw materials may impact the
products or services we are able to offer which could negatively
 
affect our ability to compete and could adversely affect
 
our liquidity,
financial position and results of operations.
Loss of a significant manufacturing facility or disruptions within our supply
 
chain or in transportation could have a material
adverse effect on our liquidity, financial
 
position and results of operations.
Our manufacturing facilities are located throughout the world.
 
While we have some redundant capabilities, if one of our facilities
is forced to shut down or curtail operations because of damage or other factors,
 
including natural disasters, labor difficulties or
widespread public health crises, such as the ongoing COVID-19 pandemic,
 
we may not be able to timely supply our customers.
 
This
could result in a loss of sales over an extended period or permanently.
 
While the Company seeks to mitigate this risk through business
continuity and contingency planning and other measures, the loss of production
 
in any one region over an extended period of time
could have a material adverse effect on our liquidity,
 
financial position and results of operations.
 
In addition, the coronavirus
pandemic has caused, and may in the future cause, significant travel disruptions,
 
quarantines and/or closures, which could result in
disruptions to our manufacturing and production operations at our facilities,
 
as well as those of our suppliers and customers.
 
Any
losses due to these events may not be covered by our existing insurance policies
 
or may be subject to certain deductibles.
We could be
 
similarly adversely affected by other disruptions to our supply
 
chain and transportation network.
 
The Company
relies heavily on railroads, ships, and over-the-road shipping
 
methods to transport raw materials to its manufacturing facilities and to
transport finished products to customers.
 
The costs of transporting our products could be negatively affected
 
by factors outside of our
control, including shipping container shortages or global imbalances in
 
shipping capabilities, transportation disruptions or rate
increases, increased border controls or closures, extreme weather events,
 
tariffs, rising fuel costs and capacity constraints.
 
Significant
delays or increased costs affecting our supply chain, such as we experienced
 
in 2021 could materially affect our financial condition
and results of operations.
 
Disruptions at our suppliers have recently and could in the future lead to short term or longer
 
term increases
in raw material or energy costs and/or reduced availability of materials
 
or energy,
 
potentially affecting our financial condition and
results of operations.
 
12
Risks Relating to Domestic and Foreign Taxation
 
and Government Regulation and Oversight
Changes in tax laws could result in fluctuations in our effective tax
 
rate and have a material effect on our liquidity,
 
financial
position and results of operation.
We pay income
 
taxes in the U.S. and various foreign jurisdictions.
 
Our effective tax rate is derived from a combination of local
tax rates and tax attributes applicable to our operations in the various countries,
 
states and other jurisdictions in which we operate.
 
Our effective tax rate and respective tax liabilities could therefore
 
be materially affected by changes in the mix of earnings in countries
with differing statutory tax rates, changes in tax rates, expiration
 
or lapses of tax credits or incentives, changes in uncertain tax
positions, changes in the valuation of deferred tax assets and liabilities, or changes
 
in tax laws or in how they are interpreted or
enforced, including matters such as transfer pricing.
 
In addition, we are regularly under audit by tax authorities, and the final
decisions of such audits could materially affect our current
 
tax estimates and tax positions.
 
See Note 10 and Note 26 of Notes to
Consolidated Financial Statements in Item 8 of this Report for a discussion
 
of certain income and non-income tax audits and
inspections.
 
Any of these factors or similar tax-related risks could cause our effective
 
tax rate and tax-related payments, including any
such payments related to tax liabilities of businesses we have acquired, to
 
significantly differ from previous periods and current or
future expectations which could have a material effect on our liquidity,
 
financial position and results of operations.
Pending and future legal proceedings including environmental
 
matters could have a material adverse effect on our liquidity,
financial position and results of operations, as well as our reputation in the markets it serves.
The Company and its subsidiaries are routinely party to proceedings, cases, and
 
requests for information from, and negotiations
with, various claimants and federal and state agencies relating to various
 
legal matters, including tax and environmental matters.
 
See
Note 10 and Note 26 of Notes to Consolidated Financial Statements in Item
 
8 of this Report, which describes uncertain tax positions
and tax audits and inspections, as well as certain information concerning
 
pending asbestos-related litigation against an inactive
subsidiary, amounts
 
accrued associated with certain environmental, non-capital remediation costs and
 
other potential commitments or
contingencies.
 
An adverse result in one or more pending or ongoing matters or any potential future
 
matter of a similar nature could
materially and adversely affect our liquidity,
 
financial position, and results of operations, as well as our reputation in the markets
 
we
serve.
 
Failure to comply with the complex global regulatory environment in which we operate
 
could have an adverse impact on our
reputation and/or a material adverse effect on our liquidity,
 
financial position and results of operations.
 
We are subject to
 
government regulation in all of the jurisdictions in which we conduct our business.
 
Changes in the regulatory
environments
 
in which we operate, particularly,
 
but not limited to, the U.S., Mexico, Brazil, China, India, Thailand, Australia, the
U.K. and the EU, could lead to heightened regulatory compliance costs and
 
scrutiny, could adversely
 
impact our ability to continue
selling certain products in the U.S. or foreign markets, and/or could otherwise
 
increase the cost of doing business.
 
While we seek to
mitigate these risks through a variety of actions,
 
including receiving Responsible Care Certification, ongoing employee
 
training, and
employing a comprehensive environmental, health and safety program,
 
there is no guarantee these actions will prevent all potential
regulatory compliance issues.
 
For instance, failure to comply with the EU’s
 
Registration, Evaluation, Authorization and Restriction of
Chemicals (“REACH”) regulations or other similar laws and regulations
 
could result in our inability to sell certain products or we
could incur fines, ongoing monitoring obligations or other future business consequences,
 
which could have a material adverse effect
on our liquidity, financial
 
position and results of operations.
 
In addition, the U.S. Toxic
 
Substances Control Act (“TSCA”) requires
chemicals to be assessed against a risk-based safety standard and
 
that unreasonable risks identified during risk evaluation be
eliminated.
 
This regulation and other pending initiatives at the U.S. state level, as well as initiatives
 
in Canada, Asia and other
regions, could potentially require toxicological testing and risk assessments of
 
a wide variety of chemicals, including chemicals used
or produced by us.
 
These assessments may result in heightened concerns about the chemicals involved
 
and additional requirements
being placed on their production, handling, labeling or use.
 
These concerns and additional requirements could also increase the cost
incurred by our customers to use our chemical products and otherwise
 
limit their use which could lead to a decrease in demand for
these products.
 
A decrease in demand due to these issues could have an adverse impact on our business
 
and results of operation.
 
 
Further, we are subject to the U.S. Foreign
 
Corrupt Practices Act (the “FCPA”),
 
the U.K. Bribery Act and other anti-bribery,
 
anti-
corruption and anti-money laundering laws in jurisdictions around
 
the world.
 
These and similar laws generally prohibit companies
and their officers, directors, employees and third-party
 
intermediaries, business partners and agents, from making improper payments
or providing other improper items of value to government officials
 
or other persons.
 
While we have policies and procedures and
internal controls designed to address compliance with such laws, including
 
employee training programs, we cannot guarantee that our
employees and third-party intermediaries, business partners
 
and agents will not take, or be alleged to have taken, actions in violation
of such policies and laws for which we may be ultimately held responsible.
 
Detecting, investigating and resolving actual or alleged
violations can be extensive and require a significant diversion of time, resources
 
and attention from senior management.
 
Any
violation of these or other applicable anti-bribery,
 
anti-corruption and anti-money laundering laws could result in whistleblower
complaints, adverse media coverage, investigations, loss of export privileges,
 
and criminal or civil sanctions, penalties and fines, any
of which could adversely affect our business and financial
 
condition.
 
The shipment of goods, services and technology across international
 
borders subjects us to extensive trade laws and regulations.
Our import activities are governed by the unique customs laws and
 
regulations in each of the countries where we operate.
 
Moreover,
many countries, including the U.S., control the export and re-export of
 
certain goods, services and technology and impose related
13
export record-keeping and reporting obligations.
 
Governments may also impose economic sanctions against certain countries, persons
and entities that may restrict or prohibit transactions involving such
 
countries, persons and entities, which may limit or prevent our
conduct of business in certain jurisdictions.
 
The laws and regulations concerning import activity,
 
export record-keeping and reporting, export control and economic
 
sanctions
are complex and constantly changing.
 
These laws and regulations can cause delays in shipments and unscheduled operational
downtime.
 
Moreover, any failure to comply with applicable legal and
 
regulatory trading obligations could result in criminal and civil
penalties and sanctions such as fines, imprisonment, debarment from governmental
 
contracts, seizure of shipments and loss of import
and export privileges.
 
In addition, investigations by governmental authorities as well as legal, social, economic
 
and political issues in
these countries could have a material adverse effect on our
 
business, results of operations and financial condition.
 
We are also subject
to the risks that our employees, joint venture partners and agents outside of
 
the U.S. may fail to comply with other applicable laws.
Uncertainty related to environmental regulation and industry standards relating
 
to, as well as physical risks of, climate change and
biodiversity loss, could impact our results of operations and financial position
 
.
 
Increased public and stakeholder awareness and concern regarding global
 
climate change, biodiversity loss, and other
environmental risks may result in more extensive international, regional
 
and/or federal requirements or industry standards to reduce or
mitigate the effects of these changes.
 
These regulations could mandate even more restrictive standards or industry
 
standards than the
voluntary goals that we have established or require changes to be adopted
 
on a more accelerated time frame.
 
There continues to be a
lack of consistent climate legislation, which creates economic and regulatory
 
uncertainty.
 
Though we are closely following
developments in this area and changes in the regulatory landscape in the U.S.,
 
we cannot predict how or when those challenges may
ultimately impact our business.
 
While certain climate change initiatives may result in new business opportunities
 
for us in the area of
alternative fuel technologies and emissions control, compliance with
 
these initiatives may also result in additional costs to us
including, among other things, increased production costs, additional
 
taxes, reduced emission allowances or additional restrictions on
production or operations.
 
In addition, the potential physical impacts of climate change and biodiversity
 
loss are highly uncertain and will be particular to the
circumstances developing in various geographical regions.
 
These may include extreme weather events and long-term changes
 
in
temperature levels and water availability as well as damaged ecosystems.
 
The physical risks of climate change and biodiversity loss
may impact our facilities, our customers and suppliers, and the availability
 
and costs of materials and natural resources, sources and
supply of energy,
 
product demand and manufacturing.
 
In particular, climate change serves as a risk multiplier
 
increasing both the
frequency and severity of natural disasters that may affect
 
our business operations.
 
If environmental laws or regulations or industry standards are either
 
changed or adopted and impose significant operational
restrictions and compliance requirements upon us or our products, or
 
our operations are disrupted due to physical impacts of climate
change or biodiversity loss, our business, capital expenditures, results of
 
operations, financial condition and competitive position could
be negatively impacted.
We are subject to stringent labor
 
and employment laws in many jurisdictions in which we operate, and
 
our relationship with our
employees could deteriorate which could adversely impact our operations.
 
A majority of our full-time employees are employed outside the U.S.
 
In many jurisdictions where we operate, labor and
employment laws grant significant job protection to certain employees including
 
rights on termination of employment.
 
In addition, in
certain countries our employees are represented by works councils or are governed
 
by collective bargaining agreements and we are
often required to consult with and seek the consent or advice of such representatives
 
.
 
These regulations and laws, together with our
obligations to seek consent or consult with the relevant unions or works councils,
 
could have a significant impact on our flexibility in
managing costs and responding to market changes.
 
While the Company believes it has generally positive relations with its labor
unions and employees, there is no guarantee the Company will be able to successfully
 
negotiate new or renew labor agreements
without work stoppages, labor difficulties or unfavorable
 
terms.
 
If we were to experience any extended interruption of operations at
any of our facilities because of strikes or other work stoppages, our results of operations
 
and financial condition could be materially
and adversely affected.
We may be
 
unable to adequately protect our proprietary rights and trade brands, which may
 
limit our ability to compete in our
markets and could adversely affect our liquidity,
 
financial position and results of operations.
 
We have a limited
 
number of patents and patent applications, including patents issued, applied
 
for, or acquired in the U.S. and in
various foreign countries, some of which are material to our business.
 
However, we rely principally on our proprietary
 
formulae and
the applications know-how and experience to meet customer needs.
 
Also, our products are identified by trademarks that are registered
throughout our marketing area.
 
Despite our efforts to protect our proprietary information through
 
patent and trademark filings, and
the use of appropriate trade secret protections, it is possible that competitors
 
or other unauthorized third parties may obtain, copy,
 
use,
disclose or replicate our formulae, products, and processes.
 
Similarly, third parties
 
may assert claims against us and our customers
and distributors alleging our products infringe upon third-party intellectual
 
property rights.
 
In addition, the laws and/or judicial
systems of foreign countries in which we design, manufacture, market
 
and sell our products may afford little or no effective protection
of our proprietary technology or trade brands.
 
Also, security over our global information technology structure
 
is subject to increasing
risks associated with cyber-crime and other related cyber-security
 
threats.
 
These potential risks to our proprietary information, trade
brands and other intellectual property could subject us to increased competition
 
and a failure to protect, defend or enforce our
intellectual property rights could negatively impact our liquidity,
 
financial position and results of operations.
 
14
General Risk Factors
Our business could be adversely affected by environmental,
 
health and safety laws and regulations or by potential product, service
or other related liability claims.
The development, manufacture and sale of specialty chemical products and
 
other related services involve inherent exposure to
potential product liability claims, service level claims, product recalls and
 
related adverse publicity.
 
Some customers have and may in
the future require us to represent that our products conform to certain product
 
specifications provided by them.
 
Any failure to comply
with such specifications could result in claims or legal action against us.
 
Any of the foregoing potential product or service risks could
also result in substantial and unexpected expenditures and affect
 
customer confidence in our products and services, which could have
 
a
material adverse effect on our liquidity,
 
financial position and results of operations.
In addition, our business is subject to hazards associated with the manufacturing,
 
handling, use, storage, and transportation of
chemical materials and products, including historical operations at our
 
current and former facilities.
 
These potential hazards could
cause personal injury and loss of life, severe damage to, or destruction of,
 
property or equipment and environmental contamination or
other environmental damage, which could have an adverse effect
 
on our business, financial condition or results of operations.
 
In the
jurisdictions in which we operate, we are subject to numerous U.S. and non-U.S.
 
national, federal, state and local environmental,
health and safety laws and regulations, including those governing
 
the discharge of pollutants into the air and water,
 
the management
and disposal of hazardous substances and wastes and the cleanup
 
of contaminated properties.
 
We currently
 
use, and in the past have
used, hazardous substances at many of our facilities, and we have in the past been,
 
and may in the future be, subject to claims relating
to exposure to hazardous materials.
 
We also have
 
generated, and continue to generate, hazardous wastes at a number of our
 
facilities.
Liabilities associated with the investigation and cleanup of hazardous
 
substances, as well as personal injury,
 
property damages or
natural resource damages arising from the release of, or exposure to, such hazardous
 
substances, may be imposed in many situations
without regard to violations of laws or regulations or other fault, and
 
may also be imposed jointly and severally (so that a responsible
party may be held liable for more than its share of the losses involved, or
 
even the entire loss).
 
These liabilities may also be imposed
on many different entities, including, for example,
 
current and prior property owners or operators, as well as entities that arranged for
the disposal of the hazardous substances.
 
The liabilities may be material and can be difficult to identify or quantify.
 
In addition, the
occurrence of disruptions, shutdowns or other material operating problems
 
at our facilities or those of our customers due to any of
these risks could adversely affect our reputation and have
 
a material adverse effect on our operations as a whole, including
 
our results
of operations and cash flows, both during and after the period of operational
 
difficulties.
 
Further, some of the raw materials we handle
 
are subject to government regulation that affect the manufacturing
 
processes,
handling, uses and applications of our products. In addition, our production
 
facilities and a number of our distribution centers require
numerous operating permits.
 
Due to the nature of these requirements and changes in our operations, our
 
operations may exceed limits
under permits or we may not have the proper permits to conduct our operations.
 
Ongoing compliance with environmental laws, regulations and permits that
 
impact registration/approval requirements,
transportation and storage of raw materials and finished products, and
 
storage and disposal of wastes could require us to make changes
in manufacturing processes or product formulations and could have
 
a material adverse effect on our results of operations.
 
We may
incur substantial costs, including fines, damages, criminal or civil sanctions
 
and remediation costs, or experience interruptions in our
operations, including as a result of revocation, non-renewal or modification
 
of the Company’s operating permits and
 
revocation of the
Company’s product registrations,
 
for violations arising under these laws or permit requirements.
 
Any such revocation, modification or
non-renewal may require the Company to cease or limit the manufacture
 
and sale of its products at one or more of its facilities, which
may limit or prevent the Company’s
 
ability to meet product demand or build new facilities and may have a material
 
adverse effect on
the Company’s business, financial position,
 
results of operations and cash flows.
 
Additional information may arise in the future
concerning the nature or extent of our liability with respect to identified
 
sites, and additional sites may be identified for which we are
alleged to be liable, that could cause us to materially increase our environmental
 
accrual or the upper range of the costs we believe we
could reasonably incur for such matters.
 
Increased compliance costs may not affect competitors in the
 
same way that they affect us
due to differences in product formulations, manufacturing
 
locations or other factors, and we could be at a competitive disadvantage,
which might adversely affect our financial performance.
We could be subject
 
to indemnity claims and liable for other payments relating to properties or businesses
 
we have divested.
 
In connection with the sale of certain properties and businesses, we agreed
 
to indemnify the purchasers for certain types of
matters, including certain breaches of representations and
 
warranties, taxes and certain environmental matters.
 
With respect to
environmental matters, the discovery of contamination arising
 
from properties that we have divested may expose us to indemnity
obligations under the sale agreements with the buyers of such properties or
 
cleanup obligations and other damages under applicable
environmental laws, even if we were not aware of the contamination.
 
We may not have insurance
 
coverage for such indemnity
obligations.
 
Further, we cannot predict the nature or amount of
 
any indemnity or other obligations we may have to pay the applicable
purchaser.
 
These payments may be costly and may adversely affect our financial
 
condition and results of operations.
Our insurance may not fully cover all potential exposures.
We maintain product,
 
property, business interruption,
 
casualty, and other general
 
liability insurance, but this may not cover all
risks associated with the hazards of our business and these coverages
 
are subject to limitations, including deductibles and coverage
limits.
 
We may incur
 
losses beyond the limits, or outside the coverage, of our insurance policies, including
 
liabilities for
15
environmental remediation.
 
In addition, from time to time, various types of insurance for companies in
 
the specialty chemical
industry have not been available on commercially acceptable terms and,
 
in some cases, have not been available at all.
 
We are
potentially at additional risk if one or more of our insurance carriers fail.
 
Additionally, severe disruptions
 
in the domestic and global
financial markets could adversely impact the ratings and survival
 
of some of our insurers.
 
Future downgrades in the ratings of enough
insurers could adversely impact both the availability of appropriate insurance
 
coverage and its cost.
 
In the future, we may not be able
to obtain coverage at current levels, if at all, and our premiums may increase
 
significantly on coverage that we maintain.
Impairment evaluations of goodwill, intangible assets, investments or other long-lived
 
assets could result in a reduction in our
recorded asset values which could have a material adverse effect
 
on our financial position and results of operation.
We perform
 
reviews of goodwill and indefinite-lived intangible assets on an annual
 
basis, or more frequently if triggering events
indicate a possible impairment.
 
We test goodwill
 
at the reporting unit level by comparing the carrying value of the net assets of the
reporting unit, including goodwill, to the reporting unit's fair value.
 
Similarly, we test indefinite-lived
 
intangible assets by comparing
the fair value of the assets to their carrying values.
 
If the carrying values of goodwill or indefinite-lived intangible assets exceed
 
their
fair value, the goodwill or indefinite-lived intangible assets would be considered
 
impaired.
 
In addition, we perform a review of a
definite-lived intangible asset or other long-lived asset when changes
 
in circumstances or events indicate a possible impairment.
 
If
any impairment or related charge is warranted, then our
 
financial position and results of operations could be materially affected.
 
See
Note 16 of Notes to Consolidated Financial Statements included in Item 8
 
of this Report.
Disruption of critical information systems or material breaches in the security
 
of our systems could adversely affect our business
and our customer relationships and subject us to fines or other regulatory actions.
We rely on
 
information technology systems to obtain, process, analyze, manage, transmit, and
 
store electronic information in our
day-to-day operations.
 
We also rely
 
on our technology infrastructure in all aspects of our business, including to interact with
customers and suppliers, fulfill orders and bill, collect and make payments,
 
ship products, provide support to customers, and fulfill
contractual obligations.
 
Our information technology systems are subject to potential disruptions,
 
including significant network or
power outages, cyberattacks, computer viruses, other malicious codes,
 
and/or unauthorized access attempts, any of which, if
successful, could result in data leaks or otherwise compromise our
 
confidential or proprietary information and disrupt our operations.
Security breaches could result in unauthorized disclosure of confidential
 
information or personal data belonging to our employees,
partners, customers or suppliers for which we may incur liability.
 
Cybersecurity threats, attempted intrusions and other incidents, such
as these, are becoming more sophisticated and frequent.
 
Security breaches and cyber incidents have, from time to time, occurred and
may occur in the future.
 
Although the breaches and cyber incidents experienced
 
to date have not had a material impact, there can be
no assurance that our protective measures will prevent security breaches
 
that could have a significant impact on our business,
reputation and financial results.
 
We are subject to
 
the data privacy and protection laws and regulations adopted by federal, state and
 
foreign legislatures and
governmental agencies in various countries in which we operate, including
 
the EU General Data Protection Regulation.
 
Implementing
and complying with these laws and regulations may be more costly or
 
take longer than we anticipate or could otherwise affect our
business operations.
 
Breaches, cyber incidents and disruptions, or failure to comply with
 
laws and regulations related to information security or
privacy could result in legal claims or proceedings against us by governmental
 
entities or individuals, significant fines, penalties or
judgements, disruption of our operations, remediation requirements,
 
changes to our business practices, and damage to our reputation.
Therefore, a failure to monitor, maintain
 
or protect our information technology systems and data integrity effectively
 
or to anticipate,
plan for and recover from significant disruptions to these systems could have a material
 
adverse effect on our business, results of
operations or financial condition.
Our business depends on attracting and retaining qualified management
 
and other key personnel.
Due to the specialized and technical nature of our business, our future performance
 
is dependent on our ability to attract, develop
and retain qualified management, commercial, technical, and
 
other key personnel.
 
Competition for such personnel is intense, and we
may be unable to continue to attract or retain such personnel.
 
In an effort to mitigate such risks, the Company utilizes retention
bonuses, offers competitive pay and maintains continuous
 
succession planning, including for our senior executive officers.
 
However,
there can be no assurance that these mitigating factors will be adequate to attract
 
or retain qualified management or other key
personnel.
 
Failure to retain key employees,
 
failure to successfully transition key roles, or the inability to hire, train, retain and
 
manage
qualified personnel could also adversely affect our business
 
.
Increasing scrutiny and changing expectations from stakeholders with respect
 
to our ESG practices may impose additional costs
on us or expose us to new or additional risks.
Companies across all industries are facing increasing scrutiny from
 
stakeholders related to their ESG practices.
 
Investor
advocacy groups, institutional investors, investment funds, and
 
other influential investors are also increasingly focused on ESG
practices and in recent years have placed increasing importance on
 
the implications and social cost of their investments.
 
Regardless of
the industry, investors’
 
increased focus and activism related to ESG and similar matters may impact access to
 
capital, as investors may
decide to reallocate capital or to not commit capital as a result of their assessment of
 
a company’s ESG practices.
 
16
We face pressures
 
from certain stakeholders to prioritize and promote sustainable
 
practices and reduce our carbon footprint.
 
Our
stakeholders may pressure us to implement ESG procedures or standards
 
beyond those we have in place in order to continue engaging
with us, to remain invested in us, or before they will make further investments
 
in us.
 
Additionally, we may
 
face reputational
challenges in the event our ESG procedures or standards do not meet the standards set by
 
certain constituencies.
 
We have adopted
certain practices as highlighted in the Company’s
 
Sustainability Report, including with respect to environmental stewardship.
 
Further, as we work to align with the recommendations
 
of the Financial Stability Board’s Task
 
Force on Climate-related Financial
Disclosures and the Sustainability Accounting Standards Board, we
 
continue to expand our disclosures in these areas.
 
This is
consistent with our commitment to executing on a strategy that reflects the
 
economic, social, and environmental impact we have on
the world while advancing and complementing our business strategy.
 
Our disclosures on these matters and standards we set for
ourselves or a failure to meet these standards, may influence our
 
reputation and the value of our brand.
 
It is possible that our
stakeholders might not be satisfied with our ESG efforts or
 
the speed of their adoption.
 
If we do not meet our stakeholders’
expectations, our business and/or our ability to access capital could be
 
harmed.
 
Any harm to our reputation resulting from setting
these standards or our failure or perceived failure to meet such standards
 
could adversely affect our business, financial performance,
and growth.
 
Additionally, adverse
 
effects upon our customers’ industries related to the worldwide social and
 
political environment, including
uncertainty or instability resulting from climate change or biodiversity
 
loss, changes in political leadership and environmental policies,
changes in geopolitical-social views toward fossil fuels and renewable
 
energy,
 
concern about the environmental impact of climate
change or biodiversity loss, and investors’ expectations regarding
 
ESG matters, may also adversely affect demand for our services.
Any long-term material adverse effect on our customers
 
or their industries could have a significant financial and operational adverse
impact on our business.
Terrorist
 
attacks, other acts of violence or war,
 
natural disasters, widespread public health crises or other uncommon
 
global events
may affect the markets in which we operate and our profitability which could
 
adversely affect our liquidity, financial
 
position and
results of operations.
 
Terrorist attacks,
 
other acts of violence or war, natural disasters, widespread
 
public health crises, including the ongoing COVID-
19 pandemic, or other uncommon global events such as the current conflict
 
between Russia and Ukraine, may negatively affect our
operations.
 
There can be no assurance that there will not be terrorist attacks against the U.S. or other locations
 
where we do business.
 
Also, other uncommon global events such as earthquakes, hurricanes,
 
fires and tsunamis cannot be predicted.
 
Terrorist attacks,
 
other acts of violence
 
or armed conflicts, and natural disasters, which may be amplified by ongoing global
climate change and biodiversity loss, may directly impact our physical
 
facilities and/or those of our suppliers or customers.
 
In
addition, terrorist attacks or natural disasters may disrupt the global
 
insurance and reinsurance industries with the result that we may
not be able to obtain insurance at historical terms and levels, if at all, for
 
all of our facilities.
 
In addition, available insurance coverage
may not be sufficient to cover all of the damage incurred or,
 
if available, may be prohibitively expensive.
 
Widespread public health
crises could also disrupt operations of the Company,
 
its suppliers and customers which could have a material adverse impact on our
results of operations.
The consequences of terrorist attacks, other acts of violence or armed
 
conflicts, natural disasters, widespread public health crises
or other uncommon global events can be unpredictable, and we may not be
 
able to foresee or effectively plan for these events,
resulting in a material adverse effect on our business, results of
 
operations or financial condition.
The COVID-19 pandemic and its impact on business and economic conditions
 
have negatively affected our business, results of
operations and financial condition and the extent and duration of
 
those effects is uncertain.
 
The COVID-19 pandemic that began in the first quarter of 2020 and the resulting
 
impacts significantly disrupted the global
economy and financial markets and adversely affected
 
the Company’s operations as well as those of
 
its suppliers and customers.
 
The
Company experienced material disruptions as a result of COVID-19 globally
 
which negatively impacted all locations where the
Company does business.
 
Although the Company has now operated in this COVID-19 environment
 
for almost two years, the full extent of the outbreak and
related business impacts continue to remain uncertain and volatile.
 
This outbreak has significantly disrupted the operations of the
Company and those of its suppliers and customers.
 
During the pandemic, the Company initially experienced volume declines and
lower net sales as compared to pre-COVID-19 levels.
 
In addition, the COVID-19 pandemic and responses to the pandemic have at
times significantly disrupted the global supply chain and have had
 
a significant impact on raw material prices.
 
These impacts may
continue to occur and may become more significant and could continue
 
to result in disruptions in our supply chain and our difficulty
in procuring or inability to procure raw materials necessary for the manufacturing
 
of our products.
 
The impact of the COVID-19
pandemic and responses to it has increased and could continue to increase
 
the costs of making and distributing our products or result
in delays in delivering, or an inability to deliver,
 
them to our customers.
Given the continuously evolving developments with respect to this pandemic,
 
the Company cannot, as of the date of this Report,
reasonably estimate the magnitude or the full extent of the impact to its future results of
 
operations or to the ability of it or its
customers to resume more normal operations, even as certain restrictions are
 
lifted.
 
The prolonged pandemic and resurgences of the
 
17
outbreak including as new variants continue to emerge,
 
and continued restrictions on day-to-day life and business operations as well as
increased border controls or closures and transportation disruptions,
 
may result in volume declines and lower net sales in future
periods.
To the extent
 
that the Company’s customers and suppliers continue
 
to be significantly and adversely impacted by COVID-19, this
could reduce the availability,
 
or result in delays, of materials or supplies to or from the Company,
 
which in turn could significantly
interrupt the Company’s business operations.
 
Given this ongoing uncertainty,
 
the Company cautions that its future results of
operations could be significantly adversely impacted by COVID-19.
 
Further, management continued to evaluate how
 
COVID-19
related circumstances, such as remote work arrangements, illness or staffing
 
shortages and travel restrictions have affected financial
reporting processes and systems, internal control over financial reporting,
 
and disclosure controls and procedures.
 
While the
circumstances have presented and are expected to continue to present challenges,
 
and have necessitated additional time and resources
to be deployed to sufficiently address the challenges
 
brought on by the pandemic, at this time, management does not believe that
COVID-19 has had a material impact on financial reporting processes, internal
 
controls over financial reporting, or disclosure controls
and procedures.
Although we have implemented business continuity and emergency
 
response plans as well as health and safety measures to
permit us to continue to provide services and products to customers and support
 
our operations, there can be no assurance that the
continued spread of COVID-19 and its variants and efforts to
 
contain the virus (including, but not limited to, vaccines and treatments,
voluntary and mandatory quarantines, restrictions on travel, limiting
 
gatherings of people, reduced operations and extended closures of
 
many businesses and institutions) will not further impact our business, results of
 
operations and financial condition.
 
However, given
the unprecedented and continually evolving developments
 
with respect to this pandemic, the Company cannot, as of the date of this
Report, reasonably estimate with certainty the full extent of the impact to
 
its future results of operations or to the ability of it or its
customers to resume more normal operations.
 
A further prolonged outbreak or resurgence and period of continued
 
restrictions on day-
to-day life and business operations would likely result in volume declines
 
and lower net sales in future periods as well.
The ultimate significance of COVID-19 impacts on our business will depend
 
on, among other things, the extent and duration of
the pandemic, the severity of the disease and the number of people infected
 
with the virus, the development and continued uncertainty
regarding availability,
 
continued administration and long-term efficacy of vaccines or
 
other treatments, including on new strains or
mutations of the virus, the longer-term effects
 
on the economy, including
 
market volatility, and the measures
 
taken by governmental
authorities and other third parties restricting day-to-day life and
 
the length of time that such measures remain in place, as well as laws
and other governmental programs implemented to address the pandemic
 
or assist impacted businesses, such as fiscal stimulus and
other legislation designed to deliver monetary aid and other relief.
Epidemic diseases could negatively affect various aspects of
 
our business, make it more difficult to meet our obligations to our
customers, and could result in reduced demand from our customers.
 
These could have a material adverse effect on our business,
financial condition, results of operations, or cash flows.
 
Our business could be adversely affected by the effects
 
of a widespread outbreak of contagious disease, similar to the COVID-19
pandemic.
 
A significant outbreak of contagious diseases in the human population could result in a widespread
 
health crisis that could
adversely affect the economies and financial markets of many
 
countries, resulting in an economic downturn that could affect demand
for our products and likely impact our operating results.
 
To the extent that
 
the Company’s customers and
 
suppliers are materially and
adversely impacted by a widespread outbreak of contagious disease, this could
 
reduce the availability, or
 
result in delays, of materials
or supplies to or from the Company,
 
which in turn could materially interrupt the Company’s
 
business operations.
The ultimate impact on our business of a widespread outbreak of a contagious disease will depend
 
on, among other things, the
extent and duration of the outbreak,
 
the severity of the disease and the number of people infected, the development
 
and continued
uncertainty regarding availability,
 
administration and long-term efficacy of a vaccine or other
 
treatments, the longer-term effects on
the economy, including
 
market volatility, and
 
the measures taken by governmental authorities and other third parties restricting day-
to-day life and the length of time that such measures remain in place, as well as laws and
 
other governmental programs implemented
to address the outbreak or assist impacted businesses, such as fiscal stimulus and
 
other legislation designed to deliver monetary aid
and other relief.
We have previously identified
 
material weaknesses in our internal control over financial reporting that could have
 
resulted in
material misstatements in our financial statements and in the inability of our independent
 
registered public accounting firm to
provide an unqualified audit opinion which could have a material adverse effect
 
on us.
 
As a public company,
 
we are required to comply with the SEC’s rules implementing
 
Sections 302 and 404 of the Sarbanes-Oxley
Act of 2002, or the Sarbanes-Oxley Act, which require management to certify
 
financial and other information in our quarterly and
annual reports and provide an annual management report on the effectiveness
 
of controls over financial reporting.
As disclosed under “Item 9A. Controls and Procedures” of this Report, during
 
the course of preparing our audited financial
statements for the Company’s annual
 
report on Form 10-K for 2019 and 2020, we, in conjunction with our independent registered
public accounting firm, identified certain material weaknesses.
 
A material weakness is a deficiency,
 
or combination of deficiencies, in
internal control over financial reporting, such that there is a reasonable possibility
 
that a material misstatement of annual or interim
financial statements will not be prevented or detected on a timely basis.
 
18
During 2020 and 2021, the Company dedicated multiple internal resources
 
and supplemented those internal resources with
various third-party specialists to assist with the formalization of
 
a robust and detailed remediation plan.
 
In undertaking remediation
activities, the Company has established a global network of personnel
 
to assist local management in understanding control
performance and documentation requirements.
 
In order to sustain this network, the Company conducts periodic trainings and hosts
discussions to address questions on a current basis.
 
As of December 31, 2021, the Company has remediated all of the previously
identified material weaknesses and concluded that the Company’s
 
internal control over financial reporting is effective.
Our Management, including our chief executive officer
 
and chief financial officer, does not expect
 
that our internal control over
financial reporting will prevent all errors and all fraud.
 
A control system, no matter how well designed and operated, can provide
 
only
reasonable, not absolute, assurance that the control system’s
 
objectives will be met.
 
Further, the design of a control system must
reflect the fact that there are resource constraints, and the benefits of
 
controls must be considered relative to their costs.
 
Controls can
be circumvented by the individual acts of some persons, by collusion of two or
 
more people, or by management override of the
controls.
 
Over time, controls may become inadequate because of changes in circumstances or deterioration
 
in the degree of
compliance with policies or procedures may occur.
 
Because of the inherent limitations in a cost-effective control
 
system,
misstatements due to error or fraud may occur and may not be detected.
Item 1B.
 
Unresolved Staff Comments.
None.
Item 2.
 
Properties.
Quaker Houghton’s corporate
 
headquarters and a laboratory facility are located in its Americas segment’s
 
Conshohocken,
Pennsylvania location.
 
The Company’s other principal facilities in
 
its America’s segment are located
 
in Carrollton, Georgia; Zion,
Illinois;
 
Detroit, Michigan; Dayton, Ohio; Middletown, Ohio; Strongsville,
 
Ohio; Waterloo, Ontario;
 
Monterrey, N.L., Mexico;
 
Rio
de Janeiro, Brazil and Sao Paulo, Brazil.
 
The Company’s EMEA segment has
 
principal facilities in Uithoorn, The Netherlands;
Dortmund, Germany; Barcelona, Spain; Navarra, Spain; Karlshamn, Sweden;
 
Tradate, Italy; and Turin, Italy.
 
The Company’s
Asia/Pacific segment operates out of its principal facilities located in
 
Qingpu, China; Songjiang, China; Kolkata, India; Rayong,
Thailand; and Moorabbin, Australia.
 
The Company’s Global Specialty Businesses
 
segment operates out of its principal facilities in
Aurora, Illinois; Santa Fe Springs, California; Batavia, New York;
 
Waukegan, Illinois;
 
Zion, Illinois; Madison Heights, Michigan;
Lewisburg, Tennessee;
 
and Coventry, U.K.
 
With the exception of the Conshohocken, Santa Fe Springs,
 
Madison Heights, Lewisburg,
Aurora, Karlshamn, Rayong, Coventry,
 
and Sydney sites, which are leased, the remaining principal facilities are owned by the
Company and, as of December 31, 2021, were mortgage free.
 
Quaker Houghton also leases sales, laboratory,
 
manufacturing, and
warehouse facilities in other locations.
Quaker Houghton’s principal
 
facilities consist of various manufacturing, administrative, warehouse,
 
and laboratory buildings.
 
Most of the buildings are of fire-resistant construction and are equipped
 
with sprinkler systems.
 
The Company has a program to
identify needed capital improvements that are implemented as management
 
considers necessary or desirable.
 
Most locations have raw
material storage tanks, ranging from 1 to 155 at each location with capacities
 
ranging from 1,000 to 82,000 gallons, and processing or
manufacturing vessels ranging in capacity from 2 to 29,000 gallons.
Each of Quaker Houghton’s
 
non-U.S. associated companies (in which it owns a 50% or less interest and has significant
 
influence)
owns or leases a plant and/or sales facilities in various locations,
 
with the exception of Primex, Ltd.
Item 3.
 
Legal Proceedings.
The Company is a party to proceedings, cases, and requests for information from,
 
and negotiations with, various claimants and
Federal and state agencies relating to various matters, including environmental
 
matters.
 
For information concerning pending asbestos-
related litigation against an inactive subsidiary,
 
certain environmental non-capital remediation costs and other legal-related
 
matters,
reference is made to Note 26 of Notes to Consolidated Financial Statements, included
 
in Item 8 of this Report, which is incorporated
herein by this reference.
 
The Company is a party to other litigation which management currently believes will not have
 
a material
adverse effect on the Company’s
 
results of operations, cash flow or financial condition.
Item 4.
 
Mine Safety Disclosures.
Not applicable.
 
 
19
Item 4(a).
 
Information about our
Executive Officers.
Set forth below is information regarding the executive officers
 
of the Company,
 
each of whom (with the exception of Andrew E.
Tometich) have
 
been employed by the Company or by Houghton for at least five years, including the respective
 
positions and offices
with the Company (or Houghton) held by each over the respective periods
 
indicated.
 
Each of the executive officers, with the
exception of David A. Will,
 
is appointed annually to a one year term.
 
Mr. Will is considered
 
an executive officer in his capacity as
principal accounting officer for purposes of this Item
 
4(a).
Name, Age, and Present
Position with the Company
 
Business Experience During the Past Five
Years
 
and Period Served as an Officer
 
 
Andrew E. Tometich,
 
55
 
Chief Executive Officer and President
Mr. Tometich,
 
who has been employed by the Company since October 13, 2021, has
served as Chief Executive Officer and President since December
 
1, 2021.
 
Prior to
joining the Company, Mr.
 
Tometich served as Executive Vice
 
President, Hygiene,
Health and Consumable Adhesives at H.B. Fuller from August 2019 until
September 17, 2021.
 
Before that, Mr. Tometich
 
was Senior Vice President,
Specialty Materials Business at Corning Incorporated from September
 
2017 until
August 2019 and President, Performance Silicones Business Unit at The Dow
Chemical Company from June 2016 until February 2017 after having positions
 
of
increasing responsibility at Dow Corning Corporation and its subsidiaries
 
from 1989
through 2016.
Joseph A. Berquist, 50
 
Executive Vice President,
 
Chief Strategy
Officer, and Managing Director,
 
Global
Specialty Businesses
Mr. Berquist, who has been employed
 
by the Company since 1997, has served as
Executive Vice President,
 
Chief Strategy Officer, and Managing
 
Director, Global
Specialty Businesses since September 9, 2021.
 
Prior to that role, he served as
Senior Vice President, Global Specialty
 
Businesses and Chief Strategy Officer from
August 2019 to September 8, 2021.
 
Mr. Berquist served as Vice
 
President and
Managing Director – North America from April 2010 until July 2019.
Jeewat Bijlani, 45
Senior Vice President,
 
Managing Director - Americas
Mr. Bijlani has served as Senior
 
Vice President, Managing Director
 
- Americas
since he joined the Company in August 2019.
 
Prior to joining the Company,
 
Mr.
Bijlani served as President, Americas and Global Strategic Businesses of Houghton
from March 2015 until July 2019.
Shane W.
 
Hostetter, 40
Senior Vice President,
 
Chief Financial
 
Officer
Mr. Hostetter,
 
who has been employed by the Company since July 2011,
 
has served
as Senior Vice President, Chief
 
Financial Officer since April 19, 2021.
 
Prior to that
role, he served as Vice President,
 
Finance and Chief Accounting Officer from
August 2019 until April 18, 2021.
 
He served as Global Controller and Principal
Accounting Officer from September 2014 until July 2019.
Dieter Laininger, 58
Senior Vice President, Managing
 
Director - Asia / Pacific
Mr. Laininger,
 
who has been employed by the Company since 1991, has served as
Senior Vice President, Managing
 
Director – Asia / Pacific since August 2019.
 
He
served as Vice President and Managing
 
Director – Asia / Pacific from April 2018
until July 2019, in addition to his role as Vice
 
President and Managing Director -
South America, a position he assumed in January 2013 and held until
 
July 2019.
 
Mr. Laininger also served
 
as Vice President and Global Leader
 
– Primary Metals, a
position which he assumed in June 2011 and
 
held until July 2019.
 
Wilbert Platzer, 60
Senior Vice President, Global
 
Operations,
 
Environmental Health & Safety (“EHS”) and
 
Procurement
Mr. Platzer,
 
who has been employed by the Company since 1995, has served as
Senior Vice President, Global Operations,
 
EHS and Procurement since August
2019.
 
He previously served as Vice President, Global
 
Operations, EHS and
Procurement from April 2018 until July 2019.
 
Prior to that role, Mr. Platzer served
as Vice President and Managing
 
Director – EMEA from January 2006 through
March 2018.
 
 
 
20
Name, Age, and Present
Position with the Company
 
Business Experience During the Past Five
Years
 
and Period Served as an Officer
Dr. David Slinkman, 57
Senior Vice President, Chief Technology
Officer
Dr.
 
Slinkman has
 
served as
 
Senior Vice
 
President,
 
Chief Technology
 
Officer
 
since
he joined
 
the Company
 
in August 2019.
 
Prior to
 
joining the
 
Company,
Dr.
 
Slinkman
 
served as
 
Vice President
 
of Technology
 
of Houghton
 
from March
2012 until
 
July 2019.
Adrian Steeples, 61
Senior Vice President, Managing
Director – EMEA
Mr. Steeples, who has been employed
 
by the Company since 2010, has served as
Senior Vice President, Managing
 
Director – EMEA since August 2019.
 
He
previously served as Vice President
 
and Managing Director – EMEA from April
2018 until July 2019.
 
Prior to that role, he served as Vice President and
 
Managing
Director - Asia/Pacific from July 2013 through March 2018.
 
Robert T. Traub,
 
57
Senior Vice President, General
 
Counsel and
Corporate Secretary
Mr. Traub,
 
who has been employed by the Company since 2000, has served as
Senior Vice President, General Counsel
 
and Corporate Secretary since August 2019.
 
He previously served as Vice President,
 
General Counsel and Corporate Secretary
from April 2015 until July 2019.
David A. Will, 37
Vice President, Global Controller
 
and
Principal Accounting Officer
Mr. Will,
 
who has been employed by the Company since 2014, has served as Vice
President, Global Controller, and Principal
 
Accounting Officer since April 19, 2021.
Prior to that role, Mr. Will
 
served as the Corporate Controller from August 2019
until April 18, 2021.
 
Before that, he served as the Global Assistant Controller from
December 2014 to August 2019.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
21
PART
 
II
Item 5.
 
Market for Registrant’s Common
 
Equity, Related Stockholder Matters and Issuer Purchases
 
of Equity Securities.
The Company’s common
 
stock is listed on the New York
 
Stock Exchange (“NYSE”) under the trading symbol KWR.
 
Our Board
declared cash dividends that totaled $1.62 per share of outstanding
 
common stock or $29.0 million during the year ended December
31, 2021 and $1.56 per share of outstanding common stock or $27.8 million
 
during the year ended December 31, 2020.
 
In February
and May 2021, our Board declared quarterly cash dividends of
 
$0.395 per share of outstanding common stock, payable to shareholders
of record in April 2021 and July 2021, respectively.
 
Subsequently, our Board declared
 
quarterly dividends of $0.415 per share of
outstanding common stock in August and November 2021, respectively,
 
payable to shareholders of record in October 2021 and
January 2022, respectively.
 
We currently
 
expect to continue to pay comparable cash dividends on a quarterly basis in the future.
 
Future declaration of dividends
 
and the establishment of future record dates and payment dates are subject
 
to the final determination of
our Board, and will be based on our future financial condition, results of
 
operations, capital requirements, capital expenditure
requirements, contractual restrictions, anticipated cash needs, business
 
prospects, provisions of applicable law and other factors our
Board may deem relevant.
There are no restrictions that the Company believes are likely to materially
 
limit the payment of future dividends.
 
However,
under the Credit Facility there are certain restrictions, including a limit on dividends
 
paid not to exceed the greater of $50.0 million
annually and 20% of consolidated EBITDA so long as there is no default under
 
the Credit Facility.
 
Reference is made to the
“Liquidity and Capital Resources” disclosure contained in Item 7 of this Report.
As of January 17, 2022, 17,899,286 shares of Quaker common stock
 
were issued and outstanding and were held by 649
shareholders of record.
 
Each share of common stock is entitled to one vote per share.
Reference is made to the information in Item 12 of this Report under the
 
caption “Equity Compensation Plans,” which is
incorporated herein by this reference.
The following table sets forth information concerning shares of
 
the Company’s common stock acquired
 
by the Company during
the fourth quarter of 2021 for the period covered by this report:
Issuer Purchases of Equity Securities
(c)
(d)
Total
 
Number of
 
Approximate Dollar
(a)
(b)
Shares Purchased
Value of
 
Shares that
Total
 
Number
Average
as part of Publicly
May Yet
 
be
of Shares
Price Paid
Announced Plans
 
Purchased Under the
Period
Purchased (1)
Per Share (2)
or Programs
Plans or Programs (3)
October 1 - October 31, 2021
-
$
-
-
$
86,865,026
 
November 1 - November 30, 2021
-
$
-
-
$
86,865,026
 
December
 
1 - December 31, 2021
-
$
-
-
$
86,865,026
 
Total
-
$
-
-
$
86,865,026
 
(1)
The Company did not acquire any shares of the Company’s
 
common stock from employees during the fourth quarter of 2021.
 
All shares that would be acquired from employees are related to the surrender of
 
Quaker Chemical Corporation shares in
payment of the exercise price of employee stock options exercised or
 
for the payment of taxes upon exercise of employee
stock options or the vesting of restricted stock.
 
(2)
The Company did not acquire any shares of the Company’s
 
common stock from employees during the fourth quarter of 2021.
 
The price that would be paid for shares acquired from employees pursuant to employee
 
benefit and share-based compensation
plans is based on the closing price of the Company’s
 
common stock on the date of exercise or vesting as specified by the plan
pursuant to which the applicable option, restricted stock award, or restricted
 
stock unit was granted.
 
(3)
On May 6, 2015, the Board of Directors of the Company approved, and
 
the Company announced, a share repurchase
program, pursuant to which the Company is authorized to repurchase
 
up to $100,000,000 of Quaker Chemical Corporation
common stock (the “2015 Share Repurchase Program”), and it has no expiration
 
date.
 
There were no shares acquired by the
Company pursuant to the 2015 Share Repurchase Program during
 
the quarter ended December 31, 2021.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
https://cdn.kscope.io/56396d4ccd17d25bc45fe500b7d82e0a-kwr-20211231p23i0.gif
22
Stock Performance
 
Graph:
 
The following
 
graph compares
 
the cumulative
 
total return (assuming
 
reinvestment of
 
dividends) from
December 31, 2016 to December
 
31, 2021 for (i) Quaker’s
 
common stock, (ii) the S&P MidCap
 
400 Index (the “MidCap Index”),
 
and
(iii) the S&P 400
 
Materials Group Index
 
(the “Materials Group
 
Index”).
 
The graph assumes the
 
investment of $100 on
 
December 31,
2016 in each of Quaker’s common stock, the stocks comprising
 
the MidCap Index and the Materials Group Index, respectively.
 
 
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
Quaker
$
100.00
$
119.03
$
141.53
$
132.11
$
205.30
$
188.21
MidCap Index
100.00
116.24
103.36
130.44
148.26
184.97
Materials Group Index
100.00
121.55
96.79
116.99
129.45
171.17
Item 6.
 
Selected Financial Data.
Reserved.
23
Item 7.
 
Management’s Discussion and Analysis
 
of Financial Condition and Results of Operations.
As used in this Annual Report on Form 10-K (the “Report”), the terms “Quaker
 
Houghton,” the “Company,”
 
“we,” and “our”
refer to Quaker Chemical Corporation (doing business as Quaker
 
Houghton), its subsidiaries, and associated companies, unless the
context otherwise requires.
 
The term Legacy Quaker refers to the Company prior to the closing of its combination
 
with Houghton
International, Inc. (“Houghton”) (herein referred to as the “Combination”)
 
on August 1, 2019.
 
Throughout the Report, all figures
presented, unless otherwise stated, reflect the results of operations
 
of the combined company for the years ended December 31, 2020
and 2021; and for the year ended
 
December 31, 2019, the results of Legacy Quaker plus five months
 
of Houghton’s operations post-
closing of the Combination on August 1, 2019.
Executive Summary
Quaker Houghton is the global leader in industrial process fluids.
 
With a presence around the world, including
 
operations in over
25 countries, our customers include thousands of the world’s
 
most advanced and specialized steel, aluminum, automotive, aerospace,
offshore, can, mining, and metalworking companies.
 
Our high-performing, innovative and sustainable solutions are backed by best-
in-class technology,
 
deep process knowledge, and customized services.
 
Quaker Houghton is headquartered in Conshohocken,
Pennsylvania, located near Philadelphia in the U.S.
Overall, the Company’s 2021 performance
 
was highlighted by the continued recovery from the impacts of COVID-19 in
 
2020 as
well as the ongoing execution of integration activities and synergy
 
realization, which led to record net sales and adjusted EBITDA in
2021 despite the continued escalation in raw material cost headwinds
 
and global supply chain pressures.
 
Specifically, net sales of
$1,761.2 million in 2021
 
increased 24% compared to $1,417.7 million in 2020, primarily
 
due to higher volumes of approximately
13%, including additional net sales from acquisitions of 4%, increases from
 
selling price and product mix of approximately 8% and
the positive impact from foreign currency translation of 3%.
 
The increase in sales volumes
 
compared to 2020 was primarily a result
of continued new business wins and the year-over-year
 
improvement in end market conditions since the beginning of the COVID-19
pandemic in early 2020, partially offset by lower automotive
 
sales due to semiconductor shortages and delayed shipments due
 
to
supply chain challenges that occurred towards the end of 2021.
 
The increase in selling price and product mix is primarily the result of
the Company’s broad price
 
increases implemented during 2021 to help offset the unprecedented
 
increases in raw material costs as well
as global supply chain and logistics cost pressures the Company has experienced
 
throughout 2021.
The Company’s net income and
 
earnings per diluted share of $121.4 million and $6.77 in 2021, respectively,
 
increased compared
to $39.7 million and $2.22 per diluted share, respectively,
 
in 2020.
 
Excluding non-recurring items, including costs associated with the
Combination and other non-core items in each period, the Company’s
 
current year non-GAAP net income and non-GAAP earnings
per diluted share were $122.8 million and $6.85, respectively,
 
compared to $85.2 million and $4.78, respectively,
 
in 2020.
 
The
increase in the Company’s current
 
year earnings drove a 23% higher adjusted EBITDA to a full year record
 
of $274.1 million
compared to $222.0 million in 2020, primarily due to the significant increase
 
in net sales year-over-year as well as higher realized cost
synergies from the Combination, partially offset
 
by lower gross margins driven by higher raw material and input costs and the
 
impacts
of disruptions in the global supply chain experienced in 2021 as well as higher selling,
 
general and administrative expenses (“SG&A”)
including the impact of higher sales on direct selling expenses and additional
 
SG&A from recent acquisitions.
The Company’s 2021
 
operating performance in each of its four reportable segments: (i) Americas; (ii) EMEA;
 
(iii) Asia/Pacific;
and (iv) Global Specialty Businesses, reflect similar drivers to that of
 
its consolidated performance.
 
All four segments had higher net
sales compared to 2020 reflecting the continued rebound in 2021
 
from the negative impacts of COVID-19 on the Company’s
 
end
markets as well as continued success of winning new business in each of the
 
Company’s segments during 2021.
 
Each of the
Company’s geographic segments
 
benefited from higher organic sales volumes in 2021
 
while all of the Company’s segments also
benefitted from additional net sales from acquisitions, the positive impact
 
from foreign currency translation due to the strengthening of
most major currencies against the U.S. dollar,
 
and from increases in selling price and product mix.
 
As reported, each of the
Company’s reportable
 
segment operating earnings were higher compared to 2020 reflecting the increase
 
in net sales including the
benefits of acquisitions and other factors mentioned;
 
however, all of the Company’s
 
segment’s operating earnings were negatively
impacted by persistent raw material inflation, higher logistics, labor and manufacturing
 
costs, impacts of disruptions to the global
supply chain as well as higher SG&A which were a result of an increase
 
in direct selling expenses associated with year-over-year
inflation increases and increases due to the increase in net sales as well as the lower levels
 
of prior year SG&A as a result of
temporary cost saving measures implemented in response to COVID-19.
 
Additional details of each segment’s
 
operating performance
are further discussed in the Company’s
 
reportable segments review, in the
 
Operations section of this Item 7, below.
 
The Company generated net operating cash flow of $48.9 million in 2021
 
compared to $178.4 million in 2020.
 
The decrease in
net operating cash flow year-over-year
 
was primarily driven by a significant change in working capital compared
 
to the prior year,
mainly increases in accounts receivable, due to higher net sales and in inventory,
 
due to higher costs as well as building inventories in
response to global supply chain and logistics pressures.
 
The key drivers of the Company’s operating
 
cash flow and overall liquidity
are further discussed in the Company’s
 
Liquidity and Capital Resources section of this Item 7, below.
 
Overall, the Company’s 2021 results
 
were good and reflected the Company’s
 
ability to navigate through persistent raw material
cost pressures, supply chain challenges and automotive semiconductor
 
shortages.
 
Increases in net sales in all segments were driven by
the continued year-over-year improvement
 
in the Company’s end-markets and increased
 
customer demand from lower levels
experienced during 2020 as a result of COVID-19; however,
 
each segment was negatively impacted by the significant
 
escalation of
24
raw material costs as well as higher levels of SG&A compared to the prior
 
year which included certain temporary cost saving
measures adopted during the onset of COVID-19.
 
Continued strong customer demand in 2021 coupled with ongoing new business
wins and the execution of integration activities and synergy realization
 
helped to partially offset the negative impacts from the
continued escalation of raw material costs and continued supply chain pressures.
As the Company looks toward 2022, the business is well positioned to
 
continue to outpace market growth rates and deliver value-
added solutions and services to its customers.
 
Demand remains healthy across most of our end markets; however,
 
the Company
expects raw material cost pressures and supply chain disruptions to persist throughout
 
2022.
 
To mitigate these headwinds,
 
the
Company continues to implement further price actions and is actively
 
managing its cost structure.
 
The Company believes these
actions will begin to drive a recovery in margins as it progresses through
 
2022.
 
The Company remains committed to advancing its
customer intimate strategy and sustainability program and delivering
 
earnings growth in 2022 and beyond.
On-going impact of COVID-19
The global outbreak of COVID-19 has negatively impacted all locations where
 
the Company does business.
 
Although the
Company has now operated in this COVID-19 environment for almost
 
two years, the full extent of the outbreak and related business
impacts continue to remain uncertain and volatile, and therefore the
 
full extent to which COVID-19 may impact the Company’s
 
future
results of operations or financial condition is uncertain.
 
This outbreak has significantly disrupted the operations of the Company
 
and
those of its suppliers and customers.
 
During the pandemic, the Company initially experienced volume declines
 
and lower net sales as
compared to pre-COVID-19 levels, as further described in this section.
 
Management continues to monitor the impact that the
COVID-19 pandemic is having on the Company,
 
the overall specialty chemical industry and the economies and markets in which the
Company operates.
 
The prolonged pandemic and resurgences of the outbreak including as new
 
variants continue to emerge, and
continued restrictions on day-to-day life and business
 
operations as well as increased border controls or closures and transportation
disruptions may result in volume declines and lower net sales in future periods.
 
To the extent that the Company’s
 
customers and
suppliers continue to be significantly and adversely impacted by
 
COVID-19, this could reduce the availability,
 
or result in delays, of
materials or supplies to or from the Company,
 
which in turn could significantly interrupt the Company’s
 
business operations.
 
Given
this ongoing uncertainty,
 
the Company cautions that its future results of operations could be significantly adversely
 
impacted by
COVID-19.
 
Further, management continues to evaluate
 
how COVID-19-related circumstances, such as remote work arrangements,
illness or staffing shortages and travel restrictions have affected
 
financial reporting processes and systems, internal control over
financial reporting, and disclosure controls and procedures.
 
While the circumstances have presented and are expected to continue
 
to
present challenges, and have necessitated additional time and resources
 
to be deployed to sufficiently address the challenges brought
on by the pandemic, at this time, management does not believe that COVID-19
 
has had a material impact on financial reporting
processes, internal controls over financial reporting, or disclosure controls
 
and procedures.
 
The Company’s top priority,
 
especially during this pandemic, is to protect the health and safety of its employees
 
and customers,
while working to ensure business continuity to meet customers’ needs.
 
The Company continues to take steps to protect the health and
wellbeing of its people in affected areas through various
 
actions, including enabling work at home where needed and practicable, and
employing social distancing standards, implementing
 
travel restrictions where applicable, enhancing onsite hygiene practices, and
instituting visitation restrictions at the Company’s
 
facilities.
 
The Company has not and does not expect that it will incur material
expenses implementing these health and safety policies.
 
All of the Company’s more than 30 production
 
facilities worldwide are open
and operating and are deemed as essential businesses in the jurisdictions where
 
they are operating.
 
The Company believes that to date
it has been able to meet the needs of all its customers across the globe despite
 
the current economic challenges.
 
The Company’s fiscal
year 2021 showed year-over-year improvement
 
from the prior fiscal year and continued a trend of gradual volume improvement which
began in the second half of 2020.
 
The Company continues to expect that the impacts from COVID-19 will gradually
 
decline subject
to the effective containment of the virus and its variants and successful
 
distribution and acceptance of the available vaccines and
treatments.
 
However, the incidence of reported cases of COVID-19
 
or a variant in several geographies where the Company has
significant operations remains high and continues to evolve and it remains
 
highly uncertain as to how long the global pandemic and
related economic challenges will last and when our customers’ businesses will recover
 
to pre-COVID-19 levels.
 
The Company took
various actions to temporarily conserve cash and reduce costs since the onset of
 
the pandemic and these temporary initiatives were
designed and implemented so that the Company could successfully manage
 
through the challenging COVID-19 situation while
continuing to protect the health of its employees, meet customers’ needs,
 
maintain the Company’s long-term competitive
 
advantages
and above-market growth, and enable it to continue to effectively
 
integrate Houghton.
 
While the actions taken to date to protect our
workforce, to continue to serve our customers with excellence and to conserve
 
cash and reduce costs, have been effective thus far,
further actions to respond to the pandemic and its effects may
 
be necessary as conditions continue to evolve.
Critical Accounting Policies and Estimates
Quaker Houghton’s discussion
 
and analysis of its financial condition and results of operations are based
 
upon its consolidated
financial statements which have been prepared in accordance with accounting
 
principles generally accepted in the United States (“U.S.
GAAP”).
 
The preparation of these financial statements requires the Company
 
to make estimates and judgments that affect the
reported amounts of assets, liabilities, revenues and expenses, and related disclosure
 
of contingent assets and liabilities.
 
On an
ongoing basis, the Company evaluates its estimates, including those related
 
to customer sales incentives, product returns, bad debts,
inventories, property,
 
plant and equipment (“PP&E”), investments, goodwill, intangible assets, income taxes,
 
business combinations,
restructuring, incentive compensation plans (including equity-based
 
compensation), pensions and other postretirement benefits,
25
contingencies and litigation.
 
Quaker Houghton bases its estimates on historical experience and on various
 
other assumptions that are
believed to be reasonable under such circumstances, the results of which
 
form the basis for making judgments about the carrying
values of assets and liabilities that are not readily apparent from other sources.
 
However, actual results may differ from
 
these
estimates under different assumptions or conditions.
Quaker Houghton believes the following critical accounting policies describe
 
the more significant judgments and estimates used
in the preparation of its consolidated financial statements:
Accounts receivable and inventory exposures:
 
Quaker Houghton establishes allowances for doubtful accounts for estimated
losses resulting from the inability of its customers to make required
 
payments.
 
If the financial condition of the Company’s
 
customers
were to deteriorate, resulting in an impairment of their ability to make payments,
 
additional allowances may be required.
 
As part of
our terms of trade, we may custom manufacture products for certain large
 
customers and/or may ship products on a consignment basis.
Further, a significant portion of our revenue
 
is derived from sales to customers in industries where companies have experienced
 
past
financial difficulties.
 
If a significant customer bankruptcy occurs, then we must judge the amount of proceeds,
 
if any, that may
ultimately be received through the bankruptcy or liquidation process.
 
These matters may increase the Company’s
 
exposure should a
bankruptcy occur, and may require
 
a write down or a disposal of certain inventory as well as the failure to collect receivables.
 
Reserves for customers filing for bankruptcy protection are established
 
based on a percentage of the amount of receivables outstanding
at the bankruptcy filing date.
 
However, initially establishing this reserve
 
and the amount thereof is dependent on the Company’s
evaluation of likely proceeds to be received from the bankruptcy process, which
 
could result in the Company recognizing minimal or
no reserve at the date of bankruptcy.
 
We generally reserve
 
for large and/or financially distressed customers on a specific review
 
basis,
while a general reserve is maintained for other customers based on
 
historical experience.
 
The Company’s consolidated
 
allowance for
doubtful accounts was $12.3 million and $13.1 million as of December 31,
 
2021
 
and 2020, respectively.
 
The Company recorded
expense to increase its provision for doubtful accounts by $0.7 million,
 
$3.6 million and $1.9 million for the years ended December
31, 2021, 2020 and 2019, respectively.
 
Changing the amount of expense recorded to the Company’s
 
provisions by 10% would have
increased or decreased the Company’s
 
pre-tax earnings by $0.1 million, $0.4
 
million and $0.2 million for the years ended December
31, 2021, 2020 and 2019, respectively.
 
See Note 13 of Notes to Consolidated Financial Statements in Item 8 of this Report.
Environmental and litigation reserves:
 
Accruals
 
for environmental and litigation matters are recorded when
 
it is probable that a
liability has been incurred and the amount of the liability can be reasonably
 
estimated.
 
Environmental costs and remediation costs are
capitalized if the costs extend the life, increase the capacity or improve
 
the safety or efficiency of the property from the date acquired
or constructed, and/or mitigate or prevent contamination in the future.
 
Estimates for accruals for environmental matters are based on a
variety of potential technical solutions, governmental regulations and
 
other factors, and are subject to a wide range of potential costs
for remediation and other actions.
 
A considerable amount of judgment is required in determining the most likely
 
estimate within the
range of total costs, and the factors determining this judgment may vary
 
over time.
 
Similarly, reserves for litigation
 
and similar
matters are based on a range of potential outcomes and require considerable
 
judgment in determining the most probable outcome.
 
If
no amount within the range is considered more probable than any other
 
amount, the Company accrues the lowest amount in that range
in accordance with generally accepted accounting principles.
 
See Note 26 of Notes to Consolidated Financial Statements in Item 8 of
this Report.
Realizability of equity investments:
 
The Company holds equity investments in various foreign companies
 
where it has the
ability to influence, but not control, the operations of the entity
 
and its future results.
 
The Company would record an impairment
charge to an investment if it concluded that a decline in value that was other
 
than temporary occurred.
 
Adverse changes in market
conditions, poor operating results of underlying investments, devaluation
 
of foreign currencies or other events or circumstances could
result in losses or an inability to recover the carrying value of the investments,
 
potentially leading to an impairment charge in the
future.
 
The carrying amount of the Company’s
 
equity investments as of December 31, 2021
 
was $95.3
 
million, which included four
investments: $21.5 million for a 32% interest in Primex, Ltd. (Barbados);
 
$7.1 million for a 50% interest in Nippon Quaker Chemical,
Ltd. (Japan); $0.3 million for a 50% interest in Kelko Quaker Chemical, S.A.
 
(Panama); and $66.4 million for a 50% interest in Korea
Houghton Corporation (Korea).
 
The Company also has a 50% interest in a Venezuelan
 
affiliate, Kelko Quaker Chemical, S.A
(Venezuela).
 
Due to heightened foreign exchange controls, deteriorating economic circumstances
 
and other restrictions in Venezuela,
during 2018 the Company concluded that it no longer had significant
 
influence over this affiliate.
 
Prior to this determination, the
Company historically accounted for this affiliate under
 
the equity method.
 
As of December 31, 2021
 
and 2020, the Company had no
remaining carrying value for its investment in Venezuela.
 
See Note 17 of Notes to Consolidated Financial Statements in Item 8 of this
Report.
Tax
 
exposures, uncertain tax positions and valuation allowances:
 
Quaker Houghton records expenses and liabilities for taxes
based on estimates of amounts that will be determined as deductible in tax
 
returns filed in various jurisdictions.
 
The filed tax returns
are subject to audit, which often occur several years subsequent to
 
the date of the financial statements.
 
Disputes or disagreements may
arise during audits over the timing or validity of certain items or deductions,
 
which may not be resolved for extended periods of time.
 
The Company also evaluates uncertain tax positions on all income tax
 
positions taken on previously filed tax returns or expected to be
taken on a future tax return in accordance with FIN 48, which prescribes
 
the recognition threshold and measurement attributes for
financial statement recognition and measurement of tax positions taken
 
or expected to be taken on a tax return and, also, whether the
benefits of tax positions are probable or if they will be more likely than not to be sustained upon
 
audit based upon the technical merits
of the tax position.
 
For tax positions that are determined to be more likely than not to be sustained upon audit, the
 
Company
26
recognizes the largest amount of benefit that is greater
 
than 50% likely of being realized upon ultimate settlement in the financial
statements.
 
For tax positions that are not determined to be more likely than not
 
sustained upon audit, the Company does not recognize
any portion of the benefit in its financial statements.
 
In addition, the Company’s
 
continuing practice is to recognize interest and/or
penalties related to income tax matters in income tax expense.
 
Also, the Company nets its liability for unrecognized tax benefits
against deferred tax assets related to net operating losses or other tax credit carryforward
 
on the basis that the uncertain tax position is
settled for the presumed amount at the balance sheet date.
Quaker Houghton also records valuation allowances when necessary
 
to reduce its deferred tax assets to the amount that is more
likely than not to be realized.
 
While the Company has considered future taxable income and assesses the need for
 
a valuation
allowance, in the event Quaker Houghton were to determine that it would
 
be able to realize its deferred tax assets in the future in
excess of its net recorded amount, an adjustment to the deferred
 
tax asset would increase income in the period such determination was
made.
 
Likewise, should the Company determine that it would not be able to realize all or part of
 
its net deferred tax assets in the
future, an adjustment to the deferred tax asset would be charged
 
to income in the period such determination was made.
 
Both
determinations could have a material impact on the Company’s
 
financial statements.
Pursuant to the Tax
 
Cuts and Jobs Act (“U.S. Tax
 
Reform”), the Company recorded a $15.5 million transition tax liability
 
for
U.S. income taxes on the undistributed earnings of non-U.S. subsidiaries.
 
As of December 31, 2021, $7.0 million in installment have
been paid with the remaining $8.5 million to be paid through installments in future
 
years.
 
However, the Company may also be subject
to other taxes, such as withholding taxes and dividend distribution taxes,
 
if these undistributed earnings are ultimately remitted to the
U.S.
 
As of December 31, 2021, the Company has a deferred tax liability of
 
$8.4 million, which primarily represents the estimate of
the non-U.S. taxes the Company will incur to remit certain previously
 
taxed earnings to the U.S.
 
It is the Company’s current intention
to reinvest its future undistributed earnings of non-U.S. subsidiaries to support
 
working capital needs and certain other growth
initiatives outside of the U.S.
 
The amount of such undistributed earnings at December 31, 2021
 
was approximately $377.4
million.
 
Any tax liability which might result from ultimate remittance of these earnings
 
is expected to be substantially offset by
foreign tax credits (subject to certain limitations).
 
It is currently impractical to estimate any such incremental tax expense.
 
See Note
10 of Notes to Consolidated Financial Statements in Item 8 of this Report.
Goodwill and other intangible assets:
 
The Company accounts for business combinations under the acquisition
 
method of
accounting.
 
This method requires the recording of acquired assets, including separately identifiable
 
intangible assets, at their
acquisition date fair values.
 
Any excess of the purchase price over the estimated fair value of the identifiable
 
net assets acquired is
recorded as goodwill.
 
The determination of the estimated fair value of assets acquired requires management’s
 
judgment and often
involves the use of significant estimates and assumptions, including
 
assumptions with respect to future cash inflows and outflows,
discount rates, royalty rates, asset lives and market multiples, among other
 
items.
 
When necessary, the Company consults with
external advisors to help determine fair value.
 
For non-observable market values, the Company may determine fair value
 
using
acceptable valuation principles, including the excess earnings, relief
 
from royalty, lost profit or cost
 
methods.
The Company amortizes definite-lived intangible assets on a straight-line
 
basis over their useful lives.
 
Goodwill and intangible
assets that have indefinite lives are not amortized and are required to be assessed at least annually
 
for impairment.
 
The Company
completes its annual goodwill and indefinite-lived intangible asset impairment
 
test during the fourth quarter of each year, or
 
more
frequently if triggering events indicate a possible impairment.
 
The Company’s consolidated
 
goodwill at both December 31, 2021 and
2020 was $631.2 million.
 
The Company completed its annual impairment assessment over goodwill during
 
the fourth quarter of 2021
by performing a qualitative assessment.
 
Based on the assessment performed, the Company concluded that there
 
was no evidence of
events or circumstances that would indicate a material change from
 
the Company’s prior year quantitative
 
assessment by reporting
unit and, therefore, no impairment charges were
 
warranted.
 
The Company’s consolidated indefinite
 
-lived intangible assets at
December 31, 2021 and 2020 were $196.9 million and $205.1 million,
 
respectively, which primarily
 
consists of Houghton and
Fluidcare
TM
 
trademarks and tradename.
 
The Company completed its annual indefinite-lived intangible asset impairment assessment
during the fourth quarter of 2021, and determined that no impairment
 
charge was warranted.
 
The determination of estimated fair
value of these indefinite-lived intangible assets is based on a relief from royalty
 
valuation method, which requires management’s
judgment and often involves the use of significant estimates and assumptions,
 
including assumptions with respect to royalty rates, as
well as revenue growth rates and terminal growth rates.
 
The Company’s impairment assessment
 
concluded that the carrying value of
acquired Houghton and Fluidcare
TM
 
trademarks and tradename intangible assets exceeded fair value by
 
approximately 61%.
 
See Note
16 of Notes to Consolidated Financial Statements in Item 8 of this Report.
As previously disclosed, as of March 31, 2020, the Company concluded that
 
the impact of COVID-19 did not represent a
triggering
 
event with regards to any of the Company’s
 
indefinite-lived and long-lived assets, except for the Company’s
 
Houghton and
Fluidcare
TM
 
trademarks and tradename indefinite-lived intangible assets.
 
In the first quarter of 2020, as a result of the impact of
COVID-19 driving a decrease in projected legacy Houghton net sales during
 
that year and the impact of the sales decline on projected
future legacy Houghton net sales as well as an increase in the weighted average
 
cost of capital assumption utilized in the quantitative
impairment assessment, the Company concluded that the estimated fair
 
values of the Houghton and Fluidcare
TM
 
trademarks and
tradename intangible assets were less than their carrying values.
 
As a result, an impairment charge of $38.0 million
 
was recorded
during the first quarter of 2020 to write down the carrying values of these intangible
 
assets to their estimated fair values.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
27
Pension and Postretirement benefits:
 
The Company provides certain defined benefit pension and
 
other postretirement benefits
to current employees, former employees and retirees.
 
Independent actuaries, in accordance with U.S. GAAP,
 
perform the required
valuations to determine benefit expense and, if necessary,
 
non-cash charges to equity for additional minimum pension liabilities.
 
Critical assumptions used in the actuarial valuation include the weighted
 
average discount rate, which is based on applicable yield
curve data, including the use of a split discount rate (spot-rate approach)
 
for the U.S. plans and certain foreign plans, rates of increase
in compensation levels, and expected long-term rates of return
 
on assets.
 
If different assumptions were used, additional pension
expense or charges to equity might be required.
The following table highlights the potential impact on the Company’s
 
pre-tax earnings due to changes in assumptions with respect
to the Company’s defined benefit pension
 
and postretirement benefit plans, based on assets and liabilities as of December 31,
 
2021:
1/2 Percentage Point Increase
1/2 Percentage Point Decrease
(dollars in millions)
Foreign
U.S.
Total
Foreign
U.S.
Total
Discount rate (1)
$
(0.2)
$
0.2
$
0.0
 
$
0.3
$
(0.2)
$
0.1
Expected rate of return on plan
assets (2)
0.5
0.2
0.7
(0.5)
(0.2)
(0.7)
(1)
The weighted-average discount rate used to determine net periodic benefit
 
costs for the year ended December 31, 2021 was
1.4% for Foreign plans and 2.7% for U.S. plans.
(2)
The weighted average expected rate of return on plan assets used to determine
 
net periodic benefit costs for the year ended
December 31, 2021 was 2.1% for Foreign plans and 5.8% for U.S. plans.
Restructuring and other related liabilities:
 
A restructuring related program may consist of charges for
 
employee severance,
rationalization of manufacturing facilities and other related expenses.
 
To account for such, the
 
Company applies the Financial
Accounting Standards Board’s
 
guidance regarding exit or disposal cost obligations.
 
This guidance requires that a liability for a cost
associated with an exit or disposal activity be recognized when the liability
 
is incurred, is estimable, and payment is probable.
 
See
Note 7 of Notes to Consolidated Financial Statements in Item 8 of this Report.
Recently Issued Accounting Standards
See Note 3 of Notes to the Consolidated Financial Statements in Item 8 of this Report
 
for a discussion regarding recently issued
accounting standards.
 
Liquidity and Capital Resources
At December 31, 2021, the Company had cash, cash equivalents and
 
restricted cash of $165.2 million.
 
Total cash, cash
equivalents and restricted cash was $181.9 million at December
 
31, 2020.
 
The $16.7 million decrease in cash, cash equivalents and
restricted cash was the net result $49.1 million of cash used in investing
 
activities, $13.5 million of cash used in financing activities
 
and approximately $3.1 million of negative impacts due to the effect
 
of foreign currency translation on cash, partially offset by $48.9
million of cash provided by operating activities.
Net cash flows provided by operating activities were $48.9 million in
 
2021 compared to $178.4 million in 2020.
 
The Company’s
current year net operating cash flow decrease was primarily driven by
 
a significant change in working capital which more than offset
the Company’s higher earnings in 2021
 
.
 
The significant increase in current year net sales resulted in a large
 
increase in accounts
receivable in 2021 as compared to a significant decrease during
 
2020 as net sales and the associated accounts receivables significantly
declined in 2020
 
due to the negative impact from COVID-19.
 
In addition, the Company has experienced an increase in inventory in
2021 as a result of continued rising raw material costs as well as a build in
 
inventory to ensure the Company has appropriate stock to
meet customer demands in response to ongoing stress on the global supply
 
chain.
Net cash flows used in investing activities were $49.1 million in 2021
 
compared to $71.4 million in 2020.
 
This $22.3 million
decrease in cash outflows used in investing activities was due to lower cash payments
 
related to acquisitions during 2021 as a result of
the level of acquisition activity in each year and higher cash proceeds
 
from the disposition of assets, which includes the sale of certain
held-for-sale real property assets related to the Combination.
 
Capital expenditures also increased to $21.5 million in 2021 compared
to $17.9 million in 2020 due to the continued strategic and integration related
 
capital investments the Company has and continues to
make.
 
Net cash flows used in financing activities were $13.5 million in 2021
 
compared to $75.3 million in 2020.
 
The $61.8 million
decrease in net cash outflows from financing activities was primarily
 
driven by an increase in borrowings in the current year under the
Company’s revolving credit
 
facility compared to repayments in the prior year which was driven by significant
 
working capital
investment in the current year described above.
 
In addition, the Company paid $28.6 million of cash dividend during
 
2021, a $1.0
million or 4% increase in cash dividends compared to the prior year due to cash dividend
 
per share increases.
 
Finally, during 2020,
the Company used $1.0 million to purchase the remaining noncontrolling
 
interest in one of its South African affiliates.
 
Prior to this
buyout, this South African affiliate made a distribution
 
to the prior noncontrolling affiliate shareholder of approximately $0.8
 
million
in 2020.
 
There were no similar noncontrolling interest activities in 2021.
 
 
28
The Company’s primary credit facility
 
(the “Credit Facility”) is comprised of a $400.0 million multicurrency
 
revolver (the
“Revolver”), a $600.0 million term loan (the “U.S. Term
 
Loan”), each with the Company as borrower, and
 
a $150.0 million (as of
August 1, 2019) Euro equivalent term loan (the “Euro Term
 
Loan” and together with the “U.S. Term
 
Loan”, the “Term Loans”)
 
with
Quaker Chemical B.V.,
 
a Dutch subsidiary of the Company as borrower,
 
each with a five year term maturing in August 2024.
 
Subject
to the consent of the administrative agent and certain other conditions,
 
the Company may designate additional borrowers.
 
The
maximum amount available under the Credit Facility can be increased by
 
up to $300.0 million at the Company’s request
 
if there are
lenders who agree to accept additional commitments and the Company has
 
satisfied certain other conditions.
 
Borrowings under the
Credit Facility bear interest at a base rate or LIBOR plus an applicable margin
 
based upon the Company’s consolidated
 
net leverage
ratio.
 
On December 10, 2021, the Company amended the Credit Facility to include an update
 
to provide for the use of a non-USD
currency LIBOR successor rate.
 
The weighted average interest rate incurred on the outstanding borrowings
 
under the Credit Facility
during the year ended and as of December 31, 2021 was approximately
 
1.6%.
 
In addition to paying interest on outstanding principal
under the Credit Facility,
 
the Company is required to pay a commitment fee ranging from 0.2% to 0.3% depending
 
on the Company’s
consolidated net leverage ratio to the lenders under the Revolver in respect of
 
the unutilized commitments thereunder.
The Credit Facility is subject to certain financial and other covenants.
 
The Company’s initial consolidated net
 
debt to
consolidated adjusted EBITDA ratio could not exceed 4.25 to 1,
 
with step downs in the permitted ratio over the term of the Credit
Facility.
 
As of December 31, 2021, the consolidated net debt to consolidated
 
adjusted EBITDA ratio may not exceed 3.75 to 1.
 
The
Company’s consolidated
 
adjusted EBITDA to interest expense ratio may not be less than 3.0 to 1 over the
 
term of the agreement.
 
The
Credit Facility also prohibits the payment of cash dividends
 
if the Company is in default or if the amount of the dividends
 
paid
annually exceeds the greater of $50.0 million and 20% of consolidated adjusted
 
EBITDA unless the ratio of consolidated net debt to
consolidated adjusted EBITDA is less than 2.0 to 1, in which case there is no
 
such limitation on amount.
 
As of December 31, 2021
and 2020, the Company was in compliance with all of the Credit Facility covenants.
 
The Term Loans have quarterly
 
principal
amortization during their five year terms, with 5.0% amortization of
 
the principal balance due in years 1 and 2, 7.5% in year 3, and
10.0% in years 4 and 5, with the remaining principal amount due at maturity.
 
The Credit Facility is guaranteed by certain of the
Company’s domestic subsidiaries
 
and is secured by first-priority liens on substantially all of the assets of the
 
Company and the
domestic subsidiary guarantors, subject to certain customary exclusions.
 
The obligations of the Dutch borrower are guaranteed only
by certain foreign subsidiaries on an unsecured basis.
The Credit Facility required the Company to fix its variable interest rates on at least 20%
 
of its total Term Loans.
 
In order to
satisfy this requirement as well as to manage the Company’s
 
exposure to variable interest rate risk associated with the Credit Facility,
in November 2019, the Company entered into $170.0
 
million notional amounts of three year interest rate swaps at a base rate of 1.64%
plus an applicable margin as provided in the Credit Facility,
 
based on the Company’s consolidated
 
net leverage ratio.
 
At the time the
Company entered into the swaps, and as of December 31, 2021, the
 
aggregate interest rate on the swaps, including the fixed base rate
plus an applicable margin, was 3.1%.
 
The Company capitalized $23.7 million of certain third-party debt issuance
 
costs in connection with executing the Credit Facility.
 
Approximately $15.5 million of the capitalized costs were attributed to
 
the Term Loans and recorded
 
as a direct reduction of long-
term debt on the Company’s Consolidated
 
Balance Sheet.
 
Approximately $8.3 million of the capitalized costs were attributed
 
to the
Revolver and recorded within other assets on the Company’s
 
Consolidated Balance Sheet.
 
These capitalized costs are being
amortized into interest expense over the five year term of the Credit Facility.
 
As of December 31, 2021, the Company had Credit Facility borrowings
 
outstanding of $889.6 million.
 
As of December 31, 2020,
the Company had Credit Facility borrowings outstanding of $887.1
 
million.
 
The Company has unused capacity under the Revolver of
approximately $184 million, net of bank letters of credit of approximately
 
$4 million, as of December 31, 2021.
 
The Company’s other
debt obligations are primarily industrial development bonds
 
,
 
bank lines of credit and municipality-related loans, which totaled $11.8
million and $12.1
 
million as of December 31, 2021
 
and 2020, respectively.
 
Total unused capacity under
 
these arrangements as of
December 31, 2021 was approximately $26 million.
 
The Company’s total net debt
 
as of December 31, 2021 was $736.2 million.
The Company estimates that it realized full year cost synergies related
 
to the Combination in 2021
 
of approximately $75 million
compared to $58 million in 2020.
 
The Company has fully achieved its annual target Combination cost synergies
 
of approximately $80
million going forward.
 
The Company incurred $18.6 million of total Combination, integration
 
and other acquisition-related expenses
in 2021, which includes $0.7 million of accelerated depreciation
 
and is net of a $5.4 million gain on the sale of certain held-for-sale
real property assets and $0.6 million of other income related to an indemnification
 
asset, described in the Non-GAAP Measures
section of this Item below.
 
The Company had aggregate net cash outflows of approximately $20.6 million
 
related to the Combination,
integration and other acquisition-related expenses during 2021.
 
Comparatively, in 2020, the
 
Company incurred $30.3 million of total
Combination, integration and other acquisition-related expenses, including
 
$0.8 million of accelerated depreciation, a $0.6 million loss
on the sale of held-for-sale assets, an $0.8 million of other income related to an indemnification
 
asset, and aggregate net cash outflows
related to these costs were approximately $29.4 million.
While the Company has incurred significant integration costs in 2019, 2020
and 2021, the Company expects to incur additional integration and operating
 
costs as well as higher capital expenditures to further
optimize its footprint, processes and other functions over the next several years.
 
 
29
Quaker Houghton’s management
 
approved, and the Company initiated, a global restructuring plan (the
 
“QH Program”) in the
third quarter of 2019 as part of its planned cost synergies associated
 
with the Combination and recorded $26.7 million in restructuring
and related charges in 2019.
 
The Company recognized an additional $1.4 million and $5.5 million
 
of restructuring and related charges
in 2021 and 2020, respectively,
 
as a result of the QH Program.
 
The QH Program includes restructuring and associated severance costs
to reduce total headcount by approximately 400 people globally and
 
plans for the closure of certain manufacturing and non-
manufacturing facilities.
 
In connection with the plans for closure of certain manufacturing and non-manufacturing
 
facilities, the
Company made a decision to make available for sale certain facilities during
 
the second quarter of 2020.
 
During the first quarter of
2021 and fourth quarter of 2020, certain of these facilities were sold
 
and the Company recognized a gain on disposal of $5.4 million
and a loss on disposal of $0.6 million, respectively,
 
included within other income (expense), net on the Consolidated Statement of
Income.
 
The exact timing and total costs associated with the QH Program will depend on a number of
 
factors and is subject to
change; however, reductions in headcount
 
and site closures have continued,
 
and the Company currently expects additional headcount
reductions and site closures to occur into 2022 and estimates that the anticipated
 
cost synergies realized under the QH Program will
approximate one-times restructuring costs incurred.
 
The Company made cash payments related to the settlement of restructuring
liabilities under the QH Program during 2021 of approximately $5.3 million
 
compared to $15.7 million in 2020.
During the first quarter of 2020, the Company completed the termination
 
of the Legacy Quaker U.S. Pension Plan and funded the
plan on a termination basis with approximately $1.8 million, subject to final
 
true up adjustments.
 
In the third quarter of 2020, the
Company finalized the amount of liability and related annuity payments and
 
received a refund in premium of $1.6 million.
 
In
addition, the Company recorded a non-cash pension settlement charge
 
at plan termination of approximately $22.7 million in the first
quarter of 2020.
As of December 31, 2021, the Company’s
 
gross liability for uncertain tax positions, including interest and penalties,
 
was $28.7
million.
 
The Company cannot determine a reliable estimate of the timing of cash flows
 
by period related to its uncertain tax position
liability.
 
However, should the entire liability be
 
paid, the amount of the payment may be reduced by up to $7.3 million as a result of
offsetting benefits in other tax jurisdictions.
 
During the year ended 2021, the Company recorded $13.1 million of non-income tax
credits for certain of its Brazilian subsidiaries.
 
The Company expects to utilize these credits to offset certain Brazilian
 
federal tax
payments over approximately two years, which began in the fourth quarter
 
of 2021.
 
See Note 26 of Notes to Consolidated Financial
Statements in Item 8 of this Report.
During the third quarter of 2021, two of the Company’s
 
locations suffered property damage as a result of flooding and fire.
 
The
Company maintains property insurance for all of its facilities globally.
 
The Company, its insurance
 
adjuster and insurance carrier are
actively managing the remediation and restoration activities associated
 
with both of these events and at this time the Company has
concluded, based on all available information and discussions with its insurance
 
adjuster and insurance carrier, that the losses incurred
during 2021 will be covered under the Company’s
 
property insurance coverage, net of an aggregate deductible of $2.0 million.
 
The
Company has received payments from its insurers of $2.1 million and has
 
recorded an insurance receivable associated with these
events of $0.7 million as of December 31, 2021.
 
The Company and its insurance carrier continue to review the impact on operations
as it relates to a potential business interruption insurance claim; however,
 
as of the date of this report, the Company cannot reasonably
estimate any probable amount of business interruption insurance
 
claim recoverable, therefore the Company has not recorded a gain
contingency for a possible business interruption insurance claim as of December
 
31, 2021.
 
See Note 26 of Notes to Consolidated
Financial Statements in Item 8 of this Report.
 
The Company believes that its existing cash, anticipated cash flows from
 
operations and available additional liquidity will be
sufficient to support its operating requirements and fund
 
its business objectives for at least the next twelve months and beyond,
including but not limited to, payments of dividends to shareholders, costs
 
related to the Combination and other acquisitions and as
well as ongoing integration and optimization,
 
pension plan contributions, capital expenditures, other business opportunities
 
(including
potential acquisitions),
 
implementing actions to achieve the Company’s
 
sustainability goals and other potential contingencies.
 
The
Company’s liquidity is affected
 
by many factors, some based on normal operations of our business and
 
others related to the impact of
the pandemic on our business and on global economic conditions as well as industry
 
uncertainties, which we cannot predict.
 
We also
cannot predict economic conditions and industry downturns or the
 
timing, strength or duration of recoveries.
 
We may seek,
 
as we
believe appropriate, additional debt or equity financing which would
 
provide capital for corporate purposes, working capital funding,
additional liquidity needs or to fund future growth opportunities, including
 
possible acquisitions and investments.
 
The timing and
amount of potential capital requirements cannot be determined at this time
 
and will depend on a number of factors, including the
actual and projected demand for our products, specialty chemical industry
 
conditions, competitive factors, and the condition of
financial markets, among others.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
30
The following table summarizes the Company’s
 
contractual obligations as of December 31, 2021, and the effect such
 
obligations
are expected to have on its liquidity and cash flows in future periods.
 
Pension and postretirement plan contributions beyond 2021 are
not determinable since the amount of any contribution is heavily dependent
 
on the future economic environment and investment
returns on pension trust assets.
 
The timing of payments related to other long-term liabilities which consists primarily
 
of deferred
compensation agreements and environmental reserves, also cannot
 
be readily determined due to their uncertainty.
 
Interest obligations
on the Company’s long-term
 
debt and capital leases assume the current debt levels will be outstanding for
 
the entire respective period
and apply the interest rates in effect as of December 31, 2021.
Payments due by period
(dollars in thousands)
2027 and
Contractual Obligations
Total
2022
2023
2024
2025
2026
Beyond
Long-term debt
$
900,633
$
56,759
$
75,553
$
758,045
$
122
$
80
$
10,074
Interest obligations
39,975
14,287
13,184
10,751
526
526
701
Capital lease obligations
868
219
212
196
176
65
-
Operating leases
41,395
11,346
9,041
7,017
5,292
4,197
4,502
Purchase obligations
3,652
3,197
416
39
-
-
-
Transition tax
8,500
-
1,529
3,099
3,872
-
-
Pension and other postretirement plan
 
contributions
13,347
13,347
-
-
-
-
-
Other long-term liabilities (See Note 22 of
Notes to Consolidated Financial Statements)
12,040
-
-
-
-
-
12,040
Total contractual
 
cash obligations
$
1,020,410
$
99,155
$
99,935
$
779,147
$
9,988
$
4,868
$
27,317
Non-GAAP Measures
The information in this Form 10-K filing includes non-GAAP (unaudited)
 
financial information that includes EBITDA, adjusted
EBITDA, adjusted EBITDA margin, non-GAAP operating
 
income, non-GAAP operating margin, non-GAAP net
 
income and non-
GAAP earnings per diluted share.
 
The Company believes these non-GAAP financial measures provide meaningful supplemental
information as they enhance a reader’s understanding
 
of the financial performance of the Company,
 
are indicative of future operating
performance of the Company,
 
and facilitate a comparison among fiscal periods, as the non-GAAP financial
 
measures exclude items
that are not indicative of future operating performance or not considered
 
core to the Company’s operations.
 
Non-GAAP results are
presented for supplemental informational purposes only and should not be
 
considered a substitute for the financial information
presented in accordance with GAAP.
 
The Company presents EBITDA which is calculated as net income attributable
 
to the Company before depreciation and
amortization, interest expense, net, and taxes on income before equity in net income
 
of associated companies.
 
The Company also
presents adjusted EBITDA which is calculated as EBITDA plus or minus
 
certain items that are not indicative of future operating
performance or not considered core to the Company’s
 
operations.
 
In addition, the Company presents non-GAAP operating income
which is calculated as operating income plus or minus certain items that are
 
not indicative of future operating performance or not
considered core to the Company’s
 
operations.
 
Adjusted EBITDA margin and non-GAAP operating margin
 
are calculated as the
percentage of adjusted EBITDA and non-GAAP operating income
 
to consolidated net sales, respectively.
 
The Company believes
these non-GAAP measures provide transparent and useful information and
 
are widely used by analysts, investors, and competitors in
our industry as well as by management in assessing the operating performance
 
of the Company on a consistent basis.
Additionally, the
 
Company presents non-GAAP net income and non-GAAP earnings per diluted share
 
as additional performance
measures.
 
Non-GAAP net income is calculated as adjusted EBITDA, defined above,
 
less depreciation and amortization, interest
expense, net, and taxes on income before equity in net income of associated
 
companies, in each case adjusted, as applicable, for any
depreciation, amortization, interest or tax impacts resulting from the non-core
 
items identified in the reconciliation of net income
attributable to the Company to adjusted EBITDA.
 
Non-GAAP earnings per diluted share is calculated as non-GAAP net income
 
per
diluted share as accounted for under the “two-class share method.”
 
The Company believes that non-GAAP net income and non-
GAAP earnings per diluted share provide transparent and useful information
 
and are widely used by analysts, investors, and
competitors in our industry as well as by management in assessing the operating
 
performance of the Company on a consistent basis.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
31
The following tables reconcile the Company’s
 
non-GAAP financial measures (unaudited) to their most directly comparable
GAAP financial measures (dollars in thousands, unless otherwise noted,
 
except per share amounts):
Non-GAAP Operating Income and Margin Reconciliations
For the years ended December 31,
2021
2020
2019
Operating income
$
150,466
$
59,360
$
46,134
Houghton combination, integration and other
 
acquisition-related expenses (a)
24,611
30,446
35,945
Restructuring and related charges (b)
1,433
5,541
26,678
Fair value step up of acquired inventory sold (c)
801
226
11,714
Executive transition costs (d)
2,986
-
-
Inactive subsidiary's non-operating litigation costs (e)
819
-
-
Customer bankruptcy costs (f)
-
463
1,073
Facility remediation costs, net (g)
1,509
-
-
Charges related to the settlement of a non-core equipment sale (h)
-
-
384
Indefinite-lived intangible asset impairment (i)
-
38,000
-
Non-GAAP operating income
$
182,625
$
134,036
$
121,928
Non-GAAP operating margin (%) (r)
10.4%
9.5%
10.8%
EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and
Non-GAAP Net Income Reconciliations
For the years ended December 31,
2021
2020
2019
Net income attributable to Quaker Chemical Corporation
$
121,369
$
39,658
$
31,622
Depreciation and amortization (a)(p)
87,728
84,494
45,264
Interest expense, net (a)
22,326
26,603
16,976
Taxes on income before
 
equity in net income of associated companies (q)
34,939
(5,296)
2,084
EBITDA
266,362
145,459
95,946
Equity income in a captive insurance company (j)
(4,993)
(1,151)
(1,822)
Houghton combination, integration and other
 
acquisition-related expenses (a)
17,917
29,538
35,361
Restructuring and related charges (b)
1,433
5,541
26,678
Fair value step up of acquired inventory sold (c)
801
226
11,714
Executive transition costs (d)
2,986
-
-
Inactive subsidiary’s non
 
-operating litigation cost (e)
819
-
-
Customer bankruptcy costs (f)
-
463
1,073
Facility remediation costs, net (g)
2,066
-
-
Charges related to the settlement of a non-core equipment sale (h)
-
-
384
Indefinite-lived intangible asset impairment (i)
-
38,000
-
Pension and postretirement benefit (income) costs,
 
non-service components (k)
(759)
21,592
2,805
Gain on changes in insurance settlement restrictions of an inactive
 
subsidiary and related insurance insolvency recovery (l)
-
(18,144)
(60)
Brazilian non-income tax credits (m)
(13,087)
-
-
Currency conversion impacts of hyper-inflationary economies (n)
564
450
1,033
Adjusted EBITDA
$
274,109
$
221,974
$
173,112
Adjusted EBITDA margin (%) (r)
15.6%
15.7%
15.3%
Adjusted EBITDA
$
274,109
$
221,974
$
173,112
Less: Depreciation and amortization - adjusted (a)
87,002
83,732
44,680
Less: Interest expense, net - adjusted (a)
22,326
26,603
14,896
Less: Taxes on income
 
before equity in net income
 
of associated companies - adjusted (o)(q)
41,976
26,488
24,825
Non-GAAP net income
$
122,805
$
85,151
$
88,711
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
32
Non-GAAP Earnings per Diluted Share Reconciliations
For the years ending December 31,
2021
2020
2019
GAAP earnings per diluted share attributable to
Quaker Chemical Corporation common shareholders
$
6.77
$
2.22
$
2.08
Equity income in a captive insurance company per diluted share (j)
(0.28)
(0.07)
(0.12)
Houghton combination, integration and other
 
 
acquisition-related expenses per diluted share (a)
0.79
1.31
2.05
Restructuring and related charges per diluted share (b)
0.07
0.23
1.34
Fair value step up of acquired inventory sold per diluted share (c)
0.03
0.01
0.58
Executive transition costs per diluted share (d)
0.13
-
-
Inactive subsidiary’s non
 
-operating litigation costs per diluted share (e)
0.04
-
-
Customer bankruptcy costs per diluted share (f)
-
0.02
0.05
Facility remediation costs, net per diluted share (g)
0.09
-
-
Charges related to the settlement of a non-core equipment
 
sale per diluted share (h)
-
-
0.02
Indefinite-lived intangible asset impairment per diluted share (i)
-
1.65
-
Pension and postretirement benefit costs, non-service
 
 
components per diluted share (k)
(0.04)
0.79
0.14
Gain on changes in insurance settlement restrictions of an inactive
 
 
subsidiary and related insurance insolvency recovery per diluted share (l)
-
(0.78)
0.00
Brazilian non-income tax credits per diluted share (m)
(0.46)
-
-
Currency conversion impacts of hyper-inflationary economies
 
per diluted share (n)
0.03
0.02
0.07
Impact of certain discrete tax items per diluted share (o)
(0.32)
(0.62)
(0.38)
Non-GAAP earnings per diluted share (s)
$
6.85
$
4.78
$
5.83
(a)
Houghton combination, integration and other acquisition-related
 
expenses include certain legal, financial, and other advisory and
consultant costs incurred in connection with post-closing integration
 
activities including internal control readiness and
remediation, as well as due diligence, regulatory approvals and closing
 
the Combination.
 
These costs are not indicative of the
future operating performance of the Company.
 
Approximately $0.6 million, $1.5 million and $9.4 million for the years ended
December 31, 2021, 2020 and 2019, respectively,
 
of these pre-tax costs were considered non-deductible for the purpose of
determining the Company’s
 
effective tax rate, and, therefore, taxes on income before equity in
 
net income of associated
companies - adjusted reflects the impact of these items.
 
During 2021, 2020 and 2019, the Company recorded $0.7 million, $0.8
million, and $0.6 million, respectively,
 
of accelerated depreciation related to certain of the Company’s
 
facilities, which is
included in the caption “Houghton combination, integration and other
 
acquisition-related expenses” in the reconciliation of
operating income to non-GAAP operating income and included in the
 
caption “Depreciation and amortization” in the
reconciliation of net income attributable to the Company to EBITDA, but
 
excluded from the caption “Depreciation and
amortization – adjusted” in the reconciliation of adjusted EBITDA to
 
non-GAAP net income attributable to the Company.
 
During
2019, the Company incurred $2.1 million of ticking fees to maintain the bank
 
commitment related to the Combination.
 
These
interest costs are included in the caption “Interest expense, net” in the reconciliation
 
of net income attributable to the Company to
EBITDA, but are excluded from the caption “Interest expense, net
 
– adjusted” in the reconciliation of adjusted EBITDA to non-
GAAP net income.
 
During 2021 and 2020, the Company recorded $0.6 million and $0.8 million, respectively,
 
of other income
related to an indemnification asset.
 
During 2021 and 2020, the Company recorded a gain of $5.4 million
 
and a loss of $0.6
million, respectively,
 
on the sale of certain held-for-sale real property assets related to
 
the Combination.
 
Each of these items are
included in the caption “Houghton combination, integration and other
 
acquisition expenses” in the reconciliation of GAAP
earnings per diluted share attributable to Quaker Chemical Corporation
 
common shareholders to Non-GAAP earnings per diluted
share as well as the reconciliation of Net Income attributable to Quaker
 
Chemical Corporation to Adjusted EBITDA and Non-
GAAP net income See Note 2 and Note 9 of Notes to Consolidated Financial
 
Statements, which appears in Item 8 of this Report.
(b)
Restructuring and related charges represent the
 
costs incurred by the Company associated with the QH restructuring program
which was initiated in the third quarter of 2019 as part of the Company’s
 
plan to realize cost synergies associated with the
Combination.
 
These costs are not indicative of the future operating performance of the Company.
 
See Note 7 of Notes to
Consolidated Financial Statements,
 
which appears in Item 8 of this Report.
 
(c)
Fair value step up of inventory sold relates to expense associated with selling
 
inventory of acquired businesses which was
adjusted to fair value as part of purchase accounting.
 
This increases to costs of goods sold (“COGS”) are not indicative of the
future operating performance of the Company.
 
33
(d)
Executive transition costs represent the costs related to the Company’s
 
search, hiring and transition to a new CEO in connection
with the executive transition that look place in 2021.
 
These expenses are not indicative of the future operating performance of the
Company.
 
(e)
Inactive subsidiary’s non
 
-operating litigation costs represents the charges incurred by
 
an inactive subsidiary of the Company and
are a result of the termination of restrictions on insurance settlement reserves.
 
These charges are not indicative of the future
operating performance of the Company.
 
See Note 26 of Notes to Consolidated Financial Statements, which appears
 
in Item 8 of
this Report.
(f)
Customer bankruptcy costs represent the cost associated with a specific
 
reserve for trade accounts receivable related to a customer
who filed for bankruptcy protection.
 
These expenses are not indicative of the future operating performance
 
of the Company.
 
See
Note 13 of Notes to Consolidated Financial Statements, which appears
 
in Item 8 of this Report.
(g)
Facility remediation costs, net, presents the gross costs associated with remediation,
 
cleaning and subsequent restoration costs
associated with the property damage to certain of the Company’s
 
facilities, net of insurance recoveries received.
 
These charges
are non-recurring and are not indicative of the future operating performance
 
of the Company.
 
See Note 26 of Notes to
Consolidated Financial Statements, which appears in Item 8 of this Report.
(h)
Charges related to the settlement of a non-core equipment
 
sale represent the pre-tax charge related to a one-time, uncommon,
customer settlement associated with a prior sale of non-core equipment.
 
These charges are not indicative of the future operating
performance of the Company.
(i)
Indefinite-lived intangible asset impairment represents the non-cash
 
charge taken to write down the value of certain indefinite-
lived intangible assets associated with the Combination.
 
The Company has no prior history of goodwill or intangible asset
impairments and this charge is not indicative of the future operating
 
performance of the Company.
 
See Note 16 of Notes to
Consolidated Financial Statements, which appears in Item 8 of this Report.
(j)
Equity income in a captive insurance company represents the after-tax
 
income attributable to the Company’s
 
interest in Primex,
Ltd. (“Primex”), a captive insurance company.
 
The Company holds a 32% investment in and has significant influence over
Primex, and therefore accounts for this investment under the equity method of
 
accounting.
 
The income attributable to Primex is
not indicative of the future operating performance of the Company
 
and is not considered core to the Company’s operations.
(k)
Pension and postretirement benefit (income) costs, non-service components
 
represent the pre-tax, non-service components of the
Company’s pension and postretirement
 
net periodic benefit cost in each period.
 
These costs are not indicative of the future
operating performance of the Company.
 
The year ended December 31, 2020 includes a $22.7 million settlement charge
 
for the
Company’s termination
 
of the Legacy Quaker U.S. Pension Plan.
 
See Note 21 of Notes to Consolidated Financial Statements,
which appears in Item 8 of this Report.
(l)
Gain on changes in insurance settlement restrictions of an inactive subsidiary
 
and related insurance insolvency recovery
represents income associated with the gain on the termination of restrictions
 
on insurance settlement reserves and the cash
receipts from an insolvent insurance carrier for previously submitted
 
claims by an inactive subsidiary of the Company.
 
This other
income is not indicative of the future operating performance of the Company.
 
See Notes 9 and 26 of Notes to Consolidated
Financial Statements, which appears in Item 8 of this Report.
(m)
Brazilian non-income tax credits represent indirect tax credits related to certain
 
of the Company’s Brazilian subsidiaries
prevailing in a legal claim as well as the Brazil Supreme Court ruling on these non
 
-income tax matters.
 
The non-income tax
credit is non-recurring and not indicative of the future operating performance
 
of the Company.
 
See Note 26 of Note to
Consolidated Financial Statements, which appears in Item 8 of this Report.
(n)
Currency conversion impacts of hyper-inflationary economies represents
 
the foreign currency remeasurement impacts associated
with the Company’s affiliates
 
whose local economies are designated as hyper-inflationary under
 
U.S. GAAP.
 
An entity which
operates within an economy deemed to be hyper-inflationary
 
under U.S. GAAP is required to remeasure its monetary assets and
liabilities to the applicable published exchange rates and record the
 
associated gains or losses resulting from the remeasurement
directly to the Consolidated Statements of Income.
 
Venezuela’s
 
economy has been considered hyper-inflationary under
 
U.S.
GAAP since 2010, while Argentina’s
 
economy has been considered hyper-inflationary beginning
 
July 1, 2018.
 
In addition, the
Company’s Argentine
 
Houghton subsidiary also applies hyper-inflationary accounting.
 
During 2021, 2020 and 2019, the
Company incurred non-deductible, pre-tax charges
 
related to the Company’s Argentine
 
affiliates.
 
The charges incurred related to
the immediate recognition of foreign currency remeasurement in the
 
Consolidated Statements of Income associated with these
entities are not indicative of the future operating performance of the Company.
 
See Notes 1, 9 and 17 of Notes to Consolidated
Financial Statements, which appears in Item 8 of this Report.
 
(o)
The impacts of certain discrete tax items includes
 
the impact of changes in certain valuation allowances
 
recorded on certain of the
Company’s foreign
 
tax credits, tax law changes in foreign jurisdictions, changes in withholding tax rates, the
 
tax impacts of non-
income tax credits associated with certain of the Company’s
 
Brazilian subsidiaries and the associated impact on previously
accrued for distributions at certain of the Company’s
 
Asia/Pacific subsidiaries, the one-time deferred tax benefit recorded on the
transfer of intangible assets between the Company’s
 
subsidiaries as well as the offsetting impact and amortization
 
of a deferred
 
34
tax benefit the Company recorded during 2020 and 2019 related to
 
similar intercompany intangible asset transfers.
 
Additionally,
the 2019 amounts include certain transition tax adjustments related to adjustments
 
to adopt U.S. Tax Reform.
 
See Note 10 of
Notes to Consolidated Financial Statements, which appears in Item
 
8 of this Report.
(p)
Depreciation and amortization for the years ended December 31, 2021,
 
2020 and 2019 includes $1.2 million, $1.2 million and
$0.4 million, respectively,
 
of amortization expense recorded within equity in net income of associated
 
companies in the
Company’s Consolidated
 
Statements of Income, which is attributable to the amortization of the fair value step up for
 
the
Company’s 50% interest Korea Houghton
 
Corporation as a result of required purchase accounting.
(q)
Taxes on income
 
before equity in net income of associated companies – adjusted presents the impact
 
of any current and deferred
income tax expense (benefit), as applicable, of the reconciling items presented
 
in the reconciliation of net income attributable to
Quaker Chemical Corporation to adjusted EBITDA, and was determined
 
utilizing the applicable rates in the taxing jurisdictions in
which these adjustments occurred, subject to deductibility.
 
Houghton combination, integration and other acquisition-related
expenses described in (a) resulted in incremental taxes of $4.2 million
 
for 2021, $6.9 million for 2020, and $6.7 million for 2019.
 
Restructuring and related charges described in (b)
 
resulted in incremental taxes of $0.3 million for 2021, $1.4 million for 2020
and $6.2 million for 2019.
 
Fair value step up of inventory sold described in (c) resulted in incremental taxes of $0.2 million,
 
less
than $0.1 million and $2.9 million for 2021, 2020 and 2019, respectively.
 
Executive transition expenses described in (d) resulted
in incremental taxes of $0.7 million for 2021.
 
Inactive subsidiary non-operating litigation costs described in (e) resulted in
incremental taxes of $0.2
 
million for 2021.
 
Customer bankruptcy costs described in (f) resulted in incremental taxes of $0.1
million in 2020 and $0.3 million in 2019.
 
Facility remediation costs, net described in (g) results in incremental taxes of $0.5
million for 2021.
 
Charges related to the settlement of a non-core equipment
 
sale described in (h) resulted in incremental taxes of
$0.1 million for 2019.
 
Indefinite-lived intangible asset impairment described in (i) resulted in
 
incremental taxes of $8.7 million
for 2020.
 
Pension and postretirement benefit (income) costs, non-service components
 
described in (k) resulted in a reduction of
taxes of $0.1 million for 2021 and incremental taxes of $7.5 million for 2020,
 
and $0.7 million for 2019.
 
Gain on changes in
insurance settlement restrictions of an inactive subsidiary
 
and related insurance insolvency recovery described in (l) resulted in a
reduction of taxes of $4.2 million in 2020 and less than $0.1 million in
 
2019.
 
Brazilian non-income tax credits described in (m)
resulted in a reduction of taxes of $4.8 million for 2021.
 
The impact of certain discrete items described in (o) resulted in a tax
benefit of $5.8 million for 2021, incremental taxes of $11.2
 
million for 2020, and a reduction of taxes of $5.7 million in 2019.
 
(r)
The Company calculates adjusted EBITDA margin
 
and non-GAAP operating margin as the percentage of adjusted EBITDA
 
and
non-GAAP operating income to consolidated net sales.
(s)
The Company calculates non-GAAP earnings per diluted share as non
 
-GAAP net income attributable to the Company per
weighted average diluted shares outstanding using the “two-class share method”
 
to calculate such in each given period.
Off-Balance Sheet Arrangements
The Company had no material off-balance sheet commitments or
 
obligations as of December 31, 2021.
 
The Company’s only off-
balance sheet commitments or obligations outstanding as of December 31,
 
2021 represented approximately $6 million of total bank
letters of credit and guarantees.
 
The bank letters of credit and guarantees are not significant to the Company’s
 
liquidity or capital
resources.
 
See Note 20 of Notes to Consolidated Financial Statements in Item 8 of this Report.
Operations
Consolidated Operations Review – Comparison of 2021 with 2020
Net sales were $1,761.2 million in 2021 compared to $1,417.7 million
 
in 2020.
 
The net sales increase of approximately $343.5
million or 24% year-over-year was primarily due to higher sales volumes of
 
13%, which includes additional net sales from recent
acquisitions of 4%, increases from selling price and product mix of 8% and
 
the positive impact of foreign currency translation of 3%.
 
The increase in organic sales volumes compared to 2020
 
was primarily the result of the continued year-over-year
 
improvement in end
market conditions from the prior year impacts of COVID-19 and continued
 
market share gains.
 
Sales from acquisitions is primarily
driven by the Company’s acquisition
 
of Coral Chemical Company (“Coral”) in December 2020 and
 
the tin-plating solutions business
acquired in February 2021.
 
The increase from selling price and product mix includes the impact of current
 
year selling price increases
implemented in response to the increases in raw material costs experienced
 
in 2021.
 
The positive impact from foreign currency
translation is primarily the result of the strengthening of the Chinese renminbi,
 
euro, Mexican peso, the Canadian dollar and the
British pound against the U.S. dollar year-over-year.
COGS were $1,166.5 million in 2021 compared to $904.2 million in 2020.
 
The increase in COGS of 29% was driven by the
associated COGS on the increase in net sales described above, and
 
continued increases in the Company’s global
 
raw material costs
compared to the prior year and the impacts of supply constraints in the current year.
Gross profit in 2021 of $594.6 million increased $81.2 million or approximately
 
16% from 2020, due primarily to the increase in
net sales noted above.
 
The Company’s reported gross margin
 
in 2021 was 33.8% compared to 36.2% in 2020.
 
The lower current year
gross margin is primarily attributable to increased raw materials and
 
other costs that began in the fourth quarter of 2020 and have
continued throughout 2021 and the impacts of constraints on the world’s
 
global supply chain partially offset by the Company’s
ongoing pricing initiatives.
35
SG&A in 2021 increased $38.1 million compared to 2020 due primarily to
 
the impact of sales increases on direct selling costs,
year-over-year inflation increases, additional
 
SG&A from recent acquisitions and higher SG&A due to foreign currency
 
translation,
partially offset by lower incentive compensation year-over
 
-year as well as the benefits of additional realized cost synergies associated
with the Combination year-over-year.
 
In addition, SG&A was lower in the prior year period as a result of temporary
 
cost saving
measures the Company implemented in response to COVID-19.
 
While the Company continues to manage costs during the on-going
pandemic, it has incurred higher SG&A year-over-year
 
as the global economy continues to gradually rebound.
During 2021 and 2020, the Company incurred $23.9 million and $29.8
 
million, respectively, of
 
Combination, integration and
other acquisition-related expenses primarily for professional fees related
 
to Houghton integration and other acquisition-related
activities.
 
See the Non-GAAP Measures section of this Item, above.
The Company initiated a restructuring program during 2019 as part of
 
its global plan to realize cost synergies associated with the
Combination.
 
The Company incurred restructuring and related charges for reductions
 
in headcount and site closures under this
program, net of adjustments to initial estimates for severance, of
 
an expense of $1.4 million and $5.5 million during 2021 and 2020,
respectively.
 
See the Non-GAAP Measures section of this Item, above.
Operating income in 2021 was $150.5 million compared to $59.4 million
 
in 2020.
 
Excluding Combination, integration and other
acquisition-related expenses, restructuring and related charges and
 
other non-core items, the Company’s
 
current year non-GAAP
operating income of $182.6 million increased compared to $134.0
 
million in the prior year, primarily due
 
to the increase in net sales
described above and the benefits from cost savings related to the Combination
 
offset by an increase in SG&A as well as the significant
increases in raw material costs year-over-year.
 
The Company estimates that it realized cost synergies associated with the
 
Combination
of approximately $75 million during 2021 compared to approximately
 
$58 million during 2020.
The Company had other income, net, of $18.9 million in 2021 compared
 
to other expense, net, of $5.6 million in 2020.
 
The year-
over-year change was primarily a result of other income related to certain
 
non-income tax credits recorded by the Company’s
Brazilian subsidiaries, the gain on the sale of certain held-for-sale real property assets and lower
 
foreign currency transaction losses in
2021 as compared to the prior year.
 
The Company had non-service components of pension and postretirement
 
benefit income in the
current year compared to an expense in the prior year as a result of the $22.7
 
million pension settlement charge directly related to the
termination of the Legacy Quaker U.S. pension plan partially offset
 
by a $18.1 million gain related to the lapse of restrictions over
certain cash that was previously designated solely for the settlement of
 
asbestos claims at an inactive subsidiary,
 
all of which are
described in the Non-GAAP Measures section of this Item, above.
Interest expense, net, decreased $4.3 million compared to 2020 driven
 
by lower current year average borrowings outstanding as a
result of the additional revolver borrowings drawn during part of 2020
 
at the onset of the pandemic to add additional liquidity,
 
coupled
with a decline in overall interest rates year-over-year,
 
as the weighted average interest rate incurred on borrowings under the
Company’s credit facility was approximately
 
1.6% during 2021 compared to approximately 2.2% during 2020.
The Company’s effective
 
tax rates for 2021 and 2020 were an expense of 23.8% and benefit of 19.5%, respectively.
 
The
Company’s higher current year
 
effective tax rate is driven by a higher level of pre-tax earnings and
 
mix of earnings, as well as
deferred tax expense related to the planned repatriation of non-U.S.
 
earnings.
 
In addition, the rate was impacted by certain one-time
charges and benefits related to an intercompany intangible
 
asset transfer and related royalty income recognition offset
 
by changes in
the valuation allowance for foreign tax credits.
 
Comparatively, the prior
 
year effective tax rate was impacted by the tax effect of
certain one-time tax charges and benefits related to a 2020 intercompany
 
intangible asset transfer, additional charges
 
for uncertain tax
positions relating to certain foreign tax audits, and the tax impact of the Company’s
 
termination of its Legacy Quaker U.S. pension
plan.
 
Excluding the impact of these items as well as all other non-core items in
 
each year, described in the Non-GAAP Measures
section of this Item, above, the Company estimates that the 2021 and 2020
 
effective tax rates would have been approximately 26%
and 25%, respectively.
 
The higher estimated current year tax rate was primarily driven by a higher level of pre
 
-tax earnings and the
impact of changes in mix of earnings,
 
deferred taxes related to the planned repatriation of non-U.S. earnings, and provision
 
to return
adjustments in the prior period.
 
The Company may experience continued volatility in its effective tax
 
rates due to several factors,
including the timing of tax audits and the expiration of applicable statutes of
 
limitations as they relate to uncertain tax positions, the
unpredictability of the timing and amount of certain incentives in various
 
tax jurisdictions, the treatment of certain acquisition-related
costs and the timing and amount of certain share-based compensation-related
 
tax benefits, among other factors.
 
In addition, the
foreign tax credit valuation allowance, or absence thereof, is based on
 
a number of variables, including forecasted earnings, which
may vary.
Equity in net income of associated companies increased $2.0 million in
 
2021 compared to 2020, primarily due to higher current
year income from the Company’s interest
 
in a captive insurance company partially offset by lower earnings
 
from the Company’s 50%
interest in a joint venture in Korea compared to the prior year.
 
See the Non-GAAP Measures section of this Item, above.
 
Net income attributable to noncontrolling interest was less than $0.1 million
 
in 2021 compared to $0.1 million in 2020
primarily a
result of the first quarter of 2020 acquisition of the remaining ownership
 
interest in one of the Company’s South
 
African affiliates
.
Foreign exchange positively impacted the Company’s
 
yearly results by approximately 6% driven by the positive impact from
foreign currency translation on earnings as well as lower foreign exchange
 
transaction losses in the current year as compared to the
prior year.
 
36
Consolidated Operations Review – Comparison of 2020 with 2019
Net sales were $1,417.7 million in 2020 compared to $1,133.5 million
 
in 2019.
 
The net sales increase of 25% year-over-year
includes additional net sales from acquisitions, primarily Houghton
 
and Norman Hay, of $408.6 million.
 
Excluding net sales related
to acquisitions, the Company’s prior
 
year net sales would have declined approximately 11%
 
which reflects a decrease in sales volumes
of 9%, a negative impact from foreign currency translation of 1% and
 
a decrease from selling price and product mix of 1%.
 
The
primary driver of the volume decline in the prior year was the negative
 
impact of COVID-19 on global production levels.
COGS were $904.2 million in 2020 compared to $741.4 million in
 
2019.
 
The increase in COGS of 22% was primarily due to the
inclusion of a full year of Houghton and Norman Hay COGS and $0.8 million of
 
accelerated depreciation charges in 2020, partially
offset by lower prior year COGS on the decline in net sales due
 
to COVID-19 and 2019 charges of $11.7
 
million to increase acquired
inventory to its fair value, described in the Non-GAAP Measures section of this Item
 
above.
Gross profit in 2020 increased $121.3 million or 31% from 2019 due primarily
 
to additional gross profit from Houghton and
Norman Hay.
 
The Company’s reported gross
 
margin in 2020 was 36.2% compared to 34.6% in 2019, which included
 
the inventory
fair value step up described above.
 
Excluding one-time increases to COGS in both periods, the Company
 
estimates that its gross
margins for 2020 and 2019 would have been 36.3% and 35.7%,
 
respectively.
 
The estimated increase in gross margin year-over-year
was primarily due to lower COGS as a result of the Company’s
 
progress on Combination-related logistics, procurement and
manufacturing cost savings initiatives, partially offset
 
by the lower sales volumes on certain fixed manufacturing costs.
SG&A in 2020 increased $96.9 million compared to 2019 due primarily to
 
additional SG&A from Houghton and Norman Hay,
partially offset by the impact of COVID-19 cost savings
 
actions, including lower travel expenses, and the benefits of realized costs
savings associated with the Combination.
During 2020, the Company incurred $29.8 million of Combination,
 
integration and other acquisition-related expenses, primarily
for professional fees related to Houghton integration and other acquisition
 
-related activities.
 
Comparatively,
 
the Company incurred
$35.5 million of similar expenses in 2019,
 
primarily due to various professional fees related to integration planning
 
and regulatory
approval as well as professional fees associated with closing the Combination.
 
See the Non-GAAP Measures section of this Item,
above.
The Company initiated a restructuring program during the third quarter
 
of 2019 as part of its global plan to realize cost synergies
associated with the Combination.
 
The Company recorded additional restructuring and related charges
 
of $5.5 million during 2020
compared
 
to $26.7 million during 2019 under this program.
 
See the Non-GAAP Measures section of this Item, above.
During the first quarter of 2020, the Company recorded a $38.0 million
 
non-cash impairment charge to write down the value of
certain indefinite-lived intangible assets associated with the Combination.
 
This non-cash impairment charge is related to certain
acquired Houghton trademarks and tradenames and is primarily the
 
result of the negative impacts of COVID-19 on their estimated fair
values.
 
There were no additional impairment charges in the remainder of
 
2020 or in 2019.
 
See the Critical Accounting Policies and
Estimates section as well as the Non-GAAP Measures section, of this Item, above.
Operating income in 2020 was $59.4 million compared to $46.1 million
 
in 2019.
 
Excluding Combination, integration and other
acquisition-related expenses, restructuring and related charges, the
 
non-cash indefinite-lived intangible asset impairment charge,
 
and
other expenses that are not indicative of the Company’s
 
future operating performance, the Company’s
 
non-GAAP operating income
during 2020 of $134.0 million increased compared to $121.9 million
 
in 2019, primarily due to additional operating income from
Houghton and Norman Hay and the benefits from costs savings initiatives related
 
to the Combination, partially offset by the current
year negative impact due to COVID-19.
The Company’s other
 
expense, net, was $5.6 million in 2020 compared to $0.3 million in 2019.
 
The year-over-year increase in
other expense, net was primarily due to the first quarter of 2020 non-cash
 
settlement charge of $22.7 million associated with the
termination of the Legacy Quaker U.S. Pension Plan, partially offset
 
by a fourth quarter of 2020 gain of $18.1 million related to the
lapsing of restrictions over certain cash that was previously designated
 
solely for the settlement of asbestos claims at an inactive
subsidiary of the Company,
 
which are both described in the Non-GAAP Measures section of this Item, above.
 
Additionally, the
increase year-over-year in other expense,
 
net, includes higher foreign currency transaction losses in 2020.
 
Interest expense, net, increased $9.6 million in 2020 compared to 2019 primarily
 
due to a full year of borrowings under the
Company’s Credit Facility to
 
finance the closing of the Combination on August 1, 2019, partially offset
 
by lower overall interest rates
in the 2020.
The Company’s effective
 
tax rates for 2020 and 2019 were a benefit of 19.5% and an expense of 7.2%, respectively.
 
The
Company’s 2020 effective
 
tax rate was impacted by the tax effect of certain one-time
 
tax charges and benefits, including deferred tax
benefits related to an intercompany intangible asset transfer,
 
as well as changes in the valuation allowance for foreign tax credits,
additional charges for uncertain tax positions relating to
 
certain foreign tax audits, and the tax impact of the Company’s
 
termination of
its Legacy Quaker U.S. pension plan.
 
Comparatively, the 2019 effectiv
 
e
 
tax rate was primarily impacted by certain non-deductible
costs associated with the Combination as well as a deferred tax benefit related
 
to a separate intercompany intangible asset transfer.
 
Excluding the impact of all non-core items in each year,
 
described in the Non-GAAP measures section of this Item, above, the
Company estimates that its effective tax rates for 2020
 
and 2019 were approximately 25% and 22%, respectively.
 
The year-over-year
increase is driven primarily by higher U.S. income taxes resulting from a
 
change in certain deductions and the taxability of foreign
earnings in the U.S., partially offset by a change in the mix of earnings.
 
 
37
Equity in net income of associated companies increased $2.3 million in
 
2020 compared to 2019, primarily due to additional
earnings from our 50% interest in a joint venture in Korea partially offset
 
by lower earnings from the Company’s
 
interest in a captive
insurance company.
 
See the Non-GAAP Measures section of this Item, above.
Net income attributable to noncontrolling interest was $0.1 million in
 
2020 compared to $0.3 million in 2019 primarily a result of
the first quarter of 2020 acquisition of the remaining ownership interest
 
in one of the Company’s South African
 
affiliates.
Foreign exchange negatively impacted the Company’s
 
2020 results by approximately $0.38 per diluted share, primarily due
 
to
higher foreign exchange transaction losses year-over-year and, to
 
a lesser extent, an aggregate negative impact from foreign currency
translation on earnings.
Reportable Segments Review - Comparison of 2021 with 2020
The Company’s reportable
 
segments reflect the structure of the Company’s
 
internal organization, the method by which the
Company’s resources are allocated
 
and the manner by which the chief operating decision maker of the Company
 
assesses its
performance.
 
The Company has four reportable segments: (i) Americas; (ii) EMEA; (iii)
 
Asia/Pacific; and (iv) Global Specialty
Businesses.
 
The three geographic segments are composed of the net sales and operations
 
in each respective region, excluding net
sales and operations managed globally by the Global Specialty Businesses
 
segment, which includes the Company’s
 
container, metal
finishing, mining, offshore, specialty coatings, specialty grease and
 
Norman Hay businesses.
 
Segment operating earnings for the Company’s
 
reportable segments are comprised of net sales less COGS and SG&A directly
related to the respective segment’s product
 
sales.
 
Operating expenses not directly attributable to the net sales of each respective
segment, such as certain corporate and administrative costs, Combination,
 
integration and other acquisition-related expenses,
Restructuring and related charges, and COGS related
 
to acquired inventory sold, which is adjusted to fair value as part of purchase
accounting, are not included in segment operating earnings.
 
Other items not specifically identified with the Company’s
 
reportable
segments include interest expense, net, and other income (expense),
 
net.
Americas
Americas represented approximately 33% of the Company’s
 
consolidated net sales in 2021.
 
The segment’s net sales were $572.6
million, an increase of $122.5 million or 27% compared to 2020.
 
The increase in net sales was driven by a benefit in selling price and
product mix of 11%, increases in organic
 
volumes of approximately 10%, additional net sales from acquisitions of 5%, and the
positive impact of foreign currency translation of 1%.
 
The current year organic volume increase was driven by the continued
improvement in end market conditions compared to the prior year which
 
was impacted by COVID-19.
 
The increase in selling price
and product mix is primarily driven by price increases implemented
 
to help offset the significant increases in raw material and other
input costs incurred during 2021.
 
The foreign exchange impact was primarily driven by the strengthening of
 
the Mexican peso against
the U.S. dollar, as this exchange rate averaged
 
20.27 in 2021 compared to 21.34 during 2020.
 
This segment’s operating earnings were
$124.9 million, an increase of $28.5 million or 30% compared to 2020.
 
The increase in segment operating earnings reflects the higher
net sales, described above, partially offset by lower gross
 
margins driven by the continued raw material cost increases and
 
global
supply chain and logistics pressures coupled with higher SG&A including
 
an increase in direct selling costs associated with higher net
sales, SG&A from acquisitions and an increase in SG&A as the prior year
 
included temporary cost savings measures implemented in
response to the onset of the COVID-19 pandemic.
EMEA
EMEA represented approximately 27% of the Company’s
 
consolidated net sales in 2021.
 
The segment’s net sales were $480.1
million, an increase of $96.9 million or 25% compared to 2020.
 
The increase in net sales was driven by a benefit from selling price
and product mix of 10%, increases in organic volumes of
 
approximately 9%, the positive impact of foreign currency translation of 4%,
and additional net sales from acquisitions of 2%.
 
The increase in selling price and product mix is primarily driven by price increases
implemented to offset the significant increase in raw
 
material and other input costs incurred during 2021.
 
The current year volume
increase was driven by the continued improvement in end market conditions
 
compared to the prior year which was heavily impacted
by COVID-19.
 
The foreign exchange impact was primarily driven by the strengthening
 
of the euro against the U.S. dollar as this
exchange rate averaged 1.18 in 2021 compared to 1.14 in 2020.
 
This segment’s operating earnings were
 
$85.2 million, an increase of
$16.0 million or 23% compared to 2020.
 
The increase in segment operating earnings reflects the higher net sales described
 
above,
partially offset by lower current year gross margins
 
driven by the continued raw material cost increases and global supply chain and
logistics pressures as well as higher SG&A including increases in direct selling
 
costs associated with higher net sales as well as
increases as the prior year included temporary cost savings measures implemented
 
in response to the onset of the COVID-19
pandemic.
Asia/Pacific
Asia/Pacific represented approximately 22% of the Company’s
 
consolidated net sales in 2021.
 
The segment’s net sales were
$388.2 million, an increase of approximately $72.9 million or 23%
 
compared to 2020.
 
The increase in net sales year-over-year was
driven by increases in volumes of approximately 15%, the positive impact
 
of foreign currency translation of 5%, increases from
selling price and product mix of 2% and additional net sales from
 
acquisitions of 1%.
 
The current year volume increase was driven by
the continued improvement in end market conditions compared to the prior
 
year which was impacted by COVID-19.
 
The foreign
 
38
exchange impact was primarily due to the strengthening of the Chinese renminbi
 
against the U.S. dollar as this exchange rate averaged
6.45 in 2021 compared to 6.90 in 2020.
 
This segment’s operating earnings were
 
$96.3 million, an increase of $8.0 million or 9%
compared to 2020.
 
The increase in segment operating earnings was driven by the higher net sales described above,
 
partially offset by
lower gross margins driven by the continued raw material cost increases
 
and global supply chain and logistics pressures as well as
higher direct selling costs associated with higher net sales and an increase
 
in SG&A as the prior year included temporary cost savings
measures implemented in response to the onset of the COVID-19 pandemic
 
.
Global Specialty Businesses
Global Specialty Businesses represented approximately 18% of the
 
Company’s consolidated net sales in
 
2021.
 
The segment’s net
sales were $320.2 million, an increase of $51.2 million or 19% compared
 
to 2020.
 
The increase in net sales was driven by increases in
selling price and product mix, including Norman Hay,
 
of 14%, additional net sales from acquisitions of 8%, and the positive impact
 
of
foreign currency translation of 2% partially offset by volume declines
 
of approximately 5%.
 
Both the changes in selling price and
product mix and sales volumes were primarily driven by higher amounts of
 
shipments of a lower priced product in the Company’s
mining business in the prior year.
 
The foreign exchange impact was a result of similar strengthening of certain
 
currencies in EMEA
and Americas as described above.
 
This segment’s
 
operating earnings were $90.6 million, an increase of $10.9 million or 14%
compared to 2020.
 
The increase in segment operating earnings reflects the higher net sales, described
 
above, partially offset by lower
gross margins in the current year coupled with higher SG&A, including
 
an increase in direct selling costs associated with higher net
sales, SG&A from acquisitions and an increase in SG&A as the prior year
 
included temporary cost savings measures implemented in
response to the onset of the COVID-19 pandemic.
Reportable Segments Review – Comparison of 2020 with 2019
Americas
Americas represented approximately 32% of the Company’s
 
consolidated net sales in 2020.
 
The segment’s net sales were $450.2
million, an increase of $58.0 million or 15% compared to 2019.
 
The increase in net sales reflects additional net sales from
acquisitions of $120.4 million, primarily a result of the inclusion of
 
seven additional months of Houghton net sales, as the
Combination closed on August 1, 2019.
 
Excluding net sales from acquisitions, the segment’s
 
net sales decreased by approximately
16% due to lower volumes of 12% and a negative impact of foreign
 
currency translation of 4%.
 
The volume decline was driven by
the economic slowdown that began in late March and continued throughout
 
2020 due to the impacts of COVID-19.
 
The foreign
exchange impact was primarily due to the weakening of the Brazilian real
 
and the Mexican peso against the U.S. dollar,
 
as these
exchange rates averaged 5.10 and 21.34, respectively,
 
in 2020 compared to 3.94 and 19.24, respectively in 2019.
 
This segment’s
operating earnings were $96.4 million, an increase of $18.1 million or
 
23% compared to 2019.
 
The increase in segment operating
earnings reflects the inclusion of a full year of Houghton net sales, noted,
 
above, and the impacts on gross margins and SG&A due to
the Combination’s cost synergies
 
and costs savings actions related to COVID-19 year-over-year,
 
partially offset by the impact of
COVID-19 on sales volumes and higher COGS and SG&A due to seven additional
 
months of Houghton in 2020.
EMEA
EMEA represented approximately 27% of the Company’s
 
consolidated net sales in 2020.
 
The segment’s net sales were $383.2
million, an increase of $97.6 million or 34% compared to 2019.
 
The increase in net sales reflects additional net sales from
acquisitions of $117.9 million, primarily
 
a result of the inclusion of seven additional months of Houghton net sales, as the
Combination closed on August 1, 2019.
 
Excluding net sales from acquisitions, the segment’s
 
net sales decreased year-over-year by
approximately 7% due to lower volumes of 10%, partially offset by
 
a positive impact of foreign currency translation of 2% and
increases in selling price and product mix of 1%.
 
The current year volume decline was driven by the economic slowdown that began
in late March and continued throughout 2020 due to the impacts of COVID-19.
 
The foreign exchange impact was primarily due to the
strengthening of the euro against the U.S. dollar as this exchange rate averaged
 
1.14 in 2020 compared to 1.12 in 2019.
 
This
segment’s operating earnings were
 
$69.2 million, an increase of $22.1 million or 47% compared to 2019.
 
The increase in segment
operating earnings reflects the inclusion of a full year of Houghton net sales,
 
noted, above, and the impacts on gross margins and
SG&A due to the Combination’s cost synergies
 
and costs savings actions related to COVID-19 year-over-year,
 
partially offset by the
impact of COVID-19 on sales volumes and higher COGS and SG&A due
 
to seven additional months of Houghton in 2020.
Asia/Pacific
Asia/Pacific represented approximately 22% of the Company’s
 
consolidated net sales in 2020.
 
The segment’s net sales were
$315.3 million, an increase of $67.5 million or 27% compared to 2019.
 
The increase in net sales reflects the inclusion of seven
additional months of Houghton net sales of $79.7 million, as the Combination
 
closed on August 1, 2019.
 
Excluding Houghton net
sales, the segment’s net sales decreased
 
by approximately 5% year-over-year was due
 
to lower volumes of 3% and decreases in selling
price and product mix of 3% partially offset by the positive
 
impact of foreign currency translation of 1%.
 
The current year volume
decline was driven by the economic slowdown that began in the first quarter
 
of 2020 in China and in late March throughout the rest of
the region due to the impacts of COVID-19.
 
The foreign exchange impact was primarily due to the strengthening of the Chinese
renminbi against the U.S. dollar.
 
While this exchange rate averaged 6.90 in each of 2020 and 2019, respectively,
 
post the closing of
the Combination, this exchange rate strengthened in the last 5 months of 2020
 
to average 6.72 compared to 7.06 in the last 5 months of
2019, partially offset by the weakening of the Indian rupee against the
 
U.S. dollar as this exchange rate averaged 73.95 in 2020
compared to 70.35 in 2019.
 
This segment’s operating earnings were
 
$88.4 million, an increase of $20.8 million or 31% compared to
39
2019.
 
The increase in segment operating earnings reflects the inclusion of incremental
 
Houghton net sales, noted, above, and the
impacts on gross margins and SG&A due to the Combination’s
 
cost synergies and costs savings actions related to COVID-19 year-
over-year, partially offset
 
by the impact of COVID-19 on sales volumes and higher COGS and SG&A due
 
to seven additional months
of Houghton in 2020.
Global Specialty Businesses
Global Specialty Businesses represented approximately 19% of the
 
Company’s consolidated net sales in
 
2020.
 
The segment’s net
sales were $269.0 million, an increase of $61.1 million or 29% compared
 
to 2019.
 
The increase in net sales reflects the inclusion of
seven additional months of Houghton net sales and nine additional months
 
of Norman Hay net sales, totaling $90.6 million, as the
Combination closed on August 1, 2019 and the Norman Hay acquisition
 
closed on October 1, 2019.
 
Excluding Houghton and
Norman Hay net sales, the segment’s
 
net sales decreased by approximately 14% year-over-year
 
due to lower volumes of 7%,
decreases in selling price and product mix of 5% and a negative impact from foreign
 
currency translation of 2%.
 
The current year
volume decline was primarily due to a decrease in the Company’s
 
specialty coatings business driven by Boeing’s
 
decision to
temporarily stop production of the 737 Max aircraft and volume declines
 
due to the economic slowdown resulting from COVID-19.
 
Partially offsetting these volume declines, and
 
contributing to the decrease in selling price and product mix, were higher shipments of
a lower priced product in the Company’s
 
mining business compared to 2019.
 
The foreign exchange impact was primarily due to the
weakening of the Brazilian real against the U.S. dollar described
 
in the Americas section, above.
 
This segment’s operating earnings
were $79.7 million, an increase of $20.8 million or 35% compared
 
to 2019.
 
The increase in segment operating earnings reflects the
inclusion of incremental Houghton and Norman Hay net sales, noted
 
above, coupled with an increase in gross margin due to the
Company’s progress on Combination
 
-related logistics, procurement and manufacturing cost savings initiatives, partially
 
offset by
higher SG&A, including seven additional months of Houghton
 
and nine additional months of Norman Hay SG&A in 2020.
Environmental Clean-up Activities
The Company is involved in environmental clean-up activities in connection
 
with an existing plant location and former waste
disposal sites.
 
This includes certain soil and groundwater contamination the
 
Company identified in 1992 at AC Products, Inc.
(“ACP”), a wholly owned subsidiary.
 
In voluntary coordination with the Santa Ana California Regional Water
 
Quality Board, ACP
has been remediating the contamination.
 
In 2007, ACP agreed to operate two groundwater treatment systems, so as to hydraulically
contain groundwater contamination emanating from ACP’s
 
site until such time as the concentrations of contaminants are below
 
the
current Federal maximum contaminant level for four consecutive
 
quarterly sampling events.
 
In 2014, ACP ceased operation at one of
its two groundwater treatment systems, as it had met the above condition
 
for closure.
 
In 2020, the Santa Ana Regional Water
 
Quality
Control Board asked that ACP conduct some additional indoor
 
and outdoor soil vapor testing on and near the ACP site to confirm that
ACP continues to meet the applicable local standards and ACP has begun the
 
testing program.
 
Such testing began in 2020 and
continued into 2021.
 
As of December 31, 2021, ACP believes it is close to meeting the conditions for closure
 
of the remaining
groundwater treatment system but continues to operate this system while in
 
discussions with the relevant authorities.
 
As of December
31, 2021, the Company believes that the range of potential-known
 
liabilities associated with the balance of the ACP water remediation
program is approximately $0.1 million to $1.0 million.
 
The low and high ends of the range are based on the length of operation of the
treatment system as determined by groundwater modeling.
 
The Company is party to environmental matters related to certain domestic
 
and foreign properties.
 
The Company’s Sao Paulo,
Brazil site was required under Brazilian environmental, health and
 
safety regulations to perform an environmental assessment as part
of a permit renewal process.
 
Initial investigations identified soil and ground water contamination in
 
select areas of the site.
 
The site
has conducted a multi-year soil and groundwater investigation and
 
corresponding risk assessments based on the result of the
investigations.
 
In 2017, the site had to submit a new 5-year permit renewal request and was asked to
 
complete additional
investigations to further delineate the site based on review of the technical
 
data by the local regulatory agency,
 
Companhia Ambiental
do Estado de São Paulo (“CETESB”).
 
Based on review of the updated investigation data, CETESB issued a Technical
 
Opinion
regarding the investigation and remedial actions taken to date.
 
The site developed an action plan and submitted it to CETESB in 2018
based on CETESB requirements.
 
The site intervention plan primarily requires the site, among other actions,
 
to conduct periodic
monitoring for methane in soil vapors, source zone delineation, groundwater
 
plume delineation, bedrock aquifer assessment, update
the human health risk assessment, develop a current site conceptual model
 
and conduct a remedial feasibility study and provide a
revised intervention plan.
 
In 2019, the site submitted a report on the activities completed including the revised
 
site conceptual model
and results of the remedial feasibility study and recommended remedial
 
strategy for the site.
 
Other environmental matters include
participation in certain payments in connection with four currently
 
active environmental consent orders related to certain hazardous
waste cleanup activities under the U.S. Federal Superfund statute.
 
The Company has been designated a potentially responsible party
(“PRP”) by the Environmental Protection Agency along with other
 
PRPs depending on the site, and has other obligations to perform
cleanup activities at certain other foreign subsidiaries.
 
These environmental matters primarily require the Company to perform
 
long-
term monitoring as well as operating and maintenance at each of the applicable
 
sites.
 
The Company continually evaluates its obligations related to such matters,
 
and based on historical costs incurred and projected
costs to be incurred over the next 27 years, has estimated the present value range
 
of costs for these environmental matters, on a
discounted basis, to be between approximately $5.0 million and $6.0
 
million as of December 31, 2021, for which $5.6 million is
accrued within other accrued liabilities and other non-current liabilities on
 
the Company’s Consolidated
 
Balance Sheet as of
December 31, 2021.
 
Comparatively, as of
 
December 31, 2020, the Company had $6.0 million accrued with respect
 
to these matters.
40
The Company believes, although there can be no assurance regarding the
 
outcome of other unrelated environmental matters, that
it has made adequate accruals for costs associated with other environmental
 
problems of which it is aware.
 
Approximately $0.4
million and $0.1 million were accrued as of December 31, 2021
 
and 2020, respectively, to provide for
 
such anticipated future
environmental assessments and remediation costs.
Notwithstanding the foregoing, the Company cannot be certain that
 
future liabilities in the form of remediation expenses and
damages will not exceed amounts reserved.
 
See Note 26 of Notes to Consolidated Financial Statements in Item 8 of this Report
General
See Item 7A of this Report, below,
 
for further discussion of certain quantitative and qualitative disclosures
 
about market risk.
 
Item 7A.
 
Quantitative and Qualitative Disclosures About Market Risk.
Quaker Houghton is exposed to the impact of interest rates, foreign
 
currency fluctuations, changes in commodity prices, and
credit risk.
 
The current economic environment associated with COVID-19 has led to significant volatility
 
and uncertainty with each
of these market risks.
 
See Item 1A. “Risk Factors.” of this Report for additional discussions of
 
the current and potential risks
associated with the COVID-19 pandemic.
 
Except as otherwise disclosed below,
 
the market risks discussed below did not change
materially from December 31, 2020.
Interest Rate Risk.
 
The Company’s exposure
 
to changes in interest rates relates primarily to its borrowings under the Credit
Facility.
 
Borrowings under the Credit Facility bear interest at a specified benchmark
 
plus an applicable margin based upon the
Company’s consolidated
 
net leverage ratio and the currency of the borrowing.
 
In December 2021, the Company entered into the
Second Amendment to provide an update for the use of a non-USD currency LIBOR successor
 
rate.
 
At this time, it remains uncertain
what rate will succeed LIBOR for loans denominated in U.S. dollars.
 
As a result of the variable interest rates applicable under the
Credit Facility, including
 
with respect to any future successor rate if interest rates rise significantly,
 
the cost of debt to the Company
could increase as well.
 
This could have an adverse effect on the Company,
 
depending on the extent of the Company’s
 
borrowings
outstanding throughout a given year.
 
As of December 31, 2021, the Company had outstanding borrowings under
 
the Credit Facility of
approximately $889.6 million.
 
The variable interest rate incurred on the outstanding borrowings under
 
the Credit Facility during the
year ended December 31, 2021 was approximately 1.6%.
 
If interest rates had changed by 10% during 2021, the Company’s
 
interest
expense for the period ended December 31, 2021 on its credit facilities, including
 
the Credit Facility borrowings outstanding post-
closing of the Combination, would have correspondingly
 
increased or decreased by approximately $0.8 million.
 
The Credit Facility required the Company to fix its variable interest rates on at least 20%
 
of its total Term Loans.
 
In order to
satisfy this requirement as well as to manage the Company’s
 
exposure to variable interest rate risk associated with the Credit Facility,
in November 2019, the Company entered into $170.0 million notional amounts
 
of three year interest rate swaps at a base rate of 1.64%
plus an applicable margin as provided in the Credit Facility,
 
based on the Company’s consolidated
 
net leverage ratio.
 
At the time the
Company entered into the swaps and as of December 31, 2021, the aggregate
 
interest rate on the swaps, including the fixed base rate
plus an applicable margin, was 3.1%.
 
These interest rate swaps are designated and qualify as cash flow hedges.
 
The Company has
previously used derivative financial instruments primarily for the
 
purpose of hedging exposures to fluctuations in interest rates.
 
Foreign Exchange
 
Risk
.
 
A significant portion of the Company’s
 
revenues and earnings are generated by its foreign operations.
 
These foreign operations also represent a significant portion of Quake
 
r
 
Houghton’s assets and liabilities.
 
Generally, all of these
foreign operations use the local currency as their functional currency.
 
Accordingly, Quaker Houghton’s
 
financial results are affected
by foreign currency fluctuations, particularly between the U.S. dollar
 
and the euro, the British pound sterling, the Brazilian real, the
Mexican peso, the Chinese renminbi and the Indian rupee.
 
Quaker Houghton’s results can
 
be materially affected depending on the
volatility and magnitude of foreign exchange rate changes.
 
If the euro, the British pound sterling, the Brazilian real, the Mexican
peso, the Chinese renminbi and the Indian rupee had all weakened or strengthened
 
by 10% against the U.S. dollar, the Company’s
2021 revenues and pre-tax earnings would have correspondingly
 
decreased or increased by approximately $98.8 million and $11.7
million, respectively.
The Company generally does not use financial instruments that expose
 
it to significant risk involving foreign currency
transactions.
 
However, the size of its non-U.S. activities has a significant
 
impact on reported operating results and the attendant net
assets.
 
During the past three years, sales by its non-U.S. subsidiaries accounted
 
for approximately 60% to 70% of its consolidated net
sales.
 
In addition, the Company occasionally sources inventory among
 
its worldwide operations.
 
This practice can give rise to
foreign exchange risk resulting from the varying cost of inventory to the receiving
 
location, as well as from the revaluation of
intercompany balances.
 
The Company primarily mitigates this risk through local sourcing efforts.
Commodity Price Risk
.
 
Many of the raw materials used by Quaker Houghton are
 
derivatives of commodity chemicals, which can
experience significant price volatility,
 
and therefore Quaker Houghton’s
 
earnings can be materially affected by market changes in raw
material prices.
 
At times, the Company has entered into fixed-price purchase contracts to manage
 
this risk.
 
These contracts provide
protection to Quaker Houghton if the prices for the contracted raw materials
 
rise; however, in certain circumstances, the Company
may not realize the benefit if such prices decline.
 
A gross margin change of one percentage point, would correspondingly
 
have
increased or decreased the Company’s
 
pre-tax earnings by approximately $17.6 million.
 
41
Credit Risk
.
 
Quaker Houghton establishes allowances for doubtful
 
accounts for estimated losses resulting from the inability of its
customers to make required payments.
 
If the financial condition of Quaker Houghton’s
 
customers were to deteriorate, resulting in an
impairment of their ability to make payments, additional allowances might
 
be required.
 
Downturns in the overall economic climate
may also exacerbate specific customer financial issues.
 
A significant portion of the Company’s
 
revenues are derived from sales to
customers in the steel and automotive industries, including some of
 
our larger customers, where bankruptcies have occurred
 
in the past
and where companies have experienced past financial difficulties.
 
Though infrequent, when a bankruptcy occurs, Quaker Houghton
must judge the amount of proceeds, if any,
 
that may ultimately be received through the bankruptcy or liquidation process.
 
In addition, as part of its terms of trade, Quaker Houghton may custom
 
manufacture products for certain large customers and/or
may ship product on a consignment basis.
 
These practices may increase the Company’s
 
exposure should a bankruptcy occur and may
require a write-down or disposal of certain inventory due to its estimated obsolescence
 
or limited marketability as well as of accounts
receivable.
 
Customer returns of products or disputes may also result in similar issues related to
 
the realizability of recorded accounts
receivable or returned inventory.
 
The Company recorded expense to its provision for doubtful accounts by $0.7
 
million, $3.6 million
and $1.9 million for the years ended December 31, 2021, 2020 and 2019,
 
respectively.
 
A change of 10% to the expense recorded to
the Company’s provision would
 
have increased or decreased the Company’s
 
pre-tax earnings by $0.1 million, $0.4 million and $0.2
million for the years ended December 31, 2021, 2020 and 2019, respectively.
 
42
Item 8.
 
Financial Statements and Supplementary Data.
QUAKER CHEMICAL CORPORATION
INDEX TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
 
Page
Financial Statements:
 
 
(PCAOB ID
238
)
43
45
46
47
48
49
50
43
Report of Independent Registered Public Accounting Firm
 
To the Board of
 
Directors and Shareholders of Quaker Chemical Corporation
Opinions on the Financial Statements and Internal Control over
 
Financial Reporting
We have audited
 
the accompanying consolidated balance sheets of Quaker Chemical Corporation
 
and its subsidiaries (the
“Company”) as of December 31, 2021 and 2020, and the related consolidated
 
statements of income, of comprehensive income, of
changes in equity and of cash flows for each of the three years in the period ended December
 
31, 2021, including the related notes
(collectively referred to as the “consolidated financial statements”).
 
We also have audited
 
the Company's internal control over
financial reporting as of December 31, 2021, based on criteria established in Internal
 
Control - Integrated Framework (2013) issued by
the Committee of Sponsoring Organizations of
 
the Treadway Commission (COSO).
 
In our opinion, the consolidated financial statements referred to above present
 
fairly, in all material respects, the financial
 
position of
the Company as of December 31, 2021 and 2020, and the results of its operations
 
and its cash flows for each of the three years in the
period ended December 31, 2021 in conformity with accounting principles
 
generally accepted in the United States of America.
 
Also
in our opinion, the Company maintained, in all material respects, effective
 
internal control over financial reporting as of December 31,
2021, based on criteria established in Internal Control - Integrated Framework
 
(2013) issued by the COSO.
Basis for Opinions
The Company's management is responsible for these consolidated
 
financial statements, for maintaining effective internal control
 
over
financial reporting, and for its assessment of the effectiveness of
 
internal control over financial reporting, included in Management's
Report on Internal Control over Financial Reporting appearing under
 
Item 9A.
 
Our responsibility is to express opinions on the
Company’s consolidated
 
financial statements and on the Company's internal control over financial reporting based
 
on our audits.
 
We
are a public accounting firm registered with the Public Company Accounting Oversight
 
Board (United States) (PCAOB) and are
required to be independent with respect to the Company in accordance with
 
the U.S. federal securities laws and the applicable rules
and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted
 
our audits in accordance with the standards of the PCAOB.
 
Those standards require that we plan and perform the
audits to obtain reasonable assurance about whether the consolidated
 
financial statements are free of material misstatement, whether
due to error or fraud, and whether effective
 
internal control over financial reporting was maintained in all material respects.
 
Our audits of the consolidated financial statements included performing procedures
 
to assess the risks of material misstatement of the
consolidated financial statements, whether due to error or fraud, and
 
performing procedures that respond to those risks.
 
Such
procedures included examining, on a test basis, evidence regarding the amounts
 
and disclosures in the consolidated financial
statements.
 
Our audits also included evaluating the accounting principles used
 
and significant estimates made by management, as well
as evaluating the overall presentation of the consolidated financial statements.
 
Our audit of internal control over financial reporting
included obtaining an understanding of internal control over financial reporting,
 
assessing the risk that a material weakness exists, and
testing and evaluating the design and operating effectiveness of
 
internal control based on the assessed risk.
 
Our audits also included
performing such other procedures as we considered necessary in the circumstances.
 
We believe that our
 
audits provide a reasonable
basis for our opinions.
As described in Management’s Report
 
on Internal Control over Financial Reporting, management has excluded
 
Baron Industries and
Grindaix GmbH from its assessment of internal control over financial reporting
 
as of December 31, 2021 because they were acquired
by the Company in purchase business combinations during 2021.
 
We have also excluded Baron
 
Industries and Grindaix from our
audit of internal control over financial reporting.
 
Baron Industries and Grindaix are wholly-owned subsidiaries whose total assets and
total revenues excluded from management’s
 
assessment and our audit of internal control over financial reporting for each entity
represent less than 1% of the related consolidated financial statement amounts
 
as of and for the year ended December 31, 2021.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over
 
financial reporting is a process designed to provide reasonable assurance regarding
 
the reliability of
financial reporting and the preparation of financial statements for external
 
purposes in accordance with generally accepted accounting
principles.
 
A company’s internal control over financial
 
reporting includes those policies and procedures that (i) pertain to the
maintenance of records that, in reasonable detail, accurately and fairly reflect
 
the transactions and dispositions of the assets of the
company; (ii) provide reasonable assurance that transactions are recorded
 
as necessary to permit preparation of financial statements in
accordance with generally accepted accounting principles, and that receipts
 
and expenditures of the company are being made only in
accordance with authorizations of management and directors of the
 
company; and (iii) provide reasonable assurance regarding
prevention or timely detection of unauthorized acquisition, use, or disposition
 
of the company’s assets that could have
 
a material effect
on the financial statements.
44
Because of its inherent limitations, internal control over financial reporting
 
may not prevent or detect misstatements.
 
Also, projections
of any evaluation of effectiveness to future periods are subject
 
to the risk that controls may become inadequate because of changes
 
in
conditions, or that the degree of compliance with the policies or procedures
 
may deteriorate.
Critical Audit Matters
The critical audit matter communicated below is a matter arising from the current period
 
audit of the consolidated financial statements
that was communicated or required to be communicated to the audit committee and
 
that (i) relates to accounts or disclosures that are
material to the consolidated financial statements and (ii) involved our especially
 
challenging, subjective, or complex judgments.
 
The
communication of critical audit matters does not alter in any way our opinion
 
on the consolidated financial statements, taken as a
whole, and we are not, by communicating the critical audit matter below,
 
providing a separate opinion on the critical audit matter or
on the accounts or disclosures to which it relates.
Houghton Trademarks and
 
Tradename – Annual Impairment Assessment
As described in Note 16 to the consolidated financial statements, the Company’s
 
consolidated other intangible assets, net balance was
$1,027.8 million as of December 31, 2021, and the indefinite-lived
 
intangible asset was $196.9 million, which substantially relates to
the Houghton trademarks and tradename.
 
Management completes its annual indefinite-lived intangible asset impairment test during
the fourth quarter of each year, or more frequently
 
if triggering events indicate a possible impairment.
 
Management completed its
annual impairment assessment during the fourth quarter of 2021 for the Houghton
 
trademarks and tradename and concluded no
impairment charge was warranted.
 
The determination of estimated fair value of the Houghton trademarks and
 
tradename is based on a
relief from royalty valuation method, which requires management’s
 
judgment and often involves the use of significant estimates and
assumptions with respect to the weighted average cost of capital and royalty rates,
 
as well as revenue growth rates and terminal growth
rates.
The principal considerations for our determination that performing procedures
 
relating to the Houghton trademarks and tradename
annual impairment assessment is a critical audit matter are (i) the significant
 
judgment by management when determining the fair
value of the Houghton trademarks and tradename; (ii) a high degree of
 
auditor judgment, subjectivity,
 
and effort in performing
procedures and evaluating management’s
 
significant assumptions related to the royalty rate, revenue growth rates, and terminal
growth rates; and (iii) the audit effort involved the use of professionals with specialized
 
skill and knowledge.
 
Addressing the matter involved performing procedures and evaluating
 
audit evidence in connection with forming our overall opinion
on the consolidated financial statements.
 
These procedures included testing the effectiveness of controls
 
relating to management’s
indefinite-lived intangible assets annual impairment assessment, including
 
controls over the valuation of the Houghton trademarks and
tradename.
 
These procedures also included, among others (i) testing management’s
 
process for determining the fair value estimate;
(ii) evaluating the appropriateness of the relief from royalty valuation
 
method; (iii) testing the completeness and accuracy of
underlying data used in the method; and (iv) evaluating the reasonableness
 
of significant assumptions related to the royalty rate,
revenue growth rates and terminal growth rates.
 
Evaluating management’s assumptions
 
related to the royalty rate, revenue growth
rates, and terminal growth rates involved evaluating whether the
 
assumptions used by management were reasonable considering (i) the
current and past performance of the legacy Houghton business; (ii) the consistency
 
with external market and industry data; and (iii)
whether these assumptions were consistent with evidence obtained in other
 
areas of the audit.
 
Professionals with specialized skill and
knowledge were used to assist in the evaluation of the relief from royalty valuation
 
method and the royalty rate assumption.
/s/
PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
March 1, 2022
We have served
 
as the Company’s auditor since at least 1972.
 
We have not been able
 
to determine the specific year we began serving
as auditor of the Company.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
45
QUAKER CHEMICAL CORPORATION
CONSOLIDATED STATEMENTS
 
OF INCOME
(
Dollars in thousands, except per share data
)
Year
 
Ended December 31,
 
2021
2020
2019
Net sales
$
1,761,158
$
1,417,677
$
1,133,503
Cost of goods sold (excluding amortization expense - See Note 16)
1,166,518
904,234
741,386
Gross profit
594,640
513,443
392,117
Selling, general and administrative expenses
418,856
380,752
283,828
Indefinite-lived intangible asset impairment
-
38,000
-
Restructuring and related charges
1,433
5,541
26,678
Combination, integration and other acquisition-related expenses
23,885
29,790
35,477
Operating income
150,466
59,360
46,134
Other income (expense), net
18,851
(5,618)
(254)
Interest expense, net
(22,326)
(26,603)
(16,976)
Income before taxes and equity in net income of associated companies
146,991
27,139
28,904
Taxes on income
 
before equity in net income of associated companies
34,939
(5,296)
2,084
Income before equity in net income of associated companies
112,052
32,435
26,820
Equity in net income of associated companies
9,379
7,352
5,064
Net income
121,431
39,787
31,884
Less: Net income attributable to noncontrolling interest
62
129
262
Net income attributable to Quaker Chemical Corporation
$
121,369
$
39,658
$
31,622
Per share data:
Net income attributable to Quaker Chemical Corporation
 
common
 
shareholders – basic
$
6.79
$
2.23
$
2.08
Net income attributable to Quaker Chemical Corporation common
 
shareholders – diluted
$
6.77
$
2.22
$
2.08
The accompanying notes are an integral part
 
of these consolidated financial statements.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
46
QUAKER CHEMICAL CORPORATION
CONSOLIDATED STATEMENTS
 
OF COMPREHENSIVE INCOME
(
Dollars in thousands
)
Year
 
Ended December 31,
2021
2020
2019
Net income
$
121,431
$
39,787
$
31,884
Other comprehensive (loss) income, net of tax
Currency translation adjustments
(46,952)
41,601
4,779
Defined benefit retirement plans
Net gain (loss) arising during the period, other
9,210
8,827
(6,289)
Amortization of actuarial loss
1,078
2,308
2,458
Amortization of prior service gain
7
(69)
(151)
Current period change in fair value of derivatives
2,226
(3,278)
(320)
Unrealized (loss) gain on available-for-sale securities
(2,945)
2,091
2,093
Other comprehensive (loss) income
(37,376)
51,480
2,570
Comprehensive income
84,055
91,267
34,454
Less: Comprehensive income attributable to noncontrolling
 
interest
(78)
(37)
(287)
Comprehensive income attributable to Quaker Chemical Corporation
$
83,977
$
91,230
$
34,167
The accompanying notes are an integral part
 
of these consolidated financial statements.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
47
QUAKER CHEMICAL CORPORATION
CONSOLIDATED
 
BALANCE SHEETS
(
Dollars in thousands, except par value
)
December 31,
2021
2020
 
ASSETS
Current assets
Cash and cash equivalents
$
165,176
$
181,833
Accounts receivable, net
 
430,676
372,974
Inventories, net
 
264,531
187,764
Prepaid expenses and other current assets
 
59,871
50,156
Total current
 
assets
 
920,254
 
792,727
Property, plant and equipment,
 
net
 
197,520
203,883
Right of use lease assets
36,635
38,507
Goodwill
631,194
631,212
Other intangible assets, net
 
1,027,782
1,081,358
Investments in associated companies
 
95,278
95,785
Deferred tax assets
 
16,138
16,566
Other non-current assets
 
30,959
31,796
Total assets
$
2,955,760
$
2,891,834
 
 
 
LIABILITIES AND EQUITY
 
 
Current liabilities
 
 
Short-term borrowings and current portion of long-term debt
$
56,935
$
38,967
Accounts payable
 
226,656
 
191,821
Dividends payable
7,427
7,051
Accrued compensation
 
38,197
 
43,300
Accrued restructuring
4,087
8,248
Accrued pension and postretirement benefits
1,548
1,466
Other accrued liabilities
 
95,617
 
92,107
Total current
 
liabilities
 
430,467
 
382,960
Long-term debt
 
836,412
 
849,068
Long-term lease liabilities
26,335
27,070
Deferred tax liabilities
179,025
192,763
Non-current accrued pension and postretirement benefits
45,984
63,890
Other non-current liabilities
 
49,615
 
55,169
Total liabilities
 
1,567,838
 
1,570,920
Commitments and contingencies (Note 26)
-
-
Equity
 
 
Common stock, $
1
 
par value; authorized
30,000,000
 
shares; issued and outstanding
 
 
2021 –
17,897,033
 
shares; 2020 –
17,850,616
 
shares
17,897
17,851
Capital in excess of par value
 
917,053
 
905,171
Retained earnings
 
516,334
 
423,940
Accumulated other comprehensive loss
 
(63,990)
 
(26,598)
Total Quaker
 
shareholders’ equity
 
1,387,294
 
1,320,364
Noncontrolling interest
 
628
550
Total equity
1,387,922
1,320,914
Total liabilities and equity
$
2,955,760
$
2,891,834
The accompanying notes are an integral part
 
of these consolidated financial statements.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
48
QUAKER CHEMICAL CORPORATION
CONSOLIDATED STATEMENTS
 
OF CASH FLOWS
(
Dollars in thousands
)
Year Ended
 
December 31,
 
2021
2020
2019
Cash flows from operating activities
 
 
 
 
 
 
Net income
 
$
121,431
$
39,787
$
31,884
Adjustments to reconcile net income to net cash provided by operating activities:
Amortization of debt issuance costs
4,749
4,749
1,979
Depreciation and amortization
 
86,550
83,246
44,895
Equity in undistributed earnings of associated companies, net of dividends
 
(8,971)
4,862
(2,115)
Acquisition-related fair value adjustments related to inventory
801
229
11,714
Deferred income taxes
(12,506)
(38,281)
(24,242)
Uncertain tax positions (non-deferred portion)
(922)
1,075
958
Non-current income taxes payable
-
-
856
Deferred compensation and other, net
(5,325)
(471)
(6,789)
Share-based compensation
 
11,038
10,996
4,861
(Gain) loss on disposal of property, plant, equipment and other assets
 
(4,695)
871
(58)
Insurance settlement realized
 
-
(1,035)
(822)
Indefinite-lived intangible asset impairment
-
38,000
-
Gain on inactive subsidiary litigation and settlement reserve
-
(18,144)
-
Combination and other acquisition-related expenses, net of payments
(1,974)
860
(14,414)
Restructuring and related charges
1,433
5,541
26,678
Pension and other postretirement benefits
 
(6,330)
16,535
46
(Decrease) increase in cash from changes in current assets and current
 
 
liabilities, net of acquisitions:
Accounts receivable
 
(67,473)
17,170
19,926
Inventories
 
(84,428)
(3,854)
10,844
Prepaid expenses and other current assets
 
(21,174)
927
(4,640)
Change in restructuring liabilities
(5,266)
(15,745)
(8,899)
Accounts payable and accrued liabilities
 
37,998
22,308
(8,915)
Estimated taxes on income
3,997
8,763
(1,373)
 
Net cash provided by operating activities
 
48,933
 
178,389
 
82,374
Cash flows from investing activities
 
 
 
Investments in property, plant and equipment
 
(21,457)
(17,901)
(15,545)
Payments related to acquisitions, net of cash acquired
 
(42,417)
(56,230)
(893,412)
Proceeds from disposition of assets
14,744
2,702
103
Insurance settlement interest earned
 
-
44
222
 
Net cash used in investing activities
 
(49,130)
 
(71,385)
 
(908,632)
Cash flows from financing activities
 
 
 
Payments of long-term debt
(38,011)
(37,615)
-
Proceeds from term loan debt
 
-
-
750,000
Borrowings (repayments) on revolving credit facilities, net
 
53,031
(11,485)
147,135
Repayments on other debt, net
 
(776)
(661)
(8,798)
Financing-related debt issuance costs
-
-
(23,747)
Dividends paid
 
(28,599)
(27,563)
(21,830)
Stock options exercised, other
 
890
3,867
1,370
Purchase of noncontrolling interest in affiliates
-
(1,047)
-
Distributions to noncontrolling affiliate shareholders
-
(751)
-
 
Net cash (used in) provided by financing activities
 
(13,465)
 
(75,255)
 
844,130
Effect of foreign exchange rate changes on cash
 
(3,057)
6,591
1,258
Net (decrease) increase in cash, cash equivalents and restricted cash
 
(16,719)
38,340
19,130
Cash, cash equivalents and restricted cash at the beginning of the period
 
181,895
143,555
124,425
Cash, cash equivalents and restricted cash at the end of the period
$
165,176
$
181,895
$
143,555
Supplemental cash flow disclosures:
Cash paid during the year for:
Income taxes, net of refunds
$
34,775
$
20,253
$
15,499
Interest
19,298
23,653
19,553
Non-cash activities:
Change in accrued purchases of property, plant and equipment, net
$
2,132
$
(1,376)
$
1,978
The accompanying notes are an integral part
 
of these consolidated financial statements.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
49
QUAKER CHEMICAL CORPORATION
CONSOLIDATED STATEMENTS
 
OF CHANGES IN EQUITY
(
Dollars in thousands, except per share amounts
)
Accumulated
Capital in
other
Common
excess of
Retained
comprehensive
Noncontrollin
stock
par value
earnings
loss
interest
Total
Balance as of December 31, 2018
$
13,338
$
97,304
$
405,125
$
(80,715)
$
1,317
$
436,369
Cumulative effect of an accounting change
-
-
(44)
-
-
(44)
Balance as of January 1, 2019
13,338
97,304
405,081
(80,715)
1,317
436,325
Net income
-
-
31,622
-
262
31,884
Amounts reported in other comprehensive
 
income
-
-
-
2,545
25
2,570
Dividends declared ($
1.525
 
per share)
-
-
(23,724)
-
-
(23,724)
Shares issued related to the Combination
4,329
784,751
-
-
-
789,080
Shares issued upon exercise of stock options
 
and other
23
871
-
-
-
894
Shares issued for employee stock purchase plan
3
473
-
-
-
476
Share-based compensation plans
42
4,819
-
-
-
4,861
Balance as of December 31, 2019
17,735
888,218
412,979
(78,170)
1,604
1,242,366
Cumulative effect of an accounting change
-
-
(911)
-
-
(911)
Balance as of January 1, 2020
17,735
888,218
412,068
(78,170)
1,604
1,241,455
Net income
-
-
39,658
-
129
39,787
Amounts reported in other comprehensive
income (loss)
-
-
-
51,572
(92)
51,480
Dividends declared ($
1.56
 
per share)
-
-
(27,786)
-
-
(27,786)
Acquisition of noncontrolling interest
-
(707)
-
-
(340)
(1,047)
Distributions to noncontrolling affiliate
 
shareholders
-
-
-
-
(751)
(751)
Shares issued upon exercise of stock options
 
and other
66
6,714
-
-
-
6,780
Share-based compensation plans
50
10,946
-
-
-
10,996
Balance as of December 31, 2020
17,851
905,171
423,940
(26,598)
550
1,320,914
Net income
-
-
121,369
-
62
121,431
Amounts reported in other comprehensive
(loss) income
-
-
-
(37,392)
16
(37,376)
Dividends declared ($
1.62
 
per share)
-
-
(28,975)
-
-
(28,975)
Shares issued upon exercise of stock options
 
and other
17
1,677
-
-
-
1,694
Share-based compensation plans
29
10,205
-
-
-
10,234
Balance as of December 31, 2021
$
17,897
$
917,053
$
516,334
$
(63,990)
$
628
$
1,387,922
The accompanying notes are an integral part of these consolidated financial statements.
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
50
Note 1 – Significant Accounting Policies
As used in these Notes to Consolidated Financial Statements, the terms
 
“Quaker,” “Quaker Houghton,” the “Company,”
 
“we,”
and “our” refer to Quaker Chemical Corporation (doing business as Quaker Houghton),
 
its subsidiaries, and associated companies,
unless the context otherwise requires.
 
As used in these Notes to Consolidated Financial Statements, the term Legacy Quaker
 
refers to
the Company prior to the closing of its combination with Houghton International,
 
Inc. (“Houghton”) (herein referred to as the
“Combination”).
 
Principles of consolidation:
All majority-owned subsidiaries are included in the Company’s
 
consolidated financial statements,
with appropriate elimination of intercompany balances and transactions.
 
Investments in associated companies (less than majority-
owned and in which the Company has significant influence) are accounted
 
for under the equity method.
 
The Company’s share of net
income or losses in these investments in associated companies is included in
 
the Consolidated Statements of Income.
 
The Company
periodically reviews these investments for impairments and, if necessary,
 
would adjust these investments to their fair value when a
decline in market value or other impairment indicators are deemed to be other
 
than temporary.
 
See Note 17 of Notes to Consolidated
Financial Statements.
 
The Company is not the primary beneficiary of any variable interest entities (“VIEs”)
 
and therefore the
Company’s consolidated
 
financial statements do not include the accounts of any VIEs.
Translation of foreign
 
currency:
Assets and liabilities of non-U.S. subsidiaries and associated companies are translated into
U.S. dollars at the respective rates of exchange prevailing at the end of the year.
 
Income and expense accounts are translated at
average exchange rates prevailing during the year.
 
Translation adjustments resulting from this process are
 
recorded directly in equity
as accumulated other comprehensive (loss) income (“AOCI”) and
 
will be included as income or expense only upon sale or liquidation
of the underlying entity or asset.
 
Generally, all of the Company’s
 
non-U.S. subsidiaries use their local currency as their functional
currency.
Cash and cash equivalents:
The Company invests temporary and excess funds in money market securities and financial
instruments having maturities within 90 days. The Company considers all highly liquid investments with original maturities of three
months or less to be cash equivalents.
 
The Company has not experienced losses from the aforementioned
 
investments.
 
Accounts receivable and allowance for doubtful accounts:
Trade accounts receivable subject the Company to credit risk.
 
Trade accounts receivable are recorded at the
 
invoiced amount and generally do not bear interest.
 
The allowance for doubtful
accounts is the Company’s best estimate of
 
the amount of expected credit losses with its existing accounts receivable.
 
The Company
adopted ASU 2016-13,
Financial Instruments - Credit Losses (Topic
326): Measurement of Credit
Losses on Financial Instruments
on
a modified retrospective basis, effective January 1, 2020.
 
The Company recognizes an allowance for credit losses, which represents
 
the portion of the receivable that the Company does not
expect to collect over its contractual life, considering past events and reasonable
 
and supportable forecasts of future economic
conditions.
 
The Company’s allowance for credit losses on
 
its trade accounts receivable is based on specific collectability facts and
circumstances for each outstanding receivable and customer,
 
the aging of outstanding receivables, and the associated collection risk
the Company estimates for certain past due aging categories, and also,
 
the general risk to all outstanding accounts receivable based on
historical amounts determined to be uncollectible.
 
The Company does not have any off-balance-sheet credit exposure related
 
to its
customers.
 
See Note 13 of Notes to Consolidated Financial Statements.
 
Inventories:
Inventories are valued at the lower of cost or net realizable value,
 
and are valued using the first-in, first-out method.
 
See Note 14 of Notes to Consolidated Financial Statements.
Right of use lease assets and lease liabilities:
The Company determines if an arrangement is a lease at its inception.
 
This
determination generally depends on whether the arrangement conveys
 
the right to control the use of an identified fixed asset explicitly
or implicitly for a period of time in exchange for consideration.
 
Control of an underlying asset is conveyed if the Company obtains
the rights to direct the use of, and obtains substantially all of the economic benefits from
 
the use of, the underlying asset.
 
Lease
expense for variable leases and short-term leases is recognized when
 
the obligation is incurred.
 
The lease term for all of the Company’s
 
leases includes the non-cancellable period of the lease plus any additional periods
covered by an option to extend the lease that the Company is reasonably certain
 
it will exercise.
 
Operating leases are included in right
of use lease assets, other accrued liabilities and long-term lease liabilities on the Consolidated
 
Balance Sheet.
 
Right of use lease assets
and liabilities are recognized at each lease’s
 
commencement date based on the present value of its lease payments over its respective
lease term.
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
51
The Company uses the stated borrowing rate for a lease when readily determinable.
 
When a stated borrowing rate is not available
in a lease agreement, the Company uses its incremental borrowing rate
 
based on information available at the lease’s
 
commencement
date to determine the present value of its lease payments.
 
In determining the incremental borrowing rate used to present value each
 
of
its leases, the Company considers certain information including fully
 
secured borrowing rates readily available to the Company and its
subsidiaries.
 
The Company has immaterial finance leases, which are included in
 
Property, plant and equipment (“PP&E”)
 
,
 
current
portion of long-term debt and long-term debt on the Consolidated Balance
 
Sheet.
 
Long-lived assets:
PP&E is stated at gross cost, less accumulated depreciation.
 
Depreciation is computed using the straight-
line method on an individual asset basis over the following estimated useful lives: buildings
 
and improvements,
10
 
to
45
 
years; and
machinery and equipment,
1
 
to
15
 
years.
 
The carrying values of long-lived assets are evaluated whenever changes in circumstances
 
or
current events indicate the carrying amount of such assets may not be
 
recoverable.
 
An estimate of undiscounted cash flows produced
by the asset, or the appropriate group of assets, is compared with the carrying value to
 
determine whether an impairment exists.
 
If
necessary, the Company
 
recognizes an impairment loss for the difference between the carrying
 
amount of the assets and their
estimated fair value.
 
Fair value is based on current and anticipated future cash flows.
 
Upon sale or other dispositions of long-lived
assets, the applicable amounts of asset cost and accumulated depreciation
 
are removed from the accounts and the net amount, less
proceeds from disposals, is recorded in the Consolidated Statements of Income.
 
Expenditures for renewals or improvements that
increase the estimated useful life or capacity of the assets are capitalized, whereas
 
expenditures for repairs and maintenance are
expensed when incurred.
 
See Notes 9 and 15 of Notes to Consolidated Financial Statements.
 
Capitalized software:
The Company capitalizes certain costs in connection with developing or obtaining
 
software for internal
use, depending on the associated project.
 
These costs are amortized over a period of
3
 
to
5
 
years once the assets are ready for their
intended use.
 
In connection with the implementations and upgrades to the Company’s
 
global transaction, consolidation and other
related systems, approximately $
3.6
 
million and $
2.3
 
million of net costs were capitalized in PP&E on the Company’s
 
Consolidated
Balance Sheets at December 31, 2021 and 2020, respectively.
 
Goodwill and other intangible assets:
The Company records goodwill, definite-lived intangible
 
assets and indefinite-lived
intangible assets at fair value at the date of acquisition.
 
Goodwill and indefinite-lived intangible assets are not amortized but
 
tested for
impairment at least annually.
 
These tests will be performed more frequently if triggering events indicate
 
potential impairment.
Definite-lived intangible assets are amortized on a straight-line basis over their estimated
 
useful lives, generally for periods ranging
from
3
 
to
24
 
years.
 
The Company continually evaluates the reasonableness of the useful lives of these assets, consistent
 
with the
discussion of long-lived assets, above.
 
See Note 16 of Notes to Consolidated Financial Statements.
Revenue recognition:
The Company applies the Financial Accounting Standards Board’s
 
(“FASB’s”)
 
guidance on revenue
recognition which requires the Company to recognize revenue in an amount
 
that reflects the consideration to which the Company
expects to be entitled in exchange for goods or services transferred
 
to its customers.
 
To do this, the Company
 
applies the five-step
model in the FASB’s
 
guidance, which requires the Company to: (i) identify the contract
 
with a customer; (ii) identify the performance
obligations in the contract; (iii) determine the transaction price; (iv) allocate
 
the transaction price to the performance obligations in the
contract; and (v) recognize revenue when, or as, the Company satisfies a performance
 
obligation.
 
The Company identifies a contract with a customer when a sales agreement indicates
 
approval and commitment of the parties;
identifies the rights of the parties; identifies the payment terms; has commercial
 
substance; and it is probable that the Company will
collect the consideration to which it will be entitled in exchange for the goods
 
or services that will be transferred to the customer.
The Company identifies a performance obligation in a contract for each promised
 
good or service that is separately identifiable
from other obligations in the contract and for which the customer can benefit
 
from the good or service either on its own or together
with other resources that are readily available to the customer.
 
The Company determines the transaction price as the amount of
consideration it expects to be entitled to in exchange for fulfilling the performance
 
obligations, including the effects of any variable
consideration, significant financing elements, amounts payable to the customer
 
or noncash consideration.
 
For any contracts that have
more than one performance obligation, the Company allocates the transaction
 
price to each performance obligation in an amount that
depicts the amount of consideration to which the Company expects to be entitled
 
in exchange for satisfying each performance
obligation.
In accordance with the last step of the FASB’s
 
guidance, the Company recognizes revenue when, or as, it satisfies the
performance obligation in a contract by transferring control of a promised
 
good or providing the service to the customer.
 
The
Company typically satisfies its performance obligations and recognizes
 
revenue at a point in time for product sales, generally when
products are shipped or delivered to the customer,
 
depending on the terms underlying each arrangement.
 
In circumstances where the
Company’s products are on
 
consignment, revenue is generally recognized upon usage or consumption by the customer.
 
For any
Fluidcare
TM
 
or other services provided by the Company to the customer,
 
the Company typically satisfies its performance obligations
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
52
and recognizes revenue over time, as the promised services are performed.
 
The Company uses input methods to recognize revenue
over time related to these services, including labor costs and time incurred.
 
The Company believes that these input methods represent
the most indicative measure of the Fluidcare
TM
 
or other service work performed by the Company.
The Company does not have standard payment terms for all customers,
 
however the Company’s general
 
payment terms require
customers to pay for products or services provided after the performance
 
obligation is satisfied.
 
The Company does not have
significant financing arrangements with its customers.
 
Therefore, the Company does not adjust the promised amount of consideration
for the effects of a significant financing component as the Company
 
expects, at contract inception, that the period between when the
Company transfers a promised good or service to the customer and when the
 
customer pays for that good or service will be one year or
less.
 
In addition, the Company expenses costs to obtain a contract as incurred
 
when the expected period of benefit, and therefore the
amortization period, is one year or less.
 
In addition, the Company excludes from the measurement of the transaction price all taxes
assessed by a governmental authority that are both imposed on and concurrent
 
with a specific revenue-producing transaction and
collected by the entity from a customer,
 
including sales, use, value added, excise and various other taxes.
 
Lastly, the Company has
elected to account for shipping and handling activities that occur after the
 
customer has obtained control of a good as a fulfilment cost,
rather than an additional promised service.
 
The Company does not have significant amounts of variable consideration in
 
its contracts
with customers and where applicable, the Company’s
 
estimates of variable consideration are not constrained.
 
The Company records certain third-party license fees in other income
 
(expense), net, in its Consolidated Statement of Income,
which generally include sales-based royalties in exchange for the license of
 
intellectual property.
 
These license fees are recognized in
accordance with their agreed-upon terms and when performance obligations are
 
satisfied, which is generally when the third party has a
subsequent sale.
The Company recognizes a contract asset or receivable on its Consolidated Balance Sheet
 
when the Company performs a service
or transfers a good in advance of receiving consideration.
 
A receivable is the Company’s right to consideration
 
that is unconditional
and only the passage of time is required before payment of that consideration
 
is due.
 
A contract asset is the Company’s right
 
to
consideration in exchange for goods or services that the Company has transferred
 
to a customer.
 
A contract liability is recognized when the Company receives consideration,
 
or if it has the unconditional right to receive
consideration, in advance of performance.
 
A contract liability is the Company’s
 
obligation to transfer goods or services to a customer
for which the Company has received consideration, or a specified amount
 
of consideration is due, from the customer.
 
See Note 5 of Notes to Consolidated Financial Statements.
 
Research and development costs:
Research and development costs are expensed as incurred and are included
 
in selling, general
and administrative expenses (“SG&A”).
 
Research and development expenses were $
44.9
 
million, $
40.0
 
million and $
32.1
 
million for
the years ended December 31, 2021, 2020 and 2019, respectively.
 
Environmental liabilities and expenditures:
Accruals for environmental matters are recorded when it is probable
 
that a liability
has been incurred and the amount of the liability can be reasonably estimated.
 
If there is a range of estimated liability and no amount
in that range is considered more probable than another,
 
then the Company records the lowest amount in the range in accordance with
generally accepted accounting principles in the United States (“U.S. GAAP”).
 
Environmental costs and remediation costs are
capitalized if the costs extend the life, increase the capacity or improve
 
safety or efficiency of the property from the date acquired or
constructed, and/or mitigate or prevent contamination in the future.
 
See Note 26 of Notes to Consolidated Financial Statements.
 
Asset retirement obligations:
The Company follows the FASB’s
 
guidance regarding asset retirement obligations, which
addresses the accounting and reporting for obligations associated with the
 
retirement of tangible long-lived assets and the associated
retirement costs.
 
Also, the Company follows the FASB’s
 
guidance for conditional asset retirement obligations (“CARO”),
 
which
relates to legal obligations to perform an asset retirement activity in which
 
the timing and (or) method of settlement are conditional on
a future event that may or may not be within the control of the entity.
 
In accordance with this guidance, the Company records a
liability when there is enough information regarding the timing of the CARO to perform
 
a probability-weighted discounted cash flow
analysis.
 
As of December 31, 2021 and 2020, the Company had limited exposure
 
to such obligations and had immaterial liabilities
recorded for such on its Consolidated Balance Sheets.
Pension and other postretirement benefits:
The Company maintains various noncontributory retirement plans,
 
covering a
portion of its employees in the U.S. and certain other countries, including
 
the Netherlands, the United Kingdom (“U.K.”), Mexico,
Sweden, Germany and France.
 
These retirement plans are subject to the provisions of FASB’s
 
guidance regarding employers’
accounting for defined benefit pension plans.
 
The plans of the remaining non-U.S. subsidiaries are, for the most part, either
 
fully
insured or integrated with the local governments’ plans and are not subject
 
to the provisions of the guidance.
 
The guidance requires
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
53
that employers recognize on a prospective basis the funded status of their
 
defined benefit pension and other postretirement plans on
their consolidated balance sheet and, also, recognize as a component of AOCI,
 
net of tax, the gains or losses and prior service costs or
credits that arise during the period but are not recognized as components of
 
net periodic benefit cost.
 
In addition, the guidance
requires that an employer recognize a settlement charge in
 
their consolidated statement of income when certain events occur,
including plan termination or the settlement of certain plan liabilities.
 
A settlement charge represents the immediate recognition
 
into
expense of a portion of the unrecognized loss within AOCI on the balance sheet in
 
proportion to the share of the projected benefit
obligation that was settled.
 
The measurement date for the Company’s
 
postretirement benefits plan is December 31.
 
The Company’s global pension
 
investment policies are designed to ensure that pension assets are invested in a manner
 
consistent
with meeting the future benefit obligations of the pension plans and maintaining
 
compliance with various laws and regulations
including the Employee Retirement Income Security Act of 1974.
 
The Company establishes strategic asset allocation percentage
targets and benchmarks for significant asset classes with the aim of
 
achieving a prudent balance between return and risk.
 
The
Company’s investment horizon
 
is generally long term, and, accordingly,
 
the target asset allocations encompass a long-term
perspective of capital markets, expected risk and return and perceived future
 
economic conditions while also considering the profile of
plan liabilities.
 
To the extent feasible,
 
the short-term investment portfolio is managed to match the short
 
-term obligations, the
intermediate portfolio duration is matched to reduce the risk of volatility in
 
intermediate plan distributions, and the total return
portfolio is managed to maximize the long-term real growth of plan
 
assets.
 
The critical investment principles of diversification,
assessment of risk and targeting the optimal expected returns for
 
given levels of risk are applied.
 
The Company’s investment
guidelines prohibit the use of securities such as letter stock and other unregistered
 
securities, commodities or commodity contracts,
short sales, margin transactions, private placements
 
(unless specifically addressed by addendum), or any derivatives, options or futures
for the purpose of portfolio leveraging.
 
The target asset allocation is reviewed periodically and is determined
 
based on a long-term projection of capital market outcomes,
inflation rates, fixed income yields, returns, volatilities and correlation
 
relationships.
 
The interaction between plan assets and benefit
obligations is periodically studied to assist in establishing such strategic asset allocation
 
targets.
 
Asset performance is monitored with
an overall expectation that plan assets will meet or exceed benchmark performance
 
over rolling five year periods.
 
The Company’s
pension committee, as authorized by the Company’s
 
Board of Directors (the “Board”), has discretion to manage the assets within
established asset allocation ranges approved by senior management
 
of the Company.
 
See Note 21 of Notes to Consolidated Financial
Statements.
 
Comprehensive income (loss):
The Company presents other comprehensive income (loss) in its Statements of Comprehensive
Income.
 
The Company follows the FASB’s
 
guidance regarding the disclosure of reclassifications from AOCI
 
which requires the
disclosure of significant amounts reclassified from each component of
 
AOCI, the related tax amounts and the income statement line
items affected by such reclassifications.
 
See Note 23 of Notes to Consolidated Financial Statements.
 
Income taxes and uncertain tax positions:
The provision for income taxes is determined using the asset and liability approach
of accounting for income taxes.
 
Under this approach, deferred taxes represent the future tax consequences expected
 
to occur when the
reported amounts of assets and liabilities are recovered or paid.
 
The provision for income taxes represents income taxes paid or
payable for the current year and the change in deferred taxes during the year.
 
Deferred taxes result from differences between the
financial and tax bases of the Company’s
 
assets and liabilities and are adjusted for changes in tax rates and tax laws when changes are
enacted.
 
Valuation
 
allowances are recorded to reduce deferred tax assets when it is more likely than not
 
that a tax benefit will not be
realized.
 
The FASB’s
 
guidance regarding accounting for uncertainty in income taxes prescribes the
 
recognition threshold and
measurement attributes for financial statement recognition and measurement
 
of tax positions taken or expected to be taken on a tax
return.
 
The guidance further requires the determination of whether the benefits
 
of tax positions are probable or more likely than not
sustained upon audit based upon the technical merits of the tax position.
 
For tax positions that are determined to be more likely than
not sustained upon audit, a company recognizes the largest amount
 
of benefit that is greater than
50
% likely of being realized upon
ultimate settlement in the financial statements.
 
For tax positions that are not determined to be more likely than not sustained upon
audit, a company does not recognize any portion of the benefit in the financial statements.
 
Additionally, the
 
Company monitors and
adjusts for derecognition, classification, and penalties and interest in interim
 
periods, with appropriate disclosure and transition
thereto.
 
Also, the amount of interest expense and income related to uncertain tax positions is computed
 
by applying the applicable
statutory rate of interest to the difference between the
 
tax position recognized, including timing differences, and the amount previously
taken or expected to be taken in a tax return.
 
The Company recognizes
 
interest and/or penalties related to income tax matters in
income tax expense.
 
Finally, when applicable, the
 
Company nets its liability for unrecognized tax benefits against deferred
 
tax assets
related to net operating losses or other tax credit carryforwards that would apply
 
if the uncertain tax position were settled for the
presumed amount at the balance sheet date.
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
54
Pursuant to the Tax Cuts and
 
Jobs Act (“U.S. Tax
 
Reform”),
 
specifically the one-time tax on deemed repatriation (the “Transition
Tax”),
 
the Company has provided for U.S. income tax on its undistributed earnings of non-U.S.
 
subsidiaries, however, the Company
 
is
subject to and will incur other taxes, such as withholding taxes and dividend
 
distribution taxes, if these undistributed earnings were
ultimately remitted to the U.S.
 
The Company currently intends to reinvest its future undistributed
 
earnings of non-U.S. subsidiaries to
support working capital needs and certain other growth initiatives of
 
those subsidiaries.
 
However, in certain cases the Company has
and may in the future change its indefinite reinvestment assertion for any or
 
all of these undistributed earnings.
 
In this case, the
Company would estimate and record a tax liability and corresponding
 
tax expense for the amount of non-U.S. income taxes it would
incur to ultimately remit these earnings to the U.S.
 
See Note 10 of Notes to Consolidated Financial Statements.
Derivatives:
The Company is exposed to the impact of changes in interest rates, foreign currency fluctuations,
 
changes in
commodity prices and credit risk.
 
The Company utilizes interest rate swap agreements to enhance its ability to manage
 
risk, including
exposure to variability in interest payments associated with its variable rate debt.
 
Derivative instruments are entered into for periods
consistent with the related underlying exposures and do not constitute positions
 
independent of those exposures.
 
As of December 31,
2021 and 2020, the Company had certain interest rate swap agreements
 
that were designated as cash flow hedges.
 
Interest rate swaps
are entered into with a limited number of counterparties, each of which allows for net
 
settlement of all contracts through a single
payment in a single currency in the event of a default on or termination of any one
 
contract.
 
The Company records these instruments
on a net basis within the Consolidated Balance Sheets.
 
The effective portion of the change in fair value of the agreement is recorded
in AOCI and will be recognized in the Consolidated Statements of Income when the
 
hedge item affects earnings or losses or it
becomes probable that the forecasted transaction will not occur.
 
See Note 25 of Notes to Consolidated Financial Statements.
 
Fair value measurements:
The Company utilizes the FASB’s
 
guidance regarding fair value measurements, which establishes a
common definition for fair value to be applied to guidance requiring use
 
of fair value, establishes a framework for measuring fair
value and expands disclosure about such fair value measurements.
 
Specifically, the guidance utilizes
 
a fair value hierarchy that
prioritizes the inputs to valuation techniques used to measure fair value
 
into three broad levels.
 
See Notes 21 and 24 of Notes to
Consolidated Financial Statements.
 
The following is a brief description of those three levels:
Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical
 
assets or liabilities.
Level 2: Inputs other than quoted prices that are observable for the asset or liability,
 
either directly or indirectly.
 
These
include quoted prices for similar assets or liabilities in active markets and quoted
 
prices for identical or similar assets or
liabilities in markets that are not active.
Level 3: Unobservable inputs that reflect the reporting entity's own assumptions.
Share-based compensation:
The Company applies the FASB’s
 
guidance regarding share-based payments, which
 
requires the
recognition of the fair value of share-based compensation as a component
 
of expense.
 
The Company has a long-term incentive
program (“LTIP”)
 
for key employees which provides for the granting of options to purchase stock at prices not
 
less than its market
value on the date of the grant.
 
Most options become exercisable within
three years
 
after the date of the grant for a period of time
determined by the Company,
 
but not to exceed
seven years
 
from the date of grant.
 
Restricted stock awards and restricted stock units
issued under the LTIP
 
program are subject to time vesting generally over a
one
 
to
three year
 
period.
 
In addition, as part of the
Company’s Annual Incentive Plan,
 
nonvested shares may be issued to key employees, which generally would
 
vest over a
two
 
to
five
year period.
 
In addition, while the FASB’s
 
guidance permits the Company to make an accounting policy election
 
to account for forfeitures as
they occur for service condition aspects of certain share-based awards, the
 
Company has decided not to elect this accounting policy
and instead has elected to continue utilizing a forfeiture rate assumption.
 
Based on historical experience, the Company has assumed a
forfeiture rate of
13
% on certain of its nonvested stock awards.
 
The Company will record additional expense if the actual forfeiture
rate is lower than estimated and will record a recovery of prior expense if the
 
actual forfeiture is higher than estimated.
 
The Company also issues performance-dependent stock awards as a component
 
of its LTIP.
 
The fair value of the performance-
dependent stock awards is based on their grant-date market value adjusted
 
for the likelihood of attaining certain pre-determined
performance goals and is calculated by utilizing a Monte Carlo simulation
 
model.
 
Compensation expense is recognized on a straight-
line basis over the vesting period, generally
three years
.
See Note 8 of the Notes to Consolidated Financial Statements.
 
Earnings per share:
The Company follows the FASB’s
 
guidance regarding the calculation of earnings per share for nonvested
stock awards with rights to non-forfeitable dividends.
 
The guidance requires nonvested stock awards with rights to non-forfeitable
dividends to be included as part of the basic weighted average share calculation
 
under the two-class method.
 
See Note 11 of Notes to
Consolidated Financial Statements.
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
55
Segments:
The Company’s operating
 
segments, which are consistent with its reportable segments, reflect the
 
structure of the
Company’s internal organization,
 
the method by which the Company’s
 
resources are allocated and the manner by which the chief
operating decision maker assesses the Company’s
 
performance
.
 
See Note 4 of Notes to Consolidated Financial Statements.
 
Hyper-inflationary accounting:
Economies that have a cumulative three year rate of inflation exceeding
100
% are considered
hyper-inflationary in accordance with U.S. GAAP.
 
A legal entity that operates within an economy deemed to be hyper-inflationary
 
is
required to remeasure its monetary assets and liabilities to the applicable published
 
exchange rates and record the associated gains or
losses resulting from the remeasurement directly to the Consolidated Statements of
 
Income.
Based on various indices or index compilations being used to monitor inflation
 
in Argentina as well as recent economic
instability, effective
 
July 1, 2018, Argentina’s
 
economy was considered hyper-inflationary under U.S. GAAP.
 
As of, and for the year
ended December 31, 2021, the Company's Argentine subsidiaries represented
 
less than
1
% of the Company’s consolidated total assets
and net sales, respectively.
 
During the years ended December 31, 2021, 2020 and 2019, the Company recorded
 
$
0.6
 
million, $
0.4
million, and $
1.0
 
million, respectively, of remeasurement
 
losses associated with the applicable currency conversions related to
Argentina.
 
Business combinations:
The Company accounts for business combinations under the acquisition method
 
of accounting.
 
This
method requires the recording of acquired assets, including separately
 
identifiable intangible assets, and assumed liabilities at their
respective acquisition date estimated fair values.
 
Any excess of the purchase price over the estimated fair value of the identifiable
 
net
assets acquired is recorded as goodwill.
 
The determination of the estimated fair value of assets acquired and liabilities assumed
requires significant estimates and assumptions.
 
Based on the assessment of additional information during the measurement period,
which may be up to one year from the acquisition date, the Company may record
 
adjustments to the estimated fair value of assets
acquired and liabilities assumed.
 
See Note 2 of Notes to Consolidated Financial Statements.
 
Restructuring activities:
Restructuring programs consist of employee severance, rationalization of
 
manufacturing or other
facilities and other related items.
 
To account for such programs,
 
the Company applies FASB’s
 
guidance regarding exit or disposal
cost obligations.
 
This guidance requires that a liability for a cost associated with an exit or disposal activity
 
be recognized when the
liability is incurred, is estimable, and payment is probable.
 
See Note 7 of Notes to Consolidated Financial Statements.
 
Reclassifications:
Certain information has been reclassified to conform to the current year presentation.
Accounting estimates:
The preparation of financial statements in conformity with generally accepted
 
accounting principles
requires management to make estimates and assumptions that affect
 
the reported amounts of assets, liabilities and disclosure of
contingencies at the date of the financial statements and the reported amounts
 
of net sales and expenses during the reporting period.
 
Actual results could differ from such estimates.
Note 2 – Business Combinations
 
2021 Acquisitions
 
In November 2021, the Company acquired Baron Industries (“Baron”),
 
a privately held Company that provides vacuum
impregnation services of castings, powder metals and electrical components for
 
its Global Specialty Businesses reportable segment for
$
11.0
 
million, including an initial cash payment of $
7.1
 
million, subject to post-closing adjustments as well as certain earn-out
provisions currently estimated at $
3.9
 
million that are payable at different times from 2022 through
 
2025.
 
The earn-out provisions
could total a maximum of $
4.5
 
million.
 
The Company allocated $
8.0
 
million of the purchase price to intangible assets, $
1.1
 
million of
property, plant and
 
equipment and $
1.5
 
million of other assets acquired net of liabilities assumed, which includes $
0.3
 
million of cash
acquired.
 
In addition, the Company recorded $
0.4
 
million of goodwill, none of which is expected to be tax deductible.
 
Intangible
assets comprised $
7.2
 
million of customer relationships to be amortized over
15 years
; and $
0.8
 
million of existing product technology
to be amortized over
13 years
.
 
 
In November 2021, the Company acquired a business that provides
 
hydraulic fluids, coolants, cleaners, and rust preventative oils
in Turkey for its EMEA reportable segment
 
for
3.2
 
million EUR or approximately $
3.7
 
million.
 
In September 2021, the Company acquired the remaining interest in Grindaix
 
-GmbH (“Grindaix”), a Germany-based, high-tech
provider of coolant control and delivery systems for its Global Specialty Businesses reportable
 
segment for
2.4
 
million EUR or
approximately $
2.9
 
million, which is gross of approximately $
0.3
 
million of cash acquired.
 
Previously, in February
 
2021, the
Company acquired a
38
% ownership interest in Grindaix for
1.4
 
million EUR or approximately $
1.7
 
million.
 
The Company recorded
its initial investment as an equity method investment within the Condensed Consolidated
 
Financial Statements and accounted for the
purchase of the remaining interest as a step acquisition whereby the Company
 
remeasured the previously held equity method
investment to its fair value.
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
56
 
In June 2021, the Company acquired certain assets for its chemical milling
 
maskants product line in the Global Specialty
Businesses reportable segment for
2.3
 
million EUR or approximately $
2.8
 
million.
 
In February 2021, the Company acquired a tin-plating solutions business for
 
the steel end market for $
25.0
 
million.
 
This
acquisition is part of each of the Company’s
 
geographic reportable segments.
 
The Company allocated $
19.6
 
million of the purchase
price to intangible assets, comprised of $
18.3
 
million of customer relationships, to be amortized over
19 years
; $
0.9
 
million of existing
product technology to be amortized over
14 years
; and $
0.4
 
million of a licensed trademark to be amortized over
3 years
.
 
In addition,
the Company recorded $
5.0
 
million of goodwill, all of which is expected to be tax deductible in various jurisdictions
 
in which we
operate.
 
Factors contributing to the purchase price that resulted in goodwill included
 
the acquisition of business processes and
personnel that will allow Quaker Houghton to better serve its customers.
 
As of December 31, 2021, the allocation of the purchase price of the 2021
 
acquisitions has not been finalized and the one year
measurement period has not ended for any of these acquisitions.
 
Further adjustments may be necessary as a result of the Company’s
on-going assessment of additional information related to the fair value
 
of assets acquired and liabilities assumed.
 
The results of operations of the 2021 acquired assets and businesses subsequent
 
to the respective acquisition dates are included in
the Consolidated Statements of Income for the year ended December
 
31, 2021.
 
Applicable transaction expenses associated with these
acquisitions are included in Combination, integration and other acquisition
 
-related expenses in the Company’s Consolidated
Statements of Income.
 
Certain pro forma and other information is not presented, as the operations of the acquired
 
assets and
businesses are not considered material to the overall operations of the Company
 
for the periods presented.
2022 Acquisitions
 
In January 2022, the Company acquired a business related to the sealing and impregnation
 
of metal castings for the automotive
sector, as well as impregnation resin and
 
impregnation systems for metal parts, for its Global Specialty Business reporting segment for
approximately
1.2
 
million EUR or approximately $
1.4
 
million.
 
This business expands the Company's geographic presence in
Germany as well as broadens its product offerings and
 
service capabilities within its existing impregnation business that was initially
entered into as part of its past acquisition of Norman Hay.
 
Also in in January 2022, the Company acquired a business that provides
pickling inhibitor technologies for the steel industry,
 
drawing lubricants and stamping oil for metalworking, and various other
lubrication, rust preventative, and cleaner applications, for its Americas reportable
 
segment for approximately $
8.0
 
million.
 
This
business broadens the Company’s
 
product offerings within its existing metals and metalworking business
 
in the Americas region.
 
The results of operations of these two January 2022 acquisitions are not included
 
in the Consolidated Statements of Income
because the date of closing for each was subsequent to December 31, 2021.
 
Preliminary purchase price allocation of assets acquired
and liabilities assumed have not been presented as that information is not
 
available as of the date of these Consolidated Financial
Statements.
Houghton
In August 2019, the Company completed the Combination, whereby
 
the Company acquired all of the issued and outstanding
shares of Houghton from Gulf Houghton Lubricants, Ltd. and certain
 
other selling shareholders in exchange for a combination of cash
and shares of the Company’s common
 
stock in accordance with the Share Purchase Agreement dated April 4,
 
2017.
Commencing August 1, 2019, the Company’s
 
Consolidated Statements of Income included the results of Houghton.
 
Net sales of
Houghton subsequent to closing of the Combination and included in the Company’s
 
Consolidated Statements of Income for the year
ended December 31, 2019 were $
299.8
 
million.
 
The following unaudited pro forma consolidated financial information
 
has been
prepared as if the Combination had taken place on January 1, 2018.
 
The unaudited pro forma results include certain adjustments to
each company’s historical
 
actual results, including: (i) additional depreciation and amortization expense based
 
on the initial estimates
of fair value step up and estimated useful lives of depreciable fixed
 
assets, definite-lived intangible assets and investment in associated
companies acquired; (ii) adoption of required accounting
 
guidance and alignment of related accounting policies, (iii) elimination
 
of
transactions between Legacy Quaker and Houghton; (iv) elimination
 
of results associated with the divested product lines; (v)
adjustment to interest expense, net, to reflect the impact of the financing
 
and capital structure of the combined Company; and (vi)
adjustment for certain Combination,
 
integration and other acquisition-related costs to reflect such costs as if they were
 
incurred in the
period immediately following the pro-forma closing of the
 
Combination on January 1, 2018.
 
The adjustments described in (vi)
include an expense recorded in costs of goods sold (“COGS”) associated with selling
 
inventory acquired in the Combination which
was adjusted to fair value as part of purchase accounting, restructuring expense incurred
 
associated with the Company’s global
restructuring program initiated post-closing of the Combination
 
and certain other integration costs incurred post-closing included in
combination and other acquisition-related expenses.
 
These costs have been presented in the unaudited pro forma table below
 
as these
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
57
costs on a pro forma basis were incurred during the year ended December 31,
 
2018.
 
Unaudited pro forma results are not necessarily
indicative of the results that would have occurred if the acquisition had occurred
 
on the date indicated, or that may result in the future
for various reasons, including the potential impact of revenue and cost
 
synergies on the business.
For the
 
year ending
Unaudited Pro Forma
 
 
December 31,
(as if the Combination occurred on January 1,
 
2018)
2019
Net sales
$
1,562,427
Net income attributable to Quaker Chemical Corporation
94,537
Combination,
 
integration and other acquisition-related expenses have been and are expected to
 
continue to be significant.
 
The
Company incurred total costs of $
18.6
 
million, $
30.3
 
million and $
38.0
 
million for the years ended December 31, 2021, 2020 and
2019, respectively, related
 
to the Combination,
 
integration and other acquisition-related activities.
 
These costs included certain legal,
financial and other advisory and consultant costs incurred in connection with
 
post-closing integration activities including internal
control readiness and remediation,
 
as well as due diligence, regulatory approvals and closing the Combination.
 
These costs also
included
 
interest costs to maintain the bank commitment (“ticking fees”) for the Combination
 
during the year ended December 31,
2019,
 
accelerated depreciation charges during the years ended December
 
31, 2021, 2020 and 2019, a gain on the sale of a held-for-sale
real property during the year ended December 31, 2021, a loss on the sale of a held-for-sale
 
asset during the year ended December 31,
2020, and recorded income related to indemnification rights during the
 
years ended December 31, 2021 and 2020.
 
As of December
31, 2021 and 2020, the Company had current liabilities related to the Combination
 
and other acquisition-related activities of $
5.5
million and $
7.5
 
million, respectively, primarily
 
recorded within other accrued liabilities on its Consolidated Balance Sheets.
Other Previous Acquisitions
In December 2020, the Company completed its acquisition of Coral Chemical
 
Company (“Coral”), a privately held, U.S.-based
provider of metal finishing fluid solutions.
 
The acquisition provides technical expertise and product solutions for pre-treatment,
metalworking and wastewater treatment applications to the beverage
 
cans and general industrial end markets.
 
The acquired Coral
assets and liabilities were assigned to the Americas and Global Specialty Businesses reportable
 
segments.
 
The original purchase price
was approximately $
54.1
 
million, subject to routine and customary post-closing adjustments related to working
 
capital and net
indebtedness levels.
The following table presents the final estimated fair values of Coral net assets acquired:
Measurement
December 22,
December 22,
Period
2020
2020 (1)
Adjustments
(as adjusted)
Cash and cash equivalents
$
958
$
-
$
958
Accounts receivable
8,473
-
8,473
Inventories
4,527
-
4,527
Prepaid expenses and other assets
181
-
181
Property, plant and equipment
10,467
652
11,119
Intangible assets
30,300
(500)
29,800
Goodwill
2,814
804
3,618
Total assets purchased
57,720
956
58,676
Long-term debt including current portions and finance leases
183
556
739
Accounts payable, accrued expenses and other accrued liabilities
3,482
-
3,482
Total liabilities assumed
3,665
556
4,221
Total consideration
 
paid for Coral
54,055
400
54,455
Less: estimated purchase price settlement
-
400
400
Less: cash acquired
958
-
958
Net cash paid for Coral
$
53,097
$
-
$
53,097
(1)
 
As previously disclosed in the Company’s
 
2020 Form 10-K.
Measurement period adjustments recorded during the year ended December
 
31, 2021 include certain adjustments related to
refining original estimates for assets and liabilities for certain acquired finance
 
leases, as well as an adjustment to reflect the expected
settlement of post-closing working capital and net indebtedness true ups to the initial
 
purchase price.
 
The Company continues to work
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
58
with the seller to finalize certain post-closing adjustments and the above
 
table includes the Company’s best estimate
 
as of December
31, 2021.
 
As of December 31, 2021, the allocation of the purchase price for Coral has been finalized
 
and the
one year
 
measurement
period has ended.
In May 2020, the Company acquired Tel
 
Nordic ApS (“TEL”), a company that specializes in lubricants and engineering primaril
 
y
in high pressure aluminum die casting for its EMEA reportable segment.
 
Consideration paid was in the form of a convertible
promissory note in the amount of
20.0
 
million DKK, or approximately $
2.9
 
million, which was subsequently converted into shares of
the Company’s common stock.
 
An adjustment to the purchase price of approximately
0.4
 
million DKK, or less than $
0.1
 
million, was
made as a result of finalizing a post-closing settlement in the second
 
quarter of 2020.
 
The Company allocated approximately $
2.4
million of the purchase price to intangible assets to be amortized over
17 years
.
 
In addition, the Company recorded approximately
$
0.5
 
million of goodwill, related to expected value not allocated to other acquired
 
assets, none of which will be tax deductible.
 
As of
December 31, 2021, the allocation of the purchase price of TEL was finalized
 
and the one year measurement period ended.
 
In March 2020, the Company acquired the remaining
49
% ownership interest in one of its South African affiliates, Quaker
Chemical South Africa Limited (“QSA”) for
16.7
 
million ZAR, or approximately $
1.0
 
million, from its joint venture partner PQ
Holdings South Africa.
 
QSA is a part of the Company’s EMEA reportable
 
segment.
 
As this acquisition was a change in an existing
controlling ownership, the Company recorded $
0.7
 
million of excess purchase price over the carrying value of the noncontrolling
interest in Capital in excess of par value.
In October 2019, the Company completed its acquisition of the operating
 
divisions of Norman Hay plc (“Norman Hay”), a private
U.K. company that provides specialty chemicals, operating equipment, and
 
services to industrial end markets.
 
The original purchase
price was
80.0
 
million GBP,
 
on a cash-free and debt-free basis, subject to routine and customary
 
post-closing adjustments related to
working capital and net indebtedness levels.
 
The Company finalized its post-closing adjustments for the
 
Norman Hay acquisition and
paid approximately
2.5
 
million GBP during the first quarter of 2020 to settle such adjustments.
Note 3 – Recently Issued Accounting Standards
Recently Issued Accounting Standards
 
Adopted
The Financial Accounting Standards Board (“FASB”)
 
issued Account Standards Update (“ASU”)
ASU 2019-12
, Income Taxes
(Topic
 
740): Simplifying the Accounting for Income Taxes
 
in December 2019 to simplify the accounting for income taxes.
 
The
guidance within this accounting standard update removes
 
certain exceptions, including the exception to the incremental approach for
certain intra-period tax allocations, to the requirement to recognize
 
or not recognize certain deferred tax liabilities for equity method
investments and foreign subsidiaries, and to the general methodology for
 
calculating income taxes in an interim period when a year-to-
date loss exceeds the anticipated loss for the year.
 
Further, the guidance simplifies the accounting related
 
to franchise taxes, the step
up in tax basis for goodwill, current and deferred tax expense, and codification
 
improvements for income taxes related to employee
stock ownership plans.
 
The guidance is effective for annual and interim periods beginning
 
after December 15, 2020.
 
The Company
adopted this standard,
 
as required, effective January 1, 2021.
 
There was no cumulative effect of adoption recorded within retained
earnings on January 1, 2021.
The FASB issued ASU 2020
 
-04
, Reference Rate Reform (Topic
 
848): Facilitation of the Effects of Reference Rate Reform
 
on
Financial Reporting
 
in March 2020.
 
The FASB subsequently
 
issued ASU 2021-01
, Reference Rate Reform (Topic
 
848): Scope
 
in
January 2021 which clarified the guidance but did not materially change
 
the guidance or its applicability to the Company.
 
The
amendments provide temporary optional expedients and exceptions
 
for applying U.S. GAAP to contract modifications, hedging
relationships and other transactions to ease the potential accounting
 
and financial reporting burden associated with transitioning away
from reference rates that are expected to be discontinued, including
 
the London Interbank Offered Rate (“LIBOR”).
 
ASU 2020-04 is
effective for the Company as of March 12, 2020 and generally can
 
be applied through December 31, 2022.
 
On December 10, 2021,
the Company entered into a Second Amendment to Credit Agreement (“Second
 
Amendment”) with Bank of America N.A., an update
to provide for the use of a non-USD currency LIBOR successor rate.
 
The Company
 
elected to apply the expedients provided in ASU
2020-04 with respect to the Second Amendment.
 
The Company will continue to monitor for potential impacts related to its USD-
based LIBOR rates.
 
See Note 20 of Notes to Consolidated Financial Statements..
 
Note 4 – Business Segments
The Company’s operating
 
segments, which are consistent with its reportable segments, reflect the structure of the Company’s
internal organization, the method by which the Company’s
 
resources are allocated and the manner by which the chief operating
decision maker assesses the Company’s
 
performance.
 
The Company has
four
 
reportable segments: (i) Americas; (ii) EMEA; (iii)
Asia/Pacific; and (iv) Global Specialty Businesses.
 
The three geographic segments are composed of the net sales and operations in
each respective region, excluding net sales and operations managed globally
 
by the Global Specialty Businesses segment, which
includes the Company’s container,
 
metal finishing, mining, offshore, specialty coatings, specialty grease
 
and Norman Hay businesses.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
59
Segment operating earnings for each of the Company’s
 
reportable segments are comprised of the segment’s
 
net sales less directly
related COGS and SG&A.
 
Operating expenses not directly attributable to the net sales of each respective
 
segment, such as certain
corporate and administrative costs, Combination, integration and other
 
acquisition-related expenses, and Restructuring and related
charges, are not included in segment operating earnings.
 
Other items not specifically identified with the Company’s
 
reportable
segments include interest expense, net and other income (expense),
 
net.
The following tables present information about the performance of the Company’s
 
reportable segments for the years ended
December 31, 2021, 2020 and 2019.
2021
2020
2019
Net sales
 
 
 
 
 
 
 
 
Americas
$
572,643
$
450,161
$
392,121
EMEA
 
480,126
 
383,187
 
285,570
Asia/Pacific
388,160
315,299
247,839
Global Specialty Businesses
320,229
269,030
207,973
Total
 
net sales
$
1,761,158
$
1,417,677
$
1,133,503
2021
2020
2019
Segment operating earnings
Americas
$
124,863
$
96,379
$
78,297
EMEA
 
85,209
 
69,163
 
47,014
Asia/Pacific
96,318
88,356
67,512
Global Specialty Businesses
90,632
79,690
58,881
Total
 
segment operating earnings
397,022
333,588
251,704
Combination, integration and other acquisition-related expenses
(23,885)
(29,790)
(35,477)
Restructuring and related charges
(1,433)
(5,541)
(26,678)
Fair value step up of acquired inventory sold
(801)
(226)
(11,714)
Indefinite-lived intangible asset impairment
-
(38,000)
-
Non-operating and administrative expenses
(157,864)
(143,202)
(104,572)
Depreciation of corporate assets and amortization
(62,573)
(57,469)
(27,129)
Operating income
150,466
59,360
46,134
Other income (expense), net
18,851
(5,618)
(254)
Interest expense, net
(22,326)
(26,603)
(16,976)
Income before taxes and equity in net income of
associated companies
$
146,991
$
27,139
$
28,904
The following tables present information regarding the Company’s
 
reportable segments’ assets and long-lived assets, including
certain identifiable assets as well as an allocation of shared assets, as of December
 
31, 2021, 2020 and 2019:
2021
2020
2019
Segment assets
Americas
$
983,521
$
969,551
$
926,122
EMEA
714,659
697,821
688,663
Asia/Pacific
750,970
713,004
685,476
Global Specialty Businesses
506,610
511,458
550,055
Total segment assets
$
2,955,760
$
2,891,834
$
2,850,316
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
60
2021
2020
2019
Segment long-lived assets
Americas
$
129,321
$
122,302
$
139,170
EMEA
69,990
69,344
56,108
Asia/Pacific
123,130
119,233
126,166
Global Specialty Businesses
37,951
59,091
69,184
Total segment long-lived
 
assets
$
360,392
$
369,970
$
390,628
The following tables present information regarding the Company’s
 
reportable segments’ capital expenditures and depreciation for
identifiable assets for the years ended December 31, 2021, 2020 and 2019:
2021
2020
2019
Capital expenditures
Americas
$
9,678
$
6,451
$
6,404
EMEA
6,767
3,844
3,263
Asia/Pacific
2,264
5,688
3,857
Global Specialty Businesses
2,748
1,918
2,021
Total segment capital
 
expenditures
$
21,457
$
17,901
$
15,545
2021
2020
2019
Depreciation
Americas
$
12,074
$
12,322
$
7,500
EMEA
6,936
6,813
4,560
Asia/Pacific
4,596
4,672
3,458
Global Specialty Businesses
3,043
3,544
2,248
Total segment depreciation
$
26,649
$
27,351
$
17,766
During the years ended December 31, 2021, 2020 and 2019, the Company
 
had approximately $
1,198.4
 
million, $
963.2
 
million
and $
719.8
 
million of net sales, respectively,
 
attributable to non-U.S. operations.
 
As of December 31, 2021, 2020 and 2019, the
Company had approximately $
155.2
 
million, $
176.6
 
million and $
174.4
 
million of long-lived assets, respectively,
 
attributable to non-
U.S. operations.
Inter-segment revenue for the years ended December
 
31, 2021, 2020 and 2019 was $
12.2
 
million, $
9.1
 
million and $
7.3
 
million
for Americas, $
29.0
 
million, $
22.0
 
million and $
20.3
 
million for EMEA, $
1.6
 
million, $
0.6
 
million and $
0.2
 
million for Asia/Pacific
and $
7.4
 
million, $
4.7
 
million and $
5.4
 
million for Global Specialty Businesses, respectively.
 
However, all inter-segment transactions
have been eliminated from each reportable operating segment’s
 
net sales and earnings for all periods presented in the above tables.
Note 5 – Net Sales and Revenue Recognition
Arrangements Resulting in Net Reporting
 
As part of the Company’s Fluidcare
TM
 
business, certain third-party product sales to customers are managed by the Company.
 
The
Company transferred third-party products under arrangements resulting
 
in net reporting of $
71.7
 
million, $
42.5
 
million and $
48.0
million for the years ended December 31, 2021, 2020 and 2019, respectively.
Customer Concentration
A significant portion of the Company’s
 
revenues are realized from the sale of process fluids and services to manufacturers of
steel, aluminum, automobiles, aircraft, industrial equipment, and durable
 
goods.
 
During the year ended December 31, 2021, the
Company’s five largest
 
customers (each composed of multiple subsidiaries or divisions with semiautonomous
 
purchasing authority)
accounted for approximately
10
% of consolidated net sales, with its largest customer accounting
 
for approximately
3
% of consolidated
net sales.
Contract Assets and Liabilities
The Company had no material contract assets recorded on its Consolidated
 
Balance Sheets as of December 31, 2021 and 2020.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
61
The Company had approximately $
7.0
 
million and $
4.0
 
million of deferred revenue as of December 31, 2021 and 2020,
respectively.
 
During the years ended December 31, 2021 and 2020, respectively,
 
the Company satisfied all of the associated
performance obligations and recognized into revenue the advance payments
 
received and recorded as of December 31, 2020 and 2019,
respectively.
Disaggregated Revenue
The Company sells its various industrial process fluids, its specialty chemicals
 
and its technical expertise as a global product
portfolio.
 
The Company generally manages and evaluates its performance by segment first, and
 
then by customer industry,
 
rather than
by individual product lines.
 
Also, net sales of each of the Company’s major product
 
lines are generally spread throughout all three of
the Company’s geographic
 
regions, and in most cases, approximately proportionate to the level of total
 
sales in each region.
The following tables present disaggregated information regarding
 
the Company’s net sales, first by major product
 
lines that
represent more than
10
% of the Company’s consolidated net sales for any
 
of the years ended December 31, 2021, 2020 and 2019, and
followed then by a disaggregation of the Company’s
 
net sales by segment, geographic region, customer industry,
 
and timing of
revenue recognized for the years ended December 31, 2021, 2020 and
 
2019.
2021
2020
2019
Metal removal fluids
23.4
%
23.9
%
19.9
%
Rolling lubricants
22.2
%
21.8
%
21.9
%
Hydraulic fluids
13.6
%
13.3
%
13.0
%
Net sales for the year ending December 31, 2021
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
210,340
$
141,950
$
207,160
$
559,450
Metalworking and other
362,303
338,176
181,000
881,479
572,643
480,126
388,160
1,440,929
Global Specialty Businesses
186,859
80,541
52,829
320,229
$
759,502
$
560,667
$
440,989
$
1,761,158
Timing of Revenue Recognized
Product sales at a point in time
$
724,357
$
527,083
$
429,130
$
1,680,570
Services transferred over time
35,145
33,584
11,859
80,588
$
759,502
$
560,667
$
440,989
$
1,761,158
Net sales for the year ending December 31, 2020
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
163,135
$
107,880
$
168,096
$
439,111
Metalworking and other
287,026
275,307
147,203
709,536
450,161
383,187
315,299
1,148,647
Global Specialty Businesses
154,796
68,164
46,070
269,030
$
604,957
$
451,351
$
361,369
$
1,417,677
Timing of Revenue Recognized
Product sales at a point in time
$
580,663
$
434,549
$
352,917
$
1,368,129
Services transferred over time
24,294
16,802
8,452
49,548
$
604,957
$
451,351
$
361,369
$
1,417,677
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
62
Net sales for the year ending December 31, 2019
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
171,784
$
100,605
$
141,870
$
414,259
Metalworking and other
220,337
184,965
105,969
511,271
392,121
285,570
247,839
925,530
Global Specialty Businesses
149,428
30,115
28,430
207,973
$
541,549
$
315,685
$
276,269
$
1,133,503
Timing of Revenue Recognized
Product sales at a point in time
$
525,802
$
310,274
$
269,228
$
1,105,304
Services transferred over time
15,747
5,411
7,041
28,199
$
541,549
$
315,685
$
276,269
$
1,133,503
Note 6 – Leases
The Company has operating leases for certain facilities, vehicles and machinery
 
and equipment with remaining lease terms up to
10
 
years.
 
In addition, the Company has certain land use leases with remaining lease terms up
 
to
94
 
years.
Operating lease expense is recognized on a straight-line basis over the
 
lease term.
 
Operating lease expense for the years ended
December 31, 2021, 2020 and 2019 was $
14.1
 
million, $
14.2
 
million, and $
9.4
 
million, respectively.
 
Short-term lease expense for the
years ended December 31, 2021, 2020 and 2019 was $
0.9
 
million, $
1.3
 
million and $
1.5
 
million, respectively.
 
The Company has
no
material variable lease costs or sublease income for the years ended
 
December 31, 2021, 2020 and 2019.
 
Cash paid for operating leases during the years ended December 31, 2021, 2020
 
and 2019 was $
13.9
 
million, $
14.1
 
million and
$
9.2
 
million, respectively.
 
The Company recorded new right of use lease assets and associated lease liabilities of
 
$
11.1
 
million during
the year ended December 31, 2021.
Supplemental balance sheet information related to the Company’s
 
leases is as follows:
December 31,
December 31,
2021
2020
Right of use lease assets
$
36,635
$
38,507
Other accrued liabilities
9,976
10,901
Long-term lease liabilities
26,335
27,070
Total operating lease liabilities
$
36,311
$
37,971
Weighted average
 
remaining lease term (years)
5.6
6.0
Weighted average
 
discount rate
4.22%
4.20%
Maturities of operating lease liabilities as of December 31, 2021 were
 
as follows:
December 31,
2021
For the year ended December 31, 2022
$
11,346
For the year ended December 31, 2023
9,041
For the year ended December 31, 2024
7,017
For the year ended December 31, 2025
5,292
For the year ended December 31, 2026
4,197
For the year ended December 31, 2027 and beyond
4,502
Total lease payments
41,395
Less: imputed interest
(5,084)
Present value of lease liabilities
$
36,311
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
63
Note 7 – Restructuring and Related Activities
The Company’s management approved
 
a global restructuring plan (the “QH Program”) as part of its plan to realize certain cost
synergies associated with the Combination in
 
the third quarter of 2019.
 
The QH Program includes restructuring and associated
severance costs to reduce total headcount by approximately
400
 
people globally, as well as plans for
 
the closure of certain
manufacturing and non-manufacturing facilities.
 
The exact timing and total costs associated with the QH Program will depend on
 
a
number of factors and is subject to change; however,
 
the Company currently expects reduction in headcount and site closures to
continue to occur into 2022 under the QH Program.
 
Employee separation benefits will vary depending on local regulations within
certain foreign countries and will include severance and other benefits.
All costs incurred to date relate to severance costs to reduce headcount,
 
including customary and routine adjustments to initial
estimates for employee separation costs, as well as costs to close certain facilities
 
and are recorded in Restructuring and related
charges in the Company’s
 
Consolidated Statements of Income.
 
As described in Note 4 of Notes to Consolidated Financial Statements,
Restructuring and related charges are not included
 
in the Company’s calculation of reportable
 
segments’ measure of operating
earnings and therefore these costs are not reviewed by or recorded
 
to reportable segments.
Activity in the Company’s accrual
 
for restructuring under the QH Program for the years ended December 31, 2021 and 2020
 
is as
follows:
QH Program
Accrued restructuring as of December 31, 2019
$
18,043
Restructuring and related charges
5,541
Cash payments
(15,745)
Currency translation adjustments
409
Accrued restructuring as of December 31, 2020
8,248
Restructuring and related charges
1,433
Cash payments
(5,266)
Currency translation adjustments
(328)
Accrued restructuring as of December 31, 2021
$
4,087
In connection with the plans for closure of certain manufacturing
 
and non-manufacturing facilities, the Company has made a
decision to make available for sale certain facilities.
 
During the years ended December 31, 2021 and 2020, certain of these facilities
were sold and the Company recognized a gain of $
5.4
 
million in 2021 and a loss of approximately $
0.6
 
million in 2020 which is
included within other income (expense), net on the Consolidated Statement of
 
Income.
 
Additionally, certain buildings
 
and land with
an aggregate book value of approximately $
0.7
 
million continues to be held-for-sale as of December 31, 2021
 
and are recorded in
prepaid expenses and other current assets on the Company’s
 
Consolidated Balance Sheet.
 
The Company will continue to evaluate for
future decisions about making certain other facilities available for
 
sale.
Note 8 – Share-Based Compensation
The Company recognized the following share-based compensation expense
 
in its Consolidated Statements
 
of Income for the years
ended December 31, 2021, 2020 and 2019:
 
2021
2020
2019
Stock options
$
1,235
$
1,491
$
1,448
Non-vested stock awards and restricted stock units
5,438
5,012
3,206
Non-elective and elective 401(k) matching contribution in stock
1,553
3,112
-
Employee stock purchase plan
-
-
84
Director stock ownership plan
901
541
123
Performance stock units
1,911
840
-
Total share-based
 
compensation expense
$
11,038
$
10,996
$
4,861
Share-based compensation expense is recorded in SG&A, except for $
0.9
 
million, $
1.5
 
million and $
0.9
 
million during the years
ended December 31, 2021, 2020 and 2019, respectively,
 
recorded within Combination,
 
integration and other acquisition-related
expenses.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
64
Stock Options
Stock option activity under all plans is as follows:
Weighted
 
Weighted
Average
Average
Exercise
 
Remaining
Aggregate
Number of
Price
 
Contractual
Intrinsic
Options
(per option)
Term
 
(years)
Value
Options outstanding as of January 1, 2021
110,336
$
143.51
Options granted
25,250
245.17
Options exercised
(22,540)
143.49
Options forfeited
(3,362)
190.65
Options outstanding as of December 31, 2021
109,684
$
165.47
4.8
$
7,550
Options expected to vest after December 31, 2021
67,680
$
178.10
5.4
$
3,929
Options exercisable as of December 31, 2021
42,004
$
145.12
3.9
$
3,621
The total intrinsic value of options exercised during the years ended December
 
31, 2021, 2020 and 2019 was approximately $
2.7
million, $
6.5
 
million and $
2.5
 
million, respectively.
 
Intrinsic value is calculated as the difference between the current
 
market price of
the underlying security and the strike price of a related option.
 
A summary of the Company’s outstanding
 
stock options as of December 31, 2021 is as follows:
Weighted
Average
Weighted
Weighted
Number
Remaining
Average
Number
Average
Range of
of Options
Contractual
Exercise Price
of Options
Exercise Price
Exercise Prices
Outstanding
Term
 
(years)
(per option)
Exercisable
(per option)
$
49.01
 
-
$
80.00
 
711
-
$
72.12
711
$
72.12
$
80.01
 
-
$
100.00
 
1,309
-
87.30
1,309
87.30
$
120.01
 
-
$
150.00
 
43,482
5.2
136.62
12,873
136.59
$
150.01
 
-
$
180.00
 
40,593
3.7
154.23
27,111
153.88
$
220.01
 
-
$
250.00
 
23,589
6.2
245.15
-
-
109,684
4.8
165.47
42,004
145.12
As of December 31, 2021, unrecognized compensation expense related
 
to options granted in 2021, 2020 and 2019 was $
1.8
million, $
1.2
 
million and $
0.3
 
million, respectively,
 
to be recognized over a weighted average period of
1.9
 
years.
The Company granted stock options under its LTIP
 
plan that are subject only to time vesting generally over a
three year
 
period
during 2021, 2020, 2019 and 2018.
 
For the purposes of determining the fair value of stock option awards, the Company
 
used a Black-
Scholes option pricing model
 
and primarily used the assumptions set forth in the table below:
 
2021
2020
2019
2018
Number of stock options granted
25,250
49,115
51,610
35,842
Dividend yield
0.85
%
0.99
%
1.12
%
1.37
%
Expected volatility
37.33
%
31.57
%
26.29
%
24.73
%
Risk-free interest rate
0.60
%
0.36
%
1.52
%
2.54
%
Expected term (years)
4.0
4.0
4.0
4.0
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
65
The fair value of these options is being amortized on a straight-line basis over
 
the respective vesting period of each award.
 
The
compensation expense recorded on each award during the years ended
 
December 31, 2021, 2020 and 2019, respectively,
 
is as follows:
 
2021
2020
2019
2021 Stock option awards
$
429
$
-
$
-
2020 Stock option awards
516
385
-
2019 Stock option awards
234
698
665
2018 Stock option awards
56
357
364
2017 Stock option awards
-
51
369
Restricted Stock Awards
Activity of non-vested restricted stock awards granted under the Company’s
 
LTIP
 
plan is shown below:
Number of
Weighted Average
 
Grant
 
Shares
Date Fair Value
 
(per share)
Nonvested awards, December 31, 2020
71,768
$
151.17
 
Granted
23,536
242.29
 
Vested
(23,638)
157.63
 
Forfeited
(2,973)
172.15
 
Nonvested awards, December 31, 2021
68,693
$
179.26
 
The fair value of the non-vested stock is based on the trading price of the Company’s
 
common stock on the date of grant.
 
The
Company adjusts the grant date fair value for expected forfeitures based
 
on historical experience for similar awards.
 
As of December
31, 2021, unrecognized compensation expense related to these awards was $
5.1
 
million, to be recognized over a weighted average
remaining period of
1.5
 
years.
Restricted Stock Units
Activity of non-vested restricted stock units granted under the Company’s
 
LTIP
 
plan is shown below:
Number of
Weighted Average
 
Grant
 
Units
Date Fair Value
 
(per unit)
Nonvested awards, December 31, 2020
10,845
$
147.70
 
Granted
2,791
245.49
 
Vested
(2,570)
155.34
 
Forfeited
(89)
141.77
 
Nonvested awards, December 31, 2021
10,977
$
170.82
 
The fair value of the non-vested restricted stock units is based on the trading price
 
of the Company’s common
 
stock on the date of
grant.
 
The Company adjusts the grant date fair value for expected forfeitures based on
 
historical experience for similar awards.
 
As of
December 31, 2021, unrecognized compensation expense related
 
to these awards was $
0.8
 
million, to be recognized over a weighted
average remaining period of
1.8
 
years.
Performance Stock Units
The Company grants performance-dependent stock awards (“PSUs”) as a component
 
of its LTIP,
 
which will be settled in a
certain number of shares subject to market-based and time-based vesting conditions.
 
The number of fully vested shares that may
ultimately be issued as settlement for each award may range from
0
% up to
200
% of the target award, subject to the achievement of
the Company’s total shareholder
 
return (“TSR”) relative to the performance of the Company’s
 
peer group, the S&P Midcap 400
Materials group.
 
The service period required for the PSUs is
three years
 
and the TSR measurement period for the PSUs is generally
from January 1 of the year of grant through December 31 of the year prior
 
to issuances of the shares upon settlement.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
66
Compensation expense for PSUs is measured based on their grant date fair value
 
and is recognized on a straight-line basis over
the
three year
 
vesting period.
 
The grant-date fair value of the PSUs was estimated using a Monte Carlo
 
simulation on the grant date
and using the following assumptions
 
set forth in the table below:
CEO Grant
2021 (1)
2021
2020
Fully vested shares
3,775
12,103
18,485
Risk-free interest rate
0.65
%
0.29
%
0.28
%
Dividend yield
0.72
%
0.64
%
1.13
%
Expected term (years)
3.0
3.0
3.0
(1)
 
On September 2, 2021, the Board appointed Andrew Tometich
 
to serve as CEO and entered into an Employment Agreement,
and granted an equity award consisting of a mix of time-based restricted
 
stock and PSUs.
As of December 31, 2021, there was approximately $
4.3
 
million of total unrecognized compensation cost related to PSUs which
the Company expects to recognize over a weighted-average period
 
of
1.4
 
years.
Defined Contribution Plan
 
The Company has a 401(k) plan with an employer match covering a majority
 
of its U.S. employees.
 
The Company matches
50
%
of the first
6
% of compensation that is contributed to the plan, with a maximum matching contribution
 
of
3
% of compensation.
 
Additionally, the plan
 
provides for non-elective nondiscretionary contributions on behalf of participants
 
who have completed one year
of service equal to
3
% of the eligible participant's compensation.
 
Beginning in April 2020 and continuing through March 2021, the
Company matched both non-elective and elective 401(k) contributions
 
in fully vested shares of the Company’s
 
common stock rather
than cash.
 
For the years ended December 31, 2021, and 2020, total contributions were $
1.5
 
million and $
3.1
 
million, respectively.
Employee Stock Purchase Plan
In 2000, the Board adopted an Employee Stock Purchase Plan (“ESPP”) whereby
 
employees may purchase Company stock
through a payroll deduction plan.
 
Purchases were made from the plan and credited to each participant’s
 
account on the last day of
each calendar month in which the organized securities
 
trading markets in the U.S. were open for business (the “Investment
 
Date”).
 
The purchase price of the stock was
85
% of the fair market value on the Investment Date.
 
The plan was compensatory, and
 
the
15
%
discount was expensed on the Investment Date.
 
All employees, including officers, were eligible to participate
 
in this plan.
 
A
participant could withdraw all uninvested payment balances credited
 
to a participant’s account at any time.
 
An employee whose stock
ownership of the Company exceeds
five percent
 
of the outstanding common stock was not eligible to participate in this plan.
 
Effective January 1, 2020, the Company discontinued
 
the ESPP.
2013 Director Stock Ownership Plan
In 2013, the Company adopted the 2013 Director Stock Ownership Plan (the
 
“Plan”), to encourage the Directors to increase their
investment in the Company,
 
which was approved at the Company’s May 2013
 
shareholders’ meeting.
 
The Plan authorizes the
issuance of up to
75,000
 
shares of Quaker common stock in accordance with the terms of the Plan in payment
 
of all or a portion of the
annual cash retainer payable to each of the Company’s
 
non-employee directors in 2013 and subsequent years during the term of the
Plan.
 
Under the Plan, each director who, on May 1
of the applicable calendar year, owns less than
400
% of the annual cash retainer
for the applicable calendar year, divided
 
by the average of the closing price of a share of Quaker Common Stock as reported by
 
the
composite tape of the New York
 
Stock Exchange for the previous calendar year (the “Threshold Amount”), is required
 
to receive
75
%
of the annual cash retainer in Quaker common stock and
25
% of the retainer in cash, unless the director elects to receive a greater
percentage of Quaker common stock, up to
100
% of the annual cash retainer for the applicable year.
 
Each director who owns more
than the Threshold Amount may elect to receive common stock in payment
 
of a percentage (up to
100
%) of the annual cash retainer.
 
The annual retainer is $
0.1
 
million and the retainer payment date is June 1.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
67
Note 9 – Other Income (Expense), net
Other income (expense), net, for the years ended December 31,
 
2021, 2020 and 2019 are as follows:
2021
2020
2019
Income from third party license fees
$
1,367
$
999
$
1,035
Foreign exchange (losses) gains, net
(3,821)
(6,082)
223
Gain (loss) on disposals of property,
 
plant, equipment and other
 
assets, net
4,695
(871)
58
Non-income
 
tax refunds and other related credits
15,155
3,345
1,118
Pension and postretirement benefit income (costs), non-service
 
components
759
(21,592)
(2,805)
Gain on changes in insurance settlement restrictions of an inactive
 
subsidiary and related insurance insolvency recovery
-
18,144
60
Other non-operating income, net
696
439
57
Total other income
 
(expense), net
$
18,851
$
(5,618)
$
(254)
Gain (loss) on disposals of property,
 
plant, equipment and other assets, net, includes losses related to certain fixed
 
assets disposals
resulting from the property damage caused by flooding of the Company’s
 
Conshohocken, Pennsylvania headquarters in 2021,
described in Note 26 of Notes to Consolidated Financial Statements, as well as a gain
 
in 2021 and a loss in 2020 on the sale of certain
held-for-sale real property assets related to the Combination,
 
described in Note 7 of Notes to Consolidated Financial Statements.
 
Non-
income tax refunds and other related credits during the year ended
 
December 31, 2021 includes certain non-income tax credits for the
Company’s Brazilian subsidiaries
 
described in Note 26 of Notes to Consolidated Financial Statements.
 
Pension and postretirement
benefit income (costs), non-service components during the year ended December
 
31, 2020 include a $
1.6
 
million refund in premium
and a $
22.7
 
million non-cash settlement charge related to the Legacy Quaker
 
U.S. Pension Plan, as described in Note 21 of Notes to
Consolidated Financial Statements.
 
Gain on changes in insurance settlement restrictions of an inactive subsidiary
 
and related
insurance insolvency recovery relate to the termination of restrictions over
 
certain cash that was previously designated solely to be
used for settlement of asbestos claims at an inactive subsidiary of the Company
 
and cash proceeds from an insolvent insurance carrier
with respect to previously filed recovery claims.
 
See Note 12, Note 19 and Note 26 of Notes to Consolidated Financial Statements.
 
Foreign exchange (losses) gains, net, during the years ended December
 
31, 2021, 2020 and 2019, include foreign currency transaction
losses of approximately $
0.6
 
million, $
0.4
 
million and $
1.0
 
million, respectively,
 
related to hyper-inflationary accounting for the
Company’s Argentine
 
subsidiaries.
 
See Note 1 of Notes to Consolidated Financial Statements.
Note 10 – Taxes
 
on Income
On December 22, 2017, the U.S. government enacted comprehensive
 
tax legislation commonly referred to as U.S. Tax
 
Reform.
 
U.S. Tax Reform
 
implemented a new system of taxation for non-U.S. earnings which eliminated U.S. federal
 
income taxes on
dividends from certain foreign subsidiaries and imposed a one-time transition
 
tax on the deemed repatriation of undistributed earnings
of certain foreign subsidiaries that is payable over eight years.
 
Following numerous regulations, notices, and other formal guidance
 
published by the Internal Revenue Service (“I.R.S.”), U.S.
Department of Treasury,
 
and various state taxing authorities, the Company completed its accounting
 
for the transition tax and has
elected to pay its $
15.5
 
million transition tax in installments over eight years as permitted under
 
U.S. Tax Reform.
 
As of December
31, 2021, $
7.0
 
million in installments have been paid with the remaining $
8.5
 
million to be paid through installments in future years.
As of December 31, 2021, the Company has a deferred tax liability of
 
$
8.4
 
million on certain undistributed foreign earnings,
which primarily represents the Company’s
 
estimate of the non-U.S. income taxes the Company will incur to ultimately remit certain
earnings to the U.S.
 
The Company’s reinvestment
 
assertions are further explained below.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
68
Taxes on income
 
before equity in net income of associated companies for the years ended December
 
31, 2021, 2020 and 2019 are
as follows:
2021
2020
2019
Current:
Federal
$
955
$
(1,359)
$
(239)
State
2,115
1,171
352
Foreign
44,375
33,173
26,213
47,445
32,985
26,326
Deferred:
Federal
(3,863)
(28,437)
(9,267)
State
(3,117)
(3,087)
(396)
Foreign
(5,526)
(6,757)
(14,579)
Total
$
34,939
$
(5,296)
$
2,084
The components of earnings before income taxes for the years ended December
 
31, 2021, 2020 and 2019 are as follows:
2021
2020
2019
U.S.
$
7,263
$
(66,585)
$
(46,697)
Foreign
139,728
93,724
75,601
Total
$
146,991
$
27,139
$
28,904
Total deferred
 
tax assets and liabilities are composed of the following as of December
 
31, 2021 and 2020:
2021
2020
Retirement benefits
$
11,860
$
15,237
Allowance for doubtful accounts
2,155
2,316
Insurance and litigation reserves
675
842
Performance incentives
2,881
5,914
Equity-based compensation
1,920
1,282
Prepaid expense
460
756
Operating loss carryforward
18,544
16,693
Foreign tax credit and other credits
16,285
24,873
Interest
9,940
16,812
Restructuring reserves
631
1,121
Right of use lease assets
8,322
9,346
Inventory reserves
2,941
2,225
Research and development
8,832
7,974
Other
2,846
3,005
88,292
108,396
Valuation
 
allowance
(17,400)
(21,511)
Total deferred tax
 
assets, net
$
70,892
$
86,885
Depreciation
11,580
15,473
Foreign pension and other
2,332
1,807
Intangibles
197,066
222,794
Lease liabilities
8,421
9,151
Outside basis in equity investment
5,999
7,938
Unremitted Earnings
8,381
5,919
Total deferred tax
 
liabilities
$
233,779
$
263,082
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
69
The Company has $
10.6
 
million of deferred tax assets related to state net operating losses.
 
A partial valuation allowance of $
8.0
million has been established against this amount resulting in a net $
2.6
 
million expected future benefit.
 
Management analyzed the
expected impact of the reversal of existing taxable temporary differences,
 
considered expiration dates, analyzed current state tax laws,
and determined that $
2.6
 
million of state net operating loss carryforwards will be realized based on
 
the reversal of deferred tax
liabilities.
 
These state net operating losses are subject to various carryforward
 
periods of
5
 
years to
20
 
years or an indefinite
carryforward period.
 
An additional $
0.5
 
million of valuation allowance was established for other net state deferred tax assets.
The Company has $
8.0
 
million of deferred tax assets related to foreign net operating loss carryforwards.
 
A partial valuation
allowance of $
2.5
 
million has been established against the $
8.0
 
million due to the expected expiration of these losses before they are
able to be utilized.
 
These foreign net operating losses are subject to various carryforward periods with the
 
majority having an
indefinite carryforward period.
 
An additional partial valuation allowance of $
0.6
 
million has been established against certain other
foreign deferred tax assets.
In conjunction with the Combination, the Company acquired foreign tax
 
credit deferred tax assets of $
41.8
 
million expiring
between 2019 and 2028.
 
Foreign tax credits may be carried forward for
10
 
years.
 
Management analyzed the expected impact of the
utilization of foreign tax credits based on certain assumptions such as projected
 
U.S. taxable income, overall domestic loss recapture,
and annual limitations due to the ownership change under the Internal Revenue
 
Code.
 
The Company had a foreign tax credit carry
forward of $15.9 million and $
24.9
 
million as of December 31, 2021 and 2020, respectively,
 
with a $5.8 million and $
10.2
 
million
valuation allowance as of December 31, 2021 and 2020, respectively,
 
reflecting the amount of credits that are not expected to be
utilized before expiration.
 
The Company also acquired disallowed interest deferred tax assets of $
14.0
 
million as part of the Combination.
 
Disallowed
interest may be carried forward indefinitely.
 
Management analyzed the expected impact of the utilization of disallowed interest
carryforwards based on projected US taxable income and determined
 
that the Company will utilize all expected future benefits by
2022.
 
As of December 31, 2021, the Company had a net realizable disallowed interest carryforward
 
of $
9.4
 
million on its balance
sheet.
As of December 31, 2021, the Company had deferred tax liabilities of $
178.0
 
million primarily related to the step-up in
intangibles resulting from the Combination and Norman Hay acquisition.
 
As part of the Combination, the Company acquired a
50
% interest in the Korea Houghton Corporation joint venture and has
recorded a $
6.0
 
million deferred tax liability for its outside basis difference.
The following are the changes in the Company’s
 
deferred tax asset valuation allowance for the years ended December 31, 2021,
2020 and 2019:
Effect of
 
Balance at
Purchase
Additional
Allowance
Exchange
Balance
 
Beginning
Accounting
Valuation
Utilization
Rate
at End
of Period
Adjustments
Allowance
and Other
Changes
of Period
Valuation
 
Allowance
Year
 
ended December 31, 2021
$
21,511
$
-
$
29
$
(4,470)
$
330
$
17,400
Year
 
ended December 31, 2020
$
13,834
$
7,148
$
2,738
$
(2,153)
$
(56)
$
21,511
Year
 
ended December 31, 2019
$
7,520
$
13,752
$
832
$
(8,227)
$
(43)
$
13,834
The Company’s net deferred
 
tax assets and liabilities are classified in the Consolidated Balance Sheets as of December
 
31, 2021
and 2020 as follows:
2021
2020
Non-current deferred tax assets
$
16,138
$
16,566
Non-current deferred tax liabilities
179,025
192,763
Net deferred tax liability
$
(162,887)
$
(176,197)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
70
The following is a reconciliation of income taxes at the Federal statutory rate with income taxes
 
recorded by the Company for the
years ended December 31, 2021, 2020 and 2019.
 
Certain immaterial reclassifications within the presentation of the reconciliation
 
of
income taxes have been made to the years ended December 31, 2020
 
and 2019:
2021
2020
2019
Income tax provision at the Federal statutory tax rate
$
30,868
$
5,699
$
6,070
Unremitted earnings
1,841
(2,308)
(4,383)
Tax law changes
 
/ reform
1,955
(1,059)
(416)
U.S. tax on foreign operations
10,479
5,140
574
Pension settlement
-
(2,247)
-
Foreign derived intangible income
(8,698)
(7,339)
(1,699)
Non-deductible acquisition expenses
129
131
1,743
Withholding taxes
6,584
7,809
8,621
Foreign tax credits
(14,725)
(4,699)
(3,787)
Share-based compensation
600
335
(540)
Foreign tax rate differential
3,090
1,139
1,444
Research and development credit
(1,685)
(1,018)
(830)
Uncertain tax positions
519
1,990
899
State income tax provisions, net
(1,446)
(2,245)
(117)
Non-deductible meals and entertainment
426
290
318
Intercompany transfer of intangible assets
4,347
(4,384)
(5,318)
Miscellaneous items, net
655
(2,530)
(495)
Taxes on income before
 
equity in net income of associated companies
$
34,939
$
(5,296)
$
2,084
Pursuant to U.S. Tax
 
Reform, the Company recorded a $
15.5
 
million transition tax liability for U.S. income taxes on the
undistributed earnings of non-U.S. subsidiaries.
 
However, the Company may also be subject to other
 
taxes, such as withholding taxes
and dividend distribution taxes, if these undistributed earnings are
 
ultimately remitted to the U.S.
 
As a result of the Combination,
additional third-party debt was incurred resulting in the Company re-evaluating
 
its global cash strategy in order to meet its goal of
reducing leverage in upcoming years.
 
As of December 31, 2021, the Company has a deferred tax liability $
8.4
 
million, which
primarily represents the estimate of the non-U.S. taxes the Company
 
will incur to ultimately remit these earnings to the U.S.
 
It is the
Company’s current intention
 
to reinvest its additional undistributed earnings of non-U.S. subsidiaries to support
 
working capital needs
and certain other growth initiatives outside of the U.S.
 
The amount of such undistributed earnings at December 31, 2021 was
approximately $
377.4
 
million.
 
Any tax liability which might result from ultimate remittance of these earnings
 
is expected to be
substantially offset by foreign tax credits (subject to certain limitations).
 
It is currently impractical to estimate any such incremental
tax expense.
As of December 31, 2021, the Company’s
 
cumulative liability for gross unrecognized tax benefits was $
22.5
 
million. The
Company had accrued approximately $
3.1
 
million for cumulative penalties and $
3.1
 
million for cumulative interest as of December
31, 2021.
 
As of December 31, 2020, the Company’s
 
cumulative liability for gross unrecognized tax benefits was $
22.2
 
million. The
Company had accrued approximately $
3.9
 
million for cumulative penalties and $
3.0
 
million for cumulative interest as of December
31, 2020.
The Company continues to recognize interest and penalties associated with uncertain
 
tax positions as a component of tax expense
on income before equity in net income of associated companies in its Consolidated
 
Statements of Income.
 
The Company recognized a
benefit of $
0.5
 
million for penalties and an expense of $
0.3
 
million for interest (net of expirations and settlements) in its Consolidated
Statement of Income for the year ended December 31, 2021, an expense of
 
less than $
0.1
 
million for penalties and $
0.6
 
million for
interest (net of expirations and settlements) in its Consolidated Statement
 
of Income for the year ended December 31, 2020, and a
credit of $
0.2
 
million for penalties and an expense of $
0.2
 
million for interest (net of expirations and settlements) in its Consolidated
Statement of Income for the year ended December 31, 201
 
9.
The Company estimates that during the year ending December 31, 2022,
 
it will reduce its cumulative liability for gross
unrecognized tax benefits by approximately $
2.3
 
million due to the expiration of the statute of limitations with regard to certain tax
positions.
 
This estimated reduction in the cumulative liability for unrecognized tax
 
benefits does not consider any increase in liability
for unrecognized tax benefits with regard to existing tax positions or any increase
 
in cumulative liability for unrecognized tax benefits
with regard to new tax positions for the year ending December 31, 2022.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
71
A reconciliation of the beginning and ending amounts of unrecognized
 
tax benefits for the years ended December 31, 2021, 2020
and 2019, respectively,
 
is as follows:
2021
2020
2019
Unrecognized tax benefits as of January 1
$
22,152
$
19,097
$
7,050
Increase (decrease) in unrecognized tax benefits taken in prior periods
1,002
2,025
(28)
Increase in unrecognized tax benefits taken in current period
2,915
3,095
1,935
Decrease in unrecognized tax benefits due to lapse of statute of limitations
(2,631)
(3,659)
(1,029)
Increase in unrecognized tax benefits due to acquisition
-
597
11,301
(Decrease) increase due to foreign exchange rates
(974)
997
(132)
Unrecognized tax benefits as of December 31
$
22,464
$
22,152
$
19,097
The amount of net unrecognized tax benefits above that, if recognized, would
 
impact the Company’s tax expense
 
and effective tax
rate is $
15.2
 
million, $
14.7
 
million and $
13.3
 
million for the years ended December 31, 2021, 2020 and 2019, respectively.
The Company and its subsidiaries are subject to U.S. Federal income tax,
 
as well as the income tax of various state and foreign
tax jurisdictions.
 
Tax years that remain
 
subject to examination by major tax jurisdictions include Italy from 2007, Brazil from
2011
,
the Netherlands, Mexico and China from
2016
, Mexico, Canada, Germany,
 
Spain, U.S. and the United Kingdom from
2017
, India
from fiscal year beginning April 1,
2019
 
and ending March 31, 2020, and various U.S. state tax jurisdictions from
2011
.
As previously reported, the Italian tax authorities have assessed additional
 
tax due from the Company’s subsidiary,
 
Quaker Italia
S.r.l., relating to the tax years 2007
 
through 2015.
 
The Company has filed for competent authority relief from these assessments under
the Mutual Agreement Procedures (“MAP”) of the Organization
 
for Economic Co-Operation and Development for all years except
2007.
 
In 2020, the respective tax authorities in Italy,
 
Spain, and Netherland reached agreement with respect to the MAP proceedings,
which the Company has accepted.
 
As of December 31, 2021, the Company has received $
1.6
 
million in refunds from the Netherlands
and Spain and has an accrual for $
2.4
 
million due to Italy.
 
In February 2022, the Company received a settlement notice from the
Italian taxing authorities confirming the amount due of $
2.6
 
million, having granted the Company’s
 
request to utilize its remaining net
operating losses to partially offset the liability.
 
This amendment to the tax assessment is expected to result in the Company
recognizing tax expense of $
0.6
 
million in Q1 2022.
Houghton Italia, S.r.l is also involved
 
in a corporate income tax audit with the Italian tax authorities covering tax years 2014
through 2018.
 
As of December 31, 2021, the Company has a $
5.0
 
million reserve for uncertain tax positions relating to matters
related to this audit.
 
Because the reserve relates to the tax periods prior to August 1, 2019, the tax liability
 
was established through
purchase accounting related to the Combination.
 
The Company has also submitted an indemnification claim against funds held in
escrow by Houghton’s former owners
 
and as a result, a corresponding $
5.9
 
million indemnification receivable has also been
established through purchase accounting.
 
During the fourth quarter of 2021, the Company settled a portion of the
 
Houghton Italia,
S.r.l. corporate income tax
 
audit with the Italian tax authorities for the tax years 2014 and 2015.
 
The Company remains under audit
for tax years 2016 through 2018 and believes it has adequate reverses
 
for the remaining uncertain tax positions.
Houghton Deutschland GmbH is also under audit by the German tax authorities for
 
tax years 2015 through 2017.
 
Based on
preliminary audit findings, primarily related to transfer pricing,
 
the Company has recorded a reserve for $
0.4
 
million as of December
31, 2021.
 
Of this amount, $
0.3
 
million relates to tax periods prior to the Combination and therefore the Company
 
has submitted an
indemnification claim with Houghton’s
 
former owners for any tax liabilities arising pre-Combination.
 
As a result, a corresponding
indemnification receivable has also been established.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
72
Note 11 – Earnings Per Share
The following table summarizes earnings per share calculations for
 
the years ended December 31, 2021, 2020 and 2019:
2021
2020
2019
Basic earnings per common share
 
 
Net income attributable to Quaker Chemical Corporation
$
 
121,369
$
 
39,658
$
 
31,622
Less: income allocated to participating securities
 
(480)
 
(148)
 
(90)
Net income available to common shareholders
$
 
120,889
$
39,510
$
31,532
Basic weighted average common shares outstanding
17,805,034
17,719,792
15,126,928
Basic earnings per common share
$
6.79
$
2.23
$
2.08
Diluted earnings per common share
Net income attributable to Quaker Chemical Corporation
$
121,369
$
39,658
$
31,622
Less: income allocated to participating securities
(479)
(148)
(90)
Net income available to common shareholders
$
120,890
$
39,510
$
31,532
Basic weighted average common shares outstanding
17,805,034
17,719,792
15,126,928
Effect of dilutive securities
50,090
31,087
36,243
Diluted weighted average common shares outstanding
17,855,124
17,750,879
15,163,171
Diluted earnings per common share
$
6.77
$
2.22
$
2.08
The Company’s calculation
 
of earnings per diluted share attributable to Quaker Chemical Corporation common
 
shareholders for
the year ended December 31, 2019 was impacted by the variability of
 
its reported earnings during the year and the approximately
4.3
million shares issued as a component of the consideration transferred in
 
the Combination, comprising
24.5
% of the common stock of
the Company immediately after the closing.
 
Certain stock options, restricted stock units and PSUs are not included in the diluted
earnings per share calculation when the effect would
 
have been anti-dilutive.
 
The calculated amount of anti-diluted shares not
included were
4,070
 
in 2021,
945
 
in 2020 and
108
 
in 2019.
Note 12 – Restricted Cash
Prior to December 2020, the Company had restricted cash recorded in other assets related to proceeds from an inactive subsidiary
of the Company which previously executed separate settlement and release agreements with two of its insurance carriers for an
original total value of $35.0 million.
 
The proceeds of both settlements were restricted and could only be used
 
to pay claims and costs
of defense associated with the subsidiary’s
 
asbestos litigation.
 
The proceeds of the settlement and release agreements were deposited
into interest bearing accounts which earned less then $
0.1
 
million and $
0.2
 
million in the years ended December 31, 2020, and 2019,
respectively, offset
 
by $
1.0
 
million and $
0.8
 
million of net payments during 2020 and 2019, respectively.
 
Due to the restricted nature
of the proceeds, a corresponding deferred credit was established in other
 
non-current liabilities for an equal and offsetting amount that
continued until the restrictions lapsed.
 
During December 2020, the restrictions ended on these previously received
 
insurance
 
settlements and the Company transferred
the cash into an operating account.
 
In connection with the termination in restrictions, the Company recognized
 
an $
18.1
 
million gain
on its Consolidated Statement of Income in Other income (expense
 
), net, for the amount of previously restricted cash, net of the
estimated liability to pay claims and associated with the inactive subsidiary’s
 
asbestos litigation as of December 31, 2020.
 
Therefore,
due to these restrictions ending, there is
no
 
restricted cash for the year ended December 31, 2021.
 
See Notes 18, 22 and 26 of Notes to
Consolidated Financial Statements.
The following table provides a reconciliation of cash, cash equivalents
 
and restricted cash as December 31, 2021, 2020, 2019 and
2018:
2021
2020
2019
2018
Cash and cash equivalents
$
165,176
$
181,833
$
123,524
$
104,147
Restricted cash included in other current assets
-
62
353
-
Restricted cash included in other assets
-
-
19,678
20,278
Cash, cash equivalents and restricted cash
$
165,176
$
181,895
$
143,555
$
124,425
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
73
Note 13 – Accounts Receivable and Allowance for Doubtful Accounts
As of December 31, 2021 and 2020, the Company had gross trade accounts receivable
 
totaling $
443.0
 
million and $
386.1
 
million,
respectively.
 
The following are changes in the allowance for doubtful accounts during the years
 
ended December 31, 2021, 2020 and 2019:
Exchange Rate
Balance at
Changes
Write-Offs
Changes
Balance
 
Beginning
to Costs and
Charged to
and Other
at End
of Period
Expenses
Allowance
Adjustments
of Period
Allowance for Doubtful Accounts
Year
 
ended December 31, 2021
$
13,145
$
653
$
(946)
$
(518)
$
12,334
Year
 
ended December 31, 2020
$
11,716
$
3,582
$
(2,187)
$
34
$
13,145
Year
 
ended December 31, 2019
$
5,187
$
1,925
$
(322)
$
4,926
$
11,716
Included in exchange rate changes and other adjustments for the year
 
ended December 31, 2019 are the allowance for doubtful
accounts of $
5.0
 
million related to the acquired receivables in connection with the Combination and
 
Norman Hay acquisition.
Note 14 – Inventories
Inventories, net, as of December 31, 2021 and 2020 were as follows:
2021
2020
Raw materials and supplies
$
129,382
$
86,148
Work in process,
 
finished goods and reserves
135,149
101,616
Total inventories, net
$
264,531
$
187,764
Note 15 – Property,
 
Plant and Equipment
Property, plant and equipment
 
as of December 31, 2021 and 2020 were as follows:
2021
2020
Land
$
30,793
$
33,009
Building and improvements
134,313
135,595
Machinery and equipment
252,779
246,242
Construction in progress
16,459
8,407
Property, plant and equipment,
 
at cost
434,344
423,253
Less: accumulated depreciation
(236,824)
(219,370)
Total property,
 
plant and equipment, net
$
197,520
$
203,883
As of December 31, 2021, PP&E includes $
0.8
 
million of finance lease assets and future minimum lease payments.
 
In connection
with the plans for closure of certain facilities, certain buildings and land with an aggregate book value of approximately $0.7 million
continue to be held-for-sale as of December 31, 2021 and are recorded in prepaid expenses and other current assets on the Company’s
Consolidated Balance Sheet.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
74
Note 16 – Goodwill and Other Intangible Assets
Changes in the carrying amount of goodwill for the years ended December 31,
 
2021 and 2020 were as follows:
Global
Specialty
Americas
EMEA
Asia/Pacific
Businesses
Total
Balance as of December 31, 2019
$
216,385
$
133,018
$
141,727
$
116,075
 
$
607,205
Goodwill additions
1,485
531
-
1,329
3,345
Currency translation and other
 
adjustments
 
(4,628)
6,613
16,363
2,314
20,662
Balance as of December 31, 2020
213,242
140,162
158,090
119,718
 
631,212
Goodwill additions
1,490
3,380
1,308
2,624
8,802
Currency translation and other
 
adjustments
(709)
(8,022)
3,060
(3,149)
(8,820)
Balance as of December 31, 2021
$
214,023
$
135,520
$
162,458
$
119,193
$
631,194
Other adjustments in the table above includes updates to the Company’s
 
allocation of the Houghton purchase price and associated
goodwill to each of the Company’s
 
reportable segments during the year ended December 31, 2020, including
 
a $
2.6
 
million decrease
in the Americas, a $
1.4
 
million decrease in EMEA, a $
8.0
 
million increase in Asia/Pacific and a $
0.5
 
million increase in Global
Specialty Businesses.
 
Gross carrying amounts and accumulated amortization for definite-lived
 
intangible assets as of December 31, 2021 and 2020 were
as follows:
Gross Carrying
Accumulated
Amount
Amortization
2021
2020
2021
2020
Customer lists and rights to sell
$
853,122
$
839,551
 
$
147,858
 
$
99,806
Trademarks, formulations and product
 
technology
 
163,974
 
166,448
 
 
38,747
 
 
30,483
Other
 
6,309
 
 
6,372
 
 
5,900
 
 
5,824
Total definite-lived
 
intangible assets
$
1,023,405
 
$
1,012,371
 
$
192,505
 
$
136,113
The Company recorded $
59.9
 
million, $
55.9
 
million and $
26.7
 
million of amortization expense during the years ended December
31, 2021, 2020 and 2019, respectively.
 
Amortization is recorded within SG&A in the Company’s
 
Consolidated Statements of Income.
 
Estimated annual aggregate amortization expense for the subsequent
 
five years is as follows:
For the year ended December 31, 2022
$
59,900
For the year ended December 31, 2023
59,727
For the year ended December 31, 2024
59,138
For the year ended December 31, 2025
58,383
For the year ended December 31, 2026
58,108
The Company has four indefinite-lived intangible assets totaling $
196.9
 
million as of December 31, 2021, including $
195.8
million of indefinite-lived intangible assets for trademarks and tradename associated
 
with the Combination.
 
Comparatively, the
Company had four indefinite-lived intangible assets for trademarks and
 
tradename totaling $
205.1
 
million as of December 31, 2020.
The Company completes its annual goodwill and indefinite-lived intangible
 
asset impairment test during the fourth quarter of
each year, or more frequently if triggering
 
events indicate a possible impairment in one or more of its reporting units.
 
The Company
completed its annual impairment assessment during the fourth quarter
 
of 2021 and concluded
no
 
impairment charge was warranted.
 
The Company continually evaluates financial performance, economic
 
conditions and other relevant developments in assessing if an
interim period impairment test for one or more of its reporting units is necessary.
 
As of March 31, 2020, the Company evaluated the initial impact of COVID-19
 
on the Company’s operations,
 
and the volatility
and uncertainty in the economic outlook as a result of COVID-19 to determine
 
if they indicated it was more likely than not that the
carrying value of any of the Company’s
 
reporting units or indefinite-lived or long-lived assets was not recoverable.
 
The Company
concluded that the impact of COVID-19 did not represent a triggering
 
event as of March 31, 2020 with regards to the Company’s
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
75
reporting units or indefinite-lived and long-lived assets, except for the Company’s
 
Houghton and Fluidcare
TM
 
trademarks
 
and
tradename indefinite-lived intangible assets.
 
The determination of estimated fair value of the Houghton and Fluidcare
TM
 
trademarks and tradename indefinite-lived assets was
based on a relief from royalty valuation method which requires management’s
 
judgment and often involves the use of significant
estimates and assumptions, including assumptions with respect to the
 
weighted average cost of capital (“WACC”)
 
and royalty rates, as
well as revenue growth rates and terminal growth rates.
 
In the first quarter of 2020, as a result of the impact of COVID-19 driving
 
a
decrease in projected legacy Houghton net sales in the current year
 
and the impact of the current year decline on projected future
legacy Houghton net sales as well as an increase in the WACC
 
assumption utilized in the quantitative impairment assessment,
 
the
Company concluded that the estimated fair values of the Houghton and
 
Fluidcare
TM
 
trademarks and tradename intangible assets were
less than their carrying values.
 
As a result, an impairment charge of $
38.0
 
million, primarily related to the Houghton trademarks and
tradename, to write down the carrying values of these intangible assets to their estimated
 
fair values was recorded in the first quarter
of 2020.
Note 17 – Investments in Associated Companies
As of December 31, 2021, the Company held a
50
% investment in and had significant influence over Nippon Quaker Chemical,
Ltd. (“Nippon Japan”), Kelko Quaker Chemical, S.A. (“Kelko Panama”)
 
and Houghton Korea acquired in 2019 in connection with the
Combination, and held a
32
% investment in and had significant influence over Primex, Ltd. (“Primex”).
The carrying amount of the Company’s
 
equity investments as of December 31, 2021 was $
95.3
 
million, which includes
investments of $
66.4
 
million in Houghton Korea; $
21.5
 
million in Primex; $
7.1
 
million in Nippon Japan; and $
0.3
 
million in Kelko
Panama.
The Company also has a
50
% equity interest in Kelko Venezuela.
 
Due to heightened foreign exchange controls, deteriorating
economic circumstances and other restrictions in Venezuela,
 
during 2018 the Company concluded that it no longer had significant
influence over this affiliate.
 
Prior to this determination, the Company historically accounted for this affiliate
 
under the equity method.
 
As of December 31, 2021 and 2020, the Company had
no
 
remaining carrying value for its investment in Kelko Venezuela.
 
The following table is a summary of equity income in associated companies by
 
investment for the years ending December 31,
2021, 2020 and 2019:
Year
 
Ended December 31,
2021
2020
2019
Houghton Korea
$
3,808
$
5,241
$
2,337
Nippon Japan
461
853
850
Kelko Panama
154
107
55
Grindaix (1)
(37)
-
-
Primex
4,993
1,151
1,822
Total equity in net
 
income of associated companies
$
9,379
$
7,352
$
5,064
(1) In February 2021, the Company acquired a
38
% ownership interest in Grindaix.
 
From that date through September 2021
when the Company purchased the remaining interest of Grindaix, the
 
Company accounted for its
38
% interest under the
equity method of accounting and recorded equity in net income of associated
 
companies.
 
See Note 2 of Notes to
Consolidated Financial Statements.
As the Combination closed on August 1, 2019, the Company included five
 
months of equity income from Houghton Korea in its
December 31, 2019 Consolidated Statement of Income.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
76
Note 18 – Other Non-Current Assets
Other non-current assets as of December 31, 2021 and 2020 were as follows:
2021
2020
Pension assets
$
7,916
 
$
6,748
Uncertain tax positions
6,931
7,209
Indemnification assets
6,630
7,615
Debt issuance costs
4,267
5,919
Supplemental retirement income program
 
2,269
 
 
1,961
Other
2,946
2,344
Total other non
 
-current assets
$
30,959
 
$
31,796
As of December 31, 2021 and 2020, indemnification assets relates to certain
 
Houghton foreign subsidiaries for which the
Company expects it will incur additional tax amounts which are subject
 
to indemnification under the terms of the Combination share
and purchase agreement.
 
These indemnification assets have a corresponding uncertain tax position recorded
 
in other non-current
liabilities.
 
As of December 31, 2021 and 2020, one of the Company’s
 
foreign pension plan’s fair value of
 
plan assets exceeded its
gross benefit obligation and was therefore over-funded,
 
which is represented by the line Pension assets in the table above.
 
See Notes
10, 12, 21 and 22 of Notes to Consolidated Financial Statements.
 
Note 19 – Other Accrued Liabilities
Other accrued liabilities as of December 31, 2021 and 2020 were as follows:
2021
2020
Non-income taxes
$
23,725
$
26,080
Current income taxes payable
16,642
13,124
Professional fees, legal, and acquisition-related accruals
12,264
11,437
Selling expenses and freight accruals
11,695
10,475
Short-term lease liabilities
9,976
10,901
Customer advances and sales return reserves
7,965
6,380
Interest rate swap
1,782
-
Other
11,568
13,710
Total other accrued
 
liabilities
$
95,617
$
92,107
Note 20 – Debt
Debt as of December 31, 2021 and 2020 includes the following:
As of December 31, 2021
As of December 31, 2020
Interest
Outstanding
 
Interest
Outstanding
 
Rate
Balance
Rate
Balance
Credit Facilities:
Revolver
1.62%
$
211,955
1.65%
$
160,000
U.S. Term Loan
1.65%
540,000
1.65%
570,000
EURO Term Loan
1.50%
137,616
1.50%
157,062
Industrial development bonds
5.26%
10,000
5.26%
10,000
Bank lines of credit and other debt obligations
Various
1,777
Various
2,072
Total debt
$
901,348
$
899,134
Less: debt issuance costs
(8,001)
(11,099)
Less: short-term and current portion of long-term debts
(56,935)
(38,967)
Total long-term debt
$
836,412
$
849,068
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
77
Credit facilities
The Company’s primary credit facility
 
(as amended, the “Credit Facility”) is comprised of a $
400.0
 
million multicurrency
revolver (the “Revolver”), a $
600.0
 
million term loan (the “U.S. Term
 
Loan”), each with the Company as borrower,
 
and a $
150.0
million (as of August 1, 2019) Euro equivalent term loan (the “EURO Term
 
Loan” and together with the “U.S. Term
 
Loan”, the
“Term Loans”)
 
with Quaker Chemical B.V.,
 
a Dutch subsidiary of the Company as borrower, each
 
with a
five year
 
term maturing in
August 2024
.
 
Subject to the consent of the administrative agent and certain other conditions, the Company
 
may designate additional
borrowers.
 
The maximum amount available under the Credit Facility can be increased by up
 
to $
300.0
 
million at the Company’s
request if there are lenders who agree to accept additional commitments and
 
the Company has satisfied certain other conditions.
 
Borrowings under the Credit Facility bear interest at a base rate or LIBOR plus an
 
applicable margin based upon the Company’s
consolidated net leverage ratio.
 
On December 10, 2021, the Company entered into the Second Amendment with Bank of America
N.A., to include among other things, an update to provide for use of a non-USD
 
currency LIBOR successor rate.
 
The variable interest
rate incurred on the outstanding borrowings under the Credit Facility as of and
 
during the year ended December 31, 2021 was
approximately
1.6
%.
 
In addition to paying interest on outstanding principal under the Credit Facility,
 
the Company is required to pay
a commitment fee ranging from
0.2
% to
0.3
% depending on the Company’s consolidated
 
net leverage ratio to the lenders under the
Revolver in respect of the unutilized commitments thereunder.
 
The Company has unused capacity under the Revolver of
approximately $
184
 
million, net of bank letters of credit of approximately $
4
 
million, as of December 31, 2021.
The Credit Facility is subject to certain financial and other covenants
 
.
 
The Company’s initial consolidated net
 
debt to
consolidated adjusted EBITDA ratio could not exceed
4.25
 
to 1, with step downs in the permitted ratio over the term of the Credit
Facility.
 
As of December 31, 2021, the consolidated net debt to adjusted EBITDA
 
may not exceed
3.75
 
to 1.
 
The Company’s
consolidated adjusted EBITDA to interest expense ratio cannot be less than
3.0
 
to 1 over the term of the agreement.
 
The Credit
Facility also prohibits the payment of cash dividends if the Company
 
is in default or if the amount of the dividend paid annually
exceeds the greater of $
50.0
 
million and
20
% of consolidated adjusted EBITDA unless the ratio of consolidated net debt
 
to
consolidated adjusted EBITDA is less than
2.0
 
to 1, in which case there is no such limitation on amount.
 
As of December 31, 2021
and December 31, 2020, the Company was in compliance with all of the Credit Facility covenants.
 
The Term Loans have quarterly
principal amortization during their five year terms, with
5.0
% amortization of the principal balance due in years 1 and 2,
7.5
% in year
3, and
10.0
% in years 4 and 5, with the remaining principal amount due at maturity.
 
During the year ended December 31, 2021, the
Company made four quarterly amortization payments related to the
 
Term Loans totaling $
38.0
 
million.
 
The Credit Facility is
guaranteed by certain of the Company’s
 
domestic subsidiaries and is secured by first priority liens on substantially all of the assets of
the Company and the domestic subsidiary guarantors, subject to certain
 
customary exclusions.
 
The obligations of the Dutch borrower
are guaranteed only by certain foreign subsidiaries on an unsecured basis.
The Credit Facility required the Company to fix its variable interest rates on at least
20
% of its total Term Loans.
 
In order to
satisfy this requirement as well as to manage the Company’s
 
exposure to variable interest rate risk associated with the Credit Facility,
in November 2019, the Company entered into $
170.0
 
million notional amounts of three year interest rate swaps at a base rate of
1.64
%
plus an applicable margin as provided in the Credit Facility,
 
based on the Company’s consolidated
 
net leverage ratio.
 
At the time the
Company entered into the swaps, and as of December 31, 2021,
 
the aggregate interest rate on the swaps, including the fixed base rate
plus an applicable margin, was
3.1
%.
 
See Note 25 of Notes to Consolidated Financial Statements.
The Company capitalized $
23.7
 
million of certain third-party debt issuance costs in connection with executing
 
the Credit Facility.
 
Approximately $
15.5
 
million of the capitalized costs were attributed to the Term
 
Loans and recorded as a direct reduction of long-
term debt on the Company’s Consolidated
 
Balance Sheet.
 
Approximately $
8.3
 
million of the capitalized costs were attributed to the
Revolver and recorded within other assets on the Company’s
 
Consolidated Balance Sheet.
 
These capitalized costs are being
amortized into interest expense over the
five year
 
term of the Credit Facility.
 
As of December 31, 2021 and 2020, the Company had
$
8.0
 
million and $
11.1
 
million, respectively, of debt
 
issuance costs recorded as a reduction of long-term debt.
 
As of December 31,
2021 and 2020, the Company had $
4.3
 
million and $
5.9
 
million, respectively, of
 
debt issuance costs recorded within other non-current
assets.
 
Industrial development bonds
As of December 31, 2021 and 2020, the Company had fixed rate, industrial
 
development authority bonds totaling $
10.0
 
million in
principal amount due in
2028
.
 
These bonds have similar covenants to the Credit Facility noted above.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
78
Bank lines of credit and other debt obligations
The Company has certain unsecured bank lines of credit and discounting
 
facilities in certain foreign subsidiaries, which are not
collateralized.
 
The Company’s other debt obligations
 
primarily consist of certain domestic and foreign low interest rate or interest-
free municipality-related loans, local credit facilities of certain foreign subsidiaries
 
and capital lease obligations.
 
Total unused
capacity under these arrangements as of December 31, 2021, was approximately
 
$
26
 
million.
In addition to the bank letters of credit described in the “Credit facilities” subsection
 
above, the Company’s only other
 
off-balance
sheet arrangements include certain financial and other guarantees.
 
The Company’s total bank letters
 
of credit and guarantees
outstanding as of December 31, 2021 were approximately $
6
 
million.
The Company incurred the following debt related expenses included
 
within Interest expense, net, in the Consolidated Statements
of Income:
Year
 
Ended December 31,
2021
2020
2019
Interest expense
$
19,089
$
23,552
$
16,788
Amortization of debt issuance costs
4,749
4,749
1,979
Total
$
23,838
$
28,301
$
18,767
Based on the variable interest rates associated with the Credit Facility,
 
as of December 31, 2021 and 2020, the amounts at which
the Company’s total debt were recorded
 
are not materially different from their fair market value.
At December 31, 2021, annual maturities on long-term borrowings maturing
 
in the next five fiscal years (excluding the reduction
to long-term debt attributed to capitalized and unamortized debt issuance costs)
 
are as follows:
 
2022
$
56,978
2023
75,765
2024
758,241
2025
298
2026
145
Note 21 – Pension and Other Postretirement
 
Benefits
The following table shows the funded status of the Company’s
 
plans’ reconciled
 
with amounts reported in the Consolidated
Balance Sheets as of December 31, 2021 and 2020:
Other Post-
Pension Benefits
Retirement Benefits
2021
2020
2021
2020
Foreign
U.S.
Total
Foreign
U.S.
Total
U.S.
U.S.
Change in benefit obligation
Gross benefit obligation at beginning
of year
$
247,675
$
109,969
$
357,644
$
217,893
$
153,723
$
371,616
$
3,234
$
4,266
Service cost
698
547
1,245
4,340
491
4,831
1
5
Interest cost
2,594
1,737
4,331
3,416
2,923
6,339
27
77
Employee contributions
71
-
71
73
-
73
-
-
Effect of plan amendments
-
-
-
-
50
50
(78)
-
Curtailment gain
-
-
-
(2,324)
-
(2,324)
-
-
Plan settlements
(541)
-
(541)
(2,316)
(53,494)
(55,810)
-
-
Benefits paid
(6,869)
(5,064)
(11,933)
(5,087)
(6,138)
(11,225)
(182)
(250)
Plan expenses and premiums paid
(74)
-
(74)
(135)
-
(135)
-
-
Transfer in of business acquisition
231
-
231
-
-
-
-
-
Actuarial (gain) loss
 
(4,160)
(3,769)
(7,929)
16,834
12,414
29,248
(992)
(864)
Translation differences and other
(10,873)
-
(10,873)
14,981
-
14,981
-
-
Gross benefit obligation at end of year
$
228,752
$
103,420
$
332,172
$
247,675
$
109,969
$
357,644
$
2,010
$
3,234
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
79
Other Post-
Pension Benefits
Retirement Benefits
2021
2020
2021
2020
Foreign
U.S.
Total
Foreign
U.S.
Total
U.S.
U.S.
Change in plan assets
Fair value of plan assets at
 
 
beginning of year
$
228,789
$
73,481
$
302,270
$
195,099
$
120,550
$
315,649
$
-
$
-
Actual return on plan assets
915
7,201
8,116
20,367
10,759
31,126
-
-
Employer contributions
4,289
2,063
6,352
6,912
2,302
9,214
182
250
Employee contributions
71
-
71
73
-
73
-
-
Plan settlements
(541)
-
(541)
(2,316)
(53,494)
(55,810)
-
-
Benefits paid
(6,869)
(5,065)
(11,934)
(5,087)
(6,138)
(11,225)
(182)
(250)
Plan expenses and premiums paid
(74)
-
(74)
(135)
(498)
(633)
-
-
Translation differences
(9,694)
-
(9,694)
13,876
-
13,876
-
-
Fair value of plan assets at end of year
$
216,886
$
77,680
$
294,566
$
228,789
$
73,481
$
302,270
$
-
$
-
Net benefit obligation recognized
$
(11,866)
$
(25,740)
$
(37,606)
$
(18,886)
$
(36,488)
$
(55,374)
$
(2,010)
$
(3,234)
Amounts recognized in the balance
 
 
sheet consist of:
 
Non-current assets
$
7,916
$
-
$
7,916
$
6,748
$
-
$
6,748
$
-
$
-
 
Current liabilities
(191)
(1,137)
(1,328)
(568)
(612)
(1,180)
(220)
(286)
 
Non-current liabilities
(19,591)
(24,603)
(44,194)
(25,066)
(35,876)
(60,942)
(1,790)
(2,948)
Net benefit obligation recognized
$
(11,866)
$
(25,740)
$
(37,606)
$
(18,886)
$
(36,488)
$
(55,374)
$
(2,010)
$
(3,234)
Amounts not yet reflected in net
 
periodic benefit costs and included in
 
accumulated other comprehensive loss:
 
Prior service (cost) credit
(22)
43
21
(26)
50
24
46
-
 
Accumulated (loss) gain
(19,163)
(9,763)
(28,926)
(21,976)
(5,532)
(27,508)
1,034
124
 
AOCI
(19,185)
(9,720)
(28,905)
(22,002)
(5,482)
(27,484)
1,080
124
 
Cumulative employer contributions
 
in excess of or (below) net
 
 
periodic benefit cost
7,319
(16,020)
(8,701)
3,116
(31,006)
(27,890)
(3,090)
(3,358)
Net benefit obligation recognized
$
(11,866)
$
(25,740)
$
(37,606)
$
(18,886)
$
(36,488)
$
(55,374)
$
(2,010)
$
(3,234)
The accumulated benefit obligation for all defined benefit pension plans was
 
$
321.5
 
million ($
103.4
 
million U.S. and $
218.1
million Foreign) and $
344.4
 
million ($
109.5
 
million U.S. and approximately $
234.9
 
million Foreign) as of December 31, 2021 and
2020, respectively.
 
Information for pension plans with an accumulated benefit obligation
 
in excess of plan assets:
2021
2020
Foreign
U.S.
Total
Foreign
U.S.
Total
Projected benefit obligation
$
138,963
$
103,420
$
242,383
$
32,373
$
109,969
$
142,342
Accumulated benefit obligation
128,268
103,420
231,688
30,892
109,540
140,432
Fair value of plan assets
119,181
77,680
196,861
18,074
73,481
91,555
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
80
Information for pension plans with a projected benefit obligation
 
in excess of plan assets:
2021
2020
Foreign
U.S.
Total
Foreign
U.S.
Total
Projected benefit obligation
$
138,963
$
103,420
$
242,383
$
32,373
$
109,969
$
142,342
Fair value of plan assets
119,181
77,680
196,861
18,074
73,481
91,555
Components of net periodic benefit costs – pension plans:
2021
2020
Foreign
U.S.
Total
Foreign
U.S.
Total
Service cost
$
698
$
547
$
1,245
$
4,340
$
491
$
4,831
Interest cost
2,594
1,737
4,331
3,416
2,923
6,339
Expected return on plan assets
(4,686)
(3,611)
(8,297)
(4,262)
(4,810)
(9,072)
Settlement loss (gain)
35
-
35
(88)
22,667
22,579
Curtailment charge
-
-
-
(1,155)
-
(1,155)
Actuarial loss amortization
996
2,252
3,248
886
2,110
2,996
Prior service cost (credit)
amortization
3
7
10
(167)
-
(167)
Net periodic benefit (income) cost
$
(360)
$
932
$
572
$
2,970
$
23,381
$
26,351
2019
Foreign
U.S.
Total
Service cost
$
3,507
$
434
$
3,941
Interest cost
3,046
3,313
6,359
Expected return on plan assets
(3,668)
(3,227)
(6,895)
Settlement loss
258
-
258
Actuarial loss amortization
757
2,348
3,105
Prior service credit amortization
(165)
-
(165)
Net periodic benefit cost
$
3,735
$
2,868
$
6,603
Other changes recognized in other comprehensive
 
income – pension plans:
2021
2020
Foreign
U.S.
Total
Foreign
U.S.
Total
Net (gain) loss arising during
 
the period
$
(388)
$
(448)
$
(836)
$
(1,594)
$
1,536
$
(58)
Effect of plan amendment
Recognition of amortization in net
periodic benefit cost
Settlement loss
(83)
(2,252)
(2,335)
(39)
(22,667)
(22,706)
Prior service (cost) credit
-
(7)
(7)
1,325
50
1,375
Actuarial (loss) gain
(954)
(6,925)
(7,879)
(758)
3,967
3,209
Curtailment Recognition
(3)
-
(3)
(3)
-
(3)
Effect of exchange rates on amounts
included in AOCI
(1,390)
-
(1,390)
1,535
-
1,535
Total recognized
 
in other
 
comprehensive (income) loss
(2,818)
(9,632)
(12,450)
466
(17,114)
(16,648)
Total recognized
 
in net periodic
 
benefit cost and other
 
comprehensive (income) loss
$
(3,178)
$
(8,700)
$
(11,878)
$
3,436
$
6,267
$
9,703
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
81
2019
Foreign
U.S.
Total
Net loss arising during period
$
3,826
$
3,926
$
7,752
Recognition of amortization in net periodic benefit
 
cost
Prior service credit
196
-
196
Actuarial loss
(1,015)
(2,347)
(3,362)
Effect of exchange rates on amounts included
 
in AOCI
(61)
-
(61)
Total recognized
 
in other comprehensive loss
2,946
1,579
4,525
Total recognized
 
in net periodic benefit cost and
 
other comprehensive loss
$
6,681
$
4,447
$
11,128
Components of net periodic benefit costs – other postretirement
 
plan:
2021
2020
2019
Service cost
$
1
$
5
$
6
Interest cost
27
77
143
Actuarial loss amortization
(82)
(5)
-
Prior service credit amortization
(31)
-
-
Net periodic benefit costs
$
(85)
$
77
$
149
Other changes recognized in other comprehensive
 
income – other postretirement benefit plans:
2021
2020
2019
Net (gain) loss arising during period
$
(992)
$
(864)
$
395
Recognition of amortizations in net periodic
benefit cost
 
(78)
-
-
Prior service credit
31
-
-
Actuarial gain amortization
82
5
-
Total recognized
 
in other comprehensive (income)
loss
(957)
(859)
395
Total recognized
 
in net periodic benefit cost and
 
other comprehensive (income) loss
 
$
(1,042)
$
(782)
$
544
Weighted-average
 
assumptions used to determine benefit obligations as of December 31, 2021 and 2020:
Other Postretirement
Pension Benefits
Benefits
2021
2020
2021
2020
U.S. Plans:
Discount rate
2.58
%
2.19
%
2.45
%
2.05
%
Rate of compensation increase
N/A
6.00
%
N/A
N/A
Foreign
 
Plans:
Discount rate
1.71
%
1.79
%
N/A
N/A
Rate of compensation increase
2.21
%
2.74
%
N/A
N/A
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
82
Weighted-average
 
assumptions used to determine net periodic benefit costs for the years ended December 31,
 
2021 and
2020:
Other Postretirement
Pension Benefits
Benefits
2021
2020
2021
2020
U.S. Plans:
Discount rate
2.67
%
3.11
%
1.90
%
2.99
%
Expected long-term return on
plan assets
5.75
%
6.50
%
N/A
N/A
Rate of compensation increase
6.00
%
6.00
%
N/A
N/A
Foreign Plans:
Discount rate
1.38
%
2.30
%
N/A
N/A
Expected long-term return on
plan assets
2.06
%
2.20
%
N/A
N/A
Rate of compensation increase
2.52
%
2.79
%
N/A
N/A
The long-term rates of return on assets were selected from within the reasonable
 
range of rates determined by (a) historical real
returns for the asset classes covered by the investment policy and (b) projections
 
of inflation over the long-term period during which
benefits are payable to plan participants.
 
See Note 1 of Notes to Consolidated Financial Statements for further
 
information.
Assumed health care cost trend rates as of December
 
31, 2021 and 2020:
 
2021
2020
Health care cost trend rate for next year
5.65
%
5.70
%
Rate to which the cost trend rate is assumed to decline (the
ultimate trend rate)
4.00
%
4.50
%
Year
 
that the rate reaches the ultimate trend rate
2046
2037
Plan Assets and Fair Value
The Company’s pension plan
 
target asset allocation and the weighted-average asset allocations as of December
 
31, 2021 and 2020
by asset category were as follows:
Asset Category
Target
2021
2020
U.S. Plans
Equity securities
44
%
46
%
58
%
Debt securities
50
%
48
%
36
%
Other
6
%
6
%
6
%
Total
100
%
100
%
100
%
Foreign Plans
Equity securities
39
%
36
%
33
%
Debt securities
50
%
43
%
45
%
Other
11
%
21
%
22
%
Total
100
%
100
%
100
%
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
83
As of December 31, 2021 and 2020, “Other” consisted principally of cash
 
and cash equivalents, and investments in real estate
funds.
 
The following is a description of the valuation methodologies used for
 
the investments measured at fair value, including the
general classification of such instruments pursuant to the valuation
 
hierarchy,
 
where applicable:
Cash and
 
Cash Equivalents
Cash and
 
cash equivalents
 
consist
 
of cash and
 
money market
 
funds and
 
are classified
 
as Level
 
1 investments.
Commingled Funds
Investments
 
in the U.S.
 
pension
 
plan and
 
foreign
 
pension
 
plan commingled
 
funds represent
 
pooled institutional
 
investments,
including
 
primarily
 
collective
 
investment
 
trusts.
 
These commingled funds are not available on an exchange or in an active market
and these investments are valued using
 
their net
 
asset value
 
(“NAV”), which is
 
generally
 
based on
 
the underlying
 
asset values
 
of the
investments
 
held in the
 
trusts.
 
As of December 31, 2021, the foreign pension plan commingled funds
 
included approximately
35
 
percent of investments in
equity securities,
51
 
percent of investments in fixed income securities, and
14
 
percent of other non-related investments, primarily
real estate.
Pooled Separate
 
Accounts
Investments
 
in the U.S.
 
pension
 
plan pooled
 
separate
 
accounts
 
consist of
 
annuity
 
contracts
 
and are
 
valued based
 
on the reported
unit value
 
at year
 
end.
 
Units of
 
the pooled
 
separate
 
account
 
are not traded
 
on an exchange
 
or in an
 
active market;
 
however, valuation
 
is
based on
 
the underlying
 
investments
 
of each
 
pooled separate
 
account
 
and are
 
classified
 
as Level
 
2 investments.
 
As of December 31,
2021, the U.S. pension plan pooled separate accounts included approximately 49 percent of investments in equity securities and 51
percent of investments in fixed income securities.
Fixed Income
 
Government
 
Securities
Investments in foreign pension plans fixed income government securities were
 
valued using third party pricing services
which are based on a combination of quoted market prices on an exchange
 
in an active market as well as proprietary pricing
models and
 
inputs
 
using observable
 
market data
 
and are
 
classified
 
as Level
 
2 investments.
Insurance
 
Contract
Investments in the foreign pension plan insurance contract are valued at
 
the highest value available for the Company at year
end, either the reported cash surrender value of the contract or the vested benefit
 
obligation.
 
Both the cash surrender value and
the vested benefit obligation are determined based on unobservable inputs, which
 
are contractually or actuarially determined,
regarding returns, fees, the present value of the future cash flows of the contract
 
and benefit obligations.
 
The contract is classified
as a Level 3 investment.
Diversified
 
Equity
 
Securities
 
- Registered
 
Investment
 
Companies
Investments
 
in the foreign
 
pension
 
plans diversified
 
equity securities
 
of registered
 
investment
 
companies
 
are based
 
upon the
quoted redemption
 
value of
 
shares in
 
the fund
 
owned by
 
the plan
 
at year end.
 
The shares
 
of the fund
 
are not
 
available
 
on an exchange
or in an
 
active market;
 
however, the
 
fair value
 
is determined
 
based on
 
the underlying
 
investments
 
in the
 
fund as
 
traded on
 
an exchange
in an active
 
market and
 
are classified
 
as Level
 
2 investments.
Fixed Income
 
– Foreign Registered
 
Investment
 
Companies
Investments
 
in the foreign
 
pension
 
plans fixed
 
income securities
 
of foreign
 
registered
 
investment
 
companies
 
are based
 
upon the
quoted redemption
 
value of
 
shares in
 
the fund
 
owned by
 
the plan
 
at year end.
 
The shares
 
of the fund
 
are not
 
available
 
on an exchange
or in an
 
active market;
 
however, the
 
fair value
 
is determined
 
based on
 
the underlying
 
investments
 
in the
 
fund as
 
traded on
 
an exchange
in an active
 
market and
 
are classified
 
as Level
 
2 investments.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
84
Diversified Investment Fund - Registered Investment
 
Companies
Investments
 
in the foreign
 
pension
 
plan diversified
 
investment
 
fund of
 
registered
 
investment
 
companies
 
are based
 
upon the
 
quoted
redemption
 
value of
 
shares in
 
the fund
 
owned by
 
the plan
 
at year
 
end.
 
This fund
 
is not available
 
on an exchange
 
or in an
 
active market
and this
 
investment
 
is valued
 
using its
 
NAV,
 
which is
 
generally
 
based on
 
the underlying
 
asset values
 
of the investments
 
held.
 
As of
December
 
31, 2021,
 
the diversified
 
investment
 
funds included
 
approximately
62
 
percent
 
of investments
 
in equity
 
securities,
20
 
percent
of investments
 
in fixed
 
income
 
securities,
 
and
18
 
percent
 
of other
 
alternative
 
investments.
Other – Alternative Investments
Investments
 
in the foreign
 
pension
 
plans include
 
certain other
 
alternative
 
investments
 
such as
 
inflation
 
and interest
 
rate swaps.
 
These investments
 
are valued
 
based on
 
unobservable
 
inputs,
 
which are
 
contractually
 
or actuarially
 
determined,
 
regarding
 
returns,
 
fees,
the present
 
value of
 
future cash
 
flows of
 
the contract
 
and benefit
 
obligations.
 
These alternative
 
investments
 
are classified
 
as Level
 
3
investments.
Real Estate
The U.S. and foreign pension plans’
 
investment in real estate consists of investments
 
in property funds.
 
The funds’
underlying investments consist of real property which are valued using unobservable
 
inputs.
 
These property
 
funds are classified
as a Level 3 investment.
As of December 31, 2021 and 2020, the U.S. and foreign plans’ investments
 
measured at fair value on a recurring basis were as
follows:
Fair Value
 
Measurements at December 31, 2021
Total
Using Fair Value
 
Hierarchy
U.S. Pension Assets
Fair Value
Level 1
Level 2
Level 3
Pooled separate accounts
$
72,721
$
-
$
72,721
$
-
Real estate
4,959
-
-
4,959
Subtotal U.S. pension plan assets in fair value hierarchy
$
77,680
$
-
$
72,721
$
4,959
Total U.S. pension
 
plan assets
$
77,680
Foreign Pension Assets
Cash and cash equivalents
$
1,989
$
1,989
$
-
$
-
Insurance contract
99,527
-
-
99,527
Diversified equity securities - registered investment companies
10,999
-
10,999
-
Fixed income – foreign registered investment companies
3,593
-
3,593
-
Fixed income government securities
35,339
-
35,339
-
Real estate
6,588
-
-
6,588
Other - alternative investments
6,979
-
-
6,979
Sub-total of foreign pension assets in fair value hierarchy
$
165,014
$
1,989
$
49,931
$
113,094
Commingled funds measured at NAV
2,300
Diversified investment fund -
 
registered investment
companies measured at NAV
49,572
Total foreign pension
 
assets
$
216,886
Total pension
 
assets in fair value hierarchy
$
242,694
$
1,989
$
122,652
$
118,053
Total pension
 
assets measured at NAV
51,872
Total pension
 
assets
$
294,566
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
85
Fair Value
 
Measurements at December 31, 2020
Total
Using Fair Value
 
Hierarchy
U.S. Pension Assets
Fair Value
Level 1
Level 2
Level 3
Pooled separate accounts
$
69,385
$
-
$
69,385
$
-
Real estate
4,096
-
-
4,096
Subtotal U.S. pension plan assets in fair value hierarchy
$
73,481
$
-
$
69,385
$
4,096
Total U.S. pension
 
plan assets
$
73,481
Foreign Pension Assets
Cash and cash equivalents
$
634
$
634
$
-
$
-
Insurance contract
112,920
-
-
112,920
Diversified equity securities - registered investment companies
8,851
-
8,851
-
Fixed income – foreign registered investment companies
3,711
-
3,711
-
Fixed income government securities
37,579
-
37,579
-
Real estate
5,679
-
-
5,679
Other - alternative investments
10,638
-
-
10,638
Sub-total of foreign pension assets in fair value hierarchy
$
180,012
$
634
$
50,141
$
129,237
Commingled funds measured at NAV
2,368
Diversified investment fund -
 
registered investment
companies measured at NAV
46,409
Total foreign pension
 
assets
$
228,789
Total pension
 
assets in fair value hierarchy
$
253,493
$
634
$
119,526
$
133,333
Total pension
 
assets measured at NAV
48,777
Total pension
 
assets
$
302,270
Certain investments that are measured at fair value using the NAV
 
per share (or its equivalent) have not been classified in the fair
value hierarchy.
 
The fair value amounts presented for these investments in the preceding
 
tables are intended to permit reconciliation
of the fair value hierarchies to the line items presented in the statements of net assets available
 
for benefits.
Changes in the fair value of the plans’ Level 3 investments during the years
 
ended December 31, 2021 and 2020 were as follows:
Insurance
Alternative
Contract
Real Estate
Investments
Total
Balance as of December 31, 2019
$
92,657
$
9,581
$
9,436
$
111,674
Purchases
3,902
18
989
4,909
Settlements
(2,027)
-
-
(2,027)
Unrealized gains (losses)
8,917
(16)
(171)
8,730
Currency translation adjustment
9,471
192
384
10,047
Balance as of December 31, 2020
112,920
9,775
10,638
133,333
Purchases
1,722
(78)
(334)
1,310
Settlements
(1,812)
-
-
(1,812)
Unrealized (losses) gains
(5,031)
1,926
(3,282)
(6,387)
Currency translation adjustment
(8,272)
(76)
(43)
(8,391)
Balance as of December
 
31, 2021
$
99,527
$
11,547
$
6,979
$
118,053
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
86
In the fourth quarter of 2018, the Company began the process of terminating
 
its Legacy Quaker noncontributory U.S. pension
plan (“Legacy Quaker U.S. Pension Plan”).
 
During the third quarter of 2019, the Company received a favorable termination
determination letter from the I.R.S. and completed the Legacy Quaker
 
U.S. Pension Plan termination during the first quarter of 2020.
 
In order to terminate the Legacy Quaker U.S. Pension Plan in accordance
 
with I.R.S. and Pension Benefit Guaranty Corporation
requirements, the Company was required to fully fund the Legacy Quaker
 
U.S. Pension Plan on a termination basis and the amount
necessary to do so was approximately $
1.8
 
million, subject to final true up adjustments.
 
In the third quarter of 2020, the Company
finalized the amount of the liability and related annuity payments and
 
received a refund in premium of approximately $
1.6
 
million.
 
In
addition, the Company recorded a non-cash pension settlement charge
 
at plan termination of approximately $
22.7
 
million.
 
This
settlement charge included the immediate recognition
 
into expense of the related unrecognized losses within AOCI on the balance
sheet as of the plan termination date.
In connection with the Combination, the Company indirectly acquired all of
 
Houghton’s defined benefit pension
 
plans, which are
included in the tables set forth above.
 
The pension plans cover certain U.S. salaried and hourly employees
 
as well as certain
employees in the U.K., France and Germany.
 
The Houghton U.S. plans provide benefits based on an employee’s
 
years of service and
compensation received for the highest five consecutive years of
 
earnings.
 
The foreign plans provide benefits based on a formula of
years and service and a percentage of compensation which varies among
 
the various countries.
 
The Company contributes to a multiemployer defined benefit pension
 
plan under terms of a collective bargaining union contract
(the Cleveland Bakers and Teamsters
 
Pension Fund, Employer Identification Number: 34-0904419-001).
 
The expiration date of the
collective bargaining contract is
May 1, 2022
.
 
As of January 1, 2020, the last valuation date available for the multiemployer plan,
total plan liabilities were approximately $
587
 
million.
 
As of December 31, 2020, the multiemployer pension plan had total plan assets
of approximately $
387
 
million.
 
The Company’s contribution
 
rate to the multiemployer pension plan is specified in the collective
bargaining union contract and contributions are made
 
to the plan based on its union employee payroll.
 
The Company contributed $
0.2
million during the year ended December 31, 2021.
 
The Employee Retirement Income Security Act of 1974, as amended by
 
the Multi-
Employer Pension Plan Amendments Act of 1980, imposes certain contingent
 
liabilities upon an employer who is a contributor to a
multiemployer pension plan if the employer withdraws from the plan
 
or the plan is terminated or experiences a mass withdrawal.
 
While the Company may also have additional liabilities imposed by
 
law as a result of its participation in the multiemployer defined
benefit pension plan, there is
no
 
liability as of December 31, 2021.
 
The Pension Protection Act of 2006 (the “PPA”)
 
also added special funding and operational rules generally applicable to plan
years beginning after 2007 for multiemployer plans with certain classifications based
 
on a multitude of factors (including, for
example, the plan’s funded
 
percentage, cash flow position and whether the plan is projected to experience
 
a minimum funding
deficiency).
 
The plan to which the Company contributes is in “critical” status.
 
Plans in the “critical” status classification must adopt
measures to improve their funded status through a funding improvement
 
or rehabilitation plan which may require additional
contributions from employers (which may take the form of a surcharge
 
on benefit contributions) and/or modifications to retiree
benefits.
 
The amount of additional funds that the Company may be obligated to contribute to the
 
plan in the future cannot be
estimated as such amounts will be likely based on future levels of work
 
that require the specific use of those union employees covered
by the plan, and the amount of that future work and the number of affected
 
employees that may be needed is not reasonably estimable.
 
Cash Flows
Contributions
The Company expects to make minimum cash contributions of approximately$
10.6
 
million to its pension plans (approximately
$
6.6
 
million U.S. and $
4.0
 
million Foreign) and approximately $
0.2
 
million to its other postretirement benefit plan in 2022.
Estimated Future Benefit Payments
Excluding any impact related to the PPA
 
noted above, the following benefit payments, which reflect expected
 
future service, as
appropriate, are expected to be paid:
Other Post-
Pension Benefits
Retirement
Foreign
U.S.
Total
Benefits
2022
$
6,678
$
6,627
$
13,305
$
220
2023
6,661
6,043
12,704
209
2024
6,475
6,205
12,680
187
2025
6,984
6,199
13,183
174
2026
7,702
6,213
13,915
157
2027 to 2031
42,577
30,169
72,746
625
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
87
The Company maintains a plan under which supplemental retirement benefits
 
are provided to certain officers.
 
Benefits payable
under the plan are based on a combination of years of service and existing
 
postretirement benefits.
 
Included in total pension costs are
charges of $
3.0
 
million, $
2.5
 
million and $
1.8
 
million for the years ended December 31, 2021, 2020 and 2019, respectively,
representing the annual accrued benefits under this plan.
Defined Contribution Plan
The Company has a 401(k) plan with an employer match covering
 
a majority of its U.S. employees.
 
The plan allows for and the
Company previously paid a nonelective contribution on behalf of participants
 
who have completed one year of service equal to 3% of
the eligible participants’ compensation in the form of Company common
 
stock.
 
During 2019 and 2018, the Company made both non-
elective and elective 401(k) matching contributions in cash, rather than stock.
 
Beginning in April 2020 and continuing through March
2021,
 
the Company matched both non-elective and elective 401(k) contributions
 
in fully vested shared of the Company’s common
stock rather than cash.
 
See Note 8 of Notes to Consolidated Financial Statements.
 
Total Company
 
contributions were $
4.8
 
million,
$
5.7
 
million and $
4.0
 
million for the years ended December 31, 2021, 2020 and 2019, respectively.
 
Note 22 – Other Non-Current Liabilities
Other non-current liabilities as of December 31, 2021 and 2020 were
 
as follows:
2021
2020
Uncertain tax positions (includes interest and penalties)
$
28,665
 
$
28,961
Non-current income taxes payable
8,500
8,500
Deferred and other long-term compensation
6,388
6,257
Environmental reserves
4,424
4,610
Inactive subsidiary litigation and settlement reserve
410
542
Fair value of interest rate swaps
 
-
 
 
4,672
Other
1,228
1,627
Total other non
 
-current liabilities
$
49,615
 
$
55,169
The Fair value of interest rate swaps as of December 31, 2021 has been reclassified to
 
other accrued liabilities in connection with
the expiration of the swap contract in November 2022.
 
See Notes 19 and 25 of Notes to Consolidated Financial Statements.
Note 23 – Equity and Accumulated Other Comprehensive Loss
The Company has
30,000,000
 
shares of common stock authorized with a par value of $
1
, and
17,897,033
 
and
17,850,616
 
shares
issued and outstanding as of December 31, 2021 and 2020, respectively.
 
The change in shares issued and outstanding during 2021
was primarily related to
29,415
 
shares issued for share-based compensation plans and
17,002
 
shares issued for the exercise of stock
options and other share activity.
 
The Company is authorized to issue
10,000,000
 
shares of preferred stock with $
1
 
par value, subject to approval by the Board.
 
The Board may designate one or more series of preferred stock and
 
the number of shares, rights, preferences, and limitations of each
series.
 
As of December 31, 2021,
no
 
preferred stock had been issued.
The Company has a share repurchase program that was approved by its Board
 
in 2015 for the repurchase of up to $
100.0
 
million
of Quaker Chemical Corporation common stock.
 
The Company has
no
t repurchased any shares under the program for the years ended
December 31, 2021, 2020 and 2019.
 
As of December 31, 2021, there was approximately $
86.9
 
million of common stock remaining to
be purchased under this share repurchase program.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
88
The following table shows the reclassifications from and resulting balances
 
of AOCI for the years ended December 31, 2021,
2020 and 2019:
Defined
Unrealized
Gain (Loss) in
Currency
Benefit
Translation
Pension
Available-for-
Derivative
Adjustments
Plans
Sale Securities
Instruments
Total
Balance as of December 31, 2018
$
(49,322)
$
(30,551)
$
(842)
$
-
$
(80,715)
Other comprehensive income (loss) before
 
reclassifications
4,754
(8,088)
2,951
(415)
(798)
Amounts reclassified from AOCI
-
3,169
(301)
-
2,868
Related tax amounts
-
937
(557)
95
475
Balance as of December 31, 2019
(44,568)
(34,533)
1,251
(320)
(78,170)
Other comprehensive income (loss) before
 
reclassifications
41,693
(6,617)
2,848
(4,257)
33,667
Amounts reclassified from AOCI
-
24,141
(202)
-
23,939
Related tax amounts
-
(6,458)
(555)
979
(6,034)
Balance as of December 31, 2020
(2,875)
(23,467)
3,342
(3,598)
(26,598)
Other comprehensive (loss) income before
 
reclassifications
(46,968)
11,948
(531)
2,890
(32,661)
Amounts reclassified from AOCI
-
1,459
(3,197)
-
(1,738)
Related tax amounts
-
(3,112)
783
(664)
(2,993)
Balance as of December 31, 2021
$
(49,843)
$
(13,172)
$
397
$
(1,372)
$
(63,990)
All reclassifications related to unrealized gain (loss) in available-for-sale securities relate
 
to the Company’s equity
 
interest in a
captive insurance company and are recorded in equity in net income
 
of associated companies.
 
The amounts reported in other
comprehensive income for non-controlling interest are related to
 
currency translation adjustments.
Note 24 – Fair Value
 
Measures
 
The Company has valued its company-owned life insurance policies at fair value.
 
These assets are subject to fair value
measurement as follows:
Fair Value
 
Measurements at December 31, 2021
Total
Using Fair Value
 
Hierarchy
Assets
Fair Value
Level 1
Level 2
Level 3
Company-owned life insurance
 
$
2,533
$
-
$
2,533
$
-
Total
$
2,533
$
-
$
2,533
$
-
Fair Value
 
Measurements at December 31, 2020
Total
Using Fair Value
 
Hierarchy
Assets
Fair Value
Level 1
Level 2
Level 3
Company-owned life insurance
 
$
1,961
$
-
$
1,961
$
-
Total
$
1,961
$
-
$
1,961
$
-
The fair values of Company-owned life insurance assets are based on quotes
 
for like instruments with similar credit ratings and
terms.
 
The Company did not hold any Level 3 investments as of December 31,
 
2021 or 2020, respectively,
 
so related disclosures have
not been included.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
89
Note 25 – Hedging Activities
In order to satisfy certain requirements of the Credit Facility as well as to manage the
 
Company’s exposure to variable
 
interest
rate risk associated with the Credit Facility,
 
in November 2019, the Company entered into $
170.0
 
million notional amounts of three
year interest rate swaps.
 
See Note 20 of Notes to Consolidated Financial Statements.
 
These interest rate swaps are designated as cash
flow hedges and, as such, the contracts are marked-to-market at each reporting
 
date and any unrealized gains or losses are included in
AOCI to the extent effective and reclassified to interest
 
expense in the period during which the transaction effects earnings or
 
it
becomes probable that the forecasted transaction will not occur.
The balance sheet classification and fair values of the Company’s
 
derivative instruments, which are Level 2 measurements, are as
follows:
Fair Value
Consolidated Balance Sheet
December 31,
Location
2021
2020
Derivatives designated as cash flow hedges:
Interest rate swaps
Other accrued liabilities
$
1,782
$
-
Other non-current liabilities
-
4,672
$
1,782
$
4,672
The following table presents the net unrealized loss deferred to AOCI:
December 31,
2021
2020
Derivatives designated as cash flow hedges:
Interest rate swaps
AOCI
$
1,372
$
3,598
$
1,372
$
3,598
The following table presents the net loss reclassified from AOCI to earnings:
For the Years
 
Ended
December 31,
2021
2020
2019
Amount and location of (expense) income reclassified
 
from AOCI into (expense) income (Effective Portion)
Interest expense, net
$
(2,649)
$
(1,754)
$
29
Interest rate swaps are entered into with a limited number of counterparties,
 
each of which allows for net settlement of all
contracts through a single payment in a single currency in the event of a default on
 
or termination of any one contract.
 
As such, in
accordance with the Company’s accounting
 
policy, these derivative instruments
 
are recorded on a net basis within the Consolidated
Balance Sheets.
Note 26 – Commitments and Contingencies
In 1992, the Company identified certain soil and groundwater contamination
 
at AC Products, Inc. (“ACP”), a wholly owned
subsidiary.
 
In voluntary coordination with the Santa Ana California Regional Water
 
Quality Board, ACP has been remediating the
contamination, the principal contaminant of which is perchloroethylene
 
(“PERC”).
 
In 2004, the Orange County Water
 
District
(“OCWD”) filed a civil complaint against ACP and other parties seeking
 
to recover compensatory and other damages related to the
investigation and remediation of the contamination in the groundwater.
 
Pursuant to a settlement agreement with OCWD, ACP agreed,
among other things, to operate the two groundwater treatment systems to hydraulically
 
contain groundwater contamination emanating
from ACP’s site until the concentrations
 
of PERC released by ACP fell below the current Federal maximum contaminant level for
four consecutive quarterly sampling events.
 
In 2014, ACP ceased operation at one of its two groundwater treatment systems,
 
as it had
met the above condition for closure.
 
In 2020, the Santa Ana Regional Water
 
Quality Control Board asked that ACP conduct some
additional indoor and outdoor soil vapor testing on and near the ACP site to confirm
 
that ACP continues to meet the applicable local
standards and ACP performed such testing program
 
work in 2021 and will continue into 2022.
 
As of December 31, 2021, ACP
believes it is close to meeting the conditions for closure of the remaining groundwater
 
treatment system but continues to operate this
system while in discussions with the relevant authorities.
 
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
90
As of December 31, 2021, the Company believes that the range of potential
 
-known liabilities associated with the balance of ACP
water remediation program is approximately $
0.1
 
million to $
1.0
 
million.
 
The low and high ends of the range are based on the length
of operation of the treatment system as determined by groundwater modeling.
 
Costs of operation include the operation and
maintenance of the extraction well, groundwater monitoring and
 
program management.
 
An inactive subsidiary of the Company that was acquired in 1978
 
sold certain products containing asbestos, primarily on an
installed basis, and is among the defendants in numerous lawsuits alleging injury
 
due to exposure to asbestos.
 
The subsidiary
discontinued operations in 1991 and has no remaining assets other than
 
proceeds received from insurance settlements.
 
To date, the
overwhelming majority of these claims have been disposed of without
 
payment and there have been no adverse judgments against the
subsidiary.
 
Based on a continued analysis of the existing and anticipated future claims against this subsidiary,
 
it is currently projected
that the subsidiary’s total liability over
 
the next 50 years for these claims is approximately $
0.4
 
million (excluding costs of defense).
 
Although the Company has also been named as a defendant in certain of these
 
cases, no claims have been actively pursued against the
Company, and the
 
Company has not contributed to the defense or settlement of any of these cases pursued against
 
the subsidiary.
 
These cases were originally handled by the subsidiary’s
 
primary and excess insurers who had agreed in 1997 to pay all defense
costs and be responsible for all damages assessed against the subsidiary arising
 
out of existing and future asbestos claims up to the
aggregate limits of their policies.
 
A significant portion of this primary insurance coverage was provided
 
by an insurer that is
insolvent, and the other primary insurers asserted that the aggregate limits
 
of their policies had been exhausted.
 
The subsidiary
challenged the applicability of these limits to the claims being brought
 
against the subsidiary.
 
In response, two of the three carriers
entered into separate settlement and release agreements with the subsidiary
 
in 2005 and 2007 for $
15.0
 
million and $
20.0
 
million,
respectively.
 
In 2007, the subsidiary and the remaining primary insurance carrier
 
entered into a Claim Handling and Funding Agreement, under
which the carrier is paying
27
% of defense and indemnity costs incurred by or on behalf of the subsidiary
 
in connection with asbestos
bodily injury claims.
 
The agreement continues until terminated and can only be terminated by either party
 
by providing a minimum of
two years prior written notice.
 
As of December 31, 2021, no notice of termination has been given under
 
this agreement.
 
At the end of the term of the agreement, the subsidiary
 
may choose to again pursue its claim against this insurer regarding the
application of the policy limits.
 
The Company believes that, if the coverage issues under the primary policies with
 
the remaining
carrier are resolved adversely to the subsidiary and
 
all settlement proceeds were used, the subsidiary may have limited additional
coverage from a state guarantee fund established following the insolvency
 
of one of the subsidiary’s primary
 
insurers.
 
Nevertheless,
liabilities in respect of claims may exceed
 
the assets and coverage available to the subsidiary.
If the subsidiary’s assets and insurance
 
coverage were to be exhausted, claimants of the subsidiary may actively pursue claims
against the Company because of the parent-subsidiary relationship.
 
The Company does not believe that such claims would have merit
or that the Company would be held to have liability for any unsatisfied obligations
 
of the subsidiary as a result of such claims.
 
After
evaluating the nature of the claims filed against the subsidiary
 
and the small number of such claims that have resulted in any payment,
the potential availability of additional insurance coverage at the subsidiary
 
level, the additional availability of the Company’s
 
own
insurance and the Company’s strong
 
defenses to claims that it should be held responsible for the subsidiary’s
 
obligations because of
the parent-subsidiary relationship, the Company believes it is not probable
 
that the Company will incur losses.
 
The Company has
been successful to date having claims naming it dismissed during
 
initial proceedings.
 
Since the Company may be in this stage of
litigation for some time, it is not possible to estimate additional losses or range of
 
loss, if any.
 
The Company is party to environmental matters related to certain domestic
 
and foreign properties.
 
These environmental matters
primarily require the Company to perform long-term monitoring
 
as well as operating and maintenance at each of the applicable sites.
 
During the year ended December 31, 2021, there have been no significant
 
changes to the facts or circumstances of these matters, aside
from ongoing monitoring and maintenance activities and routine payments
 
associated with each of these sites.
 
The Company
continually evaluates its obligations related to such matters, and
 
based on historical costs incurred and projected costs to be incurred
over the next 27 years, has estimated the present value range of costs for
 
all of these environmental matters, on a discounted basis, to
be between approximately $
5.0
 
million and $
6.0
 
million as of December 31, 2021, for which $
5.6
 
million is accrued within other
accrued liabilities and other non-current liabilities on the Company’s
 
Consolidated Balance Sheet as of December 31, 2021.
 
Comparatively,
 
as of December 31, 2020, the Company had $
6.0
 
million accrued for with respect to these matters.
The Company’s Sao Paulo,
 
Brazil site was required under Brazilian environmental, health and safety regulations
 
to perform an
environmental assessment as part of a permit renewal process.
 
Initial investigations identified soil and ground water contamination
 
in
select areas of the site.
 
The site has conducted a multi-year soil and groundwater investigation and corresponding
 
risk assessments
based on the result of the investigations.
 
In 2017, the site had to submit a new 5-year permit renewal request and was asked to
complete additional investigations to further delineate the site based on review
 
of the technical data by the local regulatory agency,
Companhia Ambiental do Estado de São Paulo (“CETESB”).
 
Based on review of the updated investigation data, CETESB issued a
Technical Opinion
 
regarding the investigation and remedial actions taken to date.
 
The site developed an action plan and submitted it
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
91
to CETESB in 2018 based on CETESB requirements.
 
The site intervention plan primarily requires the site, amongst other actions,
 
to
conduct periodic monitoring for methane in soil vapors, source zone
 
delineation, groundwater plume delineation, bedrock aquifer
assessment, update the human health risk assessment, develop a current
 
site conceptual model and conduct a remedial feasibility study
and provide a revised intervention plan.
 
In 2019, the site submitted a report on the activities completed including the revised site
conceptual model and results of the remedial feasibility study and recommended
 
remedial strategy for the site.
 
Other environmental matters include participation in certain payments
 
in connection with four currently active environmental
consent orders related to certain hazardous waste cleanup activities under
 
the U.S. Federal Superfund statute.
 
The Company has been
designated a potentially responsible party (“PRP”) by the Environmental
 
Protection Agency along with other PRPs depending on the
site, and has other obligations to perform cleanup activities at certain
 
other foreign subsidiaries.
 
These environmental matters
primarily require the Company to perform long-term monitoring
 
as well as operating and maintenance at each of the applicable sites.
 
The Company believes, although there can be no assurance regarding the
 
outcome of other unrelated environmental matters, that
it has made adequate accruals for costs associated with other environmental
 
problems of which it is aware.
 
Approximately $
0.4
million and $
0.1
 
million were accrued as of December 31, 2021 and 2020, respectively,
 
to provide for such anticipated future
environmental assessments and remediation costs.
During the fourth quarter of 2020, one of the Company’s
 
subsidiaries received a notice of inspection from a taxing authority in a
country where certain of its subsidiaries operate which related to a non-income
 
(indirect) tax that may be applicable to certain products
the subsidiary sells.
 
During the third quarter of 2021, the Company’s
 
subsidiary received notice from the
 
taxing authority that the
inspection was closed, with no tax assessment issued.
 
Based on this development, during the third quarter of 2021, the Company
reversed its previously recorded $
1.8
 
million liability related to this matter.
 
The Company also reversed the associated $
1.1
 
million
indemnification receivable, as the asserted tax liability in part related
 
to a Houghton entity acquired in the Combination and for the
periods prior to the Combination, for which the Company would have rights to indemnification
 
from Houghton’s former owners.
 
Based on all available information as of the date of this report, the Company
 
does not anticipate further tax liabilities related to this
matter to be asserted by the taxing authority.
 
During 2021, one of the Company’s
 
Brazilian subsidiaries received a notice that it had prevailed on an existing
 
legal claim in
regard to certain non-income (indirect) taxes that had been previously
 
charged and paid.
 
The matter specifically relates to companies’
rights to exclude the state tax on goods circulation
 
(a valued-added-tax or
VAT
equivalent, known in Brazil as “ICMS”) from the
calculation of certain additional indirect taxes (specifically the program of
 
social integration (“PIS”) and contribution for the financing
of social security (“COFINS”)) levied by the Brazilian States on the sale of goods.
 
In May 2021, the Brazilian Supreme Court
concluded that ICMS should not be included in the tax base of PIS and
 
COFINS, and confirmed the methodology for calculating the
PIS and COFINS tax credit claims to which taxpayers are entitled.
 
The Company’s Brazilian entities had
 
previously filed legal or
administrative disputes on this matter and are entitled to receive tax credits and
 
interest dating back to five years preceding the date of
their legal claims.
 
As a result of these court rulings, during the second quarter of 2021,
 
the Company recognized non-income tax
credits of
67.0
 
million BRL or approximately $
13.3
 
million, which included approximately $
8.4
 
million for the PIS and COFINS tax
credits as well as interest on these tax credits of $
4.9
 
million, and is recorded within prepaid and other current assets on the
Company’s Consolidated
 
Balance Sheet.
 
The tax credits to which the Company’s
 
Brazilian subsidiaries are entitled are claimable
once registered with the Brazilian tax authorities.
 
The Company submitted its formal claim for tax credits in October 2021.
 
These tax
credits can be used to offset future Brazilian federal taxes and
 
the Company currently anticipates using the full amount of credits
during the five year period of time permitted.
 
During the third quarter of 2021, the Brazilian Supreme Court ruled that interest income
to which companies are entitled for matters such as this claim should not be
 
taxable, which resulted in a reduction to the estimated
income tax expense associated with the tax credits recorded.
 
In connection with obtaining regulatory approvals for the Combination,
 
certain steel and aluminum related product lines of
Houghton were divested in August 2019.
 
In July 2021, the entity that acquired these divested product lines submitted an
indemnification claim for certain alleged breaches of representation made
 
by Houghton in the agreement pursuant to which such assets
had been divested.
 
The Company and the acquirer have agreed to extend the period for
 
a possible negotiated resolution of this claim
through March 31, 2022 so that both parties can evaluate the other’s
 
positions with respect to the subject matters of the claim.
 
The
Company is evaluating the merits of the alleged losses in the indemnification
 
claim received.
 
As of the date of this Report, the
Company does not believe it is reasonably possible to determine or quantify
 
any possible exposure.
During the third quarter of 2021, two of the Company’s
 
locations suffered property damages as a result of flooding and fire,
respectively.
 
The Company maintains property insurance for all of its facilities globally.
 
In Conshohocken, Pennsylvania, the
Company’s global headquarters
 
as well as its laboratory experienced property damages as a result of flooding from
 
Hurricane Ida.
 
Also, one of the Company’s North
 
American production facilities in its Global Specialty Businesses segment experienced an
 
electrical
fire that resulted in damage and the temporary shutdown of production,
 
and also required remediation, cleaning and subsequent
restoration.
 
The Company, its insurance
 
adjuster and insurance carrier are actively managing the remediation and restoration activities
associated with these events and at this time the Company has concluded, based
 
on all available information and discussions with its
QUAKER CHEMICAL CORPORATION
NOTES TO CONSOLIDATED
 
FINANCIAL STATEMENTS
 
- Continued
(
Dollars in thousands, except per share amounts, unless otherwise stated
)
92
insurance adjuster and insurance carrier,
 
that the losses incurred during the third quarter of 2021 will be covered under
 
the Company’s
property insurance coverage, net of an aggregate deductible of $
2.0
 
million.
 
The Company has received payments from its insurers of
$
2.1
 
million and has recorded an insurance receivable associated with these events
 
(and a gain on insurance recoveries for losses
incurred) of $
0.7
 
million as of December 31, 2021.
 
The Company and its insurance carrier are in early stages of reviewing the impact
of the electrical fire on the production facility’s
 
operations as it relates to a potential business interruption insurance claim; however,
as of the date of this Report, the Company cannot reasonably estimate any probable
 
amount of business interruption insurance claim
recoverable, therefore the Company has not recorded a gain contingency
 
for a possible business interruption insurance claim as of
December 31, 2021.
The Company is party to other litigation which management currently
 
believes will not have a material adverse effect on the
Company’s results of operations,
 
cash flows or financial condition. In addition, the Company has an
 
immaterial amount of contractual
purchase obligations.
 
93
Item 9.
 
Changes in and Disagreements With Accountants on
 
Accounting and Financial Disclosure.
Not Applicable.
 
Item 9A.
 
Controls and Procedures.
Conclusion Regarding the Effectiveness of Disclosure Controls
 
and Procedures
As required by Rule 13a-15(b) under the Securities Exchange Act of 1934,
 
as amended (the “Exchange Act”), our management,
including our principal executive officer and principal
 
financial officer, has evaluated the effectiveness
 
of our disclosure controls and
procedures (as defined in Rule 13a-15(e) under the Exchange Act) as of the end of the period
 
covered by this report.
 
Based on that
evaluation, our principal executive officer and our principal
 
financial officer have concluded that, as of December
 
31, 2021, the end of
the period covered by this Report, our disclosure controls and procedures
 
(as defined in Rule 13a-15(e) under the Exchange Act) were
effective.
Management’s Report on Internal Control
 
over Financial Reporting
Management is responsible for establishing and maintaining adequate
 
internal control over financial reporting as such term is
defined in Rule 13a-15(f) under the Exchange Act.
 
Internal control over financial reporting is a process designed to provide
reasonable assurance regarding the reliability of financial reporting
 
and the preparation of financial statements for external purposes in
accordance with generally accepted accounting principles.
Because of its inherent limitations, internal control over financial reporting
 
may not prevent or detect misstatements.
 
Also,
projections of any evaluation of effectiveness to future
 
periods are subject to the risk that controls may become inadequate because
 
of
changes in conditions or that the degree of compliance with the policies or
 
procedures may deteriorate.
Our management, with the participation of our principal executive officer
 
and principal financial officer,
 
assessed the
effectiveness of the Company’s
 
internal control over financial reporting as of December 31, 2021.
 
In making this assessment, our
management used the criteria set forth by the Committee of Sponsoring
 
Organizations of the Treadway Commission in
Internal
Control—Integrated Framework
 
(2013) (the “COSO framework”).
 
Based on its assessment, management has concluded that as of
December 31, 2021, the Company’s
 
internal control over financial reporting is effective based on those
 
criteria.
Management has excluded the internal controls of Grindaix GmbH and
 
Baron Industries from our assessment of internal control
over financial reporting as of December 31, 2021, because these entities were acquired
 
by the Company in purchase business
combinations in September and November 2021, respectively.
 
Grindaix GmbH and Baron Industries are wholly owned subsidiaries
whose total assets and total revenues excluded from our assessment of internal
 
control over financial reporting each represent less than
1% of the related consolidated financial statement amounts as of and for
 
the year ended December 31, 2021.
The effectiveness of the Company’s
 
internal control over financial reporting as of December 31, 2021 has been
 
audited by
PricewaterhouseCoopers LLP,
 
an independent registered public accounting firm, as stated in its report which is included
 
in “Item 8.
Financial Statements and Supplementary Data.”
Remediation of the Previously Identified Material Weaknesses
As disclosed in “Item 9A. Controls and Procedures.” in the Company’s
 
2020 Form 10-K, we previously identified certain
deficiencies in our application of the principles associated with the COSO framework
 
that management concluded constituted material
weaknesses.
 
We did not
 
design and maintain effective controls in response to the risks of material
 
misstatement.
 
Specifically,
changes to existing controls or the implementation of new controls were not
 
sufficient to respond to changes to the risks of material
misstatement in financial reporting as a result of becoming a larger,
 
more complex global organization due to the Combination.
 
This
material weakness also contributed to an additional material weakness as we did
 
not design and maintain effective controls over
 
the
review of pricing, quantity and customer data to verify that revenue
 
recognized was complete and accurate.
 
The Company and its Board of Directors are committed to maintaining a strong
 
internal control environment.
 
Since identifying
the material weaknesses, the Company has dedicated a significant amount
 
of time and resources to remediate all of the previously
identified material weaknesses as quickly and effectively
 
as possible.
 
During 2020 and 2021, the Company dedicated multiple
internal resources and supplemented those internal resources with various
 
third-party specialists to assist with the formalization of a
robust and detailed remediation plan.
 
In undertaking remediation activities, the Company has hired
 
additional personnel dedicated to
financial and information technology compliance to further supplement
 
its internal resources. In addition, the Company has
established a global network of personnel to assist local management
 
in understanding control performance and documentation
requirements.
 
In order to sustain this network, the Company conducts periodic trainings
 
and hosts discussions to address questions on
a current basis.
 
Risk Assessment –
Specific to the material weakness in our risk assessment process that was previously
 
disclosed in
“Item 9A.
Controls and Procedures.”
in the Company’s 2020 Form
 
10-K, we previously determined that our risk assessment process was not
designed adequately to respond to changes to the risks of material misstatement to
 
financial reporting.
 
In order to remediate this
material weakness, we have designed and implemented an improved
 
risk assessment process, including identifying and assessing
those risks attendant to the significant changes within the Company as a result of
 
becoming a larger, more
 
complex global
94
organization due to the Combination.
 
During 2020 and in 2021, a full review was performed of our processes and
 
controls across
significant and other locations in order to identify and address potential design
 
gaps.
 
In addition to individual transactional-level
control enhancements, this review resulted in (i) an enhanced financial statement
 
risk assessment, (ii) the standardization of existing
legal entity and newly implemented segment quarterly analytics and quarterly
 
closing packages completed by key financial reporting
personnel, (iii) a global account reconciliation review program and
 
(iv) enhancements to our quarterly identification and reassessment
of new and existing business and information technology risks that could
 
affect our financial reporting.
 
Monitoring is also performed
through our enhanced quarterly controls certification process, whereby
 
changes in business or information technology processes
 
or
control owners are identified and addressed timely.
 
As previously disclosed in the 2020 Form 10-K, this material weakness
remediation was also dependent on the remediation of the Revenue –
 
Price and Quantity material weakness. During the fourth quarter
of 2021, we completed testing of the operating effectiveness of
 
the controls (including Revenue-
 
Price and Quantity) and have
concluded that the material weakness has been remediated as of
 
December 31, 2021.
Revenue – Price and Quantity –
Specific to the material weakness in our revenue process that was previously
 
disclosed in
“Item 9A.
Controls and Procedures.”
in the Company’s 2020 Form 10-K,
 
we did not design and maintain effective controls over the review of
pricing, quantity and customer data to verify that revenue recognized was complete
 
and accurate.
 
In order to remediate this material
weakness, the Company redesigned certain aspects of its revenue process and
 
related controls.
 
The design included enhancements to
entity-level and transactional-level manual controls as well as IT general
 
and application controls, which were substantially
implemented during the third quarter of 2021.
 
During the fourth quarter of 2021, we completed testing of the operating effectiveness
of the controls and have concluded that the material weakness has been remediated
 
as of December 31, 2021.
 
Changes in Internal Control Over Financial Reporting
As required by Rule 13a-15(d) under the Exchange Act, our management,
 
including our principal executive officer and principal
financial officer, has evaluated
 
our internal control over financial reporting to determine whether
 
any changes to our internal control
over financial reporting occurred during the fourth quarter of the year ended
 
December 31, 2021, that have materially affected, or are
reasonably likely to materially affect, our internal control over
 
financial reporting.
 
Based on that evaluation, there were no changes
that have materially affected, or are reasonably likely to
 
materially affect, our internal control over financial reporting
 
during the
fourth quarter of the year ended December 31, 2021.
Item 9B.
 
Other Information.
Not applicable.
Item 9C.
 
Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.
 
Not applicable.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
95
PART
 
III
Item 10.
 
Directors, Executive Officers and Corporate Governance.
Incorporated by reference is (i) the information beginning
 
with and including the caption “Proposal 1—Election of Directors and
Nominee Biographies” in Quaker Houghton’s
 
definitive Proxy Statement relating to the 2022 Annual Meeting of
 
Shareholders, to be
filed with the Securities and Exchange Commission no later than
 
120 days after the close of its fiscal year ended December 31, 2021
(the “2022 Proxy Statement”) to, but not including, the sub-caption
 
“Governance Committee Procedures for Selecting Director
Nominees,” (ii) the information appearing in Item 4(a) of this Report, (iii)
 
the information in the 2022 Proxy Statement beginning with
and including the sub-caption “Code of Conduct” to, but not including,
 
the caption “Compensation Committee Interlocks and Insider
Participation,” and (iv) the information in the 2022 Proxy Statement beginning
 
with and including the sub-caption “Shareholder
Nominations and Recommendations” to, but not including,
 
the sub-caption “Board Oversight of Risk.”
 
Information about our
Executive Officers is included in Item 4(a) of this Report.
Item 11.
 
Executive Compensation.
Incorporated by reference is (i) the information in the 2022 Proxy
 
Statement beginning with and including the caption
“Compensation Committee Interlocks and Insider Participation” to, but
 
not including the caption “Stock Ownership of Certain
Beneficial Owners and Management.”
Item 12.
 
Security Ownership of Certain Beneficial Owners and Management and
 
Related Stockholder Matters.
Incorporated by reference is the information in the 2022 Proxy Statement
 
beginning with and including the caption “Stock
Ownership of Certain Beneficial Owners and Management” to, but not including,
 
the caption “Certain Relationships and Related
Transactions.”
Equity Compensation Plans
The following table sets forth certain information relating to the Company’s
 
equity compensation plans as of December 31, 2021.
 
Each number of securities reflected in the table is a reference to shares of Quaker
 
common stock.
Equity Compensation Plan Information
Number of securities
 
Number of securities
remaining available for
 
to be issued upon
 
Weighted-average
 
future issuance under
 
exercise of
exercise price of
equity compensation plans
outstanding options,
outstanding options,
 
(excluding securities
Plan Category
warrants and rights
warrants and rights
reflected in column (a))
(a)
(b)
(c)
Equity compensation plans approved
 
by security holders
109,684
 
$
165.47
 
606,155
 
(1)
Equity compensation plans not approved
 
by security holders
-
-
-
Total
109,684
 
$
165.47
 
606,155
 
(1)
(1)
As of December 31, 2021, 304,900 of these shares were available for issuance
 
as restricted stock awards under the Company’s
2001 Global Annual Incentive Plan, 240,004 shares were available for
 
issuance upon the exercise of stock options and/or as
restricted stock awards and/or restricted stock unit awards under the Company’s
 
2016 Long-Term Performance
 
Incentive Plan, and
61,251 shares were available for issuance under the 2013 Director Stock
 
Ownership Plan.
Item 13.
 
Certain Relationships and Related Transactions, and
 
Director Independence.
Incorporated by reference is (i) the information in the 2022 Proxy
 
Statement beginning with and including the caption “Certain
Relationships and Related Party Transactions”
 
to, but not including, the caption “Proposal 2 — Ratification of Appointment of
Independent Registered Public Accounting Firm,” (ii) the
 
information in the 2022 Proxy Statement beginning with and including the
sub-caption “Director Independence” to, but not including, the
 
sub-caption “Governance Committee Procedures for Selecting Director
Nominees,” and (iii) the information in the 2022 Proxy Statement beginning
 
with and including the caption “Meetings and
Committees of the Board” to, but not including, the caption “Compensation
 
Committee Interlocks and Insider Participation.”
Item 14.
 
Principal Accountant Fees and Services.
Incorporated by reference is the information in the 2022 Proxy Statement
 
beginning with and including the sub-caption “Audit
Fees” to, but not including, the statement recommending a vote for ratification
 
of the appointment of PricewaterhouseCoopers LLP as
the Company’s independent
 
registered public accounting firm for the year ending December 31, 2022.
 
96
PART
 
IV
Item 15.
 
Exhibits and Financial Statement Schedules.
(a)
Exhibits and Financial Statement Schedules
1.
Financial Statements and Supplementary Data
 
 
Page
Financial Statements:
 
 
 
43
 
45
46
 
47
 
48
 
49
 
50
2.
Financial Statement Schedules
All schedules are omitted because they are not applicable or the required
 
information is shown in the financial statements or notes
thereto.
 
Financial statements of 50% or less owned companies have been omitted because none
 
of the companies meets the criteria
requiring inclusion of such statements.
3.
 
Exhibits - filed pursuant to, and numbered in accordance
 
with Item 601 of Regulation S-K (all of which are under
Commission File number 001-12019, except as otherwise noted):
2.1 —
3.1 —
3.2 —
4.1 —
4.2 —
10.1
 
10.2
 
 
10.3
 
10.4
 
10.5
 
97
10.6
 
10.7
 
10.8
 
 
10.9 —
 
10.10 —
. †
10.11 —
. †
10.12 —
. †
10.13 —
C
.
10.14 —
10.15 —
.†
10.16 —
.†
10.17 —
.†
10.18 —
.†
10.19 —
10.20 —
10.21 —
10.22 —
10.23
 
98
10.24
 
10.25
 
10.26
 
10.27 —
10.28
 
 
10.29 —
 
10.30 —
10.31 —
10.32 —
10.33
 
10.34
 
. †
10.35
 
 
. †
10.36
 
 
10.37
 
. †
10.38
 
 
10.39 —
10.40 —
10.41 —
10.42 —
10.43 —
99
10.44 —
 
***
10.45 —
10.46 —
10.47 —
10.48 —
10.49 —
10.50 —
10.51 —
10.52 —
21 —
23 —
31.1 —
31.2 —
32.1 —
32.2 —
101.INS —
Inline XBRL Instance Document*
101.SCH —
Inline XBRL Taxonomy
 
Extension Schema Document*
101.CAL —
Inline XBRL Taxonomy
 
Calculation Linkbase
 
Document*
101.DEF —
Inline XBRL Taxonomy
 
Definition Linkbase Document*
101.LAB —
Inline XBRL Taxonomy
 
Label Linkbase Document*
101.PRE —
Inline XBRL Taxonomy
 
Presentation Linkbase Document*
104 —
Cover Page Interactive Data File (formatted as Inline XBRL and contained
 
in Exhibit 101.INS) *
* Filed herewith.
** Furnished herewith.
*** Certain exhibits and schedules have been omitted, and the Company
 
agrees to furnish supplementally to the Securities and
Exchange commission a copy of any omitted exhibits and schedules upon
 
request.
† Management contract or compensatory plan
Item 16.
Form 10-K Summary.
The Company has elected not to include a Form 10-K summary under this Item 16.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
100
SIGNATURES
Pursuant to the requirements of Section 13 or
 
15(d) of the Securities Exchange Act of 1934, the Registrant has duly
caused this Report to be signed on its behalf by the undersigned, thereunto
 
duly authorized.
 
 
 
QUAKER CHEMICAL CORPORATION
Registrant
 
 
By:
/s/
 
ANDREW E. TOMETICH
 
 
 
Andrew E. Tometich
Director,
 
Chief Executive Officer and President
 
 
Date: March 1, 2022
Pursuant to the requirements of the Securities Exchange
 
Act of 1934, this Report has been signed below by the following
persons on behalf of the Registrant and in the capacities and on the dates indicated.
Signatures
Capacity
Date
/s/
 
ANDREW E. TOMETICH
Principal Executive Officer and
March 1, 2022
Andrew E. Tometich
Director
Chief Executive Officer and President
/s/
 
SHANE W. HOSTETTER
Principal Financial Officer
March 1, 2022
Shane W. Hostetter
Senior Vice President, Chief Financial
Officer and Chief Accounting Officer
 
/s/
 
DAVID A. WILL
Principal Accounting Officer
March 1, 2022
David A. Will
Vice President, Global Controller
 
/s/
 
MICHAEL F. BARRY
Director
March 1, 2022
Michael F. Barry
Chairman of the Board
/s/
 
DONALD R. CALDWELL
Director
March 1, 2022
Donald R. Caldwell
/s/
 
CHARLOTTE C. DECKER
Director
March 1, 2022
Charlotte C. Decker
/s/
 
MARK A. DOUGLAS
Director
March 1, 2022
Mark A. Douglas
/s/
 
JEFFRY D. FRISBY
Director
March 1, 2022
Jeffry D. Frisby
/s/
 
WILLIAM H. OSBORNE
Director
March 1, 2022
William H. Osborne
/s/
 
ROBERT H. ROCK
Director
March 1, 2022
Robert H. Rock
/s/
 
FAY
 
WEST
Director
March 1, 2022
Fay West
/s/
 
SANJAY HINDUJA
Director
March 1, 2022
Sanjay Hinduja
/s/
 
RAMASWAMI SESHASAYEE
Director
March 1, 2022
Ramaswami Seshasayee
/s/
 
MICHAEL SHANNON
Director
March 1, 2022
Michael Shannon
exhibit21
 
 
 
1
EXHIBIT 21
SUBSIDIARIES AND AFFILIATES
 
OF THE REGISTRANT
Jurisdiction of
 
Percentage of Voting
 
Securities Owned
Name
Incorporation
Directly or Indirectly by Quaker
*
Quaker Chemical, S.A.
Argentina
100%
*
Houghton Argentina S.A.
Argentina
100%
+*
Quaker Australia Holdings Pty.
 
Limited
Australia
100%
*
Quaker Chemical (Australasia) Pty.
 
Ltd.
Australia
100%
+*
Quaker Houghton Australia Pty.
 
Ltd. (formerly Houghton
Australia Party Ltd)
Australia
100%
*
Surface Technology
 
Australia
Australia
100%
**
Primex, Ltd.
Barbados
32%
+*
Quaker Chemical Participacoes, Ltda.
Brazil
100%
*
Quaker Chemical Industria e Comercio Ltda.
Brazil
100%
*
Quaker Chemical Operacoes, Ltda.
Brazil
100%
*
Ultraseal Asia Limited
British Virgin Islands
100%
*
Quaker Chemical Canada Limited
Canada
100%
+*
Quaker Chemical Canada Holdings, Inc.
Canada
100%
*
Quaker Houghton Canada Inc. (formerly Lubricor,
 
Inc.)
Canada
100%
*
Houghton Canada Inc.
Canada
100%
+*
Global Houghton Ltd.
Cayman Islands
100%
*
Quaker Chemical (China) Co. Ltd.
China
100%
*
Quaker Shanghai Trading Company Limited
China
100%
+*
Quaker Houghton Chemical Investment Management
(Shanghai) Co., Ltd. (Formerly Quaker Chemical
Investment Management (Shanghai) Co Ltd)
China
100%
*
Quaker Houghton Material Science & Technology
(Suzhou) Co Ltd
China
100%
*
Wuhan Quaker Technology
 
Co., Ltd
China
60%
*
Houghton (Shanghai) Specialty Industrial Fluids Co., Ltd
China
100%
*
Ultraseal Chongqing Limited
China
100%
*
Ultraseal Machinery Dongguan Ltd
China
100%
*
Ultraseal Shanghai Limited
China
100%
*
Houghton CZ s.r.o
Czech Republic
100%
+*
Quaker Denmark ApS
Denmark
100%
*
Houghton Denmark AS
Denmark
100%
*
Tel Nordic ApS
Denmark
100%
*
SIFCO Concepts Sarl
France
100%
*
Quaker Houghton Support France EURL (Formerly
Quaker Chemical Services EURL)
France
100%
*
ECL Engineered Custom Lubricants GmbH
Germany
100%
*
Houghton Deutschland GmbH
Germany
100%
*
Grindaix GmbH
Germany
100%
*
Quaker Houghton Support Deutschland
Germany
100%
*
Ultraseal Germany GmbH
Germany
100%
 
 
 
2
EXHIBIT 21
SUBSIDIARIES AND AFFILIATES
 
OF THE REGISTRANT,
continued
Jurisdiction of
 
Percentage of Voting
 
Securities Owned
Name
Incorporation
Directly or Indirectly by Quaker
*
Internationale Metall Impragnier GmbH
Germany
100%
*
Maldaner GmbH
Germany
100%
*
Sterr & Eder Industrieservice GmbH
Germany
100%
*
Quaker Chemical Limited
Hong Kong
100%
*
Houghton Magyarország Kft
 
Hungary
100%
*
Quaker Chemical India Private Limited
India
100%
*
Houghton Hardcastle India Ltd
India
9%
*
DA Stuart India Private Limited
India
100%
*
Ultraseal India Private Ltd
India
30%
*
Quaker Italia S.r.l.
Italy
100%
*
Quaker Houghton Support Italia S.r.l.
 
(formerly:
 
Quaker
Chemical S.r.l.)
Italy
100%
*
Houghton Italia S.p.A.
Italy
100%
*
Houghton Japan Co., Ltd.
Japan
100%
**
Nippon Quaker Chemical, Ltd.
Japan
50%
*
Ultraseal Japan
Japan
100%
*
Houghton Oil (Malaysia) Sdn, Bhd.
Malaysia
100%
+*
Quaker Houghton (Finco) Ltd.
Malta
100%
+*
Quaker Houghton Ltd.
Malta
100%
+*
Quaker Houghton Holdings Ltd.
Malta
100%
+*
Quaker Houghton Investments Limited
Malta
100%
*
Tecniquimia
 
Mexicana S.A. de C.V.
Mexico
100%
*
Unitek Servicios De Asesoria Especializad S.A de C.V.
Mexico
100%
*
Lubricor Mexicana S.A. de C.V.
Mexico
100%
+*
Quaker Chemical Europe B.V.
Netherlands
100%
*
Quaker Houghton B.V.
 
(formerly Quaker Chemical BV)
Netherlands
100%
+*
Quaker Houghton Russia B.V.
 
(formerly Quaker
Chemical Russia B.V.;
 
KWR Holdings B.V.)
Netherlands
100%
+*
Quaker China Holdings B.V.
Netherlands
100%
+*
Houghton Europe BV
Netherlands
100%
+*
QH Europe BV
Netherlands
100%
*
Quaker Houghton Sales
 
BV (formerly Quaker Sales
Europe BV)
Netherlands
100%
*
Kelko Quaker Chemical, S.A.
Panama
50%
*
Houghton Polska Sp. Zo.o.
Poland
100%
+*
Quaker Chemical Holdings South Africa (Pty) Limited
Republic of South Africa
100%
*
Quaker Chemical South Africa (Pty.)
 
Limited
Republic of South Africa
100%
*
Houghton Romania S.R.L.
Romania
100%
+*
GHI Asia Pacific Pte. Ltd.
Singapore
100%
*
Quaker Houghton Singapore (formerly Houghton
Singapore)
Singapore
100%
**
Korea Houghton Corporation
South Korea
50%
*
Quaker Chemical, S.A.
Spain
100%
*
Verkol
 
S.A.U.
Spain
100%
 
 
 
3
EXHIBIT 21
SUBSIDIARIES AND AFFILIATES
 
OF THE REGISTRANT,
continued
Jurisdiction of
 
Percentage of Voting
 
Securities Owned
Name
Incorporation
Directly or Indirectly by Quaker
+*
Quaker Spain Holding, SLU
Spain
100%
*
Houghton Iberica S.A.
 
Spain
100%
*
Binol AB
Sweden
100%
*
Houghton Sverige AB
Sweden
100%
*
SIFCO Concepts Sweden
Sweden
100%
*
Houghton Taiwan
 
Co. Limited
Taiwan
100%
*
Quaker (Thailand) Ltd.
Thailand
100%
*
Quaker Houghton Thailand (formerly Thai Houghton
1993 Co., Ltd)
Thailand
100%
*
Houghton Kimya Sanayi AS
Turkey
100%
*
Houghton Ukraine ToV
Ukraine
100%
*
Quaker Chemical Limited
United Kingdom
100%
+*
GHGL London Ltd.
United Kingdom
100%
+*
GHG Lubricants Holdings Limited
United Kingdom
100%
+*
Houghton Holdings Limited
United Kingdom
100%
*
Houghton Limited (formerly Houghton plc)
United Kingdom
100%
+*
Applied Surface Concepts Holdings Ltd.
 
United Kingdom
100%
*
Norman Hay Engineering Ltd.
 
United Kingdom
100%
*
SIFCO Applied Surface Concepts (UK) Ltd
United Kingdom
100%
*
Surface Technology
 
Holdings Ltd.
 
United Kingdom
100%
*
Surface Technology
 
(Leeds) Ltd
United Kingdom
100%
*
Surface Technology
 
Aberdeen Ltd
United Kingdom
100%
*
Surface Technology
 
(East Kilbride) Ltd.
United Kingdom
100%
*
Ultraseal International Group Ltd
United Kingdom
100%
*
MX Systems International Ltd
United Kingdom
100%
+*
Quaker Houghton International LP
United Kingdom
100%
+*
Quaker Houghton Holdings Limited
United Kingdom
100%
+*
QH Holdings Limited
United Kingdom
100%
+*
QH Chemical Limited
United Kingdom
100%
+*
QH International Limited
United Kingdom
100%
+*
Quaker Specialty Chemicals (UK) Limited
United Kingdom
100%
+*
SB Decking, Inc. (formerly Selby,
 
Battersby & Co.)
United States
100%
*
AC Products, Inc.
United States
100%
*
Epmar Corporation
United States
100%
*
Summit Lubricants, Inc.
United States
100%
*
ECLI Products, LLC
United States
100%
+*
GH Holdings Inc.
United States
100%
+*
Houghton Technical
 
Corp.
United States
100%
*
SIFCO Applied Surface Concepts, LLC
United States
100%
*
Quaker Houghton PA,
 
Inc. (formerly Houghton
International, Inc.)
United States
100%
*
Ultraseal USA Inc.
United States
100%
 
 
 
4
EXHIBIT 21
SUBSIDIARIES AND AFFILIATES
 
OF THE REGISTRANT,
continued
Jurisdiction of
 
Percentage of Voting
 
Securities Owned
Name
Incorporation
Directly or Indirectly by Quaker
+*
Wallover Enterprises,
 
Inc.
United States
100%
*
Wallover Oil Company
 
Incorporated
United States
100%
*
Wallover Oil Hamilton
 
Inc.
United States
100%
+*
Quaker International Holdings, LLC
United States
100%
+*
MIH Acquisition Company,
 
LLC
United States
100%
*
Coral Chemical Company,
 
LLC
United States
100%
*
Baron Acquisition LLC (d/b/a Baron Industries LLC)
United States
100%
*
Baron of Tennessee LLC
United States
100%
*
Quaker Chemical Corporation (PA)
United States
 
100%
*
Quaker Chemical Corporation (DE)
United States
 
100%
+*
EFHCO, LLC
United States
 
100%
*
Kelko Quaker Chemical, S.A.
Venezuela
50%
+
A non-operating company
*
Included in the consolidated financial statements
**
Accounted for in the consolidated financial statements under the equity
 
method
exhibit23
1
EXHIBIT 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
 
FIRM
We hereby
 
consent to the incorporation by reference in the Registration Statements on Forms
 
S-3 (Registration Nos. 333-155607, 333-
233530, 333-233956 and 333-238508) and on Forms S-8 (Registration
 
Nos. 033-54158, 333-58676, 333-115713,
 
333-159513, 333-
174145, 333-208188, 333-188594 and 333-211238)
 
of Quaker Chemical Corporation of our report dated March 1, 2022 relating to
 
the
financial statements and the effectiveness of internal
 
control over financial reporting, which appears in this Form 10-K.
 
/s/ PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
March 1, 2022
exhibit311
 
1
 
EXHIBIT 31.1
CERTIFICATION
 
OF CHIEF EXECUTIVE OFFICER OF THE COMPANY
 
PURSUANT TO RULE 13a-14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934
I, Andrew
 
E. Tometich,
 
certify that:
1.
I have reviewed this Annual Report on Form 10-K of Quaker Chemical
 
Corporation;
2.
Based on my knowledge, this report does not contain any untrue statement of
 
a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances under
 
which such statements were made, not
misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information
 
included in this report, fairly present in
all material respects the financial condition, results of operations and
 
cash flows of the registrant as of, and for, the periods
presented in this report;
4.
The registrant’s other certifying
 
officer and I are responsible for establishing and maintaining
 
disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))
 
and internal control over financial reporting (as
defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls
 
and procedures to be designed
under our supervision, to ensure that material information relating to the
 
registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
 
during the period in which this report is
being prepared;
(b)
Designed such internal control over financial reporting, or caused such
 
internal control over financial reporting to be
designed under our supervision, to provide reasonable assurance regarding
 
the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance
 
with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant’s
 
disclosure controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and
 
procedures, as of the end of the period covered by
this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant’s
 
internal control over financial reporting that occurred during the
registrant’s most recent fiscal quarter
 
(the registrant’s fourth fiscal quarter
 
in the case of an annual report) that has
materially affected, or is reasonably likely to materially affect,
 
the registrant’s internal
 
control over financial reporting;
and
5.
The registrant’s other certifying
 
officer and I have disclosed, based on our most recent evaluation
 
of internal control over
financial reporting, to the registrant’s auditors
 
and the audit committee of the registrant’s
 
board of directors (or persons
performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the design or operation of
 
internal control over financial
reporting which are reasonably likely to adversely affect the
 
registrant’s ability to record, process,
 
summarize and
report financial information; and
(b)
Any fraud, whether or not material, that involves management or other
 
employees who have a significant role in the
registrant’s internal control
 
over financial reporting.
 
Date: March 1, 2022
 
 
/s/
 
ANDREW E. TOMETICH
 
Andrew E. Tometich
Chief Executive Officer
exhibit312
 
1
EXHIBIT 31.2
CERTIFICATION
 
OF CHIEF FINANCIAL OFFICER OF THE COMPANY
 
PURSUANT TO RULE 13a-14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934
I, Shane W.
 
Hostetter, certify that:
1.
I have reviewed this Annual Report on Form 10-K of Quaker Chemical
 
Corporation;
2.
Based on my knowledge, this report does not contain any untrue statement of
 
a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances under
 
which such statements were made, not
misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information
 
included in this report, fairly present in
all material respects the financial condition, results of operations and
 
cash flows of the registrant as of, and for, the periods
presented in this report;
4.
The registrant’s other certifying
 
officer and I are responsible for establishing and maintaining
 
disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))
 
and internal control over financial reporting (as
defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls
 
and procedures to be designed
under our supervision, to ensure that material information relating to the
 
registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
 
during the period in which this report is
being prepared;
(b)
Designed such internal control over financial reporting, or caused such
 
internal control over financial reporting to be
designed under our supervision, to provide reasonable assurance regarding
 
the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance
 
with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant’s
 
disclosure controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and procedures,
 
as of the end of the period covered by
this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant’s
 
internal control over financial reporting that occurred during the
registrant’s most recent fiscal quarter
 
(the registrant’s fourth fiscal quarter
 
in the case of an annual report) that has
materially affected, or is reasonably likely to materially affect,
 
the registrant’s internal control over
 
financial reporting;
and
5.
The registrant’s other certifying
 
officer and I have disclosed, based on our most recent evaluation
 
of internal control over
financial reporting, to the registrant’s auditors
 
and the audit committee of the registrant’s
 
board of directors (or persons
performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the design or operation of
 
internal control over financial
reporting which are reasonably likely to adversely affect the registrant’s
 
ability to record, process, summarize and
report financial information; and
(b)
Any fraud, whether or not material, that involves management or other
 
employees who have a significant role in the
registrant’s internal control
 
over financial reporting.
Date: March 1, 2022
 
 
/s/
 
Shane W.
 
Hostetter
 
Shane W. Hostetter
Chief Financial Officer
exhibit321
 
1
EXHIBIT 32.1
CERTIFICATION
 
PURSUANT TO 18 U.S.C. SECTION 1350
The undersigned hereby certifies that the Form 10-K Annual Report of
 
Quaker Chemical Corporation (the “Company”) for the
annual period ended December 31, 2021 filed with the Securities and Exchange
 
Commission (the “Report”) fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange
 
Act of 1934 and that the information contained in the Report fairly
presents, in all material respects, the financial condition and results of operations
 
of the Company.
Dated: March 1, 2022
 
 
/s/
 
ANDREW E. TOMETICH
 
Andrew E. Tometich
Chief Executive Officer of Quaker Chemical Corporation
 
exhibit322
 
1
EXHIBIT 32.2
CERTIFICATION
 
PURSUANT TO 18 U.S.C. SECTION 1350
The undersigned hereby certifies that the Form 10-K Annual Report of
 
Quaker Chemical Corporation (the “Company”) for the
annual period ended December 31, 2021 filed with the Securities and Exchange
 
Commission (the “Report”) fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange
 
Act of 1934 and that the information contained in the Report fairly
presents, in all material respects, the financial condition and results of operations
 
of the Company.
Dated: March 1, 2022
 
 
/s/
 
SHANE W. HOSTETTER
Shane W. Hostetter
Chief Financial Officer of Quaker Chemical Corporation
exhibit1026
1
EXHIBIT 10.26
QUAKER HOUGHTON
 
RETIREMENT SAVINGS
 
PLAN
(As Amended and Restated Effective January 1, 2021)
 
1
2
3
4
EXHIBIT A
 
PARTICIPATING
 
EMPLOYERS................................................................. 69
1
QUAKER HOUGHTON RETIREMENT SAVINGS
 
PLAN
(As Amended and Restated Effective January 1, 2021)
 
WHEREAS, Quaker Chemical Corporation (d/b/a Quaker Houghton)(the “Company”) maintains the
Quaker Houghton Retirement Savings Plan (the “Plan”) for the benefit of eligible employees of the Company
and participating affiliates;
 
WHEREAS, the Plan was most recently amended and restated effective January 1, 2020, and amended
on three occasions thereafter;
 
 
WHEREAS, effective as of January 1, 2020, the Houghton International Inc. Tax
 
Advantaged Capital
Accumulation Plan (the “Houghton Plan”) and the Wallover Enterprises Inc. Profit
 
Sharing Plan and Trust (the
“Wallover Plan”) merged
 
with and into the Plan;
 
 
WHEREAS, effective as of January 1, 2022, the Coral Chemical Company 401(k) Plan (the “Coral
Plan”) and the SIFCO Applied Surface Concepts, LLC 401(k) Plan (the “SIFCO Plan”) shall be merged with
and into the Plan; and
 
WHEREAS, the Company desires to amend and restate the Plan in order to incorporate all amendments
adopted after the Plan’s last amendment and restatement and reflect the merger of the SIFCO Plan
 
and Coral
Plan into the Plan;
 
 
NOW,
 
THEREFORE, the Plan is hereby amended and restated as set forth below, effective January
 
1,
2021, except as otherwise provided herein.
 
Prior to January 1, 2021, the terms of the Plan as in effect prior to
January 1, 2021 shall apply as applicable.
ARTICLE I
DEFINITIONS
 
The following words and phrases, as used in the Plan, shall have the following meanings unless
the context clearly indicates otherwise:
1.1
“AC Participant”
 
means a Participant who is employed by AC Products, Inc., other than the
individual who was the President of AC Products, Inc. on January 1, 2006.
1.2
“AC Products Discretionary Contributions”
 
means the discretionary contributions, if any, made
by AC Products, Inc. pursuant to Section 4.4(c) and allocated pursuant to Section 4.7(b)(iv).
1.3
“Administrator”
 
means the committee designated by the Company to administer the Plan on
behalf of the Employer.
1.4
“Affiliated Employer”
 
means any corporation which is a member of a controlled group of
corporations (as defined in Code section 414(b)) which includes the Company; any trade or business (whether
or not incorporated) which is under common control (as defined in Code section 414(c)) with the Company; any
organization (whether or not incorporated) which is a member of an affiliated service group (as defined in Code
section 414(m)) which includes
 
the Company; and any other entity required to be aggregated with the Company
pursuant to Regulations under Code section 414(o).
1.5
“Aggregate Account”
 
means, with respect to each Participant, the value of all accounts
maintained on behalf of the Participant, whether attributable to Employer or Employee contributions.
2
1.6
“Bargaining Component Plan”
 
means the component of the Plan that covers Employees who are
members of a collective bargaining unit.
1.7
“Base Compensation”
 
means, with respect to any Employee, the Compensation of the
Employee, excluding overtime payments, shift differential, commissions, all nonsalary and nonwage direct or
indirect compensation, Employer contributions to Social Security, contributions to this or any other retirement
plan or program, the value of any other fringe benefit provided by or at the expense of the Employer, and any
income realized upon the receipt,
 
exercise,
 
or vesting of a grant of a stock option, performance incentive unit,
restricted stock, or other equity award pursuant to the Company’s long-term performance incentive plan.
1.8
“Beneficiary” means the person to whom the share of a deceased Participant's total account is
payable, subject to the restrictions of Sections 6.3 and 6.6.
1.9
“Catch-Up Contributions”
 
means additional contributions that a Catch-Up Eligible Employee
may elect to make, including Roth Catch-Up Contributions, in accordance with Section 4.3 and Code section
414(v).
1.10
“Catch-Up Eligible Employee”
 
means, with respect to a Plan Year,
 
an Eligible Employee who is
eligible to make Elective Contributions under Section 4.2 and who has attained or will attain age 50 before the
end of such Plan Year.
1.11
“Code”
 
means the Internal Revenue Code of 1986, as amended or replaced from time to time,
and any Regulations in effect thereunder.
1.12
“Company”
 
means Quaker Chemical Corporation, a Pennsylvania corporation,
 
and any
successor thereto.
1.13
“Company Securities” means the common stock of the Company.
1.14
“Compensation”
 
means, with respect to any Employee, (a) the
 
total remuneration earned or
accrued on
 
behalf of
 
the Employee during
 
the time
 
period to
 
which reference is made, exclusive of: (i)
remuneration paid to any Participant after the date
 
on which such Participant ceased to be employed in a
classification eligible for participation in this Plan, other than remuneration with respect
 
to services
performed while the Participant was an Eligible
 
Employee that is paid prior to the later
 
of the end of the
Plan Year
 
in which the Participant’s
 
Severance from Employment occurs or two and
 
one-half months after
his or her Severance from Employment; (ii)
 
amounts realized from the exercise of a
 
stock option, when
restricted stock (or property) held by an Employee
 
is includible in the Employee’s
 
gross income, or
 
when a
stock grant
 
is
 
made; (iii)
 
restricted stock dividends;
 
(iv)
 
disqualifying
 
disposition
 
of
 
incentive
 
stock
 
option;
 
(v)
 
pay
in
 
lieu
 
of
 
30
 
days’
 
notice;
 
(vi)
 
certain
 
fringe
 
benefits
 
(such as payments for relocation expenses and any
 
gross-
up payments made with respect to such amounts,
 
taxable
 
mileage, car allowance, adoption assistance, tax
and financial planning, tax equalization payments for
 
expatriates, taxable education subsidy,
 
California
vacation pay out, unused vacation pay out after
 
Severance from Employment, meal premiums);
 
(vii) other
miscellaneous income (such as associate referral, perfect attendance award, sign on bonus, final bonus,
Presidents Award,
 
ESPP gains,
gift cards and other remuneration not received in
 
cash (and any gross-up
payments made with respect to such amounts)); and (b)
 
differential wage
 
payments (within the meaning of
Code section 414(u)(12)). For purposes of allocating AC Products Discretionary Contributions and Quaker
Discretionary Contributions pursuant to Section 4.7(b), only Compensation
 
earned by an Employee while
he or she is eligible to receive such a Contribution shall be
 
taken into account.
 
The determination of
Compensation shall be made by
 
including Deferred Compensation and salary reduction contributions
 
made
on behalf of an Employee to a plan
 
maintained under Code section 125 or
 
to a qualified transportation
fringe benefit program described under Code section
 
132(f), but shall
 
be
exclusive of any distributions
3
attributable to unused “flex dollars” accumulated by the Employer
 
pursuant to the Quaker Chemical
Corporation Flexible Benefits Program.
 
For purposes of determining Compensation, amounts
 
under Code
section 125 include any amounts not available to a Participant in cash in lieu
 
of group health coverage
because the Participant is unable to certify that he or she
 
has other health coverage.
 
An amount shall be
treated as an amount under Code section 125
 
only if the Employer does not request
 
or collect information
regarding the Participant’s
 
other health coverage as part of the
 
enrollment process for the health
 
plan.
 
The annual Compensation of each Employee taken into account in determining
allocations
under the Plan for any Plan Year shall not exceed $290,000, as
 
adjusted by the Commissioner of Internal
Revenue for increases in the cost-of-living in accordance
 
with Code section 401(a)(17)(B) for Plan Years
after 2021.
 
Annual Compensation means Compensation during the
 
Plan Year or
 
such other
 
12-consecutive-
month
 
period over
 
which Compensation is otherwise determined under the
 
Plan (the determination period).
 
The cost-of-living adjustment in effect for
 
a calendar year applies to annual Compensation for
 
the
determination period that begins with or within such
 
calendar year.
 
For purposes of determining a
Participant’s
 
Elective Contributions and Matching Contributions, the limit
 
set forth in
 
this paragraph shall
be applied to a
 
Participant’s
 
Compensation on a Plan Year
 
basis (or on a determination period basis, if
 
the
determination period is other than a Plan Year)
 
and shall not be applied on a first-dollar
 
basis.
 
Compensation, as defined above, shall include the amount that a Participant would have received
from the Employer during a period of Qualified Military Service (or, if the amount of such Compensation is not
reasonably certain, the Employee’s average earnings from the Employer or an Affiliated Employer for the 12-
month period immediately preceding the Employee’s period of Qualified Military Service or,
 
if shorter, the
period of employment immediately preceding the Qualified Military Service); provided, however, that the
Employee returns to work within the period during which his or her right to reemployment is protected by law.
1.15
“Contract”
 
means a life insurance policy or annuity contract (group or individual) issued by the
insurer as elected.
1.16
“Coral Participant”
 
means a Participant who is employed by
 
the Coral Chemical Company
.
1.17
“Deferred Compensation”
 
means, with respect to any Participant, that portion of the
Participant’s total Compensation which has been contributed to the Plan in accordance with the Participant’s
salary deferral election pursuant to Section 4.2.
 
The term “Deferred Compensation”
 
shall include Catch-Up
Contributions except to the extent provided in Section 4.3, Code section 414(v), or final Regulations or other
guidance issued by the Internal Revenue Service.
1.18
“ECLI Participant”
 
means a Participant who is employed by
 
ECLI Products, LLC
.
1.19
“Effective Date”
 
means January 1, 2021, the effective date of this amended and restated Plan,
except as otherwise provided herein or as otherwise required by applicable law. Except where an earlier
effective date is specified herein, the provisions of this amendment and restatement shall apply only to
Employees who complete an Hour of Service on or after the Effective Date.
 
The rights of individuals who
terminated employment prior to the Effective Date shall otherwise be governed by the Plan as in effect on the
date of their termination from employment.
 
The original effective date of the Plan was December 31, 1953.
1.20
“Elective Contributions”
 
means the Employer’s contributions to the Plan that are made pursuant
to the Participant’s salary deferral election provided in Section 4.2.
 
In addition, any Qualified Nonelective
Contribution shall be considered an Elective Contribution for purposes of the Plan; provided, however, that
Qualified Nonelective Contributions used to satisfy the Actual Contribution Percentage Test of Section 4.8(b)
shall not be used to satisfy the Actual Deferral Percentage Test of Section 4.8(a).
 
The term “Elective
Contributions” shall include (i) Roth Elective Contributions,
 
and (ii) Catch-Up Contributions, including Roth
4
Catch-Up Contributions, except to the extent provided in Section 4.3, Code section 414(v), or final Regulations
or other guidance issued by the Internal Revenue Service.
1.21
“Eligible Employee”
 
means any Employee, except as follows:
(a)
An Employee who is a member of UAW Local 174
 
shall be deemed an “Eligible
Employee” for purposes of being permitted to make Elective Contributions, receiving Matching Contributions,
and receiving an allocation of Quaker Discretionary Contributions (if any) and Nonelective Contributions.
(b)
Any other Employee whose employment is governed by the terms of a collective
bargaining agreement between employee representatives (within the meaning of Code section 7701(a)(46)) and
the Employer under which retirement benefits were the subject of good faith bargaining between the parties
shall not be eligible to participate in this Plan (unless such collective bargaining agreement provides for
participation in the Plan, including not limited to an Employee of the Coral Chemical Company whose
employment is governed by the terms of a collective bargaining agreement between Chauffeurs, Teamsters
 
and
Helpers Local Union 301, Cartage Division or the Plant Workers Agreement
 
and Coral Chemical Company
(Local 301”) who otherwise meets the eligibility requirements of Section 1.21).
(c)
An Employee of an Affiliated Employer shall not be eligible to participate in this Plan
unless such Affiliated Employer has specifically adopted this Plan in writing.
(d)
A Leased Employee shall not be eligible to participate in this Plan.
(e)
A nonresident alien who receives no earned income (within the meaning of Code section
911(d)(2)) which constitutes United States source income (within the meaning of Code section 861(a)(3)) shall
not be eligible to participate in this Plan.
(f)
A person shall not be eligible to participate in this Plan if he or she provides services to
an Employer or Affiliated Employer pursuant to an agreement with a leasing organization (including, but not
limited to, a Leased Employee), or if he or she is classified by an Employer or Affiliated Employer (i) as an
independent contractor, or (ii) in any other category which is not a common law employee, as reflected in the
official payroll and personnel records of the Employer or Affiliated Employer.
 
The exclusion set forth in this
subsection shall be based solely on the classification by the Employer or Affiliated Employer regardless of how
such individual is classified by any government or regulatory authority or by any court.
 
If an Employer or an
Affiliated Employer reclassifies
 
an individual as an Employee, such reclassification shall apply prospectively
from the date of such reclassification (and not retroactively to the date on which he or she was found to have
first become an employee for any other purpose), unless the Employer or Affiliated Employer specifically
provides otherwise.
(g)
Effective with respect to an Employee hired after 2010, an Employee shall not be eligible
to participate in this Plan if he or she is (i) employed by an Employer for a temporary or periodic basis or
without a regular work schedule pursuant to which the Employee accepts a job assignment having a fixed and
limited duration, and (ii) classified by the Employer as a temporary employee.
1.22
“Employee”
 
means any person who is employed by the Employer or an Affiliated Employer,
and shall also include a Leased Employee.
1.23
“Employer”
 
means the Company and any Affiliated Employer that has adopted this Plan in
writing and joins in the corresponding trust agreement.
 
The Affiliated Employers participating in the Plan as of
January 1, 2021, are listed in Exhibit A.
 
5
1.24
“Entry Date”
 
means the date as of which an Eligible Employee is eligible to become a
Participant in the Plan, as provided in Section 3.1(a).
1.25
“Epmar Participant”
 
means a Participant who is employed by Epmar Corporation.
1.26
“ERISA”
 
means the Employee Retirement Income Security Act of 1974, as it may be amended
from time to time.
1.27
“Excess Aggregate Contributions”
 
means, with respect to any Plan Year,
 
the excess of the
aggregate amount of the Matching Contributions made on behalf of Highly Compensated Employees for such
Plan Year,
 
over the maximum amount of such contributions permitted under the limitations of Section 4.8(b).
 
Excess Aggregate Contributions shall be treated as an “annual addition” pursuant to Section 4.10.
1.28
“Excess Contributions”
 
means, with respect to any Plan Year,
 
the excess of Elective
Contributions made on behalf of Highly Compensated Employees for such Plan Year
 
over the maximum
amount of such contributions permitted under Section 4.8(a).
 
Excess Contributions shall be treated as an
“annual addition” pursuant to Section 4.10.
1.29
“Excess Deferred Compensation”
 
means, with respect to any taxable year of a Participant, the
aggregate amount of the Participant’s Deferred Compensation claimed by the Participant (pursuant to Section
4.2(d)(i)) or deemed to be claimed by the Participant (pursuant to Section 4.2(d)(ii)) as exceeding the dollar
limitation provided for in Code section 402(g), which is incorporated herein by reference.
 
Excess Deferred
Compensation distributed pursuant to Section 4.2(d)(iv) shall not be treated as an “annual addition” pursuant to
Section 4.10.
1.30
“Fiduciary”
 
means any person or entity who (a) exercises any discretionary authority or
discretionary control respecting management of the Plan or exercises any authority or control respecting
management or disposition of its assets, (b) renders investment advice for a fee or other compensation, direct or
indirect, with respect to any monies or other property of the Plan or has any authority or responsibility to do so,
or (c) has any discretionary authority or discretionary responsibility in the administration of the Plan, including,
but not limited to, the Trustee,
 
the Company and its representative body, and the Administrator.
1.31
“Forfeiture”
 
means removing that portion of the Participant’s Account that is not Vested
 
from
the Participant’s Account.
 
Forfeiture shall occur on the earlier of (a) the date on which distribution is made to
the Participant of the Participant’s Vested
 
Aggregate Account,
 
or (b) the last day of the Plan Year
 
in which the
Participant incurs five consecutive 1-Year
 
Breaks in Service.
 
In addition, the term Forfeiture shall also include
amounts deemed to be Forfeitures pursuant to any other provision of this Plan.
 
If a Participant’s Vested
Aggregate Account is $0, the Participant shall be deemed to receive a distribution of his or her Vested
Aggregate Account on his or her Severance from Employment.
1.32
“415 Compensation”
 
means,
effective with respect to
 
limitation years (as defined in Section
4.10(c)) beginning on or after January 1, 2009,
 
“compensation” as such word is
 
defined in Regulation
sections 1.415(c)-2(b) and
 
(c) (including differential wage payments within the meaning of Code section
414(u)(12)). 415 Compensation shall not include compensation
 
paid following a Participant’s
 
Severance
from Employment with the Company and any Affiliated
 
Employers, except as otherwise required by
Regulation section 1.415(c)-2(e)(3)(i). In no event shall
 
a Participant’s
 
415 Compensation for any
limitation year (as defined in Section 4.10(c)) exceed
 
the annual compensation limit of Code section
401(a)(17) for such year.
1.33
“414(s) Compensation” means Compensation.
6
1.34
“Highly Compensated Employee”
 
means, with respect to a Plan Year,
 
an Employee who:
 
(a)
was a 5% owner (as defined in Code section 416(i)(1)) of the Employer or an Affiliated
Employer at any time during the current or the preceding Plan Year
 
;
 
or
 
(b)
for the immediately preceding Plan Year
 
had 415 Compensation from the Employer and
Affiliated Employers in excess of $130,000 (as adjusted by the Secretary of Treasury pursuant to Code section
414(q) for Plan Years
 
after 2021) and was in the top-paid group of Employees for such preceding year.
 
An Employee is in the top-paid group of Employees for the year if such Employee is in the group
consisting of the top 20% of employees when ranked on the basis of 415 Compensation paid during such year.
 
The determination of who is a Highly Compensated Employee, including the determination of 415
Compensation and of the number and identity of Employees in the top-paid group, shall be made in accordance
with Code section 414(q) and the Regulations thereunder.
 
In determining who is a Highly Compensated Employee, Employees who are nonresident aliens
and who received no earned income (within the meaning of Code section 911(d)(2)) from the Employer
constituting United States source income within the meaning of Code section 861(a)(3) shall not be treated as
Employees.
 
All Affiliated Employers, however, shall be taken into account as a single employer.
 
1.35
“Houghton Participant”
 
means a Participant who is employed by
 
Houghton International Inc
.
1.36
“Hour of Service”
 
means (a) each hour for which an Employee is directly or indirectly
compensated or entitled to compensation by the Employer for the performance of duties during the applicable
computation period; (b) each hour for which an Employee is directly or indirectly compensated or entitled to
compensation by the Employer (irrespective of whether the employment relationship has terminated) for
reasons other than performance of duties (such as vacation, holidays, sickness, jury duty, disability,
 
layoff,
military duty, or leave of absence) during the applicable computation period; (c) each hour for which back pay
is awarded or agreed to by the Employer without regard to mitigation of damages; and (d) each hour that
constitutes part of the Employee’s customary work week during any period of Qualified Military Service,
provided the Employee returns to service while his or her reemployment rights are protected by law.
 
For
purposes of subsection (c), these hours shall be credited to the Employee for the computation period or periods
to which the award or agreement pertains rather than the computation period in which the award, agreement, or
payment is made.
 
The same Hours of Service shall not be credited both under subsection (a) or (b), as the case
may be, and under subsection (c) or (d), as the case may be.
 
Notwithstanding the above, (i) except with respect to subsection (d), no more than 501 Hours of
Service shall be credited to an Employee on account of any single continuous period during which the
Employee performs no duties (whether or not such period occurs in a single computation period); (ii) an hour
for which an Employee is directly or indirectly paid, or entitled to payment, on account of a period during
which no duties are performed shall not be credited to the Employee if such payment is made or due under a
plan maintained solely for the purpose of complying with applicable workers’ compensation, unemployment
compensation, or disability insurance laws; and (iii) Hours of Service shall not be credited for a payment which
solely reimburses an Employee for medical or medically related expenses incurred by the Employee.
 
For purposes of this Section, a payment shall be deemed to be made by or due from the
Employer regardless of whether such payment is made by or due from the Employer directly, or indirectly
through, among others, a trust fund or insurer, to which the Employer contributes or pays premiums, and
regardless of whether contributions made or due to the trust fund, insurer, or other entity are for the benefit of
particular Employees or are on behalf of a group of Employees in the aggregate.
7
 
An Hour of Service must be counted for the purposes of determining a Year
 
of Service, a 1-Year
Break in Service, and employment commencement date (or reemployment commencement date).
 
In addition,
Hours of Service shall be credited for employment with other Affiliated Employers for all purposes under the
Plan other than Section 4.7(b)(iii) and (iv) (regarding eligibility to receive a Quaker Discretionary Contribution
or an AC Products Discretionary Contribution).
 
The provisions of 29 CFR §2530.200b-2(b) and (c) are
incorporated herein by reference.
1.37
“Investment Manager” means an entity that (a) has the power to manage, acquire, or dispose of
Plan assets and (b) acknowledges fiduciary responsibility to the Plan in writing.
 
Such entity must be a person,
firm, or corporation registered as an investment adviser under the Investment Advisers Act of 1940, a bank, or
an insurance company or other person or entity described in ERISA section 3(38).
 
1.38
“Key Employee” means any Employee or former Employee (and the beneficiaries of such
Employee) who at any time during the Plan Year
 
that includes the Determination Date (as defined in Section
2.2(d)) was:
(a)
 
an officer of an Employer or any Affiliated Employer having annual 415 Compensation
from the Employer and the Affiliated Employer greater than $185,000 (as adjusted under Code section 416(i)(1)
for Plan Years
 
beginning after December 31, 2021);
(b)
 
a 5% owner of an Employer or any Affiliated Employer; or
(c)
 
a 1% owner of an Employer or any Affiliated Employer who has annual 415
Compensation from an Employer and the Affiliated Employer for a Plan Year
 
of more than $150,000.
The determination of who is a Key Employee shall be made in accordance with Code section 416(i) and
applicable Regulations and other guidance of general applicability issued thereunder.
1.39
“Leased Employee”
 
means any person (other than a common law employee of the recipient)
who, pursuant to an agreement between the recipient and any other person (“leasing organization”), has
performed services for the recipient (or for the recipient and related persons determined in accordance with
Code section 414(n)(6)) on a substantially full-time basis for a period of at least one year, if such services are
performed under the primary direction or control by the recipient.
 
Contributions or benefits provided to a
Leased Employee by the leasing organization which are attributable to services performed for the recipient
employer shall be treated as provided by the recipient employer.
 
1.40
“Matching Contribution”
 
means the amount authorized by the Administrator as described in
Section 4.4(a) and contributed in cash or Company Securities by the Employer.
1.41
“Nonelective Contributions”
 
means the amount described in Section 4.5 and contributed in cash
or Company Securities by the Employer.
1.42
“Nonhighly Compensated Employee”
 
means an Employee who is not a Highly Compensated
Employee.
1.43
“Non-Safe Harbor Component Plan”
 
means the component of the Plan that covers Employees
who (a) are not members of a collective bargaining unit, and (b) have either not completed a Year
 
of Service
(for purposes of Section 3.1) or not attained age 21.
1.44
“Normal Retirement Age”
 
means the Participant’s 65th birthday.
8
1.45
“1-Year
 
Break in Service”
 
means the applicable computation period during which an Employee
has not completed more than 500 Hours of Service with the Employer or an Affiliated Employer.
 
Further,
solely for the purpose of determining whether a Participant has incurred a 1-Year
 
Break in Service, Hours of
Service shall be recognized for authorized leaves of absence and maternity and paternity leaves of absence.
Years
 
of Service and 1-Year
 
Breaks in Service shall be measured using the same computation period.
 
In
addition, an Employee on Qualified Military Service shall not incur a 1-Year
 
Break in Service, provided he or
she returns to service while his or her employment rights are protected by law.
 
“Authorized leave of absence” means an unpaid, temporary cessation from active employment
with the Employer pursuant to an established nondiscriminatory policy, whether occasioned by illness, military
service, or any other reason.
 
A “maternity or paternity leave of absence” means an absence from work for any period by
reason of the Employee’s pregnancy,
 
birth of the Employee’s child, placement of a child with the Employee in
connection with the adoption of such child, or any absence for the purpose of caring for such child for a period
immediately following such birth or placement.
 
For an individual who is absent from work for maternity or
paternity reasons, the 12-consecutive-month period beginning on the date of such absence or the first
anniversary of such absence shall not constitute a 1-Year
 
Break in Service.
1.46
“Participant”
 
means an Eligible Employee who is included in the Plan as provided in Article III.
1.47
“Participant’s Account”
 
means the account established and maintained by the Administrator for
each Participant with respect to his or her total interest in the Plan and Trust resulting from AC Products
Discretionary Contributions, Quaker Discretionary Contributions, Matching Contributions,
 
and Nonelective
Contributions.
 
A separate accounting shall be maintained with respect to that portion of the Participant’s
Account attributable to Nonelective Contributions for Plan Ye
 
ars prior to 2008, Nonelective Contributions for
Plan Years
 
after 2007, Matching Contributions, AC Products Discretionary Contributions,
 
and Quaker
Discretionary Contributions.
1.48
“Participant’s Elective Account”
 
means the account established and maintained by the
Administrator for each Participant with respect to his or her total interest in the Plan and Trust resulting from
Elective Contributions which are not directed by the Participant to the Quaker Stock Fund.
 
A separate
accounting shall be maintained with respect to that portion of the Participant’s Elective Account attributable to
(i) pre-tax Elective Contributions pursuant to Section 4.2 or 4.3, (ii) Roth Elective Contributions (including
Roth Catch-Up Contributions) pursuant to Section 4.2 or 4.3, (iii) any Qualified Nonelective Contributions
made pursuant to Section 4.9(f) and (iv) After-Tax
 
Coral Plan Contributions described in Section 11.2(a)(i)
transferred to the Participant’s Elective Account pursuant to Article XI.
1.49
“Plan”
 
means the Quaker Houghton Retirement Savings Plan as set forth herein, including all
amendments thereto.
 
Prior to January 1, 2020, the Plan was the “Quaker Chemical Corporation Retirement
Savings Plan”.
 
Prior to that, the Plan was known as the “Quaker Chemical Corporation Profit Sharing and
Retirement Plan”.
 
With the exception of the Stock Bonus Plan portion of the Plan, the Plan is intended to be a
profit-sharing plan under Code section 401(a)(27).
1.50
“Plan Year
 
 
means the Plan’s accounting year of 12 months commencing on January 1 of each
year and ending the following December 31.
1.51
“Quaker Discretionary Contributions”
 
means the discretionary contributions, if any, made by the
Employer pursuant to Section 4.4(b) and allocated pursuant to Section 4.7(b)(iii).
1.52
“Quaker Stock Fund”
 
means a fund that invests in Company Securities.
9
1.53
“Qualified Military Service”
 
means any service in the uniformed services (as defined in chapter
43 of title 38, United States Code) where the Employee’s right to reemployment is protected by law.
1.54
“Qualified Nonelective Contributions”
 
means the Employer’s contributions to the Plan that are
made pursuant to Section 4.9(f) and as described in Code section 401(m)(4)(C).
 
Such contributions shall be
subject to the provisions of Section 4.2(b) and (c), and either (a) considered Elective Contributions for the
purposes of the Plan and used to satisfy the Actual Deferral Percentage Test of Section 4.8(a), or (b) used to
satisfy the Actual Contribution Percentage Test of Section 4.8(b).
1.55
“Regulations”
 
means the regulations promulgated by the Secretary of the Treasury from time to
time.
1.56
“Rollover Account”
 
means the accounts or subaccounts established and maintained by the
Administrator for each Participant with respect to his or her Rollover Contributions and Roth Rollover
Contributions. The term Rollover Account shall include Roth Rollover Contributions unless expressly
distinguished or otherwise required under the Code, Regulations, or other guidance.
 
To the extent necessary for
applicable tax and recordkeeping purposes, a separate Roth Rollover subaccount shall be established.
1.57
“Rollover Contribution”
 
means a contribution or direct rollover made pursuant to Section 4.12.
1.58
“Roth Catch-Up Contributions”
 
means Catch-Up Contributions that are includible in a
Participant’s gross income at the time deferred and have been irrevocably designated as Roth Catch-Up
Contributions by the Participant, as described in Section 4.3.
1.59
“Roth Elective Contributions”
 
means Elective Contributions that are includible in a Participant’s
gross income at the time deferred and have been irrevocably designated as Roth Elective Contributions by the
Participant, as described in Section 4.2.
 
The term Roth Elective Contributions shall include Roth Catch-Up
Contributions except to the extent provided in Section 4.3, Code section 414(v), or final Regulations or other
guidance issued by the Internal Revenue Service.
1.60
“Safe Harbor Component Plan”
 
means the component of the Plan that covers employees who (a)
are not members of a collective bargaining unit, (b) have completed a Year
 
of Service (for purposes of Section
3.1), and (c) have attained age 21.
1.61
“Severance from Employment”
 
means a severance from employment within the meaning of
Code section 401(k)(2)(B)(i)(I), applicable Regulations thereunder,
 
and other guidance of general applicability
issued thereunder.
1.62
“SIFCO Participant”
means a Participant who is employed
 
by
SIFCO Applied Surface
Concepts, LLC.“Spouse” or “Surviving Spouse” shall mean the person to whom the Participant is legally
married for purposes of Federal law, provided that a former spouse shall be treated as the Spouse or Surviving
Spouse to the extent provided under a qualified domestic relations order, as defined in Code section
414(p).“Stock Bonus Plan”
 
means the portion of the Plan meant to qualify as a stock bonus plan under Code
section 401(a) that invests primarily in Company Securities.
1.65
“Stock Bonus Plan Account”
 
means the account established and maintained by the
Administrator for each Participant with respect to his or her Elective Contributions, Matching Contributions,
AC Products Discretionary Contributions, Quaker Discretionary Contributions,
 
and Nonelective Contributions
invested in the Quaker Stock Fund.
 
A separate accounting shall be maintained with respect to that portion of a
Participant’s Stock Bonus Plan Account attributable to (a) pre-tax Elective Contributions, (b) Roth Elective
10
Contributions (including Roth Catch-Up Contributions), (c) Matching Contributions, (d) AC Products
Discretionary Contributions, (e) Quaker Discretionary Contributions,
 
and (f) Nonelective Contributions.
1.66
“Summit Participant”
 
means a Participant who is employed by Summit Lubricants Inc.
1.67
“Top-Heavy Plan”
 
means a plan described in Section 2.2(a).
1.68
“Top-Heavy Plan Year
 
 
means a Plan Year
 
during which the Plan is a Top-Heavy Plan.
1.69
“Total and Permanent Disability”
 
means, (a) with respect to an Epmar Participant who had
amounts transferred to the Plan from the Epmar Corporation 401(k) Profit Sharing Plan, a physical or mental
condition of the Participant resulting from bodily injury, disease, or mental disorder which renders such
Participant incapable of continuing any gainful occupation and which condition constitutes total disability under
the Federal Social Security Acts, and (b) with respect to a Participant not described in subsection (a), a physical
or mental condition of the Participant resulting from bodily injury, disease, or mental disorder that continues for
a period of at least 24 consecutive months and that renders him or her eligible for disability benefits under Title
II of the Social Security Act.
1.70
“Trustee”
 
means the person(s) or entity named as trustee herein or in any separate trust forming
a part of this Plan, and any successors.
1.71
“Trust Fund” or “Fund” means the assets of the Plan and Trust as the same shall exist from time
to time.
1.72
“Valuation
 
Date”
 
means any business day that the New York
 
Stock Exchange is open for
trading.
1.73
“Vested
 
 
means the nonforfeitable portion of any account maintained on behalf of a Participant.
1.74
“Wallover Participant”
 
means a Participant who is employed by
Wallover Oil Company,
 
Inc.
 
1.75
“Year
 
of Service”
 
means:
(a)
For all purposes of this Plan except for purposes of Section 3.1, a Plan Year
 
during which
an Employee completes 1,000 or more Hours of Service; and
(b)
For purposes of Section 3.1, the 12-consecutive-month period beginning with the date the
Employee’s employment with the Employer or any Affiliated Employer
 
commenced (such date being the first
day for which the Employee is credited with an Hour of Service) if, during such consecutive 12-month period,
the Employee completes 1,000 Hours of Service; provided, however, that if, during such 12-consecutive-month
period, the Employee does not complete 1,000 Hours of Service, then “Year
 
of Service” shall mean any Plan
Year
 
beginning after the Employee’s date of employment during which the
 
Employee completes 1,000 or more
Hours of Service.
(c)
For purposes of Section 3.1, a Year
 
of Service is not completed until the end of the 12-
consecutive-month period or the Plan Year,
 
as the case may be, without regard to when during that period the
1,000 Hours of Service are completed, and in determining a Participant’s Years
 
of Service the Employee shall
receive credit for his or her Hours of Service for the Employer or any Affiliated Employer whether or not he or
she was an Eligible Employee at the time such Hours of Service were completed.
(d)
For purposes of this Plan, service with AC Products, Inc. shall be deemed to constitute
service with the Employer.
 
 
11
(e)
For purposes of this Plan, service with United Lubricants Corporation prior to March 1,
2002, shall be deemed to constitute service with the Employer.
(f)
For purposes of this Plan, service with D.A. Stuart prior to July 16, 2010, shall be
deemed to constitute service with the Employer.
(g)
For purposes of this Plan, all service credited under the G.W. Smith
 
Plan or the Summit
Plan shall also be credited as service under this Plan.
(h)
For purposes of this Plan, service with Lubricor
 
Inc. (“Lubricor”) prior to November
30, 2016 shall be
 
deemed to constitute service
 
with the
 
Employer, effective January 1,
 
2017.
Notwithstanding anything herein to the contrary,
 
Eligible Employees who receive credit for service
pursuant to this subsection shall not be eligible
 
for Nonelective Contributions for the 2016 Plan
 
Year.
(i)
For purposes of this Plan, service with Houghton International Inc. (“Houghton”) shall be
deemed to constitute service with the Employer.
(j)
For purposes of this Plan, service with Wallover Oil Company,
 
Inc. (“Wallover”) shall be
deemed to constitute service with the Employer.
(k)
For purposes of this Plan, service with SIFCO Applied Surface Concepts, LLC shall be
deemed to constitute service with the Employer.
(l)
For purposes of this Plan, service with Coral Chemical Company shall be deemed to
constitute service with the Employer.
ARTICLE II
TOP-HEAVY
 
RULES AND ADMINISTRATION
2.1
Top-Heavy Plan Requirements
 
For any Top-Heavy Plan Year,
 
the special minimum allocation requirements of Code section
416(c) set forth in Section 4.7(d) of the Plan shall apply.
2.2
Determination of Top-Heavy Status
(a)
Top-Heavy Plan.
 
This Plan shall be a Top-Heavy Plan for any Plan Year
 
in which, as of
the Determination Date, the present value of accrued benefits of Key Employees and the sum of the Aggregate
Accounts of Key Employees under this Plan and all plans of an Aggregation Group exceeds 60% of the present
value of accrued benefits and the sum of the Aggregate Accounts of all Key Employees and non-Key
Employees under this Plan and all plans of an Aggregation Group.
 
If any Participant is a non-Key Employee for any Plan Year,
 
but such Participant was a Key
Employee for any prior Plan Year,
 
the present value of such Participant’s accrued benefit and such
 
Participant’s
Aggregate Account balance shall not be taken into account for purposes of determining whether this Plan is a
Top-Heavy Plan (or whether any Aggregation Group which includes this Plan is a Top
 
-Heavy Group).
 
In
addition, the accrued benefits and accounts of any individual who has not performed services for an Employer
during the one-year period ending on the Determination Date shall not be taken into account.
(b)
Aggregate Account.
 
A Participant’s Aggregate Account for purposes of this Article II
only shall be defined as the sum of the following as of the Determination Date:
 
 
 
12
(i)
The balance of his or her Aggregate Account as of the most recent valuation
occurring within a 12-month period ending on the Determination Date.
(ii)
An adjustment for any contributions due as of the Determination Date, which
adjustment shall be the amount of any contributions actually made after the most recent Valuation
 
Date but due
on or before the Determination Date, except for the first Plan Year
 
of the Plan when such adjustment shall also
reflect the amount of any contributions made after the Determination Date that are allocated as of a date in that
first Plan Year.
(iii)
Any Plan distributions made with respect to the Employee under the Plan and any
Plan aggregated with the Plan under Code section 416(g)(2) during the one-year period ending on the
Determination Date.
 
The preceding sentence shall also apply to distributions under a terminated plan which,
had it not been terminated, would have been aggregated with the Plan under Code section 416(g)(2)(A)(i).
 
In
the case of a distribution made for a reason other than separation from service, death, or disability, this
provision shall be applied by substituting “five-year period” for “one-year period.”
(iv)
Any Employee contributions, whether voluntary or mandatory.
 
However,
amounts attributable to tax-deductible, qualified voluntary Employee contributions shall not be considered to be
a part of the Participant’s Aggregate Account balance.
(v)
With respect to unrelated rollovers (ones which are both initiated by the
Employee and made from a plan maintained by one employer to a plan maintained by another employer), if this
Plan permits the rollovers, it shall always consider such rollovers as a distribution for the purposes of this
Section.
(vi)
With respect to related rollovers and ones either not initiated by the Employee or
made to a plan maintained by the same employer, if this Plan permits the rollovers, they shall not be counted as
distributions for purposes of this Section.
 
If this Plan is the plan accepting such rollovers, it shall consider such
rollovers as part of the Participant’s Aggregate Account balance, irrespective of the date on which such
rollovers are accepted.
(vii)
For the purposes of determining whether two employers are to be treated as the
same employer in paragraphs (v) and (vi) above, all employers aggregated under Code section 414(b), (c), (m),
and (o) shall be treated as the same employer.
(c)
“Aggregation Group” means either a Required Aggregation Group or a Permissive
Aggregation Group as hereinafter determined.
(i)
Required Aggregation Group:
 
In determining a Required Aggregation Group
hereunder, each plan of the Employer in which a Key Employee is a Participant in the Plan Year
 
containing the
Determination Date or any of the four preceding Plan Years
 
,
 
and each other plan of the Employer which enables
any plan in which a Key Employee participates to meet the requirements of Code sections 401(a)(4) or 410,
shall be required to be aggregated.
 
Such group shall be known as a “Required Aggregation Group.”
 
In the case of a Required Aggregation Group, each plan in the group shall be considered
a Top-Heavy Plan if the Required Aggregation Group is a Top
 
-Heavy Group.
 
No plan in the Required
Aggregation Group shall be considered a Top-Heavy Plan if the Required Aggregation Group is not a Top-
Heavy Group.
(ii)
Permissive Aggregation Group:
 
The Employer may also include any other plan
not required to be included in the Required Aggregation Group, provided the resulting group, taken as a whole,
 
 
 
 
 
13
would continue to satisfy the provisions of Code sections 401(a)(4) and 410.
 
Such group shall be known as a
“Permissive Aggregation Group.”
 
In the case of a Permissive Aggregation Group, only a plan that is part of the Required
Aggregation Group shall be considered a Top-Heavy Plan if the Permissive Aggregation Group is a Top
 
-Heavy
Group.
 
No plan in the Permissive Aggregation Group shall be considered a Top-Heavy Plan if the Permissive
Aggregation Group is not a Top-Heavy Group.
(iii)
Only those plans of the Employer in which the Determination Dates fall within
the same calendar year shall be aggregated in order to determine whether such plans are Top-Heavy Plans.
(iv)
An Aggregation Group shall include any terminated plan of the Employer if it
was maintained within the last five years ending on the Determination Date.
(d)
“Determination Date” means (i) the last day of the preceding Plan Year
 
,
 
or (ii) in the case
of the first Plan Year,
 
the last day of such Plan Year.
(e)
“Present Value
 
of Accrued Benefit”
 
means, in the case of a defined benefit plan, the
present value of the accrued benefit for a Participant other than a Key Employee, determined using the single
accrual method used for all plans of the Employer and Affiliated Employers,
 
or, if no such single method exists,
using a method which results in benefits accruing not more rapidly than the slowest accrual rate permitted under
Code section 411(b)(1)(C).
 
The present value of the accrued benefit shall be determined as of the most recent
Valuation
 
Date that falls within or ends with the 12-month period ending on the Determination Date, except as
provided in Code section 416 and the Regulations thereunder for the first and second plan years of a defined
benefit plan.
(f)
“Top-Heavy Group” means an Aggregation Group in which, as of the Determination
Date, the sum of:
(i)
the present value of accrued benefits of Key Employees under all defined benefit
plans included in the group; and
(ii)
the Aggregate Accounts of Key Employees under all defined contribution plans
included in the group,
 
exceeds 60% of a similar sum determined for all Key Employees and non-Key Employees under this Plan and
all plans of the Aggregation Group.
ARTICLE III
ELIGIBILITY
3.1
Conditions of Eligibility
(a)
Elective Contributions and Matching Contributions.
 
An Eligible Employee who was a
Participant in the Plan on December 31, 2020, shall continue to be eligible to participate in the Plan, and to
make Elective Contributions to the Plan and receive Matching Contributions, on January 1, 2021.
 
Any other
Eligible Employee shall be eligible to become a Participant in the Plan and to make Elective Contributions to
the Plan and receive Matching Contributions on the date on which the Eligible Employee’s employment with
the Employer commences or as soon as administratively practicable thereafter.
(b)
Discretionary Contributions and Nonelective Contributions.
 
An Eligible Employee who
was a Participant in the Plan and was eligible to receive an allocation of AC Products Discretionary
 
 
14
Contributions, Quaker Discretionary Contributions, or Nonelective Contributions on December 31, 2020, shall
continue to be eligible to receive such contributions on January 1, 2021.
 
Any other Eligible Employee shall be
eligible to receive an allocation of AC Products Discretionary Contributions, Quaker Discretionary
Contributions,
 
or Nonelective Contributions only upon completing one Year of Service. Upon
 
completing one
Year
 
of Service, an Eligible Employee shall begin to participate in the Plan for purposes of Nonelective
Contributions as of the first day of the month coincident with or next following the date on which the Eligible
Employee meets the one Year
 
of Service requirement.
 
3.2
Procedure to Become Active Participant
 
An Eligible Employee who was a Participant in the Plan on December 31, 2021, shall continue to
be a Participant on the Effective Date.
 
Any other Eligible Employee shall become an active Participant
effective as of his or her Entry Date by completing such forms and providing such data as are reasonably
required by the Administrator at such time in advance as the Administrator may prescribe.
 
If the Eligible
Employee declines to make an Elective Contribution pursuant to Section 4.2 effective as of his or her Entry
Date, he or she may thereafter elect to make Elective Contributions on the first day of any subsequent pay
period on which he or she is an Eligible Employee.
 
3.3
Determination of Eligibility
 
The Administrator shall determine the eligibility of each Employee for participation in the Plan
based upon information furnished by the Employer.
 
Such determination shall be conclusive and binding upon
all persons, as long as the same is made pursuant to the Plan and ERISA.
3.4
Change in Eligibility Status
(a)
Return to Eligible Status.
 
In the event a Participant is no longer an Eligible Employee
and becomes ineligible to participate, such Employee shall become eligible to participate immediately upon
again becoming an Eligible Employee.
(b)
Change to Eligible Status.
 
In the event an Employee who is not an Eligible Employee
becomes an Eligible Employee, such Employee shall (i) be eligible to make Elective Contributions to the Plan
and receive Matching Contributions immediately, and (ii) be eligible to receive an AC Products Discretionary
Contribution (as described in Section 4.4(c)), Quaker Discretionary Contribution (as described in Section
4.4(b)), or a Nonelective Contribution (as described in Section 4.5) if he or she has satisfied the one Year
 
of
Service requirement.
 
Otherwise, such an Eligible Employee shall participate on the date determined under
Section 3.1.
3.5
Omission of Eligible Employee
 
If, in any Plan Year,
 
any Employee who should be included as a Participant in the Plan is
erroneously omitted and discovery of such omission is not made until after a contribution by his or her
Employer for the year has been made, the Employer shall make a subsequent contribution with respect to the
omitted Employee in the amount which the Employer would have contributed with respect to him or her had he
or she not been omitted.
 
Such contribution shall be made regardless of whether it is deductible in whole or in
part in any taxable year under applicable provisions of the Code.
ARTICLE IV
CONTRIBUTION AND ALLOCAT
 
ION
4.1
Formula for Determining Employer’s Contribution
 
 
 
 
 
15
(a)
Contributions.
 
For each Plan Year,
 
the Employer shall contribute to the Plan as follows:
(i)
The amount of the total salary deferral elections of all Participants made pursuant
to Section 4.2(a), which amount shall be deemed the Employer’s Elective Contribution.
(ii)
Matching Contributions made pursuant to Section 4.4(a).
(iii)
Such discretionary amounts, if any, made pursuant to Section 4.4(b) and Section
4.4(c), which amount shall be deemed a Quaker Discretionary Contribution or an AC Products Discretionary
Contribution, respectively.
(iv)
Qualified Nonelective Contributions made pursuant to Section 4.9(f).
(v)
Catch-Up Contributions made pursuant to Section 4.3.
(vi)
Nonelective Contributions made pursuant to Section 4.5.
(b)
Limit on Contributions.
 
Notwithstanding the foregoing, the Employer’s contributions for
any Plan Year
 
shall not exceed the maximum amount allowable as a deduction to the Employer under the
provisions of Code section 404, except as provided in Section 3.5 and to the extent necessary to provide the
Top-Heavy minimum allocations.
(c)
Form of Contributions.
 
All contributions by the Employer shall be made in cash or
newly issued or treasury stock, or in such property as is acceptable to the Trustee.
4.2
Participant’s Salary Deferral Election
(a)
Deferral Election.
 
 
(i)
Participant Deferral Election
.
Each Participant may elect to defer his
 
or her
Compensation which would have been received in the
 
Plan Year,
 
but for this deferral election, by any
whole percentage up to 75%. A deferral election
 
(or modification of an earlier
 
election) may not be
 
made
with respect to
 
Compensation which is
 
available on or before the date the
 
Participant executed such
election. A deferral election shall specify the portion
 
of the Participant’s
 
Elective Contribution that is
made on a pre-tax basis and the
 
portion of such contribution that is made on
 
a Roth basis. Elective
Contributions contributed to the Plan as
 
made on a
 
pre-tax basis may not later be reclassified as made on
Roth basis and vice
 
versa
.
 
The amount by which the Participant’s Compensation is reduced shall be the Participant’s
Deferred Compensation and shall be treated as an Elective Contribution and allocated to the Participant’s
Elective Account, unless the Participant directs all or part of his or her Elective Contributions to the Quaker
Stock Fund.
 
If the Participant directs all or part of his or her Elective Contributions
 
to the Quaker Stock Fund
,
such Elective Contributions
 
shall be allocated to the Stock Bonus Plan Account.
 
(ii)
 
Automatic Pre-Tax
 
Elective
 
Contributions.
(A)
Automatic Election.
 
Notwithstanding the foregoing, effective
January 1, 2020, an Eligible Employee shall be deemed to have
 
elected under this Section 4.2
 
to have pre-
tax Elective Contributions made on his behalf in
 
an amount equal to six percent (6%)
 
of Compensation
increasing annually by one percent (1%) of Compensation
 
up to ten percent (10%) of Compensation if
 
he
(1)
has met the eligibility requirements of Article
 
III, (2) has not elected otherwise in accordance
 
with
 
 
16
Section 4.2(a)(i), and (3) is hired on or
 
after January 1, 2020.
 
For Eligible Employees hired on or after
March 1, 2020, such deemed election shall
 
become effective starting with the paycheck for
 
the first pay
date on or after the 30th day following
 
the Eligible Employee’s
 
employment commencement date.
 
A deemed election that was in effect
 
with respect to a Houghton Participant under
 
the Houghton Plan shall
continue to be effect under this Plan,
 
and shall continue to increase annually by
 
one percent (1%) of
Compensation up to ten percent (10%) of Compensation
 
under the Plan.
 
A deemed election that was in
effect under the Plan with respect
 
to an Eligible Employee hired or rehired
 
on or after January 1, 2017 but
prior to January 1, 2020 shall continue to
 
be in effect under the Plan
 
and shall continue to increase
annually by one percent (1%) of Compensation
 
up to six percent (6%) of Compensation
 
under the Plan.
 
Wallover
 
Participants who were participating in the Wallover
 
Plan as of December 31, 2019 and
 
began to
participate in the Plan effective January
 
1, 2020 are not subject to the
 
automatic pre-tax Elective
Contributions provisions of this Section 4.2(a)(ii).
 
A deemed election that was in effect
 
with respect to a SIFCO Participant under
 
the SIFCO Plan shall
continue to be effect under this Plan
 
on and after January 1, 2022 (subject
 
to any changes made by the
Participant after that date permitted under the Plan)
 
as a deemed election under an automatic contribution
arrangement and not as a qualified automatic contribution
 
arrangement, and shall continue to increase
annually by one percent (1%) of Compensation
 
up to ten percent (10%) of Compensation under
 
the Plan.
Coral Participants who were participating in the Coral
 
Plan as of December 31, 2021 and
 
began to
participate in the Plan effective January
 
1, 2022 are not subject to the
 
automatic pre-tax Elective
Contributions provisions of this Section 4.2(a)(ii).
(B)
Notice.
 
The notice requirements of this Section 4.2(a)(ii)(B) shall
apply to
 
each Eligible Employee
 
described in Section
 
4.2(a)(ii)(A) who has not made an affirmative
election under Section 4.2(a)(i) to make (or not to
 
make) Elective Contributions. At least 30 days,
 
but not
more than 90 days, before the beginning
 
of the Plan Year,
 
the Employer shall provide each such Eligible
Employee notice of the Eligible Employee’s
 
rights and obligations under the automatic contribution
arrangement described in this subparagraph (B), written
 
in a manner calculated to be understood
 
by the
average Eligible Employee. If such an Eligible Employee
 
becomes subject to the automatic contribution
arrangement described in this subparagraph (B) after
 
the 90
th
day before the beginning of the Plan
 
Year
and does not receive the notice for that reason,
 
the notice will be provided no more
 
than 90 days before the
Eligible Employee becomes subject to the
 
automatic contribution arrangement described in this
subparagraph (B), but not later than the date the Eligible Employee becomes subject
 
to the automatic
contribution arrangement. The notice shall describe (i) the
 
amount of automatic pre-tax Election
Contribution that will be made on the Eligible
 
Employee’s behalf in
 
the absence of an affirmative
 
election,
(ii) the Eligible Employee’s
 
right to elect to have no
 
pre-tax Elective Contributions made on his behalf or
to have a different amount of
 
Elective Contributions made (on a pre-tax
 
or Roth basis), and (iii) how
automatic pre-tax Elective Contributions will be invested in
 
the absence of the Eligible Employee's
investment instructions.
(C)
Election.
 
In accordance with the procedures established by the
Administrator, an
 
Eligible Employee shall have a reasonable opportunity after receipt of the notice
described in Section 4.2(a)(ii)(B) to make an affirmative
 
election regarding Elective Contributions (either
to have no Elective Contributions made or,
 
subject to the limitations set forth in
 
Section 4.2(a)(i),
 
to have a
different amount of Elective Contributions made) prior
 
to the date pre-tax Elective Contributions
 
are
automatically made on his behalf pursuant to Section 4.2(a)(ii).
 
Automatic pre-tax Elective Contributions
being made on behalf of an Eligible Employee
 
pursuant to Section 4.2(a)(ii) shall cease as soon
 
as
 
 
 
 
17
administratively feasible after the Eligible Employee makes an
 
affirmative election under this Section
4.2(a)(ii)(C). An
Eligible
Employee may also make an affirmative
 
election pursuant to subsection 4.2(a)(i)
before receipt of the notice described in Section 4.2(a)(ii)(B),
 
or change the amount of
 
his pre-tax Elective
Contributions pursuant to Section 4.2(e).
(D)
Continuing Election.
 
A Participant’s
 
deemed election regarding pre-
tax Elective Contributions shall continue in effect
 
until the date that is as soon as
 
administratively feasible
following the earliest of (i) the date the
 
Participant elects otherwise in accordance with Section
 
4.2(a)(i),
(ii) the date the Administrator determines that all
 
or part of the amount elected (or
 
deemed to be elected)
by the Participant as pre-tax Elective Contributions may
 
not be contributed to
 
the Trust as such because of
the limitations set forth in this Article
 
IV,
 
or (iii) the date the Participant ceases
 
to be an Eligible
Employee.
(b)
Full Vesting
 
.
 
The balance in each Participant’s Elective Account and Stock Bonus Plan
Account attributable to Elective Contributions shall be fully vested at all times and shall not be subject to
forfeiture for any reason.
(c)
Limits on Distributions.
 
Elective Contribution amounts held in the Participant’s Elective
Account and Stock Bonus Plan Account may not be distributable earlier than:
(i)
the Participant’s
Severance from Employment, Total and Permanent Disability
 
,
 
or
death;
(ii)
the Participant’s attainment of age 59½ (only if permitted under any other Section
of the Plan);
(iii)
upon hardship with respect to the Participant (pursuant to Section 6.11); or
(iv)
the termination of the Plan without establishment or maintenance of another
defined contribution plan (other than an employee stock ownership plan as defined in Code section 4975(e)(7))
as described in Code section 401(k)(10).
(d)
Maximum Amount.
 
No Participant shall be permitted to have elective deferrals made
under this Plan or any other qualified plan maintained by the Employer during any taxable year in excess of the
dollar limitation contained in Code section 402(g) in effect for such taxable year, except to the extent permitted
under Section 4.3 and Code section 414(v), if applicable (the “402(g) limit”).
(i)
If the Participant’s Deferred Compensation made under this Plan (reduced by
Deferred Compensation previously distributed or returned to the Participant) and the Participant’s other elective
deferrals to a plan or arrangement described in Code section 402(g)(3) (whether or not maintained by the
Employer or an Affiliated Employer) exceed the maximum amount described in this subsection, the Participant
shall allocate to the Plan or to such other plan or arrangement described in Code section 402(g)(3) the Excess
Deferred Compensation.
The Participant shall notify the Administrator of such allocation in writing no later
than the March 1 following the Participant’s taxable year in which the Excess Deferred Compensation was
made.
(ii)
A Participant shall be deemed to have made a claim for distribution of Excess
Deferred Compensation from the Plan to the extent that the Participant’s Deferred Compensation together with
the Participant’s elective deferrals under any other plan or arrangement maintained by the Employer or an
Affiliated Employer exceeds the Code section 402(g) limit.
 
 
18
(iii)
A Participant’s Excess Deferred Compensation shall be reduced, but not below
zero, by any distribution of Excess Contributions pursuant to Section 4.9 for the Plan Year
 
beginning with or
within the taxable year of the Participant.
 
(iv)
Notwithstanding any other provisions of the Plan, not later than the April 15
following the close of the taxable year, the Administrator shall cause the Trustee to distribute to the Participant
the Excess Deferred Compensation allocated (or deemed to be allocated) to the Plan by the Participant pursuant
to this Section.
 
Any Excess Deferred Compensation shall be distributed as follows: (i) Deferred Compensation
to which Matching Contributions do not relate shall be distributed before Deferred Compensation to which
Matching Contributions relate and (ii) for any year in which a Participant makes Elective Contributions on a
pre-tax and on a Roth basis, the distribution of any Excess Deferred Compensation shall be made first from the
portion of the Participant’s Elective Contributions that is attributable to pre-tax contributions and second from
the portion of the Participant’s Elective Contributions that is attributable to Roth contributions.
 
The amount so
returned shall include the income and loss allocable thereto for the calendar year during which such elective
deferrals were made as determined pursuant to Regulations, using a uniformly applicable written determination
by the Administrator.
(v)
Any Matching Contributions,
 
with earnings thereon, attributable to such Excess
Deferred Compensation shall be forfeited and, in the discretion of the Administrator, (A) used to pay any
reasonable administrative expenses of the Plan or (B) used to reduce the Employer’s obligation to making
Matching Contributions under Section 4.4.
 
(e)
Deferral Elections; Changes in Deferral Elections.
 
The Employer and the Administrator
shall implement the Participant’s salary deferral elections provided for herein in accordance with the following:
(i)
A Participant may commence making Deferred Compensation contributions to the
Plan as of the Participant’s Entry Date.
 
If the Participant fails to make an initial salary deferral election prior to
such time, then such Participant may thereafter make a salary deferral election effective as of any subsequent
payroll period.
 
The Participant shall make such an election by filing a salary deferral election in accordance
with procedures established by the Administrator.
(ii)
A Participant may increase or decrease
 
the percentage of his or her Compensation
to be deferred and make a new election by providing the Administrator with notice of such modification in the
manner prescribed by the Administrator.
 
Such new election shall initially be effective beginning with the pay
period following the acceptance of the notice by the Administrator or as soon as practicable thereafter.
 
Any
modification shall not have retroactive effect and shall remain in force until revoked.
(iii)
A Participant may elect to revoke his or her salary reduction agreement
prospectively in its entirety at any time during the Plan Year
 
by providing the Administrator with notice of such
revocation in the manner prescribed by the Administrator.
 
Such revocation shall become effective as of the
beginning of the first pay period coincident with or next following the date of notice or as soon as practicable
thereafter.
 
Furthermore, the Participant’s Severance from Employment, change in status to other than Eligible
Employee, or the cessation of participation for any reason, shall be deemed to revoke any salary reduction
agreement then in effect, effective immediately following the close of the pay period within which such
termination or cessation occurs.
(iv)
The Administrator may, in its sole discretion, from time to time prohibit
 
or limit
the amount of Elective Contributions made to the Plan on behalf of Highly Compensated Employees to the
extent necessary to satisfy either the Actual Deferral Percentage Test set forth in Section 4.8(a) or the Actual
Contribution Percentage Test set forth in Section 4.8(b).
 
Any such limit on the amount of Elective
Contributions made to the Plan on behalf of Highly Compensated Employees, as determined by the
 
 
 
 
19
Administrator, shall be deemed an amendment to the Plan for purposes of Regulation 1.401-1, but the adoption
of such limit shall not be subject to Section 8.1.
(f)
Qualified Military Service.
 
Notwithstanding any provisions of this Plan to the contrary,
all contributions with respect to periods of Qualified Military Service shall be provided in a manner consistent
with Code section 414(u) as follows:
(i)
The Employer shall permit a reemployed Participant to make additional Deferred
Compensation contributions during the period which begins on the date of the reemployment of such Participant
and has the same length as the lesser of the product of three and the period of Qualified Military Service which
resulted in such rights, or five years.
(ii)
The amount of additional Deferred Compensation contributions permitted under
this subsection is the maximum amount of the Deferred Compensation contributions that the Participant would
have been permitted to make under the Plan during the period of Qualified Military Service if the Participant
had continued to be employed by the Employer during such period and received Compensation.
 
Proper
adjustment shall be made to the amount determined under the preceding sentence for any Deferred
Compensation contributions actually made during the period of such Qualified Military Service.
4.3
Catch-Up Contributions
(a)
In General.
 
A Catch-Up Eligible Employee shall be eligible to make Catch-Up
Contributions in accordance with, and subject to the limitations of, Code section 414(v).
 
Such Catch-Up
Contributions shall not be taken into account for purposes of the provisions of the Plan implementing the
required limitations of Code sections 402(g) and 415.
 
Furthermore, the Plan shall not be treated as failing to
satisfy the provisions of the Plan implementing the requirements of Code sections 401(k)(3), 401(k)(11),
401(k)(12), 410(b), or 416, as applicable, by reason of the making of such Catch-Up Contributions.
(b)
Rules Regarding Catch-Up Contributions.
 
The Plan shall be administered in accordance
with final Regulations and other guidance issued by the Internal Revenue Service under Code section 414(v).
 
Subject to such Regulations and other guidance, the following provisions shall apply with respect to Catch-Up
Contributions:
(i)
A Catch-Up Eligible Employee shall be given an opportunity to elect to make
Catch-Up Contributions for a Plan Year.
 
Such election shall be made at such time and in such manner as
prescribed by the Administrator and shall specify the portion of the Participant’s Catch-Up Contribution that is
made on a pre-tax basis and the portion of such contribution that is made on a Roth basis.
 
Catch-Up
Contributions contributed to the Plan as made on a pre-tax basis may not later be reclassified as made on Roth
basis and vice versa.
(ii)
No Employer Matching Contributions shall be made with respect to Catch-Up
Contributions.
(iii)
Except as otherwise provided in this Section, Catch-Up Contributions and
earnings thereon shall be treated in the same manner as Elective Contributions made pursuant to Section 4.2
(and earnings thereon) and Deferred Compensation.
4.4
Employer Matching and Discretionary Contributions
(a)
Matching Contributions.
 
For each Participant who makes Elective Contributions with
respect to one or more payroll periods for which a Matching Contribution has been authorized by the
 
 
 
20
Administrator pursuant to this subsection (the “Match Period”), the Employer shall make a Matching
Contribution to the Plan on behalf of such Participant in the amount (if any) authorized by the Administrator, in
its sole discretion; provided, however, that:
 
(i)
The amount of Matching Contribution authorized by the Administrator shall not
exceed 50% of such Participant’s Deferred Compensation (other than Catch-Up Contributions) during the
Match Period up to the first 6% of such Participant’s Compensation during such period, plus a “true-up”
Matching Contribution equal to the excess (if any) of (A) 50% of the Participant’s Deferred Compensation
(other than Catch-Up Contributions) for the Match Period (or, if less, 3% of the Participant’s
 
Compensation for
the period he or she is eligible to participate in the Plan during such Match Period), over (B) the Matching
Contribution already contributed to the Plan on behalf of the Participant for such Match Period;
(ii)
With respect to a Participant who is a member of a unit of Employees covered by
a collective bargaining unit, the Administrator shall not have the authority to decrease the Matching
Contribution to less than the amount (if any) required by such collective bargaining agreement; and
(iii)
With respect to a period of Qualified Military Service, the Administrator shall not
have the authority to decrease the Matching Contribution to less than the amount (if any) required by Code
section 414(u).
Effective with the Elective Contributions taken from
 
the paycheck for the first pay date
 
on or after April
17, 2020, the Matching Contribution may be made
 
in cash or in Company Securities
 
in the sole discretion
of the Administrator.
 
Matching Contributions made in cash will be invested
 
according to the direction of
the Participant, Beneficiary,
 
or alternate payee under Section 4.13(a).
 
To
 
the extent a Matching
Contribution is made in Company Securities, the
 
contribution shall be invested in the Quaker
 
Stock Fund,
subject to any subsequent reapportionment direction of the Participant,
 
Beneficiary, or
 
alternate payee
under Section 4.13(e).
 
(b)
Quaker Discretionary Contributions.
 
The Employer shall make such contributions to the
Fund in respect of each calendar year during which this Plan is in effect as are determined in accordance with
such formula as may from time to time be approved by the Board of Directors, in its absolute discretion.
 
Such
contributions shall be referred to as Quaker Discretionary Contributions.
 
This subsection shall not be construed
as requiring the
 
Employer to make
 
contributions in
 
any specific
 
calendar year, whether or
 
not there exists net
income out of which such contributions could be made.
 
Notwithstanding the foregoing, no Quaker
Discretionary Contributions shall be made on behalf of or allocated to the account of any AC Participant, Epmar
Participant, Summit Participant, ECLI Participant, Houghton Participant, Wallover
 
Participant, Coral
Participant or SIFCO Participant.
(c)
AC Products Discretionary Contributions.
 
AC Products, Inc. shall make such
contributions to the Fund in respect of each calendar year during which this Plan is in effect as are determined
in accordance with such formula as may from time to time be approved by the Board of Directors of AC
Products, Inc., in its absolute discretion.
 
This provision shall not be construed as requiring AC Products, Inc. to
make contributions in any specific calendar year, whether or not there exists Net Income out of which such
contributions could be made.
 
For purposes of this subsection, “Net Income” shall mean the profit from
operations of AC Products, Inc., as determined by the Board of Directors of AC Products, Inc., from the internal
financial statements of AC Products, Inc. for the calendar year.
4.5
Employer Nonelective Contributions
(a)
Eligibility Requirements.
 
Nonelective Contributions shall be made on behalf of each
Participant who (i) is not included in a unit of Employees covered by a collective bargaining agreement, except
 
 
 
 
 
21
to the extent that the applicable collective bargaining agreement so provides (including not limited to an
Eligible Employee of the Coral Chemical Company whose employment is governed by the terms of a collective
bargaining agreement between Local 301, Cartage Division or the Plant Workers
 
Agreement and Coral
Chemical Company), and (ii) has met the conditions of eligibility set forth in Section 3.1(b).
 
Notwithstanding
the foregoing, Employees hired on or after February 10, 2020 who are covered by a collective bargaining
agreement between the Employer and the International Chemical Workers
 
Union Council of the United Food
and Commercial Workers Union and its
 
Local No. 125C, shall be eligible to receive Nonelective Contributions
provided they have met the conditions of eligibility set forth in Section 3.1(b).
(b)
Amount of Contribution.
 
Subject to the limitations of Section 4.10, the Employer shall
make Nonelective Contributions to the Fund for a Plan Year
 
in an amount equal to 3% of the Compensation of
each Participant who satisfied the eligibility requirements of subsection (a) at any time during such Plan Year;
provided, however, that Compensation with respect to any period in which the Participant does not meet the
eligibility requirements of subsection (a) shall be disregarded for purposes of determining the amount of the
Nonelective Contribution.
 
(c)
Investment.
 
Effective with the first pay date
 
on or after April 17, 2020, the
Nonelective Contribution may be made in cash
 
or in Company Securities in the sole
 
discretion of the
Administrator.
 
Nonelective Contributions made in cash will be
 
invested according to the direction of the
Participant, Beneficiary,
 
or alternate payee under Section 4.13(a).
 
To the
 
extent Nonelective Contributions
are made in Company Securities, the contribution shall
 
be invested in the Quaker Stock Fund, subject
 
to
any subsequent reapportionment direction of the Participant, Beneficiary,
 
or alternate payee under Section
4.13(e).
 
4.6
Time Of Payment of Employer’s Contribution
 
The Employer shall pay to the Trustee Elective Contributions accumulated through payroll
deductions as of the earliest date on which such contributions can be reasonably segregated from the general
assets, and such amounts shall be segregated no later than the 15th business day of the month following the
month in which Elective Contributions were deducted from the Participant’s Compensation.
 
The Employer
shall pay to the Trustee Matching Contributions, AC Products Discretionary Contributions, Quaker
Discretionary Contributions,
 
and Nonelective Contributions for any Plan Year
 
under this Article IV no later
than the last day on which amounts so paid may be deducted for Federal income tax purposes for the taxable
year of the Employer in which the Plan Year
 
ends.
 
Any additional contributions made by the Employer that are
allocable to a Participant’s Elective Account for a Plan Year
 
shall be paid to the Plan no later than the end of the
12- month period immediately following the close of the Plan Year
 
in which the contributions were made.
 
4.7
Allocation of Contribution And Earnings
(a)
Accounts. The Administrator shall establish and maintain an account in the name of each
Participant to which the Administrator shall credit all amounts allocated to each such Participant as set forth
herein.
(b)
Allocation of Contributions.
 
The Employer shall provide the Administrator with all
information required by the Administrator to make a proper allocation of the Employer’s contributions for each
Plan Year.
 
Within a reasonable period of time after the date of receipt by the Administrator of such information
and sufficient funding, the Administrator shall allocate such contributions as follows:
(i)
Elective Contributions.
 
With respect to the Elective Contributions made pursuant
to Section 4.2(a) or Section 4.3,
to each Participant’s Elective Account and Stock Bonus Plan Account, as
applicable, in an amount equal to each such Participant’s Deferred Compensation for the year.
 
 
 
 
 
 
22
(ii)
Matching Contributions.
 
With respect to Matching Contributions made pursuant
to Section 4.4(a), to each Participant’s Account and Stock Bonus Plan Account,
 
as applicable, in an amount
equal to the Matching Contribution made by the Employer to the applicable account on behalf of the Participant
as set forth in Section 4.4(a).
(iii)
Quaker Discretionary Contributions.
 
Quaker Discretionary Contributions, if any,
made pursuant to Section 4.4(b) for a Plan Year
 
shall be allocated to each eligible Participant’s account in the
same proportion that each eligible Participant’s Base Compensation for such Plan Year
 
bears to the total Base
Compensation of all Participants who are eligible to receive the Quaker Discretionary Contribution for such
Plan Year,
 
such amount to be allocated to the Participant’s Account and Stock Bonus Plan Account,
 
as
applicable.
 
Except as provided in Section 4.7(b)(vi), only those Participants who (A) have completed a Year
 
of
Service during the Plan Year;
 
(B) are actively employed on the last day of the Plan Year;
 
and (C)
are not AC
Participants, Epmar Participants, Summit Participants, ECLI Participants, Houghton Participants, Wallover
Participants, Coral Participants or SIFCO Participant shall be eligible to share in the allocation of the Quaker
Discretionary Contributions for the Plan Year.
(iv)
AC Products Discretionary Contributions.
 
The AC Products Discretionary
Contributions, if any, made pursuant to Section 4.4(c) for a Plan Year
 
shall be allocated to each eligible AC
Participant’s account in the same proportion that each eligible AC Participant’s
 
Compensation for such Plan
Year
 
bears to the total Compensation of all Participants who are eligible to receive the AC Products
Discretionary Contribution for such Plan Year
 
,
 
such amount to be allocated to the Participant’s Account and
Stock Bonus Plan Account, as applicable.
 
Except as provided in Section 4.7(b)(vi), only AC Participants who:
(A)
 
have completed a Year
 
of Service during the Plan Year;
 
and (B) are actively employed on the last day of
the Plan Year,
 
shall be eligible to receive an allocation of the AC Products Discretionary Contributions for the
Plan Year.
(v)
Nonelective Contributions.
 
Nonelective Contributions made pursuant to Section
4.5 shall be allocated to each eligible Participant’s Account in an amount equal to the Nonelective Contribution
made by the Employer on behalf of the Participant as set forth in Section 4.5.
(vi)
Exception to Last Day of Year
 
Requirement.
 
Notwithstanding the foregoing,
Participants who are not actively employed on the last day of the Plan Year
 
due to Retirement (Normal or Late),
Total and Permanent Disability,
 
or death shall share in the allocation of Quaker Discretionary Contributions or
AC Products Discretionary Contributions for that Plan Year.
(c)
Allocation of Earnings and Losses.
 
As of the last day of each Plan Year
 
or other
Valuation
 
Date, before allocation of Employer contributions, any earnings or losses (net appreciation or net
depreciation) of the Fund shall be allocated in the same proportion that each Participant’s nonsegregated
accounts bear to the total of all Participants’ nonsegregated accounts as of such date.
 
Each segregated account
maintained on behalf of a Participant shall be credited or charged with its separate earnings and losses.
(d)
Top-Heavy Plan Year
 
.
 
(i)
Notwithstanding the foregoing, for any Top-Heavy Plan Year,
 
the sum of the
Employer’s contributions and forfeitures allocated to the Aggregate Account of each non-Key Employee shall
be equal to at least 3% of such non-Key Employee’s 415 Compensation (reduced by contributions and
forfeitures, if any, allocated to each non-Key Employee in any defined contribution plan included with this Plan
in a Required Aggregation Group).
 
However, if (i) the sum of the Employer’s
 
contributions and forfeitures
allocated to the Aggregate Account of each Key Employee for such Top-Heavy Plan Year
 
is less than 3% of
each Key Employee’s 415 Compensation and (ii) this Plan is not required to be included in an Aggregation
Group to enable a defined benefit plan to meet the requirements of Code section 401(a)(4) or 410, the sum of
 
 
 
 
23
the Employer’s contributions and Forfeitures allocated to the Aggregate Account of each non-Key Employee
shall be equal to the largest percentage allocated to the Aggregate Account of any Key Employee.
 
Employer
Matching Contributions shall be taken into account for purposes of satisfying the minimum contribution
requirements of Code section 416(c)(2) and this subsection.
 
Employer Matching Contributions that are used to
satisfy the minimum contribution requirements shall be treated as Matching Contributions for purposes of the
actual contribution percentage test set forth in Section 4.8(b) and other requirements of Code section 401(m).
 
However, no such minimum allocation shall be required in this Plan for any non-Key Employee who
participates in another defined contribution plan subject to Code section 412 that is included with this Plan in a
Required Aggregation Group.
(ii)
For purposes of the minimum allocations set forth above, the percentage allocated
to the Aggregate Account of any Key Employee shall be equal to the ratio of the sum of the Employer’s
contributions and Forfeitures allocated on behalf of such Key Employee divided by the 415 Compensation for
such Key Employee.
(iii)
For any Top-Heavy Plan Year,
 
the minimum allocations set forth above shall be
allocated to the Aggregate Accounts of all non-Key Employees who are Participants and who are employed by
the Employer on the last day of the Plan Year,
 
including non-Key Employees who have (A) failed to complete a
Year
 
of Service; and (B) declined to make mandatory contributions (if required) or, in the case of a cash or
deferred arrangement, Elective Contributions to the Plan.
(iv)
For the purposes of this Section, 415 Compensation shall be limited by and
adjusted in such manner as permitted under Code section 415(d).
(e)
Matching Contributions – No Hour of Service Requirement.
 
Notwithstanding anything
herein to the contrary, a Participant who terminates employment for any reason during the Plan Year,
 
has made
Elective Contributions for the Plan Year
 
,
 
and is otherwise eligible to receive an allocation of Matching
Contributions, shall share in an allocation of the Matching Contribution made by the Employer for the year of
termination without regard to the Hours of Service credited.
(f)
Forfeitures.
 
As of the last day of each Plan Year,
 
any amounts which become a
Forfeiture during such Plan Year
 
shall, in the discretion of the Administrator, be used to (i) reduce the
Employer’s obligation to make Matching Contributions, AC Products Discretionary Contributions, Quaker
Discretionary Contributions,
 
and/or Nonelective Contributions,
 
or (ii) pay any administrative expenses of the
Plan.
(g)
Reemployment after Break in Service.
 
If a Participant is reemployed after five
consecutive 1-Year
 
Breaks in Service, then separate accounts shall be maintained as follows:
(i)
one account for nonforfeitable benefits attributable to pre-break service; and
(ii)
one account representing his or her status in the Plan attributable to post-break
service.
(h)
Restoration of Forfeitures.
 
If a Participant is reemployed as an Eligible Employee, any
Forfeiture of his or her Participant’s Account that has occurred under Section 1.31(a) shall be restored to his or
her Participant’s Account by the Employer if the Participant repays to the Plan in full the amount of the
distribution he or she received; provided such repayment is made not later than the earlier of (i) the close of the
first period of five consecutive 1-Year
 
Breaks in Service commencing after the distribution,
 
or (ii) five years
after the date on which the Participant again becomes an Eligible Employee.
 
 
24
4.8
Actual Deferral Percentage Test and Actual Contribution Percentage Test
(a)
Actual Deferral Percentage Test.
 
This subsection shall be applied separately with respect
to the Non-Safe Harbor Component Plan and the Bargaining Component Plan, and the term “Plan” as used in
this subsection shall refer to the component plan being tested.
 
The safe harbor set forth in Code section
401(k)(12) shall apply to the Safe Harbor Component Plan.
 
(i)
 
The actual deferral percentage for Highly Compensated Employees who have met
the Plan’s eligibility requirements shall not be less than or equal two at least one of the following:
(A)
 
The actual deferral percentage for such Plan Year
 
for all Nonhighly
Compensated Employees who have met the Plan’s eligibility requirements,
multiplied by 1.25; or
(B)
 
The actual deferral percentage for such Plan Year
 
for all Nonhighly
Compensated Employees who have met the Plan’s eligibility requirements,
multiplied by 2.0, provided that the actual deferral percentage for Highly
Compensated Employees who have met the Plan’s eligibility requirements does
not exceed the actual deferral percentage for Nonhighly Compensated Employees
who have met the Plan’s eligibility requirements by more than two percentage
points.
 
(ii)
 
For purposes of this Section, the term “actual deferral percentage” as applied to a
specified group of Employees who have met the Plan’s eligibility requirements shall mean the average of the
ratios, calculated separately for each such Employee in such group, of:
(A)
 
The amount of Deferred Compensation paid to the Plan on behalf of each
such Employee for such Plan Year
 
(excluding (A) any amount of Deferred
Compensation paid to the Plan by a Nonhighly Compensated Employee in excess
of the Code section 402(g) limit for such Plan Ye
 
ar, and (B) Deferred
Compensation made pursuant to Code section 414(u) by reason of a Participant’s
qualified military service (provided, however, that the portion of Deferred
Compensation contributed from differential wage payments (within the meaning
of Code section 414(u)(12)) shall be disregarded only if the nondiscrimination
requirement set forth in Code section 414(u)(12)(C) is satisfied); to
(B)
 
The Participant’s 414(s) Compensation for such Plan Year;
 
provided,
however, that the Administrator may determine, for any Plan Year,
 
to consider
only that Compensation paid to an Employee while he or she is eligible to
participate in the Plan.
(b)
Actual Contribution Percentage Test.
 
The Plan shall satisfy the “actual contribution
percentage test,” which shall mean the numerical test set forth in subsection (a), revised by disregarding any
reference to component plans and substituting for the term “actual deferral percentage” the term “actual
contribution percentage”; provided, however, that pursuant to Regulation section 1.401(m)-1(b)(2), the Actual
Contribution Test shall not apply to the Bargaining
 
Component Plan.
 
The term “actual contribution percentage”
as applied to a specified group of Employees shall mean the average of the ratios, calculated separately for each
Employee in such group who, if he or she made Elective Deferrals, would have Matching Contributions
allocated to his or her account for the year, of:
 
 
 
 
25
(i)
the amount of Matching Contributions (excluding (A)
 
Matching Contributions
forfeited pursuant to Section 4.2(d) or Section 4.9(c),
 
and (B) Matching Contributions made pursuant to
Code section 414(u)
 
by reason of
 
a Participant’s qualified military service (provided, however,
 
that the
portion of the Matching Contribution that is made with
 
respect to any Deferred Compensation contributed
from differential wage payments (within the meaning
 
of Code section 414(u)(12)) shall be disregarded
only if the nondiscrimination requirement set forth in
 
Code section 414(u)(12)(C) is satisfied) paid to
 
the
Plan on behalf of such Employee for such
 
Plan year;
 
to
(ii)
the Participant’s 414(s) Compensation for such Plan Year;
 
provided, however,
that the Administrator may determine, for any Plan Year,
 
to consider only that Compensation paid to an
Employee while he or she is eligible to participate in the Plan.
(c)
Nonaggregation.
 
Pursuant to Regulation sections 1.401(k)-1(b)(4)(iii)(B) and 1.401(m)-
1(b)(4)(iii)(B), the Plan cannot be tested on an aggregate basis with any other cash or deferred arrangement that
uses a methodology to satisfy the actual deferral percentage test or the actual contribution percentage test that is
inconsistent with the Plan’s methodology to satisfy these tests.
4.9
Return of Excess Contributions, Return of Excess Aggregate Contributions, And Special Rules
 
Subsections (a) and (c) shall be applied separately to Highly Compensated Employees who are
covered by the Non-Safe Harbor Component Plan and Highly Compensated Employees who are covered by the
Bargaining Component Plan, and such subsections shall apply only to the extent of the Highly Compensated
Employee’s contributions under such Component Plan.
 
Subsections (a) and (c) shall not apply to the Safe
Harbor Component Plan.
(a)
Determination of Aggregate Amount of Excess Contributions.
 
Excess Contributions
shall be returned to Highly Compensated Employees in the manner set forth in subsection (c) if the limitations
under Section 4.8(a) are exceeded.
 
Excess Contributions to be returned to Highly Compensated Employees
shall be determined by:
(i)
reducing the actual deferral percentage of the Highly Compensated Employee
with the highest actual deferral percentage until the applicable nondiscrimination test of Section 4.8(a) has been
satisfied or until the actual deferral percentage of such Highly Compensated Employee is equal to the actual
deferral percentage of the Highly Compensated Employee with the next highest actual deferral percentage;
(ii)
repeating the process in paragraph (i) above until the applicable nondiscrimination
test of Section 4.8(a) is satisfied;
(iii)
converting into a dollar amount any reduction in the actual deferral percentage of
each affected Highly Compensated Employee; and
(iv)
adding together the dollar amounts of the excess Deferred Compensation
determined under paragraph (iii) above for each affected Highly Compensated Employee.
(b)
Determination of Aggregate Amount of Excess Aggregate Contributions.
 
The amount of
excess Matching Contributions (“Excess Aggregate Contributions”) to be returned to Highly Compensated
Employees shall be determined in the manner set forth in subsection (a).
 
Excess Aggregate Contributions, if
any, shall be returned to Highly Compensated Employees in the manner set forth in subsection (d).
(c)
Determination of Individual Amount of Excess Contributions.
 
Should the actual deferral
percentage of Highly Compensated Employees for a Plan Year
 
exceed the restrictions described in Section
 
 
 
 
26
4.8(a), the Excess Contribution shall be distributed to Highly Compensated Employees from the Elective
Account (and Stock Bonus Plan Account), starting with the Highly Compensated Employee with the greatest
dollar amount of Deferred Compensation for the Plan Year
 
or until the Deferred Compensation made by such
Highly Compensated Employee equals the Deferred Compensation made by the Highly Compensated
Employee with the next greatest dollar amount of Deferred Compensation for the Plan Year.
 
For purposes of
the preceding sentence, any Excess Contributions shall be distributed as follows: (i) Distributions to any Highly
Compensated Employee shall first be made with respect to Deferred Compensation that is not taken into
account in determining Matching Contributions pursuant to Section 4.4(a); and (ii) for any year in which a
Participant makes Elective Contributions on a pre-tax and on a Roth basis, the distribution of any Excess
Contribution shall be made first from the portion of the Participant’s Elective Contributions that is attributable
to pre-tax contributions and second from the portion of the Participant’s Elective Contributions that is
attributable to Roth contributions.
 
This process shall be repeated until all the excess Deferred Compensation
attributable to the applicable test has been distributed.
 
Any Matching Contributions attributable to such Excess
Contributions (regardless of whether such Excess Contributions are attributable to Elective Contributions made
on a pre-tax or on a Roth basis) distributed to Highly Compensated Employees shall be forfeited in accordance
with subsection (e).
(d)
Determination of Individual Amount of Excess Aggregate Contributions.
 
Should the
actual contribution percentage of Highly Compensated Employees for a Plan Year
 
exceed the restrictions
described in Section 4.8(b) the Excess Aggregate Contributions shall be forfeited, if forfeitable, or,
 
if not
forfeitable, distributed, starting with the account of the Highly Compensated Employee with the greatest dollar
amount of Matching Contributions in the manner described in subsection (c).
(e)
Timing of Distribution/Forfeiture.
 
The distribution or forfeiture made pursuant to
subsections (c) and (d) above shall be made within two and one-half months following the close of such Plan
Year,
 
if administratively practicable, but in no event later than the last day of the 12-month period following the
close of such Plan Year.
 
Any distribution or forfeiture for purposes of the preceding sentence shall be
determined after taking into account income or loss for the applicable Plan Year.
 
Any Matching Contributions,
with earnings thereon, that have been allocated to a Participant on account of Excess Contributions shall be
forfeited.
 
Amounts forfeited shall, at the discretion of the Administrator, be (i) used to pay any administrative
expenses of the Plan, or (ii) used to reduce the Employer’s obligation to make Matching Contributions allocated
under Section 4.4(a).
(f)
Special Rules.
(i)
Qualified Nonelective Contribution.
 
Notwithstanding anything to the contrary
herein, within 12 months after the end of the applicable Plan Year,
 
the Employer may make a special Qualified
Nonelective Contribution in an amount that does not exceed the minimum amount necessary to satisfy the
test(s) set forth in Section 4.8(a) and/or 4.8(b).
 
Such Qualified Nonelective Contribution shall be allocated to
the Elective Accounts of the minimum necessary number of Nonhighly Compensated Employees who met the
Plan’s eligibility requirements for the applicable Plan Year,
 
starting with the Nonhighly Compensated
Employee with the lowest Compensation for such Year
 
,
 
and shall be such percentage of the Nonhighly
 
Compensated Employee’s Compensation for the year that (i) results in the lowest aggregate amount of
Qualified Nonelective Contributions,
 
and (ii) satisfies the rule against disproportionate contributions set forth in
Regulation section 1.401(k)-2(a)(6)(iv).
 
For purposes of applying this subsection to Section 4.8(a), the term
“Plan” shall refer to the Non-Safe Harbor Component Plan or the Bargaining Component Plan, as applicable.
(ii)
Other Contributions Taken Into Account for ACP Test
 
.
 
For purposes of
determining the actual contribution percentage and the amount of Excess Aggregate Contributions pursuant to
Section 4.8(b), only Matching Contributions credited on behalf of an eligible Employee in accordance with
 
 
 
 
 
27
Regulation section 1.401(m)-2(a) for the applicable Plan Year
 
shall be counted.
 
In addition, the Administrator
may elect to take into account elective contributions and qualified nonelective contributions (as defined in
Regulation section 1.401(m)-2(a)) contributed to any plan maintained by the Employer in determining the
actual contribution percentage for each applicable Employee for the applicable Plan Year,
 
provided such
amounts comply with the provisions of Regulation section 1.401(m)-2(a).
 
Elective contributions under the Plan
shall not be taken into account for purposes of Section 4.8(b).
(iii)
Ratios.
 
All ratios and averages of ratios calculated hereunder shall be calculated
to the nearest 1/100 of 1%.
(iv)
Highly Compensated Employee Participating in Multiple Plans.
 
For purposes of
Section 4.8(a), the actual deferral percentage of a Highly Compensated Employee who is eligible to have
elective deferrals (or contributions treated as elective deferrals) allocated to his or her accounts under two or
more arrangements described in Code section 401(k), that are maintained by the Employer or an Affiliated
Employer, shall be determined as if such elective deferrals (or contributions treated as elective deferrals) were
made under a single arrangement.
 
If a Highly Compensated Employee participates in two or more cash or
deferred arrangements of the Employer or an Affiliated Employer that have different plan years, all elective
deferrals made during the Plan Year
 
under all such arrangements shall be aggregated.
 
For purposes of Section
4.8(b), the actual contribution
 
percentage of a Highly Compensated Employee who is eligible to have matching
contributions or employee contributions (or contributions treated as matching or employee contributions)
allocated to his or her accounts under two or more plans described in Code section 401(a), or arrangements
described in Code section 401(k) that are maintained by the Employer or an Affiliated Employer, shall be
determined as if the total of such matching contributions or employee contributions (or contributions treated as
matching or employee contributions) were made to each plan and arrangement.
 
If a Highly Compensated
Employee participates in two or more such plans or arrangements that have different plan years, all matching
contributions or employee contributions (or contributions treated as matching or employee contributions) made
during the Plan Year
 
under all such plans and arrangements shall be aggregated.
 
Notwithstanding the
foregoing, certain plans shall be treated as separate if mandatorily disaggregated under Regulations under Code
section 401(k) or Code section 401(m).
 
(v)
Aggregation
 
of Plans.
 
For purposes of Sections 4.8 and 4.9, the Plan shall be
aggregated and treated as a single plan with other plans maintained by the Employer and an Affiliated Employer
to the extent that the Plan is aggregated with any such other plan for purposes of satisfying Code sections
401(a)(4) and 410(b) (other than Code section 410(b)(2)(A)(ii)).
 
In addition, if this Plan is permissively
aggregated with any other plan of the Company or an Affiliated Employer for purposes of satisfying Code
section 401(k) or 401(m),
 
this Plan and such other plan or plans shall satisfy Code section 401(a)(4) and 410(b)
as if this Plan and such other plan or plans were a single plan.
 
(vi)
Prior Year
 
Testing.
 
Notwithstanding anything herein to the contrary, in
accordance with applicable Regulations and applicable guidance, the Employer may elect to apply the tests set
forth in Sections 4.8(a) and (b) using the actual deferral percentage and the actual contribution percentage, as
applicable, for the preceding Plan Year
 
for Nonhighly Compensated Employees who have met the Plan’s
eligibility requirements in lieu of such percentages for the current Year.
(vii)
Early Participation Rule.
 
For purposes of Sections 4.8(a) and 4.8(b), with respect
to any Plan Year
 
for which the Employer elects to apply Code section 410(b)(4)(B) in determining whether the
requirements of Code section 401(k)(3)(A)(i) (for purposes of Section 4.8(a)) or Code section 410(b) (for
purposes of Section 4.8(b)) are met, the Employer may elect to exclude from consideration all Eligible
Employees who are Nonhighly
 
Compensated Employees and who have not attained age 21 and completed at
least one year of eligibility service.
 
In no event, however, shall the early participation rule described in this
 
 
 
28
subsection apply to the Safe Harbor Component Plan or the Non-Safe Harbor Component Plan for purposes of
Section 4.8(a).
4.10
Maximum Annual Additions
(a)
Limit on Allocations.
 
Except to the extent permitted under Section 4.3 and Code section
414(v), if applicable, the maximum annual addition that may be contributed or allocated to a Participant’s
accounts under the Plan for any limitation year shall not exceed the lesser of:
(i)
$58,000, as adjusted for increases in the cost-of-living under Code section 415(d)
for limitation years after 2021; or
(ii)
100% of the Participant’s 415 Compensation for such limitation year.
The compensation limit referred to in paragraph (ii) shall not apply to any contribution for medical benefits
after separation from service (within the meaning of Code section 401(h) or 419(A)(f)(2)) which is otherwise
treated as an annual addition.
(b)
Annual Additions.
 
For purposes of applying the limitations of Code section 415, “annual
additions” means the sum of all contributions by the Participant, other than rollover contributions, or by the
Employer or an Affiliated Employer hereunder or under any defined contribution plan maintained by either, all
forfeitures allocated to the Participant’s accounts under such plans, and amounts treated as part of an annual
addition under the limitations of Code sections 415(l) and 419A(d)(2).
 
For purposes of applying the limitations of Code section 415, a Rollover Contributions is not an
annual addition.
 
In addition, the following are not Employee contributions for purposes of this subsection:
 
(i)
rollover contributions (as defined in Code sections 402(c), 403(a)(4), 403(b)(8), and 408(d)(3)); (ii) repayments
of loans made to a Participant from the Plan; (iii) repayments of distributions received by an Employee pursuant
to Code section 411(a)(7)(B) (cashouts); (iv) repayments of distributions received by an Employee pursuant to
Code section 411(a)(3)(D) (mandatory contributions); and (v) Employee contributions to a simplified employee
pension excludable from gross income under Code section 408(k)(6).
(c)
Limitation Year.
 
For purposes of applying the limitations of Code section 415, the
“limitation year” shall be the Plan Year.
(d)
Aggregation Rules.
 
(i)
For the purpose of this Section, all qualified defined contribution plans (whether
terminated or not) ever maintained by the Employer shall be treated as one defined contribution plan.
(ii)
For the purpose of this Section, if the Employer is a member of a controlled group
of corporations, trades or businesses under common control (as defined by Code section 1563(a) or Code
sections 414(b) and (c) as modified by Code section 415(h)), is a member of an affiliated service group (as
defined by Code section 414(m)), or is a member of a group of entities required to be aggregated pursuant to
Regulations under Code section 414(o), all Employees of such Employers shall be considered to be employed
by a single Employer.
(iii)
If a Participant participates in more than one defined contribution plan maintained
by the Employer and such plans have different Plan Years,
 
the maximum annual additions under this Plan shall
equal the maximum annual additions for the limitation year minus any annual additions previously credited to
such Participant’s accounts during the limitation year.
 
29
(iv)
If a Participant participates in both a defined contribution plan subject to Code
section 412 and a defined contribution plan not subject to Code section 412 maintained by the Employer which
have the same Plan Year,
 
annual additions shall be credited to the Participant’s accounts under the defined
contribution plan subject to Code section 412 prior to crediting annual additions to the Participant’s accounts
under the defined contribution plan not subject to Code section 412.
(v)
If a Participant participates in more than one defined contribution plan not subject
to Code section 412 maintained by the Employer and such plans have the same Plan Year,
 
the maximum annual
additions under this Plan shall equal the product of (A) the maximum annual additions for the limitation year
minus any annual additions previously credited above, multiplied by (B) a fraction (I) the numerator of which is
the annual additions which would be credited to such Participant’s Account under this Plan without regard to
the limitations of Code section 415 and (II) the denominator of which is such annual additions for all plans
described in this subsection.
4.11
Correction of Excess Annual Additions
 
If there is an excess annual addition with respect to a Participant for a limitation year, such
excess annual addition shall be corrected in accordance with the Internal Revenue Service Employee Plans
Compliance Resolution System or as otherwise permitted by applicable law and Regulations.
4.12
Rollovers From Other Plans
(a)
Rollover Contributions Accepted.
 
With the consent of the Administrator, the Plan
 
shall
accept an eligible rollover distribution by a Participant from the following:
 
(i)
a qualified plan described in Code section 401(a) or 403(a), excluding after-tax
employee contributions;
 
(ii)
an annuity contract described in Code section 403(b), excluding after-tax
contributions;
 
(iii)
an eligible plan under Code section 457(b) which is maintained by a state,
political subdivision of a state, or any agency or instrumentality of a state or political subdivision of a state;
(iv)
the portion of a distribution from an individual retirement account or annuity
described in Code section 408(a) or 408(b) that would otherwise be includable in gross income; and
(v)
the portion of a distribution from a designated Roth account under an applicable
retirement plan described in Code section 402A, but only to the extent that (i) it is a direct rollover and (ii) is
not includible in income when determined without regard to the rollover;
provided, however that (A) the rollover will not jeopardize the tax-exempt status of the Plan or Trust or create
adverse tax consequences for the Employer, and (B) a distribution to which the Participant is entitled as a
Surviving Spouse shall not be rolled over to the Plan.
 
If the Administrator determines the rollover amount
contains an invalid rollover amount, such amount plus any earnings shall be distributed within a reasonable time
after such determination.
 
The amounts transferred shall be set up in a separate account herein referred to as a
Participant’s Rollover Account.
 
Such account shall be fully vested at all times and shall not be subject to
forfeiture for any reason.
 
 
 
 
 
 
 
 
30
(b)
Withdrawals and Distributions Limited.
 
Amounts in a Participant’s Rollover Account
shall be held by the Trustee pursuant to the provisions of this Plan and may not be withdrawn by or distributed
to the Participant, in whole or in part, except as provided in subsection (c).
(c)
Distributions.
 
On such date as the Participant or his or her Beneficiary shall be entitled to
receive benefits, the fair market value of the Participant’s Rollover Account shall be used to provide additional
benefits to the Participant or his or her Beneficiary.
 
Any distributions of amounts held in a Participant’s
Rollover Account shall be made in a manner which is consistent with and satisfies the provisions of Section 6.5,
including, but not limited to, all notice and consent requirements of Code section 411(a)(11) and the
Regulations thereunder.
 
Furthermore, such amounts shall be considered as part of a Participant’s benefit in
determining whether an involuntary cash-out of benefits without the Participant’s consent may be made.
(d)
Evidence of Rollover Eligibility.
 
Prior to accepting any rollovers to which this Section
applies, the Administrator may require the Employee to establish that the amounts to be transferred to this Plan
meet the requirements of this Section and may also require the Employee to provide an opinion of counsel
satisfactory to the Employer that the amounts to be transferred meet the requirements of this Section.
4.13
Investment of Aggregate Accounts
(a)
Participant Directed.
 
Every Participant, Beneficiary,
 
and alternate payee shall have
the right to designate the investment category or
 
categories in which the Trustee
 
is to invest his or her
Aggregate Account including, pursuant to Section 4.13(e),
 
any contributions that are initially invested in
the Quaker Stock Fund at the time of
 
contribution pursuant to Section 4.4(a) or Section 4.5(c).
(b)
ERISA Section 404(c) Plan.
 
This Plan is intended to constitute a plan described in
section 404(c) of ERISA, and regulations thereunder.
 
Neither the Employer, nor the Administrator, nor
 
the
Trustee nor any other Fiduciary shall be liable for any losses which are the result of investment instructions
provided by any Participant, Beneficiary, or alternate payee. The Administrator shall designate the available
investment categories to which a Participant, Beneficiary, or alternate payee may direct the investment of
amounts credited to his or her Aggregate Account.
 
The Administrator, in its discretion, may from time to time
designate additional investment categories of the same or different types or modify,
 
cease to offer,
 
or eliminate
any existing investment categories, subject to the requirements of section 404(c) of ERISA and the regulations
thereunder.
(c)
Investment Direction – Future Contributions.
 
Each Participant may,
 
subject to the
Company’s insider trading
 
policy or other restriction(s) imposed by the
 
Company pursuant to Sections
4.13(m) or 4.13(n), designate the percentage of
 
future contributions to be invested in any investment
category, and change such designation, on any business
 
day by giving notice, in the manner prescribed by
the Trustee. Any designation
 
or change in designation of investment categories shall
 
be in increments of at
least 1%.
(d)
Default Fund.
 
In the absence of any current written
 
(or electronic) designation of
investment category(ies) from a
 
Participant, the
 
Trustee shall automatically invest such funds in the default
investment fund(s) designated by the
 
Administrator.
(e)
Investment Direction – Reapportionment of Aggregate Account.
 
A Participant,
Beneficiary, or
 
alternate payee may,
 
subject to the Company’s
 
insider trading policy or other restriction(s)
imposed by the Company pursuant to Sections
 
4.13(m) or 4.13(n), on any business day,
 
by giving notice in
the manner prescribed by the Trustee,
 
transfer all or any portion of the assets
 
held on his or her behalf in
any investment category or categories to any other
 
category or categories then provided, including any
 
 
 
 
31
contributions that are initially invested in the Quaker Stock
 
Fund at the time of contribution pursuant to
Section 4.4(a) or Section 4.5(c).
(f)
Reinvestment of Income, Etc.
 
All interest, dividends, capital gains, distributions,
 
and
other income received with respect to any shares of an investment category credited to the separate accounts of
a Participant, Beneficiary, or alternate payee under the Plan shall be reinvested by the Trustee
 
in additional
shares of the same investment fund and credited to the Participant’s, Beneficiary’s,
 
or alternate payee’s separate
accounts.
(g)
Company Securities – Rights and Equity Restructuring.
 
Each Participant, Beneficiary,
 
or
alternate payee shall have the right to direct the Trustee as to the exercise or sale of any rights to purchase
Company Securities allocated to his or her Stock Bonus Plan Account,
 
and his or her Aggregate Account (or
Stock Bonus Plan Account) shall be appropriately credited.
 
Company Securities received by the Trustee by
reason of a stock split, stock dividend, or other distribution shall be appropriately allocated to accounts holding
interests in the Quaker Stock Fund.
(h)
Company Securities – Voting
 
Rights.
 
Each Participant, Beneficiary, or alternate payee
shall have the right to direct the Trustee as to the exercise of voting rights with respect to Company Securities
allocated to his or her Stock Bonus Plan Account.
 
As soon as practicable prior to the occasion for the exercise
of such voting rights, the Employer shall deliver or cause to be delivered to each Participant, Beneficiary, or
alternate payee all notices, prospectuses, financial statements, proxies, and proxy soliciting material relating to
shares of Company Securities allocated to his or her Stock Bonus Plan Account.
 
Instructions by Participants,
Beneficiaries, or alternate payees to the Trustee shall be on such form or in such other manner and pursuant to
such regulations as the Administrator shall prescribe.
 
Any such instructions shall remain in the strict
confidence of the Trustee.
 
Any shares of Company Securities for which no instructions are received by the
Trustee within such time specified in the notice shall not be voted, except to the extent that the Trustee
determines otherwise consistent with the Trustee’s
 
duties under ERISA.
 
Any shares of Company Securities
which are not allocated to Participants’, Beneficiaries’, or alternate payees’ Stock Bonus Plan Accounts shall be
voted in the same proportions as the shares of Company Securities for which timely instructions were received
from Participants, Beneficiaries, and alternate payees except to the extent that the Trustee determines otherwise
consistent with the Trustee’s
 
duties under ERISA.
(i)
Company Securities – Confidentiality.
 
The Administrator is responsible for ensuring
that:
(i)
procedures are maintained by the Plan to safeguard the confidentiality of
information relating to the purchase, holding, and sale of the Company Securities and the exercise of voting,
tender, and similar rights with respect to the Company Securities by Participants, Beneficiaries, and alternate
payees;
(ii)
the procedures described in paragraph (i) are sufficient to maintain
confidentiality, except to the extent necessary to comply with Federal law or state laws not preempted by
ERISA;
(iii)
an independent fiduciary is appointed to carry out activities relating to any
situations involving a potential for Employer influence upon Participants, Beneficiaries, or alternate payees with
regard to the direct or indirect exercise of shareholder rights; and
 
(iv)
each Participant, Beneficiary, and alternate payee is afforded the appropriate
number of votes with respect to the Company Securities allocated to his or her Stock Bonus Plan Accounts.
 
 
 
 
 
32
(j)
Company Securities – Tender Offer.
 
In the event of a tender offer or a self tender by the
Employer for any Company Securities held in the Plan, the Employer shall as promptly as practicable request or
cause to be requested of each Participant, Beneficiary, and alternate payee instructions as to the tender offer
response desired by him or her in connection with the shares of Company Securities allocated to his or her
Stock Bonus Plan Account and the Trustee shall be bound by the instructions received.
 
Any such instructions
shall remain in the strict confidence of the Trustee.
 
Any shares of Company Securities for which no
instructions are received by the Trustee within such time specified in the notice shall not be tendered, except to
the extent that the Trustee determines otherwise consistent with the Trustee’s
 
duties under ERISA.
 
Any shares
of Company Securities which are not allocated to Participants’, Beneficiary’s,
 
or alternate payee’s Stock Bonus
Plan Accounts shall be tendered by the Trustee in the same proportion as the shares for which timely
instructions were received by the Trustee, except to the extent that the Trustee determines otherwise consistent
with the Trustee’s
 
duties under ERISA.
 
(k)
Form and Manner of Distribution.
 
At the time of distribution or withdrawal of assets
held in an Aggregate Account by a Participant, he or she shall be entitled to receive one lump-sum payment;
provided, however, that the portion of a Participant’s
 
Stock Bonus Plan Account invested in the Quaker Stock
Fund shall be distributed in full shares of Company Securities unless the Participant elects to take such
distribution in cash in an amount realized from converting such full shares of Company Securities in the
Participant’s Stock Bonus Plan Account to cash.
 
Any fractional shares of common stock of the Company shall
be distributed in cash.
 
The Employer does not guarantee that the fair market value of Company Securities will
be equal to the purchase price of such stock or that the total amount withdrawable in cash with respect to any
period will be equal to or greater than the amount of the Participant’s contributions for such period.
(l)
Change in Market Value.
 
Each Participant assumes all risk in connection with any
decrease in the market price of the Company Securities, other investments or cash allocated to his or her Stock
Bonus Plan Account
 
in accordance with the Plan.
(m)
Company Securities – Securities Laws.
 
Any transaction involving Company Securities
held in the account of a Participant who
 
is subject to Section 16(b) of the
 
Securities Exchange Act of 1934
shall be subject to all applicable laws, rules,
 
and regulations and to Company policies intended
 
to assure
compliance with such laws, rules or regulations as
 
well as to such approvals by stock
 
exchanges or
governmental agencies as may be deemed necessary or
 
appropriate by the Administrator.
 
Each Participant
may be required to give the Employer a
 
written representation that he or she will
 
not violate any state or
Federal securities laws, including the Securities Act
 
of 1933 and
 
the Securities Exchange Act of 1934,
 
as
amended; the form of such written representation shall
 
be prescribed by the Administrator.
(n)
Inappropriate Trading Practices.
 
In the event of extraordinary transactions or excessive
trading, the Administrator reserves the right to adjust the Aggregate Accounts of Participants who initiated the
extraordinary transactions or excessive trading to reflect the actual trades executed to fund the activity.
 
Such
adjustment may include, but shall not be limited to, adjustment to the unit price, the number of shares or units,
or both.
 
If such practices continue, the Administrator reserves the right to take further action to limit the ability
of a Participant to engage in extraordinary transactions or excessive trading. The Administrator, in its sole
discretion, shall determine which activities constitute extraordinary transactions or excessive trading.
 
In
addition, all designations of investment categories by a Participant, Beneficiary, or alternate payee under this
Section shall be subject to procedures established by the Administrator.
 
Such procedures may include
limitations of frequency of trading (including limitations that cause otherwise available daily elections to be
unavailable), circumstances under which investment instructions will not be implemented, redemption fees,
 
and
other mechanisms intended to inhibit excessive or inappropriate trading practices, whether instituted by the
Administrator or the investment fund.
 
 
 
 
33
ARTICLE V
VALUATIONS
5.1
Valuation
 
of The Trust Fund
 
The Administrator shall direct the Trustee, as of the Valuation
 
Date, to determine the net worth
of the assets comprising the Trust Fund as it exists on the Valuation
 
Date prior to taking into consideration any
contribution not yet allocated.
 
In determining such net worth, the Trustee shall value the assets comprising the
Trust Fund at their fair market value as of the Valuation
 
Date and shall deduct all expenses for which the
Trustee has not yet obtained reimbursement from the Employer or the Trust Fund.
5.2
Method of Valuation
 
In determining the fair market value of securities held in the Trust Fund which are listed on a
registered stock exchange, the Administrator shall direct the Trustee to value the same at the prices they were
last traded on such exchange preceding the close of business on the Valuation
 
Date.
 
If such securities were not
traded on the Valuation
 
Date, or if the exchange on which they are traded was not open for business on the
Valuation
 
Date, then the securities shall be valued at the prices at which they were last traded prior to the
Valuation
 
Date.
 
Any unlisted security held in the Trust Fund shall be valued at its bid price next preceding the
close of business on the Valuation
 
Date, which bid price shall be obtained from a registered broker or an
investment banker.
 
In determining the fair market value of assets other than securities for which trading or bid
prices can be obtained, the Trustee may appraise such assets itself, or in its discretion employ one or more
appraisers for that purpose and rely on the value established by such appraiser or appraisers.
ARTICLE VI
DETERMINATION
 
AND DISTRIBUTION OF BENEFITS
6.1
Vesting
(a)
Vesting
 
.
(i)
Full Vesting
 
.
 
A Participant’s Elective Account and Rollover Account shall be
fully vested at all times.
 
The portion of a Participant’s Stock Bonus Plan Account attributable to Elective
Contributions shall be fully vested at all times.
 
Except as provided in paragraph (iii), the portion of a
Participant’s Account attributable to AC Products Discretionary Contributions, Quaker Discretionary
Contributions, and Matching Contributions shall be fully vested at all times.
(ii)
Nonelective Contributions.
 
Nonelective Contributions for Plan Years beginning
before 2008 that had not become a Forfeiture before January 1, 2008, became fully vested on January 1, 2008.
 
Nonelective Contributions for Plan Years
 
beginning on and after January 1, 2008, shall be fully vested at all
times.
 
(Before January 1, 2008, a Participant’s Nonelective Contributions were 0% vested if the Participant had
completed fewer than three Years
 
of Service and 100% vested if the Participant had completed at least three
Years
 
of Service.)
(iii)
Complete Ve
 
sting.
 
A Participant shall be 100% vested in his or her Participant’s
Account in the event of his or her attainment of Normal Retirement Age prior to Severance from Employment,
Total and Permanent Disability prior to Severance from Employment, or death prior to Severance from
Employment.
(b)
Effect of Amendment on Nonforfeitable Percentage.
 
The computation of a Participant’s
nonforfeitable percentage of his or her interest in the Plan shall not be reduced as the result of any direct or
 
 
 
34
indirect amendment to this Plan.
 
For this purpose, the Plan shall be treated as having been amended if the Plan
provides for an automatic change in vesting due to a change in Top-Heavy status.
 
In the event that the Plan is
amended to change or modify any vesting schedule, a Participant with at least three Years
 
of Service as of the
expiration date of the election period may elect to have his or her nonforfeitable percentage computed under the
Plan without regard to such amendment.
 
If a Participant fails to make such election, then such Participant shall
be subject to the new vesting schedule.
 
The Participant’s election period shall commence on the adoption date
of the amendment and shall end 60 days after the latest of:
(i)
the adoption date of the amendment;
(ii)
the effective date of the amendment; or
(iii)
the date the Participant receives written notice of the amendment from the
Employer or Administrator.
(c)
Effect of Break in Service.
 
If a Participant is reemployed after a 1-Year
 
Break in Service
has occurred, Years
 
of Service shall include Years
 
of Service prior to his or her 1-Year
 
Break in Service subject
to the following rules:
(i)
If a Participant has a 1-Year
 
Break in Service, his or her pre-break and post-break
service shall be used for computing Years
 
of Service for vesting purposes only after he or she has been
employed for one Year
 
of Service following the date of his or her reemployment with the Employer;
(ii)
A Participant who under the Plan does not have a nonforfeitable right to any
interest in the Plan resulting from Employer contributions shall lose credits otherwise allowable under (i) above
if his or her consecutive 1-Year
 
Breaks in Service equal or exceed the greater of (A) five or (B) the aggregate
number of his or her pre-break Years
 
of Service; and
(iii)
After five consecutive 1-Year
 
Breaks in Service, a Participant’s Vested
 
Account
balance attributable to pre-break service shall not be increased as a result of post-break service.
(d)
Years
 
of Service Excluded.
 
In determining Years
 
of Service for purposes of vesting
under the Plan, Years
 
of Service prior to the vesting computation period in which an Employee attained his or
her 18th birthday shall be excluded.
(e)
Distribution Before Fully Vested.
 
If a distribution is made at a time when a Participant is
not fully Vested
 
in his or her Participant’s Account and the Participant may increase the Vested
 
percentage in
such account:
(i)
A separate account shall be established for the Participant’s interest in the Plan as
of the time of the distribution;
(ii)
At any relevant time, the Participant’s Vested
 
portion of the separate account shall
be equal to an amount (“X”) determined by the formula:
 
X equals P(AB plus (RxD)) – (RxD)
For purposes of applying the formula: P is the Vested
 
percentage at the relevant time, AB is the account balance
at the relevant time, D is the amount of distribution, and R is the ratio of the account balance at the relevant time
to the account balance after distribution.
6.2
Determination of Benefits Upon Termination
 
 
 
 
35
Upon a Participant’s Severance from Employment, the Participant’s
 
Aggregate Account shall be
subject to the Participant’s investment directions in accordance with Section 4.13 and shall share in allocations
of earnings and losses pursuant to Section 4.7(c) until such time as a distribution is made to the Participant.
 
Distribution of the Participant’s Vested
 
Aggregate Account shall be made as soon as practicable following the
Participant’s Severance from Employment; provided, however,
 
that in the case of a Participant whose Vested
Aggregate Account balance exceeds $5,000, no distribution shall be made without the written consent of the
Participant, subject to Section 6.6 (regarding Required Minimum Distributions).
 
Any distribution under this subsection shall be made in a manner which is consistent with and
satisfies the provisions of Section 6.5, including, but not limited to, all notice and consent requirements of Code
section 411(a)(11) and the Regulations thereunder.
 
If the value of a Participant’s Vested
 
Aggregate Account does not exceed $5,000, the
Administrator shall direct the Trustee to cause the entire benefit to be paid to such Participant in a single lump
sum.
 
If the value of a Participant’s Vested
 
Aggregate Account exceeds $1,000 but does not exceed $5,000, the
entire benefit shall be automatically rolled over to an IRA unless the Participant elects otherwise.
 
6.3
Determination of Benefits Upon Death
(a)
Distribution.
 
Upon the death of a Participant all Vested
 
amounts credited to such
Participant’s Aggregate Account shall be distributed, in accordance with the provisions of Section 6.5(e), to the
deceased Participant’s Beneficiary.
(b)
Loans.
 
Any security interest held by the Plan by reason of an outstanding loan to a
deceased Participant shall be taken into account in determining the amount of the death benefit.
(c)
Proof of Death.
 
The Administrator may require such proper proof of death and such
evidence of the right of any person to receive payment of the value of the account of a deceased Participant as
the Administrator may deem desirable.
 
The Administrator’s determination of death and of the right of any
person to receive payment shall be conclusive.
(d)
Beneficiary.
 
The Beneficiary of the death benefit payable pursuant to this Section shall
be the Participant’s Spouse,
 
except, however, the Participant may designate a Beneficiary other than his or her
Spouse if:
(i)
the Spouse has waived the right to be the Participant’s Beneficiary;
(ii)
the Participant is legally separated or has been abandoned (within the meaning of
local law) and the Participant has a court order to such effect (and there is no qualified domestic relations order,
as defined in Code section 414(p), which provides otherwise);
(iii)
the Participant has no Spouse; or
(iv)
the Spouse cannot be located.
 
In such event, the designation of a Beneficiary shall be made on a form satisfactory to the
Administrator.
 
A Participant may at any time revoke his or her designation of a Beneficiary or change his or
her Beneficiary by filing written notice of such revocation or change with the Administrator.
 
However, the
Participant’s Spouse must again consent in writing to any change in Beneficiary unless the original consent
acknowledged that the Spouse had the right to limit consent only to a specific Beneficiary and that the Spouse
 
 
 
 
 
 
36
voluntarily elected to relinquish such right.
 
In the event no valid designation of a Beneficiary exists at the time
of the Participant’s death, the death benefit shall be payable to his or her estate.
(e)
Spousal Consent.
 
Any consent by the Participant’s Spouse to waive any rights to the
death benefit must be in writing, must acknowledge the effect of such waiver, and must be witnessed by a Plan
representative or a notary public.
 
Further, the Spouse’s
 
consent must be irrevocable and must acknowledge the
specific nonspouse Beneficiary.
(f)
Death While Performing Qualified Military Service.
 
Notwithstanding any provision of
the Plan to the contrary, and in accordance with Code section 401(a)(37), in the case of a Participant who dies
while performing qualified military service (as defined in Code section 414(u)), the Participant’s survivors shall
be entitled to any additional benefits (other than contributions relating to the period of qualified military
service) provided under the Plan had the Participant resumed and then terminated employment on account of
death.
6.4
Determination of Benefits In Event of Disability
 
In the event of a Participant’s Total
 
and Permanent Disability prior to his or her Severance from
Employment, all amounts credited to such Participant’s Aggregate Account shall become fully Vested,
 
and
the
Trustee, in accordance with the provisions of Sections 6.5 and 6.7, shall, at the election of the Participant,
distribute to such Participant all amounts credited to such Participant’s Aggregate Account as though he or she
had retired.
6.5
Distribution of Benefits
(a)
Distribution.
 
Subject to subsections (b) and (f), the Administrator shall direct the Trustee
to distribute to the Participant or his or her Beneficiary any amount to which he or she is entitled under the Plan
in one lump-sum payment in cash.
 
(b)
Participant Consent Required.
 
Except as provided in Section 6.6, any distribution to a
Participant who has a Vested
 
Aggregate Account balance which exceeds $5,000 shall require such Participant’s
consent.
 
(c)
Required Distributions.
 
Notwithstanding any provision in the Plan to the contrary, the
distribution of a Participant’s benefits
 
shall comply with Section 6.6.
 
(d)
Direct Rollovers.
 
Notwithstanding any provision of the Plan to the contrary that would
otherwise limit a distributee’s election under this Article VI, a distributee may elect, at the time and in the
manner prescribed by the Administrator, to have all or a portion of an eligible rollover distribution paid directly
to an eligible retirement plan specified by the distributee in a direct rollover.
(i)
For purposes of this subsection, “eligible rollover distribution”
 
shall mean any
distribution of all or any portion of the balance to the credit of the distributee, except that an eligible rollover
distribution shall not include: (i) any distribution that is one of a series of substantially equal periodic payments
made (not less frequently than annually) for the life (or life expectancy) of the distributee or the joint lives (or
joint life expectancy)
 
of the distributee and the distributee’s designated Beneficiary,
 
or for a specified period of
ten years or more; (ii) any distribution to the extent such distribution is required under Code section 401(a)(9);
and (iii) any amount that is distributed on account of hardship.
 
A portion of a distribution shall not fail to be an
eligible rollover distribution merely because the portion consists of after-tax employee contributions which are
not includible in gross income.
 
However, such portion may be transferred only to an individual retirement
account or annuity described in Code sections 408(a) or (b), or to a qualified defined contribution plan
 
 
 
37
described in Code section 401(a) or Code section 403(a) or an annuity contract described in Code section
403(b), that agrees to separately account for amounts so transferred, including separately accounting for the
portion of such distribution which is includible in gross income and the portion of such distribution which is not
so includible.
(ii)
For purposes of this subsection, “eligible retirement plan” means any of the
following that accepts the distributee’s eligible rollover distribution: an individual retirement account described
in Code section 408(a), a Roth IRA described in Code section 408A provided the applicable conversion
requirements are met, an individual retirement annuity described in Code section 408(b), an annuity plan
described in Code section 403(a), a qualified trust described in Code section 401(a), an annuity contract
described in Code section 403(b), or an eligible plan under Code section 457(b) which is maintained by a state,
political subdivision of a state, or any agency or instrumentality of a state or political subdivision of a state
which agrees to separately account for amounts transferred into such plan from this Plan.
 
If any portion of an
“eligible rollover distribution” is attributable to payments or distributions from a designated Roth account, an
eligible retirement plan with respect to such portion shall include only another designated Roth account of the
individual from whose account the payments or distributions were made, or a Roth IRA of such individual, his
or her Surviving Spouse or his or her Beneficiary.
(iii)
For purposes of this subsection, “distributee” shall include an Employee or former
Employee.
 
In addition, the Employee’s or former Employee’s
 
Surviving Spouse and the Employee’s or former
Employee’s Spouse or former Spouse who is the alternate payee under a qualified domestic relations order (as
defined in Code section 414(p)) are distributees with regard to the interest of the Spouse or former spouse.
 
The
Beneficiary of a deceased Participant who is not the Surviving Spouse of the Participant is a distributee with
respect to (A) a direct rollover to an individual retirement account or annuity under Code section 408(a) or Code
section 408(b) established for the purpose of receiving such distribution and which will be treated as an
inherited IRA pursuant to Code section 402(c)(11) and (B) a direct rollover to a Roth IRA described in Code
section 408A, subject to the rules and provisions set forth in Code section 408A(e) and any related guidance
issued by the Treasury Department thereunder, if
 
such distribution otherwise meets the requirements set forth in
(i) above.
(iv)
For purposes of this subsection, “direct rollover” shall mean a payment by the
Plan to the eligible retirement plan specified by the distributee.
(e)
Death Benefit.
 
Except as provided in subsection (f), the death benefit payable pursuant to
Section 6.3 shall be paid to the Participant’s Beneficiary in one lump-sum payment in cash as soon as
practicable after the Participant’s death, subject to the rules of Section 6.6.
 
(f)
Distribution of Company Securities.
 
Notwithstanding anything to the contrary herein, the
portion of a Participant’s Stock Bonus Plan Account invested in the Quaker Stock Fund shall be distributed in
full shares of Company Securities; provided, however, that the Participant or Beneficiary may elect to take such
distribution in cash in an amount realized from converting such full shares of Company Securities in the
Participant’s Stock Bonus Plan Account to cash.
 
Any fractional shares of common stock of the Company shall
be distributed in cash.
(g)
Qualified Reservist Distributions.
 
Effective January 1, 2020, a Participant who is, by
reason of being a member of a reserve component (as defined in section 101 of title 37 of the United States
Code), ordered or called to active duty for a period in excess of 179 days or for an indefinite period after
September 11, 2001 may request a withdrawal of all or any part of his or her Elective Contributions and Catch-
Up Contributions, but not the earnings attributable to such amounts.
 
Such withdrawal may be made no earlier
than the date of such order or call and no later than the close of the active duty period.
 
 
 
 
 
 
38
(h)
Deemed Severance Distributions.
 
Effective January 1, 2020, a Participant who is on
active military duty for more than 30 days as defined in the Heroes Earnings Assistance and Relief Act of 2008
may elect to receive a distribution from his Elective Account; provided, however that such Participants may not
make any Elective Contributions or other employee contributions for six months following such a withdrawal.
 
6.6
Required Minimum Distributions
 
(a)
Precedence.
 
The requirements of this Section shall take precedence over any inconsistent
provisions of the Plan to the extent required to satisfy Code section 401(a)(9) and the Regulations thereunder.
 
The requirements set forth in this Section repeat the requirements set forth in Code section 401(a)(9), including
requirements which may not apply to the Plan because, for example, the Plan does not permit a particular form
of distribution or does not permit deferral beyond a particular date.
 
Any such requirement shall not be read as
giving a Participant or Beneficiary a form of benefit or deferral not otherwise provided under the Plan.
(b)
Requirements of Regulations Incorporated.
 
All distributions
 
required under this Section
shall be determined and made in accordance with the Regulations under Code section 401(a)(9).
(c)
Time and Manner of Distribution.
 
(i)
Required Beginning Date.
 
The Participant’s entire interest shall be distributed, or
begin to be distributed, to the Participant no later than the Participant’s Required Beginning Date.
(ii)
Death of Participant Before Distributions Begin.
 
If the Participant dies before
distributions begin, the Participant’s entire interest shall be distributed, or begin to be distributed, no later than
as follows:
(A)
If the Participant’s Surviving Spouse is the Participant’s
 
sole Designated
Beneficiary, then distributions to the Surviving Spouse shall begin by December 31 of the calendar year
immediately following the calendar year in which the Participant died, or by December 31 of the calendar year
in which the Participant would have attained age 70½, if later.
(B)
If the Participant’s Surviving Spouse is not the Participant’s
 
sole
Designated Beneficiary, then distributions to the Designated Beneficiary shall begin by December 31 of the
calendar year immediately following the calendar year in which the Participant died.
(C)
If there is no Designated Beneficiary as of September 30 of the year
following the year of the Participant’s death, the Participant’s
 
entire interest shall be distributed by December
31 of the calendar year containing the fifth anniversary of the Participant’s death.
(D)
If the Participant’s Surviving Spouse is the Participant’s
 
sole Designated
Beneficiary and the Surviving Spouse dies after the Participant but before distributions to the Surviving Spouse
begin, this paragraph (ii), other than paragraph (ii)(A), shall apply as if the Surviving Spouse were the
Participant.
For purposes of this paragraph (ii) and Section 6.6(e), unless paragraph (ii)(D) applies, distributions are
considered to begin on the Participant’s Required Beginning Date.
 
If paragraph (ii)(D) applies, distributions are
considered to begin on the date distributions are required to begin to the Surviving Spouse under paragraph
(ii)(A).
 
If distributions under an annuity purchased from an insurance company irrevocably commence to the
Participant before the Participant’s Required Beginning Date (or to the Participant’s
 
Surviving Spouse before
the date distributions are required to begin to the Surviving Spouse under paragraph (ii)(A)), the date
distributions are considered to begin is the date distributions actually commence.
 
 
 
 
 
 
39
(iii)
Forms of Distribution.
 
Unless the Participant’s interest is distributed in the form
of an annuity purchased from an insurance company or in a single sum on or before the Required Beginning
Date, as of the first Distribution Calendar Year
 
distributions shall be made in accordance with Section 6.6(d)
and Section 6.6(e).
 
If the Participant’s interest is distributed in the form of an annuity purchased from an
insurance company, distributions thereunder shall be made in accordance with
 
the requirements of Code section
401(a)(9) and the Regulations.
(d)
Required Minimum Distributions During Participant’s Lifetime.
 
(i)
Amount of Required Minimum Distributions For Each Distribution Calendar
Year
 
.
 
During the Participant’s lifetime, the minimum amount that shall be distributed for each Distribution
Calendar Year
 
is the lesser of:
(A)
The quotient obtained by dividing the Participant’s Account Balance by
the distribution period in the Uniform Lifetime Table set forth in Regulation
 
section 1.401(a)(9)-9, using the
Participant’s age as of the Participant’s
 
birthday in the Distribution Calendar Year;
 
or
(B)
If the Participant’s sole Designated Beneficiary for the Distribution
Calendar Year
 
is the Participant’s Spouse, the quotient obtained by dividing the Participant’s
 
Account Balance
by the number in the Joint and Last Survivor Table set forth in Regulation section 1.401(a)(9)-9, using the
Participant’s and Spouse’s
 
attained ages as of the Participant’s and Spouse’s
 
birthday in the Distribution
Calendar Year.
(ii)
Lifetime Required Minimum Distributions Continue Through Year
 
of
Participant’s Death.
 
Required minimum distributions shall be determined under this subsection beginning with
the first Distribution Calendar Year
 
and up to and including the Distribution Calendar Year
 
that includes the
Participant’s date of death.
(e)
Required Minimum Distributions After Participant’s Death.
(i)
Death On or After Date Distributions Begin.
(A)
Participant Survived by Designated Beneficiary.
 
If the Participant dies on
or after the date distributions begin and there is a Designated Beneficiary, the minimum amount that shall be
distributed for each Distribution Calendar Year
 
after the year of the Participant’s death is the quotient obtained
by dividing the Participant’s Account Balance by the longer of the remaining Life Expectancy of the Participant
or the remaining Life Expectancy of the Participant’s Designated Beneficiary,
 
determined as follows:
(I)
The Participant’s remaining Life Expectancy is calculated using
the age of the Participant in the year of death, reduced by one for each subsequent year.
(II)
If the Participant’s Surviving Spouse is the Participant’s
 
sole
Designated Beneficiary, the remaining Life Expectancy of the Surviving Spouse is calculated for each
Distribution Calendar Year
 
after the year of the Participant’s death using the Surviving Spouse’s
 
age as of the
Spouse’s birthday in that year.
 
For Distribution Calendar Years
 
after the year of the Surviving Spouse’s death,
the remaining Life Expectancy of the Surviving Spouse is calculated using the age of the Surviving Spouse as
of the Spouse’s birthday in the calendar year of the Spouse’s
 
death, reduced by one for each subsequent
calendar year.
(III)
If the Participant’s Surviving Spouse is not the Participant’s
 
sole
Designated Beneficiary, the Designated Beneficiary’s
 
remaining Life Expectancy is calculated using the age of
 
 
 
 
 
 
 
 
 
40
the beneficiary in the year following the year of the Participant’s death, reduced by one for each subsequent
year.
(B)
No Designated Beneficiary.
 
If the Participant dies on or after the date
distributions begin and there is no Designated Beneficiary as of September 30 of the year after the year of the
Participant’s death, the minimum amount that shall be distributed for each Distribution Calendar Year
 
after the
year of the Participant’s death is the quotient obtained by dividing the Participant’s
 
Account Balance by the
Participant’s remaining Life Expectancy calculated using the age of the Participant in the year of death, reduced
by one for each subsequent year.
(ii)
Death Before Date Distributions Begin.
(A)
Participant Survived by Designated Beneficiary.
 
If the Participant dies
before the date distributions begin and there is a Designated Beneficiary, the minimum amount that shall be
distributed for each Distribution Calendar Year
 
after the year of the Participant’s death is the quotient obtained
by dividing the Participant’s Account Balance by the remaining life expectancy of the Participant’s
 
designated
beneficiary, determined as provided in Section 6.6(e)(i).
(B)
No Designated Beneficiary.
 
If the Participant dies before the date
distributions begin and there is no Designated Beneficiary as of September 30 of the year following the year of
the Participant’s death, distribution of the Participant’s
 
entire interest shall be completed by December 31 of the
calendar year containing the fifth anniversary of the Participant’s death.
(C)
Death of Surviving Spouse Before Distributions to Surviving Spouse are
Required to Begin.
 
If the Participant dies before the date distributions begin, the Participant’s Surviving Spouse
is the Participant’s sole designated beneficiary,
 
and the Surviving Spouse dies before distributions are required
to begin to the Surviving Spouse under Section 6.6(c)(ii)(A), this paragraph (ii) shall apply as if the Surviving
Spouse were the Participant.
(f)
Distribution Forms.
 
This Section shall not entitle the Participant or beneficiary to any
form of distribution not otherwise available under the Plan, or delay the date as of which any benefit is to be
paid under any other provision of the Plan.
(g)
Definitions.
(i)
Designated Beneficiary.
 
The individual who is designated as the Beneficiary
under Section 1.8 and is the designated beneficiary under Code section 401(a)(9) and Regulation section
1.401(a)(9)-1, Q&A-4.
(ii)
Distribution Calendar Year.
 
A calendar year for which a minimum distribution is
required.
 
For distributions beginning before the Participant’s death, the first Distribution Calendar Year
 
is the
calendar year immediately preceding the calendar year which contains the Participant’s Required Beginning
Date.
 
For distributions beginning after the Participant’s death, the first Distribution Calendar Year
 
is the
calendar year in which distributions are required to begin under Section 6.6(c)(ii).
 
The required minimum
distribution for the Participant’s first Distribution Calendar Year
 
shall be made on or before the Participant’s
Required Beginning Date.
 
The required minimum distribution for other Distribution Calendar Years,
 
including
the required minimum distribution for the Distribution Calendar Year
 
in which the Participant’s Required
Beginning Date occurs, shall be made on or before December 31 of that Distribution Calendar Year.
(iii)
Life Expectancy.
 
Life expectancy as computed by use of the Single Life Table in
Regulation section 1.401(a)(9)-9.
 
 
41
(iv)
Participant’s Account Balance.
 
The balance in the Participant’s Aggregate
Account as of the last valuation date in the calendar year immediately preceding the Distribution Calendar Year
(“Valuation
 
Calendar Year
 
”) increased by the amount of any contributions made and allocated or forfeitures
allocated to the Participant’s Aggregate Account as of dates in the Valuation
 
Calendar Year
 
after the valuation
date and decreased by distributions made in the Valuation
 
Calendar Year
 
after the valuation date.
 
The balance
in the Participant’s Aggregate Account for the Valuation
 
Calendar Year
 
includes any amounts rolled over or
transferred to the Plan either in the Valuation
 
Calendar Year
 
or in the Distribution Calendar Year
 
if distributed
or transferred in the Valuation
 
Calendar Year.
(v)
Required Beginning Date.
 
Effective for Participants who attain age 70½ on or
after January 1, 1997, a Participant’s Required Beginning Date shall mean the April 1 following the later of (i)
the calendar year in which the Participant attains age 70½ or (ii) the calendar year in which the Participant
retires; provided, however, that the Required Beginning Date for a Participant who is a 5% owner (as defined in
Code section 416(i)) at any time during the five Plan Year
 
period ending in the calendar year in which he or she
attains age 70½, or in the case of a Participant who becomes a 5% owner during any subsequent Plan Year,
shall be the April 1 following the calendar year in which he or she attains age 70½.
 
Notwithstanding the
foregoing, a Participant (who is not a 5% owner) who attained age 70½ on or after January 1, 1997, but prior to
January 1, 2002, may elect to commence distribution on the April 1 of the calendar year following the calendar
year in which he or she attains age 70½.
6.7
Latest Date of Commencement of Payments
 
Unless the Participant elects otherwise, the payments of benefits shall occur not later than (a) the
60th day after the close of the Plan Year
 
in which the Participant attains his or her Normal Retirement Age, (b)
the tenth anniversary of the year in which the Participant commenced participation in the Plan, or (c) the date
the Participant terminates his or her service with the Employer.
 
A Participant’s failure to apply for benefits
shall be deemed an election to defer commencement of benefits for purposes of this Section.
6.8
Distribution for Minor Beneficiary
 
In the event a distribution is to be made to a minor, the Administrator may direct that such
distribution be paid to the legal guardian or, if none, to a parent of such Beneficiary or a responsible adult with
whom the Beneficiary maintains his or her residence,
 
or to the custodian for such Beneficiary under the
Uniform Transfers to Minors Act, if such is permitted by the laws of the state in which such Beneficiary resides.
 
Such a payment to the legal guardian, custodian or parent of a minor Beneficiary shall fully discharge the
Trustee, Employer, and Plan from further liability on account thereof.
6.9
Location of Participant or Beneficiary Unknown
 
In the event that all, or any portion, of the distribution payable to a Participant or his or her
Beneficiary hereunder shall, at his or her Normal Retirement Age, remain unpaid solely by reason of the
inability of the Administrator, after sending a registered letter, return receipt requested, to the last known
address,
 
and after further diligent effort, to ascertain the whereabouts of such Participant or his or her
Beneficiary, the amount so distributable shall be forfeited and used as provided in Section 4.7(f).
 
In the event a
Participant or Beneficiary is located subsequent to his or her benefit being reallocated, such benefit shall be
restored.
6.10
Limitations on Benefits and Distributions
 
All rights and benefits, including elections, provided to a Participant in this Plan shall be subject
to the rights afforded to any alternate payee under a qualified domestic relations order.
 
Furthermore, a
 
 
 
 
42
distribution to an alternate payee shall be permitted if such distribution is authorized by a qualified domestic
relations order, even if the affected Participant has not reached the earliest retirement age under the Plan.
 
For
the purposes of this Section, “alternate payee,” “qualified domestic relations order,” and “earliest retirement
age” shall have the meanings set forth under Code section 414(p).
6.11
Hardship Distributions
 
(a)
In General.
 
Distributions of any vested amounts (including Qualified Nonelective
Contributions) may be made to a Participant in the event of hardship.
 
For the purposes of this Section, hardship
is defined as an immediate and heavy financial need of the Participant where such Participant lacks other
available resources.
 
Hardship distributions shall be made in the minimum amount of $1,000 or to the extent of
all available vested amounts,
 
if less.
(b)
Immediate and Heavy Financial Need.
 
For purposes of this Section, an “immediate and
heavy financial need,” as such term is defined under Code section 401(k) and the Regulations thereunder, shall
include the following: (i) expenses incurred or necessary for medical care that would be deductible under Code
section 213(d) (determined without regard to whether the expenses exceed 7.5% of adjusted gross income); (ii)
costs directly related to the purchase (excluding mortgage payments) of a principal residence for the Participant;
(iii) payment of tuition, room and board, and related educational fees for up to the next 12 months of post-
secondary education for the Participant, Participant’s Spouse, children, or dependents (as defined in Code
section 152 without regard to Code sections 152(b)(1), (b)(2), and (d)(1)(B)); (iv) payments necessary to
prevent the eviction of the Participant from, or a foreclosure on the mortgage of, the Participant’s principal
residence; (v) payment of burial or funeral expenses for the Participant’s deceased parent, Spouse, children, or
dependents (as defined in Code section 152 without regard to Code section 152(d)(1)(B)); (vi) expenses for the
repair of damage to the Participant’s principal residence that would qualify for the casualty deduction under
Code section 165 (determined without regard to Code section 165(h)(5) and whether the loss exceeds 10% of
adjusted gross income); (vii) expenses and losses (including loss of income) incurred by the Participant on
account of a disaster declared by the Federal Emergency Management Agency (“FEMA”) if the Participant’s
principal residence or principal place of employment at the time of the disaster was located in an area
designated by FEMA for individual assistance; and (viii) any other type of immediate and heavy financial need
permissible under Code section 401(k) and the Regulations thereunder.
(c)
Distribution Necessary to Satisfy Need.
 
A distribution shall be considered as necessary
to satisfy an immediate and heavy financial need of the Participant only if:
(i)
the Participant has obtained all distributions, other than hardship distributions,
under all plans maintained by the Employer;
(ii)
the distribution is not in excess of the amount of an immediate and heavy
financial need (including amounts necessary to pay any Federal, state,
 
or local income taxes or penalties
reasonably anticipated to result from the distribution);
 
and
(iii)
the Participant has provided to the Administrator a written representation that he
or she has insufficient cash or liquid assets reasonably available to satisfy the need, and the Administrator does
not have actual knowledge to the contrary.
(d)
Investment Funds.
 
A distribution pursuant to this Section shall be made from one or
more of the investment categories designated by the Participant for investment of his or her Account pursuant to
Section 4.13.
6.12
Withdrawals of Previously Contributed Amounts
 
 
 
 
 
 
 
43
 
With respect to Discretionary Contributions made in Plan Years
 
ending before January 1, 1992
only (“Pre-1992 Discretionary Contributions”), each Participant who has received an allocation of such Pre-
1992 Discretionary Contributions shall have the right to elect, in writing on forms provided by the
Administrator, to withdraw (i) 100%, (ii) 50%, or (iii) 0% of the Pre-1992 Discretionary Contributions allocated
to his or her account.
 
Such permitted withdrawals shall be in cash and made as promptly as practicable after the
end of the Plan Year
 
in which the election is made.
 
Such amount shall be adjusted (as of the last day of the
calendar year preceding the date of the withdrawal) to the fair market value of the assets of the Fund attributable
to such deferred, allocated amount.
 
All elections under this Section shall be made on or before the November
30 preceding the date of the withdrawal.
 
Failure to timely file a written election with respect to the withdrawal
privilege for the respective Plan Year
 
shall constitute a binding election to waive the right of withdrawal.
6.13
Loans
(a)
In General.
 
Loans to Participants shall be allowed if such loans comply with this Section.
 
Subject to such uniform and nondiscriminatory rules as may from time to time be adopted by the Administrator,
the Trustee,
 
upon instructions from the Administrator, may make a loan or loans to a Participant; provided,
however, that a Participant may only have up to two loans outstanding at any time.
 
All loans to Participants
shall be considered investments of the Fund.
 
(b)
Limits on Loans.
 
A Participant’s loan (when added to the outstanding balance of all
other loans from the Plan) shall be limited to the lesser of (i) $50,000 reduced by the excess, if any, of the
highest outstanding balance of loans during the one-year period ending on the day before the loan is made over
the outstanding balance of loans on the date the loan is made or (ii) 50% of the vested interest in the
Participant’s Aggregate Account as of the date on which the loan is made.
 
For purposes of this limit, all loans
from all other plans maintained by the Employer or by any Affiliated Employer other entity shall be considered
as a loan from the Plan.
(c)
Quaker Stock Fund Not Available for Loans.
 
Amounts invested in the Quaker Stock
Fund shall be taken into account in calculating the amount of the loan, but such amounts may not be borrowed
from the Plan.
(d)
No Offset Until Distributable Event.
 
In the event of default, foreclosure on the note and
attachment of security shall not occur until a distributable event occurs under the terms of the Plan.
(e)
Security.
 
All loans to Participants made by the Trustee shall be secured by the pledge of
no more than 50% of the Participant’s interest in the Fund.
(f)
Interest Rate.
 
Interest shall be charged at a reasonable rate equal to the prevailing rate of
interest charged for similar loans by lending institutions in the community plus 1% on the date of the loan;
provided, however, that in no event shall the interest rate charged be in violation of any applicable state usury
law or 29 CFR §2550.408b-1(E).
 
Notwithstanding the foregoing, in the case of a loan taken by a Participant
prior to commencement of “military service” (as defined for purposes of the Servicemembers Civil Relief Act
or any successor thereto), the interest charged on such loan shall not exceed 6% for the duration of such military
service.
(g)
General Term of Loan.
 
The Administrator shall determine the term of the loan (which,
except as provided in subsection (h), may not be more than five years).
 
To the extent that a Participant
 
becomes
entitled to payments of benefits or withdraws all or a portion of the Participant’s Aggregate Account, the
payments or withdrawals, as the case may be, shall be immediately applied against the balance outstanding,
including interest on the loan, and such amount shall then be deemed immediately due and payable.
 
Loans shall
be nonrenewable and nonextendable.
 
 
 
 
 
 
 
 
 
44
(h)
Term of Principal Residence Loan.
 
To the extent
 
that a loan to a Participant is made for
the express purpose of acquiring or constructing a principal residence of the Participant, the loan shall generally
be for a term the Administrator determines to be appropriate, but in no event shall the term exceed the
maximum period of time prescribed by the Code and the rulings, announcements, and Regulations issued
thereunder.
(i)
Amortization.
 
Loans shall be amortized in level payments not less frequently than
quarterly.
 
The level amortization requirement shall not apply (A) for a period, not longer than one year, that a
Participant is on a bona fide leave of absence either without pay or at a rate of pay (after applicable employment
tax withholdings) that is less than the amount of the installment payments required under the terms of the loan,
and (B) during a period the Participant is performing service in the uniformed services (as defined in Chapter 43
of Title 38 of the United States Code), both as described in Regulation section 1.72(p)-1.
 
(j)
Offset on Default.
 
Except as described in subsection (d), if a loan is not paid as and when
due, such outstanding loan or loans may be deducted from any benefit which is or becomes payable to the
borrower-Participant, and any other security pledged shall be sold by the Trustee at public or private sale as
soon as is practicable after such default.
 
The proceeds of any sale shall first be applied to pay the expenses of
conducting the sale, including reasonable attorneys’ fees,
 
and then to pay any sums due from the borrower-
Participant to the Fund, with such payment to be applied first to accrued interest and then to principal.
 
The
Participant shall remain liable for any deficiency, and any surplus remaining shall be paid to the Participant.
(k)
Repayments.
 
All loan repayments shall be allocated to the designated investment
categories in accordance with the Participant’s investment designation applicable at the time of the repayment.
 
The Employer shall be permitted to implement salary withholding as a means of facilitating the repayment of
any loan.
(l)
Loan Under Prior Plans.
 
Notwithstanding the foregoing, any loan under a plan which is
merged with and into the Plan (“Merged Plan”) which is outstanding at the time of such merger shall continue
in accordance with the terms of the loan as made under the Merged Plan.
6.14
Distributions From the Rollover Account
 
(a)
Timing of Distribution.
 
Amounts credited to a Participant’s Rollover Account may be
distributed at any time upon a request by the Participant in accordance with the procedures established by the
Administrator.
(b)
Investment Funds.
 
A distribution
 
pursuant to this Section shall be made from one or
more of the investment categories designated by the Participant for investment of his or her Account pursuant to
Section 4.13.
6.15
Distributions at or After Age 59½.
 
(a)
Timing of Distribution.
 
Amounts credited to a Participant’s Aggregate Account may be
distributed at any time upon a request by the Participant after attainment of age 59½ in accordance with the
procedures established by the Administrator.
(b)
Investment Funds.
 
A distribution pursuant to this Section shall be made from one or
more of the investment categories designated by the Participant for investment of his or her Account pursuant to
Section 4.13.
 
 
 
45
6.16
Distributions of G.W.
 
Smith Accounts.
 
Notwithstanding any other provision of the Plan to the
contrary, any amounts attributable to employer contributions under the G.W.
 
Smith & Sons, Inc. 401(k) Profit
Sharing Plan (the “G.W.
 
Smith Plan”) which (i) were transferred to this Plan in connection with the merger of
the G.W.
 
Smith Plan with and into this Plan effective January 1, 2014, and (ii) were available under the terms of
the G.W.
 
Smith Plan for withdrawal at age 55 shall remain available for withdrawal at age 55, provided that no
more than two such withdrawals shall be permitted in any 12-month period until attainment of age 59½.
 
Separate subaccounts shall be maintained under this Plan for such amounts to the extent necessary.
6.17
Disclaimer .
 
An individual who has been designated as a Beneficiary under this Article VI may
disclaim the benefit payable to him or her under the Plan by submitting a qualified disclaimer in accordance
with Code section 2518.
ARTICLE VII
ADMINISTRATION
7.1
Powers and Responsibilities of the Company
(a)
Appointment and Removal of Trustee and Administrator.
 
The Company shall be
empowered to appoint and remove the Trustee and the Administrator from time to time as it deems necessary
for the proper administration of the Plan to assure that the Plan is being operated for the exclusive benefit of the
Participants and their Beneficiaries in accordance with the terms of the Plan, the Code, and ERISA.
(b)
Funding Policy and Method.
 
The Company shall establish a “funding policy and
method,” i.e., it shall determine whether the Plan has a short-run need for liquidity (e.g., to pay benefits) or
whether liquidity is a long-run goal and investment growth (and stability of same) is a more current need, or
shall appoint a qualified person to do so.
 
The Company or its delegate shall communicate such needs and goals
to the Trustee, who shall coordinate such Plan needs with its investment policy.
 
The communication of such a
funding policy and method shall not, however, constitute a directive to the Trustee as to investment of the Trust
Fund.
 
Such funding policy and method shall be consistent with the objectives of this Plan and with the
requirements of Title I of ERISA.
(c)
Periodic Review of Fiduciaries.
 
The Company shall periodically review the performance
of any Fiduciary or other person to whom duties have been delegated or allocated by it under the provisions of
this Plan or pursuant to procedures established hereunder.
 
This requirement may be satisfied by formal periodic
review by the Company or by a qualified person specifically designated by the Company, through day-to-day
conduct and evaluation, or through other appropriate ways.
7.2
Designation of Administrative Authority
 
The Administrator shall consist of a committee of two or more individuals appointed by the
Company.
 
Any person, including, but not limited to, an Employee of the Employer, shall be eligible to serve on
the committee.
 
Any person so appointed shall signify his or her acceptance by filing written acceptance with
the Company.
 
A member of the committee may resign by delivering his or her written resignation to the
Company or be removed by the Company by delivery of written notice of removal, to take effect at a date
specified therein, or upon delivery to the committee member if no date is specified.
 
The committee shall act in
accordance with bylaws or procedures adopted by the committee and approved by the Company.
46
 
The Company, upon the resignation or removal of a committee member,
 
shall promptly
designate in writing a successor to this position.
 
If the Company does not appoint a committee, the Company
shall function as the Administrator.
7.3
Allocation and Delegation of Responsibilities
 
If more than one person is appointed as Administrator, the responsibilities of each Administrator
may be specified by the Company and accepted in writing by each Administrator. In the event that no such
delegation is made by the Company, the Administrators may allocate the responsibilities among themselves, in
which event the Administrators shall notify the Company and the Trustee in writing of such action and specify
the responsibilities of each Administrator.
 
The Trustee thereafter shall accept and rely upon any documents
executed by the appropriate Administrator until such time as the Company or the Administrators file with the
Trustee a written revocation of such designation.
7.4
Powers and Duties of the Administrator
 
The primary responsibility of the Administrator is to administer the Plan for the exclusive benefit
of the Participants and their Beneficiaries, subject to the specific terms of the Plan.
 
The Administrator shall
administer the Plan in accordance with its terms and shall have the power and discretion to construe the terms of
the Plan and to determine all questions arising in connection with the administration, interpretation, and
application of the Plan.
 
Any such determination by the Administrator shall be conclusive and binding upon all
persons.
 
The Administrator may establish procedures, supply any information,
 
or reconcile any inconsistency
in such manner and to such extent as shall be deemed necessary or advisable to carry out the purpose of the
Plan; provided, however, that any procedure, discretionary act, interpretation,
 
or construction shall be done in a
nondiscriminatory manner based upon uniform principles consistently applied and shall be consistent with the
intent that the Plan shall continue to be deemed a qualified plan under the terms of Code section 401(a), and
shall comply with the terms of ERISA and all regulations issued pursuant thereto.
 
The Administrator shall have
all powers necessary or appropriate to accomplish his or her duties under its Plan.
 
The Administrator shall be charged with the duties of the general administration of the Plan,
including, but not limited to, the following:
(a)
the discretion to determine all questions relating to the eligibility of an Employee to
become a Participant or remain a Participant hereunder and to receive benefits under the Plan;
(b)
to correct any defect, reconcile any inconsistency, resolve any ambiguity,
 
or supply any
omission with respect to the Plan;
(c)
to make all other determinations, factual or otherwise, necessary or advisable for the
discharge of the Administrator’s duties under the Plan;
 
(d)
to compute, certify,
 
and direct the Trustee with respect to the amount and the kind of
benefits to which any Participant shall be entitled hereunder;
(e)
to authorize and direct the Trustee with respect to all nondiscretionary or otherwise
directed disbursements from the Trust;
(f)
to maintain all necessary records for the administration of the Plan;
(g)
to interpret the provisions of the Plan and to make and publish such rules for regulation of
the Plan as are consistent with the terms hereof;
47
(h)
to determine the size and type of any Contract to be purchased from any insurer, and to
designate the insurer from which such Contract shall be purchased;
(i)
to compute and certify to the Employer and to the Trustee from time to time the sums of
money necessary or desirable to be contributed to the Plan;
(j)
to consult with the Company and the Trustee regarding the short- and long-term liquidity
needs of the Plan in order that the Trustee can exercise any investment discretion in a manner designed to
accomplish specific objectives;
(k)
to prepare and implement a procedure to notify Eligible Employees that they may elect to
have a portion of their Compensation deferred or paid to them in cash;
(l)
to assist any Participant regarding his or her rights, benefits, or elections available under
the Plan; and
(m)
to determine whether any domestic relations order constitutes a qualified domestic
relations order, as defined in Code section 414(p), and to take such action as the Administrator deems
appropriate in light of such domestic relation order.
7.5
Records and Reports
 
The Administrator shall keep a record of all actions taken and shall keep all other books of
account, records, and other data that may be necessary for proper administration of the Plan and shall be
responsible for supplying all information and reports to the Internal Revenue Service, Department of Labor,
Participants, Beneficiaries and others as required by law.
7.6
Appointment of Advisers
 
The Administrator or Trustee, with the consent of the Company,
 
may appoint counsel,
specialists, advisers, and other persons as the Administrator or Trustee deems necessary or desirable in
connection with the administration of this Plan.
7.7
Information from Employer
 
To enable the Administrator to perform its functions, the Employer shall supply full and timely
information to the Administrator on all matters relating to the Compensation of all Participants, their Hours of
Service, their Years
 
of Service, their retirement, death, disability, or Severance from Employment and such
other pertinent facts as the Administrator may require; and the Administrator shall advise the Trustee of such of
the foregoing facts as may be pertinent to the Trustee’s
 
duties under the Plan.
 
The Administrator may rely upon
such information as is supplied by the Employer and shall have no duty or responsibility to verify such
information.
7.8
Payment of Expenses
 
All expenses of administration may be paid out of the Fund unless paid by the Employer.
 
Such
expenses shall include any expenses incident to the functioning of the Administrator, including, but not limited
to, fees of accountants, counsel, and other specialists and their agents, and other costs of administering the Plan.
 
Until paid, the expenses shall constitute a liability of the Fund.
 
However, the Employer may reimburse the
Fund for any administration expense incurred.
 
Any administration expense paid to the Fund as a
reimbursement shall not be considered an Employer contribution.
 
 
 
 
48
7.9
Majority Actions
 
The members of the committee shall act by a majority of their number, but may authorize one or
more of them to sign all papers on their behalf.
7.10
Claims Procedure
(a)
Initial Claim.
 
A Participant, Spouse, or Beneficiary (“claimant”) who believes he or she
is entitled to benefits hereunder, may claim those benefits by submitting to the Administrator a written
notification of any claim of right to such benefits.
 
The Administrator shall make all determinations as to the
right of any person to receive benefits under the Plan.
 
If such benefits are wholly or partially denied, the
Administrator shall notify the claimant of the denial of the claim.
(b)
Notice of Denial of Claim.
 
Any notice of denial of a claim shall:
(i)
be in writing and sent to the claimant by registered or certified mail (or by means
of an electronic medium that satisfies the requirements of 29 CFR §2520.104b-1(c)(1)(i), (iii), and (iv));
(ii)
be written in a manner calculated to be understood by the claimant;
(iii)
contain (A) the specific reason or reasons for the denial of the claim, (B) specific
reference to the pertinent provisions of the Plan upon which the denial is based, (C) a description of the required
documentation and procedures necessary to perfect the claim, along with an explanation of why such material
or information is necessary, (D) an explanation of the claims review procedure, including time limits applicable
to the procedure, and (E) a statement of the claimant’s right to bring a civil action under section 502(a) of the
Act following an adverse determination on review; and
(iv)
be given to a claimant within 90 days after receipt of his or her claim by the
Administrator unless special circumstances require an extension of time for processing of the claim.
 
If such
extension of time for processing is required, written notice of the extension shall be furnished to the claimant
prior to the termination of such 90-day period, and such notice shall indicate the special circumstances which
make the postponement appropriate and the date the determination is expected.
 
In no event may the extension
exceed a total of 180 days from the date of the original receipt of the claim.
(c)
Procedure for Appeal.
 
In case of a denial as outlined in Section 7.10(b), the claimant or
his or her representative shall have the opportunity to appeal to the Administrator for review thereof by
requesting such review in writing to the Administrator; provided, however, that such written request must be
received by the Administrator (or his or her delegate to receive such requests) within 60 days after receipt by
the claimant of written notification of the denial or limitation of the claim.
 
The claimant or his or her
representative shall have a right to review all pertinent documents and submit comments in writing.
 
The
claimant or his or her duly authorized representative shall also be provided, upon request and without charge,
reasonable access to and copies of, all documents, records,
 
or other information relevant to the claim.
 
The
claimant or his or her duly authorized representative shall also be permitted to submit to the Administrator
documents, records, and other information relating to the claim.
(d)
Decision on Appeal.
 
No later than 60 days after its receipt of the request for review, the
Administrator shall render a decision in writing (or by means of an electronic medium that satisfies the
requirements of 29 CFR §2520.104b-1(c)(1)(i), (iii), and (iv)) stating specific reasons therefor and citing
specific Plan references. If special circumstances require extension, and upon prior written notice to the
claimant, the Administrator’s decision may be given within 120 days after receipt of the request for review. The
49
extension notice shall indicate the special circumstances requiring an extension and the date that the
determination on review is expected.
 
 
Notwithstanding the foregoing, if the Administrator is a committee that holds regularly
scheduled meetings at least quarterly, an individual’s
 
request for review shall be acted upon at the meeting
immediately following the receipt of the individual’s request, unless such request is filed within 30 days
preceding such meeting.
 
In such instance, the decision shall be made no later than the date of the second
meeting following receipt of such request.
 
If special circumstances (such as a need to hold a hearing) require a
further extension of time for processing a request, a decision shall be rendered not later than the third meeting of
the Administrator following the receipt of such request for review and written notice of the extension shall be
furnished to the individual prior to the commencement of the extension. The extension notice shall indicate the
special circumstances requiring an extension and the date that the determination on review will be made.
 
The
Administrator shall notify the claimant or his or her representative of the determination as soon as possible, but
not later than five days after the determination is made.
 
In the event that the decision denies in whole or in part a claim on appeal, the notice furnished to
the claimant shall also specify that the claimant or his or her duly authorized representative has a right to be
provided, upon request and without charge, reasonable access to, and copies of, all documents, records, or other
information relevant to the claim and specify that the claimant has a right to bring a civil action under section
502(a) of the Act.
 
Claims for benefits under the Plan may be filed in writing with the Administrator. Written
notice of the disposition of a claim shall be furnished to the claimant within 90 days after the application is
filed. In the event the claim is denied, the reasons for the denial shall be specifically set forth in the notice in
language calculated to be understood by the claimant, pertinent provisions of the Plan shall be cited, and, where
appropriate, an explanation as to how the claimant can perfect the claim shall be provided. In addition, the
claimant shall be furnished with an explanation of the Plan’s claims review procedure.
 
 
(e)
 
Notwithstanding the foregoing, a claim that involves a determination regarding disability
shall be subject to the special rules for disability claims set forth in the regulations under Section 503 of ERISA.
7.11
Limitations on Actions
(a)
A claimant (as defined in Section 7.10) shall have no right to bring any action at law or in
equity regarding a claim for benefits, unless and until he or she exhausts his or her rights to review under
Section 7.10 in accordance with the time frames set forth in those procedures.
(b)
No action at law or in equity shall be brought to recover benefits under the Plan later than
two years from the date of the final adverse benefit determination of the claimant’s appeal of the denial of his or
her claim for benefits under Section 7.10.
 
Notwithstanding the foregoing, if the applicable, analogous
Pennsylvania statute of limitations has run or will run before the aforementioned two-year period, the
Pennsylvania statute of limitations is controlling.
(c)
No action at law or in equity shall be brought in connection with the Plan except in
Federal district court in Philadelphia, Pennsylvania.
7.12
Discretionary Authority
 
 
The Administrator (or its designee, in the case of any delegated duties) shall have sole discretion
to carry out its responsibilities under this Article VII, to construe and interpret the provisions of the Plan and to
determine all questions concerning benefit entitlements, including the power to construe and determine disputed
 
 
50
or doubtful terms.
 
To the maximum extent permissible under law,
 
the Administrator’s (or its designee’s)
determinations on all such matters shall be final and binding upon all persons involved.
ARTICLE VIII
AMENDMENT, TERMINATION
 
AND MERGERS
8.1
Right to Amend
(a)
By The Board of Directors.
 
The Board of Directors of the Company shall have the right
to amend the Plan at any time by resolution, subject to the following limitations:
(i)
No such amendment shall cause any part of the Trust assets to be used for or
diverted to any purpose other than the exclusive benefit of the Participants or their Beneficiaries, except as
provided in Section 9.6(b).
(ii)
No such amendment shall cause any reduction in the amount of any Participant’s
accrued benefit.
 
For purposes of this paragraph, an amendment which has the effect of (A) eliminating or
reducing an early retirement benefit or a retirement-type subsidy, or (B) eliminating an optional form of benefit,
with respect to benefits attributable to service before the amendment, shall be treated as reducing accrued
benefits except as provided in Code section 411(d)(6) and the Regulations thereunder.
(iii)
No such amendment shall change any vesting schedule unless, in the case of an
Employee who is a Participant on:
(A)
The date the amendment is adopted; or
(B)
The date the amendment is effective, if later,
 
the vested percentage of such Participant’s right to his or her Aggregate Account is not less than such
percentage computed under the Plan without regard to such amendment.
 
Furthermore, no such amendment
shall otherwise change any vesting schedule unless each Participant having three or more Years
 
of Service is
permitted to elect, in accordance with the Code and applicable Regulations, to have the vested percentage of his
or her Aggregate Account determined under the Plan without regard to such amendment; provided, however,
that no election shall be given to any Participant whose vested percentage under the Plan as amended cannot at
any time be less than such percentage determined without regard to such amendment.
(b)
By the Administrator.
 
The Administrator shall have the right to amend the Plan at any
time, subject to the limitations set forth in Section 8.1(a), except to the extent the Board of Directors of the
Company has retained amendment authority.
 
The Board has retained amendment authority with respect to (i)
any increase in the rate of Matching Contributions under the Plan (except as provided in Section 4.4(a)), (ii) any
increase in the rate of Nonelective Contributions above 3% of Compensation, (iii) any new type of employer
contribution under the Plan, (iv) any increase in the amount of any benefit payable to a terminated Participant or
Beneficiary,
 
and (v) any amendment authorizing one or more new groups of employees to become Participants
in the Plan if the aggregate number of Participants added is 5% or more of the number of Participants at the
beginning of the Plan Year,
 
except, in the case of clauses (i) and (ii), to the extent such amendment is required
under the terms of a collective bargaining agreement between employee representatives (within the meaning of
Code section 7701(a)(46)) and the Employer under which retirement benefits were the subject of good faith
bargaining between the parties.
 
The Administrator shall supply the Secretary of the Board of Directors of the
Company with copies of all Plan amendments adopted by the Administrator as well as signed resolutions
adopting such amendment.
 
 
 
51
8.2
Termination
(a)
Right to Terminate.
 
The Company shall have the right to terminate the Plan at any time
and for any reason by delivering to the Trustee and Administrator written notice of such termination.
 
Upon any
full or partial termination or complete discontinuance of the Employer’s contributions to the Plan, all amounts
credited to the affected Participants’ Aggregate Accounts shall be 100% Vested
 
and shall not thereafter be
subject to forfeiture, and any unallocated amounts shall be allocated to the accounts of all Participants in
accordance with the provisions hereof.
(b)
Distribution Upon Termination.
 
Upon the full termination of the Plan, the Company
shall direct the distribution of the assets of the Fund to Participants in a manner which is consistent with and
satisfies the provisions of Section 6.5, except that Participant consent shall not be required if not required under
applicable Regulations.
 
Distributions to a Participant shall be made in cash or through the purchase of
irrevocable nontransferable deferred commitments from an insurer.
 
Except as permitted by Regulations, the
termination of the Plan shall not result in the reduction of section 411(d)(6) protected benefits.
 
Notwithstanding
the foregoing, amounts held by a Participant’s Aggregate Account that are attributable to Nonelective
Contributions for a Plan Year
 
beginning on or after January 1, 2008 or Elective Contributions shall not be
distributed on termination of the Plan unless (i) distribution is permitted under another Section of the Plan (e.g.,
on account of Severance from Employment), or (ii) distribution may be made pursuant to Regulation section
1.401(k)-1(d)(4) (or any successor thereto).
8.3
Merger or Consolidation
 
This Plan and Trust may be merged or consolidated with, or its assets and/or liabilities may be
transferred to, any other plan and trust only if the benefits which would be received by a Participant of this Plan,
in the event of a termination of the Plan immediately after such transfer, merger or consolidation, are at least
equal to the benefits the Participant would have received if the Plan had terminated immediately before the
transfer, merger or consolidation,
 
and such transfer, merger or consolidation does not otherwise result in the
elimination or reduction of any section 411(d)(6) protected benefits.
ARTICLE IX
MISCELLANEOUS
9.1
Participant’s Rights
 
This Plan shall not be deemed to constitute a contract between the Employer and any Participant
or to be a consideration or an inducement for the employment of any Participant or Employee.
 
Nothing
contained in this Plan shall be deemed to give any Participant or Employee the right to be retained in the service
of the Employer or to interfere with the right of the Employer to discharge any Participant or Employee at any
time regardless of the effect which such discharge shall have upon him or her as a Participant of this Plan.
9.2
Alienation
(a)
In General.
 
Subject to the exceptions provided below, no benefit which shall be payable
under the Plan to any person (including a Participant or his or her Beneficiary) shall be subject in any manner to
anticipation, alienation, sale, transfer, assignment, pledge, encumbrance, or charge, and any attempt to
anticipate, alienate, sell, transfer, assign, pledge, encumber, or
 
charge the same shall be void; and no such
benefit shall in any manner be liable for, or subject to, the debts, contracts, liabilities, engagements,
 
or torts of
any such person, nor shall it be subject to attachment or legal process for or against such person, and the same
shall not be recognized by the Trustee, except to such extent as may be required by law.
 
 
 
52
(b)
Loans.
 
Subsection (a) shall not apply to the extent a Participant or Beneficiary is
indebted to the Plan as a result of a loan from the Plan.
 
At the time a distribution is to be made to or for a
Participant’s or Beneficiary’s
 
benefit, such proportion of the amount distributed as shall equal such loan
indebtedness shall be paid by the Trustee to the Trustee or the Administrator,
 
at the direction of the
Administrator, to apply against or discharge such loan indebtedness.
 
Prior to making a payment, however, the
Participant or Beneficiary must be given written notice by the Administrator that such loan indebtedness is to be
so paid in whole or part from his or her Aggregate Account.
 
If the Participant or Beneficiary does not agree that
the loan indebtedness is a valid claim against his or her Aggregate Account, he or she shall be entitled to a
review of the validity of the claim in accordance with procedures provided in Section 7.10.
(c)
Qualified Domestic Relations Orders.
 
Subsection (a) shall not apply to a qualified
domestic relations order as defined in Code section 414(p), and those other domestic relations orders permitted
to be so treated by the Administrator under the provisions of ERISA.
 
The Administrator shall establish a
written procedure to determine the qualified status of domestic relations orders and to administer distributions
under such qualified orders.
 
Further, to the extent provided under a qualified domestic relations order,
 
a former
spouse of a Participant shall be treated as the Spouse or Surviving Spouse for all purposes under the Plan.
(d)
Other Exceptions to Nonalienation.
 
Subsection (a) shall not apply to an amount
necessary to satisfy a Federal tax levy made pursuant to Code section 6331 or, subject to the provisions of Code
section 401(a)(13), a judgment relating to the Participant’s conviction of a crime involving the Plan, to a
judgment, order, decree, or settlement agreement between the Participant and the Secretary of Labor relating to
a violation (or an alleged violation) of part 4 of subtitle B of title I of ERISA.
 
Notwithstanding anything in the
Plan or this Section to the contrary, this Section is intended to address the requirements of Code section
401(a)(13)
 
and Section 206 of ERISA and Federal rulings and regulations issued thereunder, and to permit
action by Plan fiduciaries (including, but not limited to, the recovery of benefit overpayments by reducing Plan
benefits or the withholding of taxes from Plan benefits) that do not violate the principles of Code section
401(a)(13) or section 206 of ERISA as described in such rulings and regulations.
9.3
Construction of Plan
 
Construction, validity, and administration of this Plan shall be governed by the laws of the
Commonwealth of Pennsylvania (without reference to principles of conflicts of laws) except to the extent that
such laws have been superseded by ERISA.
9.4
Gender and Number
 
Wherever any words are used herein in the masculine, feminine, or neuter gender, they shall be
construed as though they were also used in another gender in all cases where they would so apply, and
whenever any words are used herein in the singular or plural form, they shall be construed as though they were
also used in the other form in all cases where they would so apply.
9.5
Legal Action
 
In the event any claim, suit,
 
or proceeding is brought regarding the Trust and/or Plan established
hereunder to which the Trustee or the Administrator may be a party,
 
and such claim, suit, or proceeding is
resolved in favor of the Trustee or Administrator, the Trustee
 
or Administrator shall be entitled to be reimbursed
from the Trust Fund for any and all costs, attorneys’ fees,
 
and other expenses pertaining thereto incurred by the
Trustee or Administrator for which the Trustee or Administrator shall have become liable.
 
53
9.6
Prohibition Against Diversion of Funds
(a)
Exclusive Benefit Rule.
 
Except as provided below and otherwise specifically permitted
by law, it shall be impossible by operation of the Plan or of the Trust,
 
by termination of either, by power of
revocation or amendment, by the happening of any contingency, by collateral arrangement,
 
or by any other
means, for any part of the corpus or income of any trust fund maintained pursuant to the Plan or any funds
contributed thereto to be used for, or diverted to, purposes other than the exclusive benefit of Participants or
their Beneficiaries.
(b)
Exceptions.
 
(i)
In the event the Employer shall make an excessive contribution under a mistake
of fact pursuant to ERISA section 403(c)(2)(A), the Employer may demand repayment of such excessive
contribution at any time within one year following the time of payment and the Trustee shall return such amount
to the Employer within the one year period.
 
Earnings of the Plan attributable to the excess contributions may
not be returned to the Employer but any losses attributable thereto must reduce the amount so returned.
(ii)
Notwithstanding any provision of the Plan to the contrary, except Section 3.5, any
contribution by the Employer to the Trust Fund is conditioned upon the deductibility of the contribution by the
Employer under the Code and, to the extent any such deduction is disallowed, the Employer may, within one
year following the disallowance of the deduction, demand repayment of such disallowed contribution,
 
and the
Trustee shall return such contribution within one year following the disallowance.
 
Earnings of the Plan
attributable to the excess contribution may not be returned to the Employer, but any losses attributable thereto
must reduce the amount so returned.
9.7
Bonding
 
Every Fiduciary, except a bank or an insurance company,
 
unless exempted by ERISA and the
regulations thereunder, shall be bonded in an amount required by law and in a form required by law.
 
Notwithstanding anything in the Plan to the contrary, the cost of such bonds shall be an expense of and may,
 
at
the election of the Administrator, be paid from the Fund or by the Employer.
 
No bonding in excess of the
amount required by law shall be considered required by the Plan.
9.8
Receipt and Release for Payments
 
Any payment to any Participant, his or her legal representative, Beneficiary, or to any guardian
or committee appointed for such Participant or Beneficiary in accordance with the provisions of the Plan, shall,
to the extent thereof, be in full satisfaction of all claims hereunder against the Trustee and the Employer,
 
either
of whom may require such Participant, legal representative, Beneficiary, guardian, or committee, as a condition
precedent to such payment, to execute a receipt and release thereof in such form as shall be determined by the
Trustee or Employer.
9.9
Action by the Employer
 
Whenever the Employer under the terms of the Plan is permitted or required to do or perform
any act or matter or thing, it shall be done and performed by a person duly authorized by its legally constituted
authority.
9.10
Named Fiduciaries and Allocation of Responsibility
 
54
 
The “Named Fiduciaries” of this Plan are (1) the Company, (2) the Administrator,
 
and (3) the
Trustee.
 
The Named Fiduciaries shall have only those specific powers, duties, responsibilities, and obligations
as are specifically given them under the Plan.
 
In general, the Company (and any other Employer) shall have the
sole responsibility for making the contributions provided for under Section 4.1.
 
The Company shall have the
sole authority to appoint and remove the Trustee and the Administrator, to formulate the Plan’s
 
funding policy
and method, and to amend or terminate, in whole or in part, the Plan.
 
The Administrator shall have the sole
responsibility for the administration of the Plan, which responsibility is specifically described in the Plan.
 
The
Trustee shall have the sole responsibility for the management of the assets held under the Trust, except those
assets the management of which has been assigned to an Investment Manager, who shall be solely responsible
for the management of the assets assigned to it, all as specifically provided in the Plan.
 
Each Named Fiduciary
warrants that any directions given, information furnished, or action taken by it shall be in accordance with the
provisions of the Plan, authorizing or providing for such direction, information,
 
or action.
 
Furthermore, each
Named Fiduciary may rely upon any such direction, information, or action of another Named Fiduciary as being
proper under the Plan, and is not required under the Plan to inquire into the propriety of any such direction,
information, or action.
 
It is intended under the Plan that each Named Fiduciary shall be responsible for the
proper exercise of its own powers, duties, responsibilities,
 
and obligations under the Plan.
 
No Named Fiduciary
shall guarantee the Trust Fund in any manner against investment loss or depreciation in asset value.
 
Any person
or group may serve in more than one fiduciary capacity.
 
9.11
Headings
 
The headings and subheadings of this Plan have been inserted for convenience of reference and
are to be ignored in any construction of the provisions hereof.
9.12
Electronic Media
 
Whenever elections, notices, consents, or other communications are required to be in writing
herein, the Administrator may designate that such elections, notices, consents, or other communications shall be
by other means, including the use of electronic media, if such use is permitted by law; provided, however, that
such elections, notices, consents, or other communications shall be in such form as the Administrator shall
specify and approve.
9.13
Clerical Error
 
If any fact pertaining to eligibility for an amount of benefits payable under the Plan to a
Participant or other payee has been misstated, or in the event of clerical error, the benefits shall be adjusted by
the committee or its delegate on the basis of the correct facts in a manner precluding individual selection.
9.14
Uniformity
 
All provisions of this Plan shall be interpreted and applied in a uniform, nondiscriminatory
manner.
 
In the event of any conflict between the terms of this Plan and any Contract purchased hereunder, the
Plan provisions shall control.
ARTICLE X
MERGER OF HOUGHTON PLAN AND WALLOVER
 
PLAN
10.1
Plan Mergers
 
(a)
In General.
 
Effective January 1, 2020, the Houghton Plan and the Wallover
 
Plan were
merged with and into the Plan.
 
Upon the merger, the account balance of each participant in the Houghton Plan
 
 
 
 
55
and the Wallover Plan shall be transferred to this Plan in
 
the manner described in Section 10.2.
 
Accounts
transferred from a Participant’s Houghton Plan accounts and future earnings thereon are referred to as the
Participant’s “Houghton Accounts” for purposes of this Article X.
 
Accounts transferred from a Participant’s
Wallover Plan accounts and future earnings thereon are referred to as the Participant’s
 
“Wallover Accounts”
 
for
purposes of this Article X.
 
(b)
Full Vesting
 
.
 
Effective December 31, 2019, all amounts under the Houghton Accounts
and Wallover Accounts shall be fully vested.
(c)
Participation.
 
Except as provided in Section 1.21 (relating to the definition of an Eligible
Employee), any Eligible Employee employed by Houghton or Wallover
 
Oil Company, Inc. on December 31,
2019 became a Participant in the Plan as of January 1, 2020.
10.2
Transfer of Accounts
 
(a)
Transfer of Houghton Accounts.
 
Effective January 1, 2020, amounts in the Houghton
Accounts were transferred to the corresponding Plan accounts as follows:
(i)
Any amounts in the Participant’s Houghton Accounts that correspond to
contributions under the Participant’s Elective Account as defined under Section 1.48 were transferred to his or
her Participant’s Elective Account under the Plan, and a separate accounting shall be maintained with respect to
each applicable classification under Section 1.48.
(ii)
Any amounts in the Participant’s Houghton Accounts that correspond to
contributions under the Participant’s Account as defined under Section 1.47 were transferred to his or her
Participant’s Account under the Plan, and a separate accounting shall be maintained with respect to each
applicable classification under Section 1.47.
(iii)
Any amounts in the Participant’s Houghton Accounts attributable to rollover
contributions were transferred to his or her Rollover Account under the Plan.
(b)
Transfer of Wallover
 
Accounts.
 
Effective January 1, 2020, amounts in the Wallover
Accounts were transferred to the corresponding Plan accounts as follows.
(i)
Any amounts in the Participant’s Wallover
 
Accounts that correspond to
contributions under the Participant’s Elective Account as defined under Section 1.48 were transferred to his or
her Participant’s Elective Account under the Plan, and a separate accounting shall be maintained with respect to
each applicable classification under Section 1.48.
(ii)
Any amounts in the Participant’s Wallover
 
Accounts that correspond to
contributions under the Participant’s Account as defined under Section 1.47 were transferred to his or her
Participant’s Account under the Plan, and a separate accounting shall be maintained with respect to each
applicable classification under Section 1.47.
(iii)
Any amounts in the Participant’s Wallover
 
Accounts attributable to rollover
contributions were transferred to his or her Rollover Account under the Plan.
10.3
Special Rules Relating To Loans
 
 
Notwithstanding Section 6.13, any loan outstanding under the Houghton Plan or Wallover Plan
at the time of the merger under Section 10.1 shall continue in accordance with the terms of the loan as made
under the Houghton Plan or Wallover Plan, as applicable.
 
 
 
 
 
 
56
10.4
Distribution Forms
 
 
A lump sum payment shall be the sole form of distribution for all amounts transferred to the Plan
from the Houghton Accounts and Wallover Accounts.
 
ARTICLE XI
MERGER OF CORAL PLAN AND SIFCO PLAN
11.1
Merger of the Coral Plan and SIFCO Plan
 
(a)
In General.
 
Effective January 1, 2022, the Coral Plan and the SIFCO Plan shall be
merged with and into the Plan.
 
Upon the merger, the account balance of each participant in the Coral Plan and
the SIFCO Plan shall be transferred to this Plan in the manner described in Section 11.2.
 
Accounts transferred
from a Participant’s Coral Plan accounts and future earnings thereon are referred to as the Participant’s
 
“Coral
Accounts” for purposes of this Article XI.
 
Accounts transferred from a Participant’s SIFCO Plan accounts and
future earnings thereon are referred to as the Participant’s “SIFCO Accounts” for purposes of this Article XI.
 
(b)
Full Vesting.
 
Effective December 31, 2021, all amounts under the Coral Accounts and
SIFCO Accounts shall be fully vested.
(c)
Participation.
 
Except as provided in Section 1.21 (relating to the definition of an Eligible
Employee), any Eligible Employee employed by Coral or SIFCO on December 31, 2021 shall became a
Participant in the Plan as of January 1, 2022.
11.2
Transfer of Accounts
 
(a)
Transfer of Coral Accounts.
 
Effective January 1, 2022, amounts in the Coral Accounts
shall be transferred to the corresponding Plan Accounts as follows:
(i)
Any amounts in the Participant’s Accounts that correspond to contributions under
the Participant’s Elective Account as defined under Section 1.48 were transferred to his or her Participant’s
Elective Account under the Plan, and a separate accounting shall be maintained with respect to each applicable
classification under Section 1.48. After-tax contributions (other than Roth contributions) contributed by the
Participant to the Coral Plan “After-Tax Coral
 
Plan Contributions”) shall be transferred to the Participant’s
Elective Account and maintained in a separate accounting.
(ii)
Any amounts in the Participant’s Coral Accounts that correspond to contributions
under the Participant’s Account as defined under Section 1.47 were transferred to his or her Participant’s
Account under the Plan, and a separate accounting shall be maintained with respect to each applicable
classification under Section 1.47.
(iii)
Any amounts in the Participant’s Coral Accounts attributable to rollover
contributions were transferred to his or her Rollover Account under the Plan.
(b)
Transfer of SIFCO Accounts.
 
Effective January 1, 2022, amounts in the SIFCO
Accounts were transferred to the corresponding Plan accounts as follows.
(i)
Any amounts in the Participant’s SIFCO Accounts that correspond to
contributions under the Participant’s Elective Account as defined under Section 1.48 were transferred to his or
her Participant’s Elective Account under the Plan, and a separate accounting shall be maintained with respect to
each applicable classification under Section 1.48.
 
 
 
 
57
(ii)
Any amounts in the Participant’s SIFCO Accounts that correspond to
contributions under the Participant’s Account as defined under Section 1.47 were transferred to his or her
Participant’s Account under the Plan, and a separate accounting shall be maintained with respect to each
applicable classification under Section 1.47.
(iii)
Any amounts in the Participant’s SIFCO Accounts attributable to rollover
contributions were transferred to his or her Rollover Account under the Plan.
11.3
Special Rules Relating To Loans
 
 
Notwithstanding Section 6.13, any loan outstanding under the Coral Plan or SIFCO Plan at the
time of the merger under Section 11.1 shall continue in accordance with the terms of the loan as made under the
Coral Plan or SIFCO Plan, as applicable.
 
11.4
Distribution Forms
 
 
A lump sum payment shall be the sole form of distribution for all amounts transferred to the Plan
from the Coral Accounts and SIFCO Accounts.
 
11.5
In-service Distribution of After-Tax Coral Plan Contributions
 
Amounts credited to a Participant’s Elective Account which are After-Tax
 
Coral Plan
Contributions and earnings credited thereto may be distributed at any time upon a request by the Participant in
accordance with the procedures established by the Administrator. A distribution pursuant to this Section shall be
made from one or more of the investment categories designated by the Participant for investment of his or
Account pursuant to Section 4.13.
IN WITNESS WHEREOF, Quaker Chemical Corporation has caused these
 
presents to be duly executed on this
 
1
 
day of
 
November
 
, 2021.
 
QUAKER CHEMICAL CORPORATION
Attest:
 
By:
 
/s/ Shane W.
 
Hostetter
 
 
Shane Hostetter
 
SVP CFO
 
58
EXHIBIT A
PARTICIPATING
 
EMPLOYERS
The following Affiliated Employers were participating in the Plan as of January 1, 2021, unless otherwise
noted:
 
AC Products, Inc.
 
ECLI Products, LLC
 
Epmar Corporation
 
Houghton International Inc.
 
Summit Lubricants Inc.
 
Wallover Oil Company,
 
Inc.
 
Ultraseal America, Inc.
 
Coral Chemical Company – participation effective January 1, 2022
 
SIFCO Applied Surface Concepts, LLC – participation effective January 1, 2022
exhibit1027
1
EXHIBIT 10.27
QUAKER HOUGHTON
ANNUAL INCENTIVE PLAN
(As Amended and Restated Effective November 17, 2021)
WHEREAS
, Quaker Chemical Corporation (the “Company”) established the Quaker Chemical
Corporation Global Annual Incentive Plan (the “Prior Plan”); and
 
WHEREAS
, the Company desires to amend and restate the Prior Plan as the Quaker Houghton Annual
Incentive Plan (the “Plan”) to update the Plan for statutory changes and to make certain other changes;
 
NOW,
 
THEREFORE
, the Plan is amended and restated, effective as of November 17, 2021, as
follows:
 
PURPOSE AND APPLICATION
The Plan is designed to reward certain employees of the Company for achieving performance objectives
that are important to the Company and its shareholders. The Plan is intended to provide an incentive for
superior work and to motivate participating employees toward even higher achievement and business results, to
increase shareholder value, to tie their goals and interests to those of the Company and its shareholders, and to
enable the Company to attract and retain highly qualified executive officers.
 
The Plan, as amended and restated effective November 17, 2021, shall apply to any bonus compensation
payable with respect to Performance Periods beginning on or after such date;
provided however,
 
that payment
of any bonus compensation in Common Stock shall be subject to approval of the Plan by the Company’s
shareholders pursuant to the rules of the New York
 
Stock Exchange.
 
ARTICLE 1
DEFINITIONS
 
The following terms, when used herein, shall have the following meanings unless otherwise required by
the context:
 
1.1
“Annual Base Salary” shall mean the salary of a Participant determined on an annualized basis
by reference to the base rate of pay in effect for such Participant.
 
1.2
“Board” shall mean the Board of Directors of the Company.
 
1.3
“Code” shall mean the Internal Revenue Code of 1986, as amended.
 
1.4
“Committee” shall mean the Compensation/Management Development Committee of the Board
and such other committee or committees as may be designated to act as the administrative committee under the
Plan by the Board, at its discretion, from time to time. Where more than one committee has been designated for
these purposes, each such committee shall act as the Committee under the Plan with respect to different
Participants or groups of Participants (which may be designated individually or by classification) as established
at the time any such committee is established.
 
1.5
“Common Stock” shall mean shares of the Company’s common stock, $1.00 par value.
 
 
 
2
1.6
 
“Company” shall mean Quaker Chemical Corporation, or any successor by merger, purchase or
otherwise, and, as appropriate, with respect to eligibility to participate in the Plan, the majority-owned
subsidiaries of Quaker Chemical Corporation.
 
1.7
“Exchange Act” shall mean the Securities Exchange Act of 1934, as amended.
1.8
“Participant” shall mean, with respect to a Performance Period, an employee of the Company
who has been designated by the Committee as a Participant in the Plan for such Performance Period.
 
1.9
“Performance Goal” shall mean, with respect to a Performance Period, an objective performance
goal established by the Committee, consistent with the express terms of the Plan, which must be met in order
for a bonus to be payable to a Participant with respect to such Performance Period, except as provided in
Section 5.4.
 
1.10
“Performance Period” shall mean the Plan Year
 
or such other period or periods as may be
established as a Performance Period by the Committee from time to time. Nothing herein shall prohibit the
creation of multiple Performance Periods which may overlap with other Performance Periods established under
the Plan.
 
1.11
“Plan” shall mean the Quaker Houghton Global Annual Incentive Plan, as amended and restated
effective November 17, 2021,
 
and as may be amended from time to time.
 
1.12
“Plan Year”
 
shall mean the calendar year.
1.13
“Short-Term Deferral Date” shall mean, with respect to bonus compensation payable for a
Performance Period, a date within the 2 1/2 month period immediately following the last day of such
Performance Period; provided that such period (measured from the last day of the period) shall be less than 2
1/2 months to the extent necessary to cause such period to be within one calendar year. A Participant shall have
no right to interest as a result of payment on a date after the first day of such period. Notwithstanding the
foregoing, for purposes of determining the date the bonus award “would otherwise be payable” under Section
5.1 and the “payment date” under Section 4.1(c), the date the bonus award is actually paid to similarly situated
Participants with respect to the Performance Period shall be determinative, and not the Short-Term Deferral
Date.
 
ARTICLE 2
ELIGIBILITY AND PARTICIPATION
 
2.1
Designation of Participants. Those employees of the Company who are designated as
Participants in the Plan by the Committee shall be eligible to participate in the Plan. Prior to or at the time
Performance Goals are established for a specified Performance Period, the Committee shall identify the
employees of the Company (by name, title, salary grade or similar classification) who are to be Participants in
the Plan with respect to such Performance Period.
 
2.2
Considerations. In making its determination as to eligibility for participation in the Plan, the
Committee shall take into account an employee’s position in the Company and the extent to which the
employee’s position affords him or her the opportunity to have a significant impact on the attainment of the
Company’s objectives.
 
 
 
 
 
3
ARTICLE 3
PERFORMANCE GOALS
 
3.1
Establishment of Performance Goals. Prior to or within the first ninety (90) days of a
Performance Period, the Committee shall establish in writing with respect to such Performance Period, one or
more objective Performance Goals, stated in terms of an objective formula or formulas or such other
appropriate method, for computing the amount of bonus compensation which may be payable to each
Participant if the specified Performance Goals or levels thereof are attained.
 
(a)
Notwithstanding the foregoing sentence, the Performance Goals for any
Performance Period may not be established after 25% of the period of service represented by the Performance
Period has elapsed, and the outcome must be substantially uncertain when the Performance Goals are
established.
 
(b)
Subject to the specific limitations set forth in the Plan, nothing herein shall limit
the authority of the Committee to establish more than one Performance Goal and more than one formula with
respect to bonus compensation of a Participant, nor limit a Participant’s ability to receive more than one bonus
payment with respect to a single Performance Period.
 
3.2
Business Criteria, Adjustments and Measurement. Performance Goals may be based upon one or
more of the following business criteria (which may be determined for these purposes by reference to (i) the
Company as a whole, (ii) any of the Company’s subsidiaries, operating divisions, regional business units or
other operating units, or (iii) any combination thereof): profit before taxes, profit after taxes, earnings before or
after taxes, interest, depreciation and/or amortization, stock price, market share, gross revenue, net revenue,
pretax income, operating income, cash flow, earnings per share, return on equity,
 
return on invested capital or
assets, cost reductions and savings, return on revenues or productivity, or any variations of the preceding
business criteria, which may be modified at the discretion of the Committee to take into account significant
nonrecurring items or which may be adjusted to reflect such costs or expense as the Committee deems
appropriate.
 
(a)
Performance Goals may also be based upon a Participant’s attainment of personal
objectives with respect to any of the foregoing business criteria or implementing policies and plans, negotiating
transactions and sales, developing long-term business goals or exercising managerial responsibility.
 
(b)
The Committee may provide for appropriate adjustments to any business criteria
used in connection with measuring attainment of Performance Goals to take into account fluctuations in
exchange rates, where relevant.
 
3.3
Changes In Eligibility During the Performance Period.
 
The Committee may, but is not required
to, establish special rules for any employee who first becomes a Participant during a Performance Period, or
whose level of participation the Committee determines should be changed during a Performance Period.
 
ARTICLE 4
DETERMINATION OF BONUS AWARDS
 
AND LIMITATIONS
 
4.1
Determination of Bonus Payment. As soon as practicable following the end of a Performance
Period, the Committee shall determine whether and to what extent the Performance Goal or Performance Goals
 
 
4
established for a Participant for such Performance Period have been achieved, including the specific target
objective or objectives and the satisfaction of any other material terms of the bonus award, and shall certify
such determination in writing, which certification may take the form of minutes of the Committee documenting
such determination.
 
(a)
The Committee shall then calculate the amount of each Participant’s bonus or
bonuses for such Performance Period based upon the levels of achievement of the relevant Performance Goals
and the formula(s) established for such purposes with respect to such Performance Period, subject to the
limitations set forth in this Article IV and the employment and proration rules set forth in Article V.
 
(b)
The Committee may, notwithstanding anything contained herein to the contrary,
reduce the amount of or totally eliminate any Participant’s bonus, if it determines, in its absolute and sole
discretion, that such a reduction or elimination is appropriate in order to reflect the Participant’s individual
performance or to take into account any other factors the Committee deems appropriate.
 
(c)
At any time before a bonus is payable under the Plan, the Committee in its sole
discretion shall determine whether the medium of payment shall be cash and/or Common Stock. To
 
the extent
an objective formula established under Section 3.1 for a Participant for a Performance Period is stated in terms
of a medium other than the final medium of payment determined by the Committee under this subsection (c),
conversion to the final medium of payment shall be determined by the last sale price for a share of Common
Stock as quoted on the New York
 
Stock Exchange for the payment date (or the trading day immediately
preceding the payment date if the payment date is not a trading day).
 
4.2
Limitations. No Participant shall be entitled to receive a bonus or bonuses in excess of the
following limitations:
 
(a)
For bonuses paid in cash, the maximum bonus payable with respect to all
Performance Periods ending in any one Plan Year
 
shall not exceed three hundred percent (300%) of such
Participant’s Annual Base Salary in effect as of September 30th during such Plan Year.
 
(b)
A Participant’s Annual Base Salary shall be deemed for these purposes to be the
lesser of his or her actual Annual Base Salary or $1,000,000.
 
4.3
Common Stock Available. Shares of Common Stock transferable under the Plan shall be shares
of authorized, but not issued Common Stock or Common Stock held in treasury. The maximum number of
shares of Common Stock which may be issued under the Plan shall not exceed 500,000 shares. If a bonus award
terminates for any reason or is canceled, forfeited or settled in cash rather than stock, the number of shares of
Common Stock with respect to which such bonus award terminated or was canceled, forfeited or settled in cash,
shall be available for future grants of bonus awards under the Plan. If tax withholding requirements are satisfied
by withholding Common Stock, only the number of shares issued net of Common Stock withheld shall be
deemed delivered for purposes of applying the limits set forth in this Section.
 
(a)
Bonuses payable in the form of a transfer of shares may be evidenced by written
grant documents in such form as the Committee shall from time to time approve, and shall set forth such terms
and conditions as the Committee shall, from time to time, at its discretion, impose on such transferred shares;
provided, however, that any such terms and conditions may not be inconsistent with any specific terms of the
Plan.
 
(b)
In the event of changes to the outstanding shares of Common Stock of the
Company through reorganization, merger, consolidation, recapitalization, reclassification, stock splits,
 
stock
dividend, spin-off, stock consolidation or otherwise, or in the event of a sale of all or substantially all of the
 
 
 
5
assets of the Company, an appropriate and proportionate adjustment shall be made in (i) the number and kind of
shares available for use under the Plan, (ii) the annual limitations on awards of Common Stock, and (iii) the
number and kind of shares of Common Stock payable under the formula(s), if any, for the Performance Period
in which such event occurs. Adjustments or changes under this Section shall be made by the Committee, whose
determination as to what adjustments or changes shall be made, and the extent thereof, shall be final, binding,
and conclusive.
ARTICLE 5
PAYMENT
 
OF AWARDS
 
5.1
Employment Requirement. No bonus shall be payable under the Plan to any Participant who is
not employed by the Company (or an affiliate of the Company) on the date such bonus would otherwise be
payable unless:
 
(a)
The Participant’s employment terminates prior to such date on account of his or
her death, disability (as determined by the Committee, in its sole discretion), or under such other circumstances
as the Committee shall, in its sole discretion, determine;
(b)
The Participant’s employment terminates prior to such date on or after attainment
of age 60;
 
(c)
An amount is payable pursuant to Section 5.4; or
 
(d)
The Committee, in its sole discretion, specifically allows the Participant’s bonus
award to remain payable, in full or in part (as determined by the Committee), if the Participant’s employment
terminates prior to such date.
If a Participant’s employment terminates prior to the date a bonus award would otherwise be payable
under any circumstances other than those described above, no bonus award shall be payable to such Participant.
 
5.2
Proration of Bonus.
 
(a)
If a Participant is on a leave of absence during a Performance Period, any bonus
award payable shall be prorated based on active service during the Performance Period, except as provided in
Section 5.4.
 
(b)
If a Participant’s employment terminates under the circumstances set forth in
Section 5.1(a) or (b), any bonus award payable will be prorated based on active service during the Performance
Period, except as provided in Section 5.4.
5.3
Payment Date. Except as provided in this Section 5.3 or in Section 5.4, no Participant may
receive any payment with respect to a bonus award unless and until the Committee has certified in writing that
the relevant Performance Goals for a Performance Period have been achieved. Notwithstanding anything herein
to the contrary, if a Participant terminates employment under the circumstances set forth in Section 5.1(a), (b),
or (d), the Committee shall have the discretion to provide for payment in respect of a bonus award for a
Performance Period regardless of whether the Performance Goals for such Performance Period have been
achieved. After the Committee has certified in writing that the relevant Performance Goals have been achieved,
bonus awards shall be paid by the Company on the Short-Term Deferral Date, to the Participant or to his
 
or her
estate in the event of death.
 
 
 
 
 
 
 
6
5.4
Change in Control. Notwithstanding any provision of the Plan to the contrary, in the event of a
Change in Control (as defined in the Quaker Chemical Corporation 2016 Long-Term Performance Incentive
Plan), each Participant who is employed by the Company on the day before such Change in Control shall be
paid (a) any bonus with respect to any Performance Period ending prior to such Change in Control (based on
achievement during such Period) that has not been paid to the Participant, such payment to be made on the
Short-Term Deferral Date for such Performance Period, and (b) with respect to the Performance Period in
which such Change in Control occurs, the amount of the bonus that would have been payable had the target
level of performance been achieved for such Performance Period, such payment to be made on the Short-Term
Deferral Date for such Performance Period.
 
5.5
Section 409A of the Code. Notwithstanding any provision of this Plan to the contrary, if a
Participant is a specified employee (as defined in Treas. Reg. §1.409A-1(i)), any payment or benefit under this
Plan that constitutes deferred compensation subject to Section 409A of the Code and for which the payment
event is separation from service (as defined in Treas. Reg. §1.409A-1(h)) shall not be made or provided to the
Participant before the date that is six months after the date of the Participant’s separation from service. Any
payment or benefit that is delayed pursuant to this Section 5.5 shall be made or provided on the first business
day of the seventh month following the month in which the Participant’s separation from service occurs. With
respect to any cash payment delayed pursuant to this Section 5.5, the delayed payment shall include interest, at
the Wall Street Journal Prime Rate published in the Wall
 
Street Journal on the date of the Participant’s
separation from service (or the previous business day if such date is not a business day), for the period from the
date the payment would have been made but for this Section 5.5 through the date payment is made. The
provisions of this Section 5.5 shall apply only to the extent required to avoid a Participant’s incurrence of any
additional tax or interest under Section 409A of the Code. To the extent any
 
payment or benefit under the Plan
constitutes deferred compensation subject to Section 409A of the Code, this Plan is intended to comply with
Section 409A of the Code and shall be administered, interpreted and construed in accordance therewith to avoid
the imposition of additional tax under Section 409A of the Code.
 
ARTICLE 6
OTHER TERMS AND CONDITIONS
 
6.1
Shareholder Approval. No bonus awards shall be paid in Common Stock unless and until the
material terms of the Plan are disclosed to and approved by the Company’s shareholders pursuant to the rules of
the New York
 
Stock Exchange.
 
6.2
Nontransferability; Unfunded Plan. Except as may be otherwise required by law, bonus awards
under the Plan shall not be subject in any manner to anticipation, alienation, sale, transfer, assignment, pledge,
encumbrance, charge, garnishment, execution, or levy of any kind, either voluntary or involuntary.
 
Bonuses
awarded under the Plan shall be payable from the general assets of the Company and no Participant shall have
any claim with respect to any specific assets of the Company.
 
6.3
Rights. No person shall have any legal claim to be granted an award under the Plan and the
Committee shall have no obligation to treat Participants uniformly. Neither the Plan nor any action taken under
the Plan shall be construed as giving any employee the right to be retained in the employ of the Company or any
subsidiary or to maintain any Participant’s compensation at any level.
 
6.4
Withholding.
 
The Company or any of its subsidiaries may deduct from any award any applicable
withholding taxes or any amounts owed by the employee to the Company or any of its subsidiaries, or take any
other actions it deems necessary or appropriate in connection with any applicable withholding requirements.
 
 
 
 
 
 
 
 
 
7
6.5
Common Stock. No Common Stock will be delivered under the Plan except in compliance with
all applicable Federal and state laws and regulations including, without limitation, compliance with all Federal
and state securities laws and with the rules of the New York
 
Stock Exchange and of all domestic stock
exchanges on which the Common Stock may be listed. Any certificate issued to evidence shares of Common
Stock awarded pursuant to the Plan may bear legends and statements the Committee shall deem advisable to
assure compliance with Federal and state laws and regulations. No shares of Common Stock shall be delivered
under the Plan until the Company has obtained consent or approval from regulatory bodies, Federal or state,
having jurisdiction over such matters as the Committee may deem advisable. In the case of a person or estate
acquiring the right to an award of Common Stock made pursuant to the Plan as a result of the death of the
Participant, the Committee may require reasonable evidence as to the ownership of the Common Stock and may
require consents and releases of taxing authorities that it may deem advisable.
 
6.6
Recoupment Policy. A Participant’s
 
right to receive payment of a bonus under the Plan, to retain
the bonus and, in the case of a non-cash bonus, to retain the profit or gain the Participant realized in connection
with such a bonus shall be subject to any recoupment or “clawback” policy adopted by the Company.
 
ARTICLE 7
ADMINISTRATION
 
7.1
The Committee. Until changed by the Board, the Compensation/Management Development
Committee of the Board shall constitute the Committee hereunder. All actions taken under the terms of the Plan
with respect to any employee who is subject to the reporting requirements of Section 16(a) of the Exchange Act
shall be taken by a Committee consisting solely of two or more members of the Board who qualify as “non-
employee directors” (as that term is used for purposes of Section 16 of the Exchange Act).
 
7.2
Committee’s Authority.
 
The Committee shall have full power and authority to administer and
interpret the provisions of the Plan and to adopt such rules, regulations, agreements, guidelines, and instruments
for the administration of the Plan and for the conduct of its business as the Committee deems necessary or
advisable.
 
7.3
Delegation of Authority. The Committee shall have full power to delegate to any officer or
employee of the Company the authority to administer and interpret the procedural aspects of the Plan, subject to
the Plan’s terms, including adopting and enforcing rules to decide procedural and administrative issues.
 
7.4
Reliance. The Committee may rely on opinions, reports or statements of officers or employees of
the Company or any subsidiary thereof and of Company counsel (inside or retained counsel), public
accountants, and other
 
professional or expert persons.
 
7.5
Liability; Indemnification. No member of the Committee shall be liable for any action taken or
omitted to be taken or for any determination made by him or her in good faith with respect to the Plan, and the
Company shall indemnify and hold harmless each member of the Committee against any cost or expense
(including counsel fees) or liability (including any sum paid in settlement of a claim with the approval of the
Committee) arising out of any act or omission in connection with the administration or interpretation of the
Plan, unless arising out of such person’s own fraud or bad faith.
7.6
Governing Law. The place of administration of the Plan shall be in the Commonwealth of
Pennsylvania, and the validity, construction, interpretation, administration, and effect of the Plan and
 
of its rules
and regulations, and rights relating to the Plan, shall be determined solely in accordance with the laws of the
Commonwealth of Pennsylvania (without reference to principles of conflicts of laws) to the extent Federal law
is not applicable.
 
 
 
 
8
ARTICLE 8
TERM OF PLAN, AMENDMENT AND TERMINATION
 
8.1
Further Shareholder Approval. The Plan shall terminate as of the date of the first meeting of the
shareholders of the Company that occurs in 2032, unless the material terms of the Plan are disclosed to and
approved by shareholders on or before the date of such shareholders meeting.
8.2
Amendment, Suspension and Termination. The Plan may be suspended, terminated, or
reinstated, in whole or in part, at any time by the Board. The Board may from time to time make such
amendments to the Plan as it may deem advisable.
 
Notwithstanding the foregoing, no amendment to the Plan
shall be made without the approval of the Company’s shareholders if it (i) increases the number of shares of
Common Stock made available under the Plan, (ii) expands the class of persons eligible for a bonus under the
Plan, (iii) materially extends the term of the Plan, or (iv) otherwise requires shareholder approval under the
rules of the exchange or market on which Common Stock is listed or traded.
 
8.3
Effect of Termination/Amendment.
 
Termination or amendment of the Plan shall not, without the
consent of the Participant, diminish a Participant’s rights with respect to any bonus program in effect with
respect to the Performance Period in which such amendment or termination occurs except to the extent that such
amendment or termination is determined by the Committee to be necessary or appropriate under applicable law.
exhibit1046
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
EXHIBIT 10.46
Execution Version
AMENDMENT NO. 2 TO CREDIT AGREEMENT (LIBOR
TRANSITION)
THIS AMENDMENT NO. 2 TO CREDIT AGREEMENT (LIBOR TRANSITION)
(this
“Agreement”)
 
is
 
made
 
and
 
entered
 
into
 
as
 
of
 
December
 
10,
 
2021
 
by
 
and
 
among
QUAKER
 
CHEMICAL
CORPORATION
, a Pennsylvania corporation (the “Company”) and
BANK OF AMERICA, N.A.
, as Administrative
Agent (in such capacity, the “Administrative Agent”).
RECITALS
WHEREAS,
 
the
 
Company,
 
certain
 
Subsidiaries
 
of
 
the
 
Company
 
party
 
thereto,
 
each
 
guarantor
 
party
 
thereto,
each
 
lender
 
party
 
thereto
 
(collectively,
 
the
 
“Lenders”
 
and
 
individually,
 
a
 
“Lender”),
 
and
 
Bank
 
of
 
America,
 
N.A.,
 
as
Administrative
 
Agent,
 
have
 
entered
 
into
 
that
 
certain
 
Credit
 
Agreement
 
dated
 
as
 
of
 
August
 
1,
 
2019
 
(as
 
amended,
modified, extended, restated, replaced, or supplemented from time to
 
time, the “Credit Agreement”);
WHEREAS,
 
certain
 
loans
 
and/or
 
other
 
extensions
 
of
 
credit
 
(the
 
“Loans”)
 
under
 
the
 
Credit
 
Agreement
denominated
 
in
 
Sterling,
 
Yen,
 
and
 
Euros
 
(collectively,
 
the
 
“Impacted
 
Currencies”)
 
incur
 
or
 
are
 
permitted
 
to
 
incur
interest, fees,
 
commissions or other
 
amounts based
 
on the
 
London Interbank Offered
 
Rate as
 
administered by the
 
ICE
Benchmark Administration (“LIBOR”) in accordance with the
 
terms of the Credit Agreement; and
WHEREAS,
 
applicable
 
parties
 
under
 
the
 
Credit
 
Agreement
 
have
 
determined
 
in
 
accordance
 
with
 
the
 
Credit
Agreement that
 
LIBOR for
 
the
 
Impacted Currencies
 
should be
 
replaced with
 
a successor
 
rate in
 
accordance with
 
the
Credit
 
Agreement
 
and,
 
in
 
connection
 
therewith,
 
the
 
Administrative
 
Agent
 
has
 
determined
 
that
 
certain
 
conforming
changes are necessary or advisable.
NOW,
 
THEREFORE,
 
in
 
consideration
 
of
 
the
 
premises
 
and
 
the
 
mutual
 
covenants
 
contained
 
herein,
 
and
 
for
other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto
agree as follows:
1.
Defined
 
Terms.
 
Capitalized
 
terms
 
used
 
herein
 
but
 
not
 
otherwise
 
defined
 
herein
 
(including
 
on
 
any
Appendix attached hereto) shall have the meanings provided to such terms in the Credit Agreement, as amended by this
Agreement.
2.
Agreement.
 
Notwithstanding
 
any
 
provision
 
of
 
the
 
Credit
 
Agreement
 
or
 
any
 
other
 
document
 
related
thereto (the “Loan Documents”) to
 
the contrary,
 
the parties hereto hereby agree
 
that the terms set
 
forth on Appendix A
shall apply to the Impacted Currencies. For the avoidance of doubt, (a) to the extent provisions in the Credit Agreement
apply to
 
the Impacted
 
Currencies and such
 
provisions are not
 
specifically addressed by
 
Appendix A, the
 
provisions in
the Credit
 
Agreement shall continue
 
to apply to
 
the Impacted
 
Currencies and (b)
 
to the
 
extent provisions in
 
the Credit
Agreement apply to Dollar-
 
denominated extensions of credit, the
 
provisions in the Credit
 
Agreement shall continue to
apply to such Dollar-denominated extensions of credit and shall not be impacted
 
by this Agreement.
3.
Conflict with
 
Loan Documents.
 
In the
 
event of
 
any conflict
 
between the
 
terms of
 
this Agreement
 
and
the terms of the Credit Agreement or the other Loan Documents, the terms hereof
 
shall control.
 
 
 
 
 
 
 
 
 
2
4.
Representations
 
and
 
Warranties.
 
The Company represents and warrants to the Administrative
Agent and the Lenders, as of the date hereof, as follows:
(a)
the execution, delivery and performance by the Company of this Agreement have been
duly
 
authorized
 
by
 
all
 
necessary
 
corporate
 
or
 
other
 
organizational
 
action
 
and
 
do
 
not
 
and
 
will
 
not
 
(i)
require
 
any
 
consent
 
or
 
approval
 
or
 
other
 
action
 
by,
 
or
 
notice
 
to,
 
or
 
filing
 
with,
 
any
 
Governmental
Authority
 
or
 
any
 
other
 
Person
 
in
 
connection
 
with
 
the
 
execution,
 
delivery
 
or
 
performance
 
by,
 
or
enforcement
 
against,
 
the
 
Company
 
of
 
this
 
Agreement
 
except
 
as
 
may
 
have
 
been
 
obtained,
 
or
 
(ii)
contravene
 
the
 
terms
 
of
 
the
 
Company’s
 
Organization
 
Documents;
 
(b)
 
conflict
 
with
 
or
 
result
 
in
 
any
breach or contravention of, or the creation of any Lien under,
 
or require any payment to be made under
(i)
 
any
 
Contractual
 
Obligation
 
to
 
which
 
the
 
Company
 
is
 
a
 
party
 
or
 
affecting
 
the
 
Company
 
or
 
the
properties of the
 
Company or (ii)
 
any order,
 
injunction, writ or
 
decree of any
 
Governmental Authority
or any arbitral award to which the Company or its property is subject; or
 
(c) violate any Law;
(b)
this
 
Agreement
 
has
 
been
 
duly
 
executed
 
and
 
delivered
 
by
 
the
 
Company,
 
and
 
this
Agreement, the
 
Credit Agreement
 
and each
 
other Loan
 
Document (in
 
each case,
 
as amended
 
hereby)
constitutes a
 
legal, valid
 
and binding
 
obligation of
 
the Company,
 
enforceable against
 
the Company
 
in
accordance with
 
its terms,
 
except to
 
the extent
 
that such
 
enforceability may
 
be limited
 
by bankruptcy,
receivership, moratorium, conservationship, or
 
other laws of
 
general application affecting the
 
rights of
creditors generally or by general principles of equity;
(c)
the representations and warranties of the Company contained in Article V of the Credit
Agreement
 
and
 
in
 
each
 
other
 
Loan
 
Document
 
are
 
true
 
and
 
correct
 
in
 
all
 
material
 
respects
 
(or,
 
with
respect to representations and warranties modified by materiality standards or Material
 
Adverse Effect,
in
 
all
 
respects)
 
on
 
and
 
as
 
of
 
the
 
date
 
hereof,
 
except
 
to
 
the
 
extent
 
that
 
such
 
representations
 
and
warranties
 
specifically
 
refer
 
to
 
an
 
earlier
 
date,
 
in
 
which
 
case
 
they
 
shall
 
be
 
true
 
and
 
correct
 
in
 
all
material respects
 
(or,
 
with respect
 
to representations
 
and warranties
 
modified by
 
materiality standards
or
 
Material
 
Adverse
 
Effect,
 
in
 
all
 
respects)
 
as
 
of
 
such
 
earlier
 
date,
 
and
 
the
 
representations
 
and
warranties contained in Sections
 
5.05(a) and (b) shall
 
be deemed to
 
refer to the most
 
recent statements
furnished pursuant to Sections 6.01(a) and (b), respectively;
(d)
immediately before and after the effectiveness of this Agreement on the Effective
Date, no Default or Event of Default has occurred and is
 
continuing.
5.
Conditions
 
Precedent.
 
This
 
Agreement
 
shall
 
become
 
effective
 
upon
 
receipt
 
by
 
the
 
Administrative
Agent of counterparts of this Agreement, properly executed by the Company
 
and the Administrative Agent.
6.
Payment of Expenses. The Company agrees to pay,
 
in accordance with and subject to the limitations in
Section
 
10.04
 
of
 
the
 
Credit
 
Agreement,
 
all
 
reasonable
 
and
 
documented
 
out-of-pocket
 
expenses
 
incurred
 
by
 
the
Administrative Agent
 
and its
 
Affiliates in
 
connection with
 
the
 
preparation, execution,
 
delivery,
 
administration of
 
this
Agreement and the other instruments and documents to be delivered hereunder.
7.
Miscellaneous.
3
(a)
The
 
Loan
 
Documents,
 
and
 
the
 
obligations
 
of
 
the
 
Company
 
under
 
the
 
Loan
 
Documents,
 
are
hereby ratified and confirmed and shall remain in full force and effect according to their terms. This Agreement
is a Loan Document.
(b)
The
 
Company
 
(i)
 
acknowledges and
 
consents
 
to
 
all
 
of
 
the
 
terms
 
and
 
conditions
 
of
 
this
Agreement, (ii) affirms all of
 
its obligations under the Loan Documents,
 
(iii) agrees that this Agreement and
 
all
documents executed
 
in
 
connection herewith
 
do not
 
operate to reduce or discharge
 
its obligations under the Loan
Documents,
 
(iv) agrees that the Collateral
 
Documents
 
continue to be in full force and effect and are not impaired
or
 
adversely affected
 
in
 
any
 
manner
 
whatsoever, (v)
 
confirms its
 
grant
 
of
 
security interests
 
pursuant
 
to
 
the
Collateral
 
Documents
 
to which it is
 
a party as Collateral
 
for the Obligations,
 
and (vi) acknowledges
 
that all Liens
granted (or purported to be granted) pursuant to the
 
Collateral Documents
 
remain and continue in full force and
effect in respect
 
of, and
 
to secure,
 
the
 
Obligations.
(c)
This Agreement
 
may be
 
in the
 
form of
 
an electronic
 
record (in
 
“.pdf” form
 
or otherwise)
 
and
may
 
be
 
executed
 
using
 
electronic
 
signatures, which
 
shall
 
be
 
considered as
 
originals
 
and
 
shall
 
have the
 
same
legal
 
effect,
 
validity
 
and
 
enforceability
 
as
 
a
 
paper
 
record.
 
This
 
Agreement
 
may
 
be
 
executed
 
in
 
as
 
many
counterparts
 
as
 
necessary
 
or
 
convenient,
 
including
 
both
 
paper
 
and
 
electronic
 
counterparts,
 
but
 
all
 
such
counterparts shall
 
be one
 
and the
 
same
 
Agreement. For
 
the avoidance
 
of doubt,
 
the authorization
 
under this
paragraph may include, without limitation, use or acceptance by the Administrative Agent of a manually signed
Agreement
 
which
 
has
 
been
 
converted
 
into
 
electronic
 
form
 
(such
 
as
 
scanned
 
into
 
“.pdf”
 
format),
 
or
 
an
electronically signed Agreement converted into another format,
 
for transmission, delivery and/or retention.
(d)
Any
 
provision
 
of
 
this
 
Agreement
 
held
 
to
 
be
 
illegal,
 
invalid
 
or
 
unenforceable
 
in
 
any
jurisdiction,
 
shall,
 
as
 
to
 
such
 
jurisdiction,
 
be
 
ineffective
 
to
 
the
 
extent
 
of
 
such
 
illegality,
 
invalidity
 
or
unenforceability without affecting the legality, validity or enforceability of the remaining provisions hereof and
the
 
illegality,
 
invalidity
 
or
 
unenforceability
 
of
 
a
 
particular
 
provision
 
in
 
a
 
particular
 
jurisdiction
 
shall
 
not
invalidate or render unenforceable such provision in any other jurisdiction.
(e)
The terms
 
of the
 
Credit Agreement
 
with respect
 
to governing
 
law,
 
submission to
 
jurisdiction,
waiver of venue and waiver of
 
jury trial are incorporated herein by
 
reference,
mutatis mutandis
, and the parties
hereto agree to such terms.
[remainder of page intentionally left blank]
 
 
4
Each of the parties hereto has caused a counterpart of this Agreement
 
to be duly executed and delivered as of the
date first above written.
BORROWER:
QUAKER CHEMICAL CORPORATION,
a Pennsylvania corporation
By: /s/ LINGLING STEWART
 
Name: LingLing Stewart
Title: Global Treasurer
 
 
5
ADMINISTRATIVE
AGENT:
BANK
OF
AMERICA,
N.A.,
as Administrative Agent
By: /s/ ELIZABETH URIBE
 
Name: Elizabeth
 
Uribe
 
Title: Assistant Vice President
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6
Appendix A
TERMS APPLICABLE TO AFFECTED ALTERNATIVE
 
CURRENCY LOANS
1.
Defined Terms.
 
The following terms shall have the meanings set forth below:
“Administrative
 
Agent’s
 
Office”
 
means,
 
with
 
respect
 
to
 
any
 
currency,
 
the
 
Administrative
 
Agent’s
address and,
 
as appropriate,
 
account specified
 
in the
 
Credit Agreement
 
with respect
 
to such
 
currency,
 
or such
other
 
address
 
or
 
account
 
with
 
respect
 
to
 
such
 
currency
 
as
 
the
 
Administrative
 
Agent
 
may
 
from
 
time
 
to
 
time
notify the Company and the Lenders.
“Affected Alternative Currency”
 
means each of the following currencies: Sterling, Yen, and Euros.
“Affected Alternative Currency Daily Rate” means, for any day,
 
with respect to any extension of credit
under the Credit Agreement
 
denominated in Sterling, the
 
rate per annum equal
 
to SONIA determined pursuant
to the definition thereof plus the SONIA Adjustment;
provided,
 
that,
 
if
 
any
 
Affected
 
Alternative
 
Currency
 
Daily
 
Rate
 
shall
 
be
 
less
 
than
 
zero,
 
such
 
rate
 
shall
 
be
deemed zero for purposes of this Agreement. Any change
 
in an Affected Alternative Currency Daily Rate shall
be effective from and including the date of such change without further notice.
“Affected Alternative
 
Currency Daily
 
Rate Loan”
 
means a
 
Loan that
 
bears interest
 
at a
 
rate based
 
on
the
 
definition
 
of
 
“Affected
 
Alternative
 
Currency
 
Daily
 
Rate.”
 
All
 
Affected
 
Alternative
 
Currency
 
Daily
 
Rate
Loans must be denominated in an Affected Alternative Currency.
“Affected Alternative Currency Loan” means an Affected Alternative Currency Daily
 
Rate Loan or an
Affected Alternative Currency Term Rate Loan, as applicable.
“Affected
 
Alternative
 
Currency
 
Term
 
Rate”
 
means,
 
for
 
any
 
Interest
 
Period,
 
with
 
respect
 
to
 
any
extension of credit under the Credit Agreement:
(a)
denominated
 
in
 
Euros,
 
the
 
rate
 
per
 
annum
 
equal
 
to
 
the
 
Euro
 
Interbank
 
Offered
 
Rate
(“EURIBOR”),
 
as
 
published
 
on
 
the
 
applicable
 
Reuters
 
screen
 
page
 
(or
 
such
 
other
 
commercially
available
 
source
 
providing
 
such
 
quotations
 
as
 
may
 
be
 
designated
 
by
 
the
 
Administrative
 
Agent
 
from
time to time) on the
 
day that is two TARGET
 
Days preceding the first day of
 
such Interest Period with
a term equivalent to such Interest Period; and
(b)
denominated
 
in
 
Yen,
 
the
 
rate
 
per
 
annum
 
equal
 
to
 
the
 
Tokyo
 
Interbank
 
Offer
 
Rate
(“TIBOR”), as
 
published on the
 
applicable Reuters screen
 
page (or such
 
other commercially available
source providing such quotations as may be designated by the Administrative Agent from time to time)
on the day
 
that is two
 
Business Days preceding the
 
first day of
 
such Interest Period (or
 
such other day
as is generally treated as the rate fixing day by market practice in such interbank market, as
 
determined
by the
 
Administrative Agent;
 
provided that,
 
to the
 
extent such
 
market practice
 
is not
 
administratively
feasible for
 
the Administrative
 
Agent, then
 
such date
 
shall be
 
such other
 
day as
 
otherwise reasonably
determined by the Administrative Agent) with a term equivalent to such Interest
 
Period;
 
 
 
 
 
 
 
 
 
 
 
7
provided, that, if any Affected Alternative Currency Term Rate shall be less than zero, such rate shall be deemed
zero for purposes of this Agreement.
“Affected Alternative
 
Currency Term
 
Rate Loan”
 
means a
 
Loan that
 
bears interest
 
at a
 
rate based
 
on
the
 
definition
 
of
 
“Affected
 
Alternative
 
Currency
 
Term
 
Rate.”
 
All
 
Affected
 
Alternative
 
Currency
 
Term
 
Rate
Loans must be denominated in an Affected Alternative Currency.
“Applicable
 
Rate”
 
means
 
the
 
Applicable
 
Rate,
 
Applicable
 
Margin
 
or
 
any
 
similar
 
or
 
analogous
definition in the Credit Agreement.
“Base Rate”
 
means the
 
Base Rate,
 
Alternative Base Rate,
 
ABR or any
 
similar or analogous
 
definition
in the Credit Agreement.
“Base Rate Loans”
 
means a Loan that bears interest at a rate based on the Base Rate.
“Basic ESTR” means, in relation to any
 
day, ESTR for
 
that day,
 
and if that rate is less
 
than zero, Basic
ESTR shall be deemed to be zero.
“Borrowing” means a
 
Committed Borrowing, Borrowing, or
 
any similar or
 
analogous definition in the
Credit Agreement.
“Business Day” means any day other than a Saturday, Sunday or other day on which commercial banks
are authorized
 
to close
 
under the
 
laws of,
 
or are
 
in fact
 
closed in,
 
the state
 
where the
 
Administrative Agent’s
Office is located; provided that
(a)
if such
 
day relates
 
to any
 
interest rate
 
settings as
 
to an
 
Affected Alternative
 
Currency
Loan denominated
 
in Euro,
 
any fundings,
 
disbursements, settlements and
 
payments in
 
Euro in
 
respect
of
 
any
 
such
 
Affected
 
Alternative
 
Currency
 
Loan,
 
or
 
any
 
other
 
dealings
 
in
 
Euro
 
to
 
be
 
carried
 
out
pursuant
 
to
 
this
 
Agreement
 
in
 
respect
 
of
 
any
 
such
 
Affected
 
Alternative
 
Currency
 
Loan,
 
means
 
a
Business Day that is also a TARGET
 
Day;
(b)
if such
 
day relates
 
to any
 
interest rate
 
settings as
 
to an
 
Affected Alternative
 
Currency
Loan denominated in (i) Sterling, means a day other than a day banks are closed for general business in
London
 
because
 
such
 
day
 
is
 
a
 
Saturday,
 
Sunday
 
or
 
a
 
legal
 
holiday
 
under
 
the
 
laws
 
of
 
the
 
United
Kingdom; and
 
(ii) Yen,
 
means a
 
day other
 
than when
 
banks are
 
closed for
 
general business
 
in Japan;
and
(c)
if
 
such
 
day
 
relates
 
to
 
any
 
fundings,
 
disbursements,
 
settlements
 
and
 
payments
 
in
 
a
currency
 
other
 
than
 
Euro
 
in
 
respect
 
of
 
an
 
Affected
 
Alternative
 
Currency
 
Loan
 
denominated
 
in
 
a
currency
 
other
 
than
 
Euro,
 
or
 
any
 
other
 
dealings
 
in
 
any
 
currency
 
other
 
than
 
Euro
 
to
 
be
 
carried
 
out
pursuant to this
 
Agreement in respect of
 
any such Affected
 
Alternative Currency Loan (other
 
than any
interest rate
 
settings), means
 
any such
 
day on
 
which banks
 
are open
 
for foreign
 
exchange business
 
in
the principal financial center of the country of such currency.
“Committed
 
Loan
 
Notice”
 
means
 
a
 
Committed
 
Loan
 
Notice,
 
Loan
 
Notice,
 
Borrowing
 
Notice,
Continuation/Conversion Notice, or any similar or analogous definition in the Credit Agreement, and such term
shall be deemed to include the Committed Loan Notice attached hereto
 
as Exhibit A.
 
 
 
 
 
 
 
 
 
 
8
“Conforming Changes”
 
means, with respect to the use, administration of or any conventions associated
with SONIA, EURIBOR, TIBOR or any proposed Successor Rate for any currency, any conforming changes to
the
 
definitions of
 
“SONIA”, “EURIBOR”,
 
“TIBOR”, “Interest
 
Period”, timing
 
and frequency
 
of
 
determining
rates and making payments of
 
interest and other technical, administrative
 
or operational matters (including, for
the
 
avoidance
 
of
 
doubt,
 
the
 
definition
 
of
 
“Business
 
Day”,
 
timing
 
of
 
borrowing
 
requests
 
or
 
prepayment,
conversion or
 
continuation notices and
 
length of
 
lookback periods) as
 
may be
 
appropriate, in the
 
discretion of
the Administrative Agent and in
 
consultation with the Company,
 
to reflect the adoption
 
and implementation of
such
 
applicable
 
rate(s)
 
and
 
to
 
permit
 
the
 
administration
 
thereof
 
by
 
the
 
Administrative
 
Agent
 
in
 
a
 
manner
substantially consistent with market practice for
 
such currency (or,
 
if the Administrative Agent determines that
adoption of
 
any portion
 
of such
 
market practice
 
is not
 
administratively feasible
 
or that
 
no market
 
practice for
the
 
administration
 
of
 
such
 
rate
 
for
 
such
 
currency
 
exists,
 
in
 
such
 
other
 
manner
 
of
 
administration
 
as
 
the
Administrative Agent determines in consultation with the Company is
 
reasonably necessary in connection with
the administration of this Agreement and any other Loan Document).
“Dollar” and “$” mean lawful money of the United States.
“Dollar Equivalent”
 
means the Dollar Equivalent or any similar or analogous definition
 
in the Credit
Agreement.
“Eurocurrency Rate” means Eurocurrency Rate, LIBOR, Adjusted LIBOR
 
Rate, LIBOR Rate or any
similar or analogous definition in the Credit Agreement.
“Eurocurrency Rate Loans”
 
means a Loan that bears interest at a rate based on the Eurocurrency Rate.
“Euro Swing Line Rate” means Basic ESTR
“ESTR” means, in relation to any day:
(a)
the
 
Euro
 
short-term
 
rate
 
administered
 
by
 
the
 
European
 
Central
 
Bank
 
(or
 
any
 
other
person which takes
 
over the administration of
 
that rate) displayed (before
 
any correction, recalculation
or republication
 
by the
 
administrator) on
 
page “EUROSTR=”
 
of the
 
Thomson Reuters
 
screen (or
 
any
replacement Thomson Reuters page which displays that rate);
 
or
(b)
if the
 
rate otherwise
 
to be
 
determined by
 
clause (a)
 
is not
 
available for
 
ESTR for
 
any
day
 
the
 
applicable
 
ESTR
 
shall
 
the
 
equal
 
the
 
rate
 
notified
 
to
 
the
 
Administrative Agent
 
by
 
the
 
Swing
Line Lender as
 
soon as practicable,
 
and in any
 
event before interest is
 
due to be
 
paid in respect
 
of that
Swing Line
 
Loan, to
 
be that
 
which expresses
 
as
 
a percentage
 
rate per
 
annum the
 
cost to
 
the relevant
Swing
 
Line
 
Lender
 
of
 
funding
 
its
 
participation in
 
that
 
Swing
 
Line
 
Loan
 
for
 
that
 
day
 
from
 
whatever
source it may reasonably select;
provided that if
 
any day during
 
an Interest Period
 
for a Euro
 
Swing Line Rate
 
Loan is not
 
a TARGET
Day, ESTR on that day will be ESTR applicable on the immediately preceding TARGET Day.
“Interest Payment Date”
 
means, (a) as to any Affected Alternative Currency Daily Rate Loan, the last
Business Day of each calendar month and the applicable maturity date
 
set forth in
 
 
 
 
 
 
 
 
 
 
9
the
 
Credit Agreement
 
and (b)
 
as
 
to
 
any Affected
 
Alternative Currency
 
Term
 
Rate Loan,
 
the
 
last day
 
of
 
each
Interest
 
Period
 
applicable
 
to
 
such
 
Loan;
 
provided,
 
however,
 
that
 
if
 
any
 
Interest
 
Period
 
for
 
an
 
Affected
Alternative Currency
 
Term
 
Rate Loan
 
exceeds three
 
months, the
 
respective dates
 
that fall
 
every three
 
months
after the beginning of such Interest Period shall be Interest Payment Dates.
“Interest
 
Period”
 
means
 
as
 
to
 
each
 
Affected
 
Alternative
 
Currency
 
Term
 
Rate
 
Loan,
 
the
 
period
commencing on
 
the date
 
such Affected
 
Alternative Currency
 
Term
 
Rate Loan
 
is disbursed
 
or converted
 
to or
continued as an Affected Alternative Currency Term Rate Loan and ending on the date one, three or six months
thereafter
 
(in
 
each
 
case,
 
subject
 
to
 
availability
 
for
 
the
 
interest
 
rate
 
applicable
 
to
 
the
 
relevant
 
currency),
 
as
selected
 
by
 
the
 
Company
 
in
 
its
 
Committed
 
Loan
 
Notice,
 
or
 
such
 
other
 
period
 
that
 
is
 
twelve
 
months
 
or
 
less
requested by the Company and consented to by all the Lenders; provided
 
that:
(a)
any Interest Period
 
that would otherwise
 
end on a
 
day that is
 
not a Business
 
Day shall
be
 
extended
 
to
 
the
 
next
 
succeeding
 
Business
 
Day
 
unless,
 
in
 
the
 
case
 
of
 
an
 
Affected
 
Alternative
Currency
 
Term
 
Rate
 
Loan,
 
such
 
Business
 
Day
 
falls
 
in
 
another
 
calendar
 
month,
 
in
 
which
 
case
 
such
Interest Period shall end on the next preceding Business Day;
(b)
any
 
Interest
 
Period
 
pertaining
 
to
 
an
 
Affected
 
Alternative
 
Currency
 
Term
 
Rate
 
Loan
that begins on the last Business Day of a calendar month (or on a day for which there is no numerically
corresponding
 
day
 
in
 
the
 
calendar
 
month
 
at
 
the
 
end
 
of
 
such
 
Interest
 
Period)
 
shall
 
end
 
on
 
the
 
last
Business Day of the calendar month at the end of such Interest Period; and
(c)
no
 
Interest
 
Period
 
shall
 
extend
 
beyond
 
the
 
applicable
 
maturity
 
date
 
set
 
forth
 
in
 
the
Credit Agreement.
“Required Lenders”
 
means the
 
Required Lenders,
 
Requisite Lenders,
 
Majority Lenders
 
or any
 
similar
or analogous definition in the Credit Agreement.
“Revaluation
 
Date”
 
means,
 
with
 
respect
 
to
 
any
 
Loan,
 
each
 
of
 
the
 
following:
 
(a)
 
each
 
date
 
of
 
a
Borrowing
 
of
 
an
 
Affected
 
Alternative
 
Currency
 
Loan,
 
(b)
 
with
 
respect
 
to
 
an
 
Affected
 
Alternative
 
Currency
Daily
 
Rate
 
Loan,
 
each
 
Interest
 
Payment
 
Date,
 
(c)
 
each
 
date
 
of
 
a
 
continuation
 
of
 
an
 
Affected
 
Alternative
Currency Term
 
Rate Loan pursuant
 
to the
 
terms of
 
the Credit
 
Agreement, and (d)
 
such additional
 
dates as
 
the
Administrative Agent shall determine or the Required Lenders shall require.
“SONIA”
 
means,
 
with
 
respect
 
to
 
any
 
applicable
 
determination
 
date,
 
the
 
Sterling
 
Overnight
 
Index
Average
 
Reference
 
Rate
 
published
 
on
 
the
 
fifth
 
Business
 
Day
 
preceding
 
such
 
date
 
on
 
the
 
applicable
 
Reuters
screen page
 
(or such
 
other commercially
 
available source
 
providing such
 
quotations as
 
may be
 
designated by
the
 
Administrative
 
Agent
 
from
 
time
 
to
 
time);
 
provided
 
however
 
that
 
if
 
such
 
determination
 
date
 
is
 
not
 
a
Business Day, SONIA means such rate that applied on the first Business Day immediately prior thereto.
“SONIA Adjustment” means, with respect to SONIA, 0.0326% per annum.
“Successor Rate” means the Successor Rate, LIBOR Successor Rate
 
or any similar or analogous
definition in the Credit Agreement.
 
 
 
 
 
 
 
 
 
 
10
“TARGET2”
 
means
 
the
 
Trans-European
 
Automated
 
Real-time
 
Gross
 
Settlement
 
Express
 
Transfer
payment system which utilizes a single shared platform and which was
 
launched on November 19, 2007.
“TARGET
 
Day”
 
means
 
any
 
day
 
on
 
which
 
TARGET2
 
(or,
 
if
 
such
 
payment
 
system
 
ceases
 
to
 
be
operative,
 
such
 
other
 
payment
 
system,
 
if
 
any,
 
determined
 
by
 
the
 
Administrative
 
Agent
 
to
 
be
 
a
 
suitable
replacement) is open for the settlement of payments in Euro.
“Type”
 
means, with respect to a Loan, its character as a Base Rate Loan, a Eurocurrency Rate Loan, an
Affected Alternative Currency Daily Rate Loan or an Affected Alternative Currency Term Rate Loan.
2.
Terms
 
Applicable
 
to
 
Affected
 
Alternative Currency
 
Loans.
 
From and after the
 
Amendment
Effective Date, the parties hereto agree as follows:
(a)
Alternative
 
Currencies.
 
(i)
 
No
 
Affected
 
Alternative
 
Currency
 
shall
 
be
 
considered
 
a
 
currency
for
 
which there
 
is
 
a
 
published LIBOR
 
rate,
 
and
 
(ii)
 
any request
 
for
 
a
 
new
 
Loan denominated
 
in
 
an
 
Affected
Alternative Currency,
 
or to
 
continue an
 
existing Loan denominated
 
in an
 
Affected Alternative
 
Currency,
 
shall
be deemed
 
to be
 
a request
 
for a
 
new Loan
 
bearing interest
 
at the
 
Affected Alternative
 
Currency Daily Rate
 
or
Affected Alternative Currency Term
 
Rate, as applicable; provided,
 
that, to the extent any
 
Loan bearing interest
at
 
the
 
Eurocurrency Rate
 
is
 
outstanding on
 
the
 
Amendment Effective
 
Date, such
 
Loan shall
 
continue to
 
bear
interest at
 
the
 
Eurocurrency Rate
 
until the
 
end
 
of the
 
current
 
Interest Period
 
or payment
 
period applicable
 
to
such Loan unless,
 
in the case
 
of a Loan
 
that bears interest
 
at a daily
 
floating rate, such
 
daily floating rate is
 
no
longer
 
representative
 
or
 
being
 
made
 
available,
 
in
 
which
 
case
 
such
 
Loan
 
shall
 
bear
 
interest
 
at
 
the
 
applicable
Affected Alternative Currency Rate immediately upon the effectiveness of this Agreement.
(b)
References to
 
Eurocurrency Rate
 
and
 
Eurocurrency Rate
 
Loans in
 
the
 
Credit Agreement
 
and
Loan Documents.
(i)
References to the Eurocurrency Rate and Eurocurrency Rate Loans in provisions of the
Credit Agreement and
 
the other Loan
 
Documents that are not
 
specifically addressed herein (other
 
than
the definitions of Eurocurrency Rate and Eurocurrency Rate Loan) shall be deemed to include Affected
Alternative
 
Currency
 
Daily
 
Rates,
 
Affected
 
Alternative
 
Currency
 
Term
 
Rates,
 
and
 
Affected
Alternative Currency Loans, as applicable.
(ii)
For purposes of any requirement for
 
the Company to compensate Lenders for losses
 
in
the
 
Credit
 
Agreement
 
resulting
 
from
 
any
 
continuation,
 
conversion,
 
payment
 
or
 
prepayment
 
of
 
any
Affected Alternative Currency
 
Loan on a
 
day other than
 
the last day
 
of any Interest
 
Period (as defined
in the
 
Credit Agreement),
 
references to
 
the Interest
 
Period (as
 
defined in
 
the Credit
 
Agreement) shall
be deemed to include any relevant interest payment date
 
or payment period for an Affected Alternative
Currency Loan.
(c)
Interest Rates. The
 
Administrative Agent does not
 
warrant, nor accept
 
responsibility,
 
nor shall
the Administrative
 
Agent have
 
any liability
 
with respect
 
to the
 
administration, submission or
 
any other
 
matter
related
 
to
 
the
 
rates
 
in
 
the
 
definition
 
of
 
“Affected
 
Alternative
 
Currency
 
Daily
 
Rate”,
 
“Affected
 
Alternative
Currency
 
Term
 
Rate”, “ESTR”,
 
“Basic ESTR”
 
or
 
with
 
respect
 
to
 
any
 
rate
 
(including,
 
for
 
the
 
avoidance
 
of
doubt, the
 
selection of
 
such
 
 
 
 
 
 
 
 
11
rate and any related spread or other adjustment) that is an alternative or
 
replacement for or successor to any such
rate or the effect of any of the foregoing, or of any Conforming Changes.
(d)
Revaluation
 
Dates.
 
The Administrative
 
Agent shall
 
determine the
 
Dollar Equivalent
 
amounts
of
 
Borrowings
 
and
 
Loans
 
denominated
 
in
 
Alternative
 
Currencies.
 
Such
 
Dollar
 
Equivalent
 
shall
 
become
effective
 
as
 
of
 
such
 
Revaluation
 
Date
 
and
 
shall
 
be
 
the
 
Dollar
 
Equivalent
 
of
 
such
 
amounts
 
until
 
the
 
next
Revaluation Date to occur.
(e)
Borrowings
 
and
 
Continuations
 
of
 
Affected
 
Alternative
 
Currency
 
Loans.
 
In
 
addition
 
to
 
any
other borrowing requirements set forth in the Credit Agreement:
(i)
Affected
 
Alternative
 
Currency
 
Loans.
 
Each
 
Borrowing
 
of
 
Affected
 
Alternative
Currency Loans,
 
and each
 
continuation of
 
an Affected
 
Alternative Currency
 
Term
 
Rate Loan
 
shall be
made upon the Company’s
 
irrevocable notice to the Administrative Agent,
 
which may be given by
 
(A)
telephone
 
or
 
(B)
 
a
 
Committed
 
Loan
 
Notice;
 
provided
 
that
 
any
 
telephonic
 
notice
 
must
 
be
 
confirmed
immediately
 
by
 
delivery
 
to
 
the
 
Administrative
 
Agent
 
of
 
a
 
Committed
 
Loan
 
Notice.
 
Each
 
such
Committed
 
Loan
 
Notice
 
must
 
be
 
received
 
by
 
the
 
Administrative
 
Agent
 
not
 
later
 
than
 
11:00
 
a.m.
(Eastern time)
 
three Business
 
Days (or
 
five Business
 
Days in
 
the case
 
of
 
a Special
 
Notice Currency)
prior
 
to
 
the
 
requested
 
date
 
of
 
any
 
Borrowing
 
or,
 
in
 
the
 
case
 
of
 
Affected
 
Alternative
 
Currency
 
Term
Rate
 
Loans,
 
any
 
continuation;
 
provided,
 
however,
 
that
 
if
 
the
 
Company
 
wishes
 
to
 
request
 
Affected
Alternative Currency Term
 
Rate Loans having an Interest Period
 
other than one, three or six months
 
in
duration as provided in the definition of “Interest Period,” the applicable notice must be received
 
by the
Administrative
 
Agent
 
not
 
later
 
than
 
11:00
 
a.m.
 
(Eastern
 
time)
 
five
 
Business
 
Days
 
(or
 
six
 
Business
Days
 
in
 
the
 
case
 
of
 
a
 
Special
 
Notice
 
Currency)
 
prior
 
to
 
the
 
requested
 
date
 
of
 
such
 
Borrowing
 
or
continuation of Affected
 
Alternative Currency Term
 
Rate Loans, whereupon the
 
Administrative Agent
shall give
 
prompt notice
 
to the
 
Lenders of
 
such request
 
and determine
 
whether the
 
requested Interest
Period
 
is
 
acceptable to
 
all of
 
them.
 
Not
 
later
 
than
 
11:00
 
a.m.
 
(Eastern time),
 
four
 
Business
 
Days
 
(or
five
 
Business
 
Days
 
in
 
the
 
case
 
of
 
a
 
Special
 
Notice
 
Currency)
 
prior
 
to
 
the
 
requested
 
date
 
of
 
such
Borrowing
 
or
 
continuation
 
of
 
Affected
 
Alternative
 
Currency
 
Term
 
Rate
 
Loans,
 
the
 
Administrative
Agent
 
shall
 
notify
 
the
 
Company
 
(which
 
notice
 
may
 
be
 
by
 
telephone)
 
whether
 
or
 
not
 
the
 
requested
Interest
 
Period
 
has
 
been
 
consented
 
to
 
by
 
all
 
the
 
Lenders.
 
Each
 
Borrowing
 
of
 
or
 
continuation
 
of
Affected
 
Alternative
 
Currency
 
Loans
 
shall
 
be
 
in
 
a
 
principal
 
amount
 
of
 
the
 
Dollar
 
Equivalent
 
of
 
$5,000,000
 
or
 
a
 
whole
 
multiple
 
of
 
the
 
Dollar
 
Equivalent
 
of
$1,000,000 in
 
excess thereof.
 
Each Committed
 
Loan Notice
 
shall specify
 
(i) whether
 
the Company
 
is
requesting a
 
Borrowing or
 
a continuation
 
of Affected
 
Alternative Currency
 
Term
 
Rate Loans,
 
(ii) the
requested date
 
of the
 
Borrowing or
 
continuation, as the
 
case may
 
be (which
 
shall be
 
a Business
 
Day),
(iii) the currency and principal amount of Loans to be borrowed or continued, (iv) the Type of Loans to
be borrowed, (v)
 
if applicable, the
 
duration of the
 
Interest Period with
 
respect thereto. If
 
the Company
fails to specify
 
a currency in
 
a Loan Notice
 
requesting a Borrowing,
 
then the Loans
 
so requested shall
be made in
 
Dollars. If the
 
Company fails to
 
specify a Type
 
of Loan in
 
a Committed Loan
 
Notice or if
such Company
 
fails to
 
give a
 
timely notice
 
requesting a
 
continuation, then
 
the applicable
 
Loans shall
be made as Base Rate Loans denominated in Dollars; provided,
 
however, that in the case of a
 
failure to
timely request a
 
continuation of
 
Affected Alternative Currency
 
Term
 
Rate Loans, such
 
Loans shall be
continued as Affected Alternative Currency Term Rate Loans in their original currency with an Interest
Period
 
of
 
one
 
(1)
 
month.
 
If
 
the
 
Company
 
requests
 
a
 
Borrowing
 
of
 
or
 
continuation
 
of
 
Affected
Alternative Currency
 
Term
 
Rate Loans
 
in any
 
such Committed
 
 
 
 
 
 
 
 
 
12
Loan
 
Notice,
 
but
 
fails
 
to
 
specify
 
an
 
Interest
 
Period,
 
it
 
will
 
be
 
deemed
 
to
 
have
 
specified
 
an
 
Interest
Period of
 
one month.
 
Except as
 
otherwise specified
 
in the
 
Credit Agreement,
 
no Affected
 
Alternative
Currency Loan may be
 
converted into or continued
 
as a Loan
 
denominated in a different
 
currency, but
instead
 
must
 
be
 
repaid
 
in
 
the
 
original
 
currency
 
of
 
such
 
Affected
 
Alternative
 
Currency
 
Loan
 
and
reborrowed in the other currency.
(ii)
Conforming
 
Changes.
 
With
 
respect
 
to
 
any
 
Affected
 
Alternative
 
Currency
 
Rate
 
the
Administrative
 
Agent
 
will
 
have
 
the
 
right
 
to
 
make
 
Conforming
 
Changes
 
from
 
time
 
to
 
time
 
and,
notwithstanding
 
anything
 
to
 
the
 
contrary
 
herein,
 
in
 
the
 
Credit
 
Agreement
 
or
 
in
 
any
 
other
 
Loan
Document,
 
any
 
amendments
 
implementing
 
such
 
Conforming
 
Changes
 
will
 
become
 
effective
 
without
any further
 
action or
 
consent of any
 
other party to
 
this Agreement,
 
the Credit
 
Agreement or any
 
other
Loan
 
Document;
 
provided,
 
that,
 
with
 
respect
 
to
 
any
 
such
 
amendment
 
effected,
 
the
 
Administrative
Agent shall
 
post each
 
such amendment
 
implementing such
 
Conforming Changes
 
to the
 
Company and
the Lenders reasonably promptly after such amendment becomes
 
effective.
(iii)
Committed
 
Loan
 
Notice.
 
For
 
purposes
 
of
 
a
 
Borrowing
 
of
 
Affected
 
Alternative
Currency
 
Loans,
 
or
 
a
 
continuation
 
of
 
any
 
Affected
 
Alternative
 
Currency
 
Term
 
Rate
 
Loan,
 
the
Company shall use the Committed Loan Notice attached hereto as Exhibit
 
A.
(f)
Interest.
(i)
Subject to
 
the provisions
 
of the
 
Credit Agreement
 
with respect
 
to default
 
interest, (x)
each
 
Affected
 
Alternative Currency
 
Daily
 
Rate
 
Loan
 
shall
 
bear
 
interest
 
on
 
the
 
outstanding
 
principal
amount
 
thereof
 
from
 
the
 
applicable
 
borrowing
 
date
 
at
 
a
 
rate
 
per
 
annum
 
equal
 
to
 
the
 
Affected
Alternative Currency
 
Daily Rate
 
plus the
 
Applicable Rate;
(y) each Affected Alternative Currency Term
 
Rate Loan shall bear interest on the outstanding principal
amount thereof for each
 
Interest Period at a
 
rate per annum equal to
 
the Affected Alternative Currency
Term
 
Rate
 
for
 
such
 
Interest
 
Period
 
plus
 
the
 
Applicable
 
Rate;
 
and
 
(z)
 
each
 
Swing
 
Line
 
Loan
denominated
 
in
 
Euros
 
shall
 
bear
 
interest
 
on
 
the
 
outstanding
 
principal
 
amount
 
thereof
 
from
 
the
applicable borrowing
 
date at
 
a rate
 
per annum
 
equal to
 
the Euro
 
Swing Line
 
Rate plus
 
the Applicable
Rate.
(ii)
Interest
 
on
 
each
 
Affected
 
Alternative
 
Currency
 
Loan
 
and
 
each
 
Swing
 
Line
 
Loan
denominated
 
in
 
Euros
 
shall
 
be
 
due
 
and
 
payable
 
in
 
arrears
 
on
 
each
 
Interest
 
Payment
 
Date
 
applicable
thereto and
 
at such
 
other times
 
as may
 
be specified
 
the Credit
 
Agreement. Interest
 
hereunder shall
 
be
due and
 
payable in
 
accordance with
 
the terms
 
hereof before
 
and after
 
judgment, and
 
before and
 
after
the commencement of any proceeding under any debtor relief law.
(g)
Computations. All
 
computations of
 
interest for
 
Affected Alternative
 
Currency Loans
 
shall be
made on the
 
basis of a
 
year of 365
 
or 366 days,
 
as the case
 
may be, and
 
actual days elapsed,
 
or, in
 
the case of
interest
 
in
 
respect
 
of
 
Affected
 
Alternative
 
Currency
 
Loans
 
as
 
to
 
which
 
market
 
practice
 
differs
 
from
 
the
foregoing,
 
in
 
accordance
 
with
 
such
 
market
 
practice.
 
Interest
 
shall
 
accrue
 
on
 
each
 
Affected
 
Alternative
Currency Loans for the day on which the Affected Alternative Currency Loans is made, and shall not accrue on
an Affected Alternative
 
Currency Loans, or any
 
portion thereof, for
 
the day on
 
which the Affected
 
Alternative
Currency Loans or such portion is paid, provided that any Affected Alternative Currency Loan that is repaid on
the same day on which it is made shall, subject to the terms
 
of the Credit Agreement, bear interest for
 
13
one day. Each determination by the Administrative Agent of an interest rate or fee hereunder
 
shall be
conclusive and binding for all purposes, absent manifest error.
(h)
Successor
 
Rates.
 
The
 
provisions
 
in
 
the
 
Credit
 
Agreement
 
addressing
 
the
 
replacement
 
of
 
a
 
current
Successor
 
Rate
 
for
 
a
 
currency
 
shall
 
be
 
deemed
 
to
 
apply
 
to
 
Affected
 
Alternative
 
Currency
 
Loans
 
and
 
SONIA,
TIBOR and EURIBOR,
 
as applicable,
 
and the
 
related defined terms
 
shall be
 
deemed to include
 
Sterling, Japanese
Yen
 
and Euros and SONIA, TIBOR and EURIBOR, as applicable.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
14
Exhibit A
FORM OF COMMITTED LOAN NOTICE
(Affected Alternative Currency Loans)
Date:
 
,
 
1
To:
 
Bank of America, N.A., as Administrative Agent
 
Ladies and
Gentlemen:
Reference
 
is
 
made
 
to
 
that
 
certain
 
Credit
 
Agreement,
 
dated
 
as
 
of
 
August
 
1,
 
2019
 
(as
 
amended,
 
restated,
 
extended,
supplemented or
 
otherwise modified
 
in
 
writing from
 
time to
 
time, the
 
“Credit
 
Agreement;” the
 
terms defined
 
therein
being
 
used
 
herein
 
as
 
therein
 
defined),
 
among
 
Quaker
 
Chemical
 
Corporation,
 
a
 
Pennsylvania
 
corporation
 
(the
“Company”), certain Subsidiaries of the Company party thereto as Designated Borrowers, each guarantor party thereto,
each lender party thereto, and Bank of America, N.A., as Administrative
 
Agent.
The undersigned hereby requests (select one)
2
:
[Revolving Credit Facility]
Indicate:
Borrowing,
Conversion or
Continuation
Indicate:
Borrower
Name
Indicate:
Requested
Amount
Indicate:
Currency
Indicate:
Affected
Alternative
Currency Daily
Rate Loan or
Affected
Alternative
Currency Term
Rate Loan
For Affected
Alternative
Currency Term
Rate Loans
Indicate:
Interest Period
(e.g., 1, 3 or 6
month interest
period)
[Euro Term
 
Facility]
1
 
Note to Borrower.
 
All requests submitted under a single Committed Loan Notice must be effective
 
on the same date. If multiple
effective dates are needed, multiple Committed Loan Notices will need
 
to be prepared and signed.
2
 
Note to Borrower. For
multiple borrowings, conversions and/or continuations for a particular
 
facility, fill out a new row for each
 
borrowing/conversion
and/or continuation.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
15
Indicate:
Borrowing,
Conversion or
Continuation
Indicate:
Borrower
Name
Indicate:
Requested
Amount
Indicate:
Currency
Indicate:
Affected
Alternative
Currency Daily
Rate Loan or
Affected
Alternative
Currency Term
Rate Loan
For Affected
Alternative
Currency Term
Rate Loans
Indicate:
Interest Period
(e.g., 1, 3 or 6
month interest
period)
The Borrowing, if any, requested herein complies with the requirements set forth in the Credit Agreement.
QUAKER CHEMICAL CORPORATION
By:
 
Name:
[Type Signatory Name]
Title: [Type
 
Signatory Title]